data_1jem_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jem _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -178.97 153.52 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -151.88 139.39 19.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.615 -0.678 . . . . 0.0 109.848 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 m -89.92 121.15 31.77 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 71.6 m-85 -103.71 152.29 21.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.65 . . . . 0.0 109.694 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -100.71 131.25 46.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 t -90.04 114.49 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.74 . . . . 0.0 109.632 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -135.42 21.18 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.595 -0.691 . . . . 0.0 109.857 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.22 32.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.545 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -69.8 -50.53 42.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -73.45 -30.31 63.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -152.62 18.86 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.7 mm . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.98 . . . . 0.0 109.143 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.18 -54.18 44.26 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 120.919 -1.113 . . . . 0.0 111.347 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.0 Cg_endo -72.56 -25.61 17.52 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 121.36 1.373 . . . . 0.0 110.313 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.45 -21.39 61.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.558 -0.714 . . . . 0.0 109.332 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.02 -31.23 23.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -71.29 -37.64 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.0 mt -75.01 -50.4 16.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.009 -0.432 . . . . 0.0 110.299 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.91 -29.12 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.241 -0.912 . . . . 0.0 109.95 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -73.6 -39.85 64.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.704 . . . . 0.0 109.472 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -68.49 -66.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.71 -23.25 16.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.52 -0.737 . . . . 0.0 110.47 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -45.0 92.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.809 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -62.7 -28.62 70.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.661 . . . . 0.0 109.479 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.95 129.17 36.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 -16.93 59.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.703 -0.623 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 150.96 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.21 -0.931 . . . . 0.0 109.91 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.01 83.38 6.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.696 -0.628 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 m -89.67 123.53 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.41 146.22 48.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 110.036 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tt -96.31 157.09 16.06 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.09 134.21 53.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CE1' HG21 ' A' ' 55' ' ' ILE . 67.2 t80 -160.17 129.33 5.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.0 109.785 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.34 30.89 20.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.631 -0.668 . . . . 0.0 109.975 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.26 30.46 71.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.38 116.46 17.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.954 . . . . 0.0 109.296 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -96.13 107.86 20.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.612 -0.68 . . . . 0.0 109.96 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.7 148.06 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -65.23 132.75 49.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -52.05 -26.78 11.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.92 53.83 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.47 84.78 1.82 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.8 mt -67.88 -40.11 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 tpt -76.52 -26.12 54.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.568 -0.708 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.03 -31.98 57.12 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -73.52 -27.8 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.97 . . . . 0.0 109.638 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.01 -33.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.376 -0.828 . . . . 0.0 109.491 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.0 p -63.26 -31.89 73.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.66 -45.51 61.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.86 62.31 5.61 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 37' ' ' TYR . 54.4 mt -75.74 153.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.985 . . . . 0.0 109.34 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.43 -166.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.0 109.702 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 142.07 34.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.649 -0.657 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 43.61 6.25 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.5 178.98 6.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.961 . . . . 0.0 109.474 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -132.77 153.5 51.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.488 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.1 pt -141.21 144.33 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.606 -0.684 . . . . 0.0 109.286 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.02 116.71 27.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 6' ' ' PHE . 85.8 mt -102.84 151.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 p -150.4 113.34 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.529 -0.732 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.81 130.48 36.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.4 99.88 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.81 -138.36 3.77 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.96 -74.14 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.975 . . . . 0.0 109.388 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.78 50.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.4 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.31 -31.44 70.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.95 -35.93 64.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.39 -0.819 . . . . 0.0 109.835 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 -26.38 63.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.428 -0.795 . . . . 0.0 110.31 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.93 -45.03 21.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 111.259 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -60.62 -41.8 95.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.935 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.97 -25.7 60.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -64.0 -57.04 10.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -28.44 70.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 109.842 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.24 -55.05 36.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.62 -26.64 65.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.4 m -72.07 -34.9 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -28.51 63.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.744 -0.597 . . . . 0.0 109.474 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -85.21 -23.32 28.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.709 . . . . 0.0 110.107 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -67.3 -50.64 59.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.396 -0.815 . . . . 0.0 109.657 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.49 -42.55 9.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 43.41 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.84 -31.33 31.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.981 . . . . 0.0 109.463 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.16 168.88 42.01 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.05 153.37 48.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 129.09 26.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 109.657 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.9 m -99.13 136.55 38.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.611 -0.681 . . . . 0.0 109.374 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 78' ' ' GLU . 76.7 m-85 -119.54 174.49 6.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.564 -0.71 . . . . 0.0 109.718 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.6 129.72 54.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.612 -0.68 . . . . 0.0 109.217 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.74 113.34 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.577 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 16.31 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.704 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.14 34.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.289 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -62.1 -49.92 73.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -69.12 -28.81 66.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.576 -0.702 . . . . 0.0 109.554 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.35 -152.01 23.11 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.979 . . . . 0.0 109.394 179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -54.58 -54.96 43.02 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.929 -1.107 . . . . 0.0 111.285 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.64 -22.74 23.82 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.114 1.21 . . . . 0.0 110.347 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.86 -22.63 59.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.13 -29.75 28.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.256 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.17 -40.16 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 109.178 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.25 -43.81 60.48 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.954 -0.467 . . . . 0.0 110.394 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.52 -29.83 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.873 . . . . 0.0 109.479 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -45.42 74.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.556 -0.715 . . . . 0.0 109.753 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -64.3 -60.48 3.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.465 -0.772 . . . . 0.0 109.758 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.8 -20.92 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.608 -0.683 . . . . 0.0 110.624 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -60.45 -40.6 91.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -66.58 -32.11 73.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 109.374 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 71.9 m-85 -90.96 130.34 36.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.2 14.13 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 177.65 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.71 78.21 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.5 m -89.39 85.86 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.677 -0.639 . . . . 0.0 109.285 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.0 123.71 34.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.738 -0.602 . . . . 0.0 109.956 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.0 tp -91.51 133.57 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -119.42 129.53 54.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.627 -0.671 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -116.4 74.16 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 109.834 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 48.3 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.574 -0.704 . . . . 0.0 111.409 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.95 -37.72 3.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -89.64 161.56 16.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -1.061 . . . . 0.0 109.597 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 m -150.1 75.93 1.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.613 -0.679 . . . . 0.0 109.708 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -92.52 145.14 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -71.87 141.79 49.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -54.9 -27.62 44.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.408 -0.808 . . . . 0.0 109.168 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 56.1 3.17 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -150.21 89.87 1.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 mt -66.43 -37.15 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.796 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 ttm -75.28 -24.93 57.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.69 -0.631 . . . . 0.0 109.906 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.12 44.68 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.33 -43.94 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.997 . . . . 0.0 109.209 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.59 -29.33 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 p -70.96 -26.27 63.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.802 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.5 mt -59.67 -33.88 72.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.466 -0.771 . . . . 0.0 109.958 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.03 38.41 35.45 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.6 mt -75.45 163.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.968 . . . . 0.0 109.123 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.56 -162.38 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.902 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.99 68.83 10.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.63 63.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.88 -175.72 4.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.884 . . . . 0.0 109.63 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -132.32 132.52 43.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.53 151.1 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.545 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 m -139.95 108.43 5.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -91.43 161.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.582 -0.699 . . . . 0.0 109.85 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 p -150.62 105.95 3.36 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.88 135.14 33.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.96 92.42 1.72 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -0.778 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.27 129.14 1.15 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 55.88 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.677 -0.896 . . . . 0.0 111.031 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -122.81 64.13 0.97 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 110.003 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -57.84 -35.24 70.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 110.342 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 -32.94 73.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.73 -25.31 53.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.453 -0.779 . . . . 0.0 110.457 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.93 -40.8 23.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.814 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -66.35 -42.21 88.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 0.0 110.451 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 22.2 p-10 -75.09 -22.99 57.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.385 -0.822 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -65.81 -58.68 5.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.091 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.74 -25.15 63.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -0.772 . . . . 0.0 110.064 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HA ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -62.81 -59.57 4.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.311 -0.868 . . . . 0.0 109.965 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -60.17 -28.97 68.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 109.774 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -66.46 -35.58 80.63 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.713 -0.617 . . . . 0.0 109.641 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -85.33 -21.59 28.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 110.283 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.8 p -70.66 -52.59 20.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.79 -29.07 22.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.726 . . . . 0.0 109.549 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.18 5.56 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.58 -44.72 16.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.644 -0.915 . . . . 0.0 109.53 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.47 141.92 7.19 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.399 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.17 153.57 25.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -140.09 164.91 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.569 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -112.12 128.78 56.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.608 -0.682 . . . . 0.0 109.329 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -117.53 150.19 39.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.418 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.72 129.49 51.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.78 118.46 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.731 -0.606 . . . . 0.0 109.554 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.5 m -140.24 24.81 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 109.755 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.28 34.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.457 -0.777 . . . . 0.0 109.47 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.16 -45.53 69.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.605 -0.685 . . . . 0.0 109.499 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -76.02 -31.66 59.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.618 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.25 -148.17 17.96 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.989 . . . . 0.0 109.498 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.038 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.404 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.9 ttt85 -56.52 -57.16 25.13 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.744 -1.223 . . . . 0.0 111.082 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -70.11 -17.81 35.74 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.076 1.184 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.65 -21.98 40.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.539 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 m -83.41 -31.32 26.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.58 -39.23 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.799 0.809 . . . . 0.0 108.933 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.95 -49.78 27.33 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.539 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.74 -29.44 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.87 -43.09 72.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.465 -0.772 . . . . 0.0 109.835 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -66.48 -59.84 3.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.934 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -23.62 63.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.542 -0.724 . . . . 0.0 110.373 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 t -61.73 -37.53 84.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.372 -0.83 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.34 -20.67 60.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.719 -0.613 . . . . 0.0 110.169 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.45 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.54 128.02 35.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.27 -0.893 . . . . 0.0 109.597 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -70.13 -24.93 63.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.646 . . . . 0.0 109.711 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.8 39.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.803 . . . . 0.0 109.852 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.72 95.57 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.672 -0.642 . . . . 0.0 109.565 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.85 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -132.6 130.59 40.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.29 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 tt -89.83 139.11 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -113.96 113.97 25.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 109.842 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.404 ' CE1' HG12 ' A' ' 55' ' ' ILE . 13.6 t80 -95.47 68.02 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.511 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m120 48.13 85.07 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.551 -0.718 . . . . 0.0 111.178 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.12 -39.82 2.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -89.53 159.01 17.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.398 -1.06 . . . . 0.0 109.37 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -150.18 91.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.585 -0.697 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -65.48 146.08 55.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.8 tp -65.54 -12.06 49.44 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.47 48.73 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.7 t -150.14 95.54 2.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.828 . . . . 0.0 109.164 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 mt -77.12 -40.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 109.589 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.65 -29.1 63.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.52 -29.43 67.96 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.8 t -73.65 -43.47 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -1.046 . . . . 0.0 109.452 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.42 -29.81 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.618 -0.676 . . . . 0.0 109.588 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.8 p -66.57 -30.65 71.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.67 -51.32 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.37 50.33 2.41 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 55' ' ' ILE . 55.2 mt -77.0 159.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.59 -0.947 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.82 179.38 7.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.852 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -61.84 147.17 47.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.529 -0.732 . . . . 0.0 109.78 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 64.07 2.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.37 125.11 9.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.991 . . . . 0.0 109.486 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.04 124.58 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.709 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.3 pt -112.48 160.85 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.249 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 m -136.0 111.5 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.645 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.2 mt -91.9 160.28 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 p -149.91 101.21 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.104 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.97 126.87 35.9 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.88 111.4 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 -135.1 2.91 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -57.08 3.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.583 -0.951 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -104.83 45.86 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.571 -0.706 . . . . 0.0 109.302 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.44 -37.01 79.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.571 -0.705 . . . . 0.0 110.191 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -67.77 -37.77 82.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 109.985 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.66 -25.28 62.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 110.138 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.87 -42.1 24.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 111.21 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -62.02 -41.59 98.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -76.17 -23.58 54.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.333 -0.854 . . . . 0.0 109.788 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -63.89 -60.09 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.306 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -28.82 69.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.007 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.31 -52.64 64.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 109.841 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.3 -27.53 69.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -68.89 -31.59 70.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.7 mmt -71.35 -30.8 66.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -86.22 -17.43 34.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 110.316 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 p -73.11 -52.95 12.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -100.9 10.71 40.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.45 99.01 0.01 OUTLIER Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 mt -140.5 -50.71 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.519 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.04 139.36 6.42 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.996 . . . . 0.0 109.522 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.72 152.34 26.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.655 -0.653 . . . . 0.0 109.589 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -142.69 142.7 32.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.566 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 m -95.14 128.58 42.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.687 -0.633 . . . . 0.0 109.373 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD2' ' HE2' ' A' ' 81' ' ' MET . 85.4 m-85 -112.88 152.62 29.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.619 -0.676 . . . . 0.0 109.583 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -116.06 116.34 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.623 -0.673 . . . . 0.0 109.203 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 t -75.5 118.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -116.63 -15.26 10.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.618 -0.676 . . . . 0.0 110.333 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.18 146.3 39.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.149 -0.97 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -49.76 71.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.657 . . . . 0.0 109.574 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -63.26 -30.96 72.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.86 -138.39 14.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.1 mt . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.937 . . . . 0.0 109.541 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 9.8 mtm180 -58.24 -60.13 11.17 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.879 -1.138 . . . . 0.0 110.527 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -70.7 -15.94 33.59 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.318 1.345 . . . . 0.0 110.681 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.56 -25.92 50.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.212 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.54 -30.47 27.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.22 -36.79 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.672 0.748 . . . . 0.0 109.044 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.26 -44.81 43.87 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.999 -0.438 . . . . 0.0 110.366 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.7 -29.07 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.31 -36.91 63.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -67.33 -60.07 2.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.48 -0.762 . . . . 0.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -21.79 59.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.446 -0.784 . . . . 0.0 110.107 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.8 t -57.2 -38.9 74.38 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.285 -0.884 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.98 -30.01 66.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.585 -0.697 . . . . 0.0 109.42 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 77.4 m-85 -92.65 124.97 37.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -82.24 2.8 30.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 110.625 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.2 -179.78 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.544 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.34 80.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 0.0 109.41 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.61 111.84 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.671 . . . . 0.0 109.248 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -120.64 134.12 55.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.551 -0.718 . . . . 0.0 110.028 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 tt -92.35 154.95 18.24 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -134.4 129.93 36.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.459 -0.776 . . . . 0.0 109.865 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CD2' HG12 ' A' ' 55' ' ' ILE . 39.3 t80 -160.31 132.47 6.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 109.687 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.16 40.71 17.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.737 . . . . 0.0 109.978 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.78 28.09 65.16 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.24 102.79 7.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.582 -0.952 . . . . 0.0 109.129 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 m -93.5 99.85 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.593 -0.692 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.65 146.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -67.79 143.02 56.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 7.4 tp -62.99 -14.98 54.54 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.164 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -87.67 49.98 1.91 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.3 t -150.24 99.23 2.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.0 mt -79.39 -39.94 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 109.858 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 ttt -75.75 -17.72 59.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.03 -44.55 4.73 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.32 -29.44 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.444 -1.033 . . . . 0.0 109.788 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.6 t -75.93 -30.68 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.48 -0.763 . . . . 0.0 109.285 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -62.23 -26.66 68.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.7 mp -62.06 -52.73 62.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.87 54.74 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 37' ' ' TYR . 46.7 mt -77.44 157.67 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.539 -0.977 . . . . 0.0 109.337 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.2 -171.22 3.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.567 -0.708 . . . . 0.0 109.421 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -68.19 144.75 54.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.641 -0.662 . . . . 0.0 109.625 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.79 54.76 7.0 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.14 155.89 48.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.956 . . . . 0.0 109.472 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.37 122.06 43.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.565 -0.71 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 pt -118.23 133.23 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -104.65 120.34 41.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.528 -0.732 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.3 mt -110.5 148.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.46 112.55 4.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 0.0 110.194 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.14 130.07 37.07 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.89 105.29 5.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.854 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.92 -136.05 3.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.9 -73.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.988 . . . . 0.0 109.659 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -90.31 51.9 2.12 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.682 -0.636 . . . . 0.0 109.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.66 -28.33 67.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.5 -0.75 . . . . 0.0 109.81 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -77.57 -35.22 53.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 109.561 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -76.8 -20.47 56.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.0 110.107 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.65 -43.65 18.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.49 -42.91 91.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.349 -0.845 . . . . 0.0 110.547 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 44.7 p-10 -75.87 -22.11 56.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.25 -57.58 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -31.18 72.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.569 -0.707 . . . . 0.0 109.648 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.55 -52.62 64.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.174 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.22 -27.58 69.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 m -69.11 -32.76 72.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.405 ' HE2' ' CD2' ' A' ' 6' ' ' PHE . 1.1 mtt -70.83 -31.5 68.24 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -77.89 -27.85 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.727 -0.608 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -77.41 -66.33 0.85 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.75 . . . . 0.0 109.651 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.87 -28.71 69.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.571 -0.706 . . . . 0.0 109.713 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 34.99 15.86 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.7 mt -81.95 -39.49 23.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.647 -0.914 . . . . 0.0 109.571 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.52 30.1 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.548 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.71 152.62 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -143.99 149.33 36.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.623 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 m -99.48 119.01 37.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -98.61 162.15 13.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.675 -0.641 . . . . 0.0 109.336 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 135.0 52.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.345 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.87 107.33 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.596 -0.69 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -122.3 -1.43 9.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.547 -0.721 . . . . 0.0 110.562 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.57 136.42 57.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.131 -0.98 . . . . 0.0 109.577 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.49 -38.97 92.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -72.48 -30.94 64.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.531 -0.731 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -151.59 20.04 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 14' ' ' ILE . 23.8 mm . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.946 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.504 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -60.51 -51.34 80.62 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.752 -1.217 . . . . 0.0 111.291 -178.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -73.08 -23.67 17.99 Favored 'Trans proline' 0 C--N 1.326 -0.637 0 C-N-CA 121.036 1.157 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.25 -27.76 62.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.352 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 m -81.83 -29.51 32.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.522 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.9 t -71.76 -40.05 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.829 0.823 . . . . 0.0 108.858 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.43 -51.4 24.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.941 -0.474 . . . . 0.0 110.208 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.79 -27.65 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.38 -0.825 . . . . 0.0 110.037 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -74.12 -37.86 63.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.709 . . . . 0.0 109.959 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -72.8 -62.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.71 -20.71 36.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.13 -40.85 91.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -71.06 -22.57 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.624 -0.672 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.421 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.4 130.21 35.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 0.0 109.647 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -73.61 -25.96 60.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.676 -0.64 . . . . 0.0 109.754 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 145.26 44.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.448 -0.783 . . . . 0.0 109.639 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.63 97.09 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.608 -0.683 . . . . 0.0 109.602 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -92.56 138.68 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -132.48 142.16 49.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.456 -0.778 . . . . 0.0 110.332 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 tt -102.47 122.61 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.44 150.75 21.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.474 -0.766 . . . . 0.0 110.026 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 55' ' ' ILE . 26.9 t80 -160.38 115.27 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.733 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 64.04 27.1 14.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.673 -0.642 . . . . 0.0 110.285 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.7 -18.13 51.55 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.338 -0.934 . . . . 0.0 110.892 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 112.28 23.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.228 -1.16 . . . . 0.0 109.169 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 m -95.84 114.19 25.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.625 . . . . 0.0 109.842 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.95 147.68 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -70.27 136.39 49.82 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.03 -25.15 28.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.429 -0.795 . . . . 0.0 109.405 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -90.28 56.57 3.42 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.37 86.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 mt -61.28 -60.73 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.739 -0.601 . . . . 0.0 109.723 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 ttp -66.64 -27.2 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.7 74.87 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.93 -32.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -1.067 . . . . 0.0 109.529 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 t -71.85 -23.8 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.471 -0.768 . . . . 0.0 109.861 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.3 p -59.24 -39.62 83.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mp -63.82 -34.02 76.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.211 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.07 4.74 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 55' ' ' ILE . 51.3 mt -75.41 153.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.963 . . . . 0.0 109.175 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.19 -179.0 6.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.701 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -62.47 136.08 57.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.756 -0.59 . . . . 0.0 109.652 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.77 56.86 1.69 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.37 -178.52 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.995 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -136.5 159.55 41.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.68 . . . . 0.0 109.277 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.3 pt -150.22 138.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -115.63 105.66 13.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.695 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 88.8 mt -92.4 148.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 p -150.52 112.92 4.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.631 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.26 134.47 34.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.66 104.66 6.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.7 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.22 -145.21 8.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -59.55 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.92 . . . . 0.0 109.584 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -96.28 42.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.602 -0.686 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.15 -32.81 73.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.707 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -72.04 -50.0 32.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 109.461 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -61.9 -21.81 65.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 0.0 110.339 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.03 -51.8 9.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.363 -0.836 . . . . 0.0 111.557 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -56.34 -42.34 77.56 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.006 . . . . 0.0 110.809 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.405 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -72.14 -27.08 62.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.0 109.106 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -60.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.378 -0.826 . . . . 0.0 109.148 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.56 -25.89 66.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 109.86 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.55 -54.45 45.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.961 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -61.79 -27.37 68.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.303 -0.873 . . . . 0.0 109.714 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.408 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 54.2 m -68.66 -34.51 75.82 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mmt -71.58 -31.87 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -91.52 -6.17 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.702 -0.624 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 p -78.09 -50.24 12.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -98.2 -59.52 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.553 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 139.55 69.22 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.39 -50.41 3.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.923 . . . . 0.0 109.662 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.55 154.24 25.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.445 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -178.01 151.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.671 -0.643 . . . . 0.0 109.28 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -146.41 148.76 32.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.618 -0.676 . . . . 0.0 109.58 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -89.59 133.12 34.77 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 63' ' ' ILE . 67.5 m-85 -117.57 148.58 41.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.954 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.72 115.75 29.6 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.9 t -68.86 109.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.687 -0.633 . . . . 0.0 109.402 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -117.03 -8.81 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 110.466 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.53 142.07 57.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.096 -1.003 . . . . 0.0 109.63 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.54 -40.75 97.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -74.83 -30.19 61.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.626 -0.671 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.71 -145.54 17.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.632 -0.922 . . . . 0.0 109.292 179.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -50.34 -53.13 48.03 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 120.965 -1.084 . . . . 0.0 111.542 -178.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -73.38 -25.2 15.68 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.389 1.392 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.83 -18.6 60.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.526 -0.734 . . . . 0.0 109.615 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.03 -32.99 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 108.941 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.57 -35.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.38 -51.24 12.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.248 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -54.8 -27.78 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.32 -0.862 . . . . 0.0 109.976 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -44.81 55.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -62.06 -62.23 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.546 -0.721 . . . . 0.0 109.845 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.22 -22.67 18.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.443 -0.786 . . . . 0.0 110.715 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -43.39 90.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.258 -0.901 . . . . 0.0 109.884 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -66.61 -29.32 69.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -90.05 126.9 35.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.487 -0.758 . . . . 0.0 109.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.84 -17.66 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.741 -0.599 . . . . 0.0 110.283 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.87 147.14 29.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.203 -0.936 . . . . 0.0 109.922 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.34 90.59 8.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.75 128.21 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.98 135.09 52.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.558 -0.714 . . . . 0.0 109.869 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tt -89.72 155.07 19.45 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.12 142.55 51.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.867 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 55' ' ' ILE . 59.3 t80 -160.37 128.09 4.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.68 36.66 19.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.477 -0.764 . . . . 0.0 110.012 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.62 22.9 78.05 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -116.2 169.28 9.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -1.059 . . . . 0.0 108.89 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 m -145.58 97.58 3.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.76 146.37 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -68.67 146.17 53.23 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.8 tp -67.0 -10.71 52.59 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -88.55 48.26 1.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.831 -1.168 . . . . 0.0 107.91 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.2 t -149.54 85.08 1.43 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.847 . . . . 0.0 109.009 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.5 mt -69.06 -39.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.801 -0.562 . . . . 0.0 109.541 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ttt -73.53 -29.37 62.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.563 -0.71 . . . . 0.0 109.606 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.27 -38.07 81.39 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.67 -27.72 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.995 . . . . 0.0 109.691 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.4 t -83.91 -25.74 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.815 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -60.37 -38.92 85.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.443 -0.786 . . . . 0.0 109.799 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.42 -55.59 15.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.454 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.27 51.93 0.85 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 37' ' ' TYR . 42.9 mt -75.62 162.16 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.562 -0.964 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.9 -163.16 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -78.85 157.0 28.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.712 . . . . 0.0 109.557 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.97 61.03 6.82 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.39 173.21 11.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.931 . . . . 0.0 109.51 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -127.98 141.45 51.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.709 . . . . 0.0 109.208 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 61' ' ' ILE . 20.2 pt -141.97 164.12 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.559 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -132.58 117.24 17.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.67 . . . . 0.0 109.836 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.401 HD11 ' CE1' ' A' ' 6' ' ' PHE . 89.6 mt -99.2 152.07 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -150.4 110.16 4.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.508 -0.745 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.35 130.09 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.99 103.19 4.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.453 -0.779 . . . . 0.0 109.98 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.27 -132.31 2.06 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.81 -67.18 0.85 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.963 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 46.53 1.19 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.548 -0.72 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.04 -37.25 86.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.49 -0.756 . . . . 0.0 110.21 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.25 -36.74 77.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.64 -20.59 56.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.457 -0.777 . . . . 0.0 110.284 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.16 -42.8 20.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.49 -41.64 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.438 -0.789 . . . . 0.0 110.047 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.415 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 15.9 p30 -79.27 -16.9 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.783 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.45 -52.37 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.28 -33.14 75.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.567 -0.708 . . . . 0.0 109.466 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.66 -52.81 63.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.551 -0.718 . . . . 0.0 109.987 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.12 -27.62 65.77 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.133 -0.98 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.2 m -69.86 -37.22 76.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mtt -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -76.15 -26.0 55.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 0.0 109.734 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -82.57 -67.03 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.729 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -66.71 -29.87 69.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.53 -0.731 . . . . 0.0 109.581 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.73 2.93 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.83 -30.37 20.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.654 -0.909 . . . . 0.0 109.743 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.7 146.94 5.91 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.479 -1.012 . . . . 0.0 109.469 -179.925 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -173.74 154.98 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.716 . . . . 0.0 109.543 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.52 139.92 19.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.561 -0.712 . . . . 0.0 109.651 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -89.96 143.15 27.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.205 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 63' ' ' ILE . 27.0 m-85 -125.92 169.76 12.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.7 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.76 135.82 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.582 -0.699 . . . . 0.0 109.332 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 t -81.43 112.08 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 109.319 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 m -114.12 -12.08 12.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 141.74 50.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -0.966 . . . . 0.0 109.985 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.71 -43.11 94.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.9 p -74.07 -32.78 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.53 -0.731 . . . . 0.0 109.366 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.54 -139.58 15.38 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.593 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -60.16 -61.31 8.18 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 120.943 -1.098 . . . . 0.0 110.589 -178.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.9 Cg_endo -69.59 -12.36 33.07 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 121.283 1.322 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.88 -28.89 32.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.867 . . . . 0.0 109.008 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -78.89 -30.02 44.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -68.78 -49.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.809 . . . . 0.0 108.979 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.91 -54.69 30.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.6 -28.58 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.307 -0.871 . . . . 0.0 110.506 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.01 -54.59 17.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.525 -0.735 . . . . 0.0 110.245 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 m -59.94 -53.35 58.87 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -0.813 . . . . 0.0 110.411 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.33 62.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.412 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.49 -37.74 79.04 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -71.57 -28.75 64.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.775 -0.578 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 81.7 m-85 -94.58 125.45 39.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.85 9.31 19.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.671 -0.643 . . . . 0.0 110.716 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.8 179.22 1.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.092 -1.005 . . . . 0.0 109.478 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -102.75 76.03 1.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.639 -0.663 . . . . 0.0 109.237 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -89.62 108.91 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -117.09 134.31 54.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.47 160.82 16.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -128.43 152.75 47.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.36 87.54 1.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.758 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 61.84 48.65 5.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.565 -0.709 . . . . 0.0 109.681 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.06 -7.47 74.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -91.09 101.32 14.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -1.204 . . . . 0.0 109.333 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.35 98.03 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.558 -0.714 . . . . 0.0 109.746 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.77 148.1 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.7 140.95 56.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.22 -28.95 63.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 0.0 109.132 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 60.52 4.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -147.67 83.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.6 mt -66.21 -40.55 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.607 . . . . 0.0 109.657 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -77.6 -27.39 51.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.56 -0.713 . . . . 0.0 109.96 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.26 -29.72 63.87 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.52 -31.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -1.011 . . . . 0.0 109.579 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.28 -28.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.6 p -63.41 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.31 -72.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.563 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.4 48.93 0.3 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.5 mt -75.97 162.05 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.981 . . . . 0.0 109.415 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.06 -177.42 5.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 109.36 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 148.26 52.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.588 -0.695 . . . . 0.0 109.398 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.07 70.94 1.0 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -175.49 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.494 -1.004 . . . . 0.0 109.569 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -131.39 148.49 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 pt -149.8 153.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.621 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -127.75 127.07 42.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.713 . . . . 0.0 109.664 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 6' ' ' PHE . 78.0 mt -112.31 148.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 p -150.77 112.11 4.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.93 134.41 35.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.83 103.3 3.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 0.0 109.661 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.73 -128.71 1.37 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.22 -59.47 2.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -104.44 52.65 0.75 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.533 -0.73 . . . . 0.0 109.637 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.5 -38.75 90.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.49 -0.756 . . . . 0.0 109.96 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.98 -37.97 75.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 110.115 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -76.71 -19.42 57.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.0 -43.9 17.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.16 -41.94 94.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.489 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 42.1 p-10 -78.08 -20.33 52.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 109.727 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.43 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.26 -55.91 9.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.903 . . . . 0.0 108.593 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -29.13 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.498 -0.751 . . . . 0.0 109.782 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -54.58 42.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.397 -0.815 . . . . 0.0 110.192 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.59 -33.54 71.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.807 . . . . 0.0 109.774 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -65.67 -34.06 77.33 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 mmm -71.94 -28.07 63.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.736 -0.603 . . . . 0.0 109.65 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -82.47 -23.8 34.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.591 -0.693 . . . . 0.0 110.177 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -85.85 -31.56 22.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 109.918 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -93.78 -21.8 19.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.725 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.06 33.3 29.75 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.94 -60.45 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.946 . . . . 0.0 109.615 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.31 156.04 26.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.423 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -117.14 150.79 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.414 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.74 142.09 31.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.754 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.5 m -96.51 143.56 27.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -127.21 174.04 9.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.547 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.86 124.39 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.596 -0.69 . . . . 0.0 109.416 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.32 123.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.382 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.84 10.95 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 110.258 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 147.13 35.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.429 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.19 -31.21 71.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.684 . . . . 0.0 109.584 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -80.68 -30.44 36.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 109.466 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.25 37.01 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 14' ' ' ILE . 65.8 mt . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.558 -0.966 . . . . 0.0 109.5 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -51.48 -54.51 38.29 Favored Pre-proline 0 N--CA 1.508 2.462 0 O-C-N 120.801 -1.187 . . . . 0.0 111.55 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.2 Cg_endo -71.28 -23.2 24.49 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.122 1.214 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.94 -19.97 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.484 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.73 -32.66 23.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 108.815 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.58 -35.37 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.656 0.741 . . . . 0.0 109.039 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.57 -43.79 37.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.0 -0.437 . . . . 0.0 110.28 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -62.63 -28.31 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.77 -48.05 60.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.529 -0.732 . . . . 0.0 109.954 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -62.1 -57.35 11.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.903 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.53 -23.18 48.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.542 -0.724 . . . . 0.0 110.372 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -59.75 -41.1 90.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.667 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -64.62 -32.04 73.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 54.4 m-85 -93.49 131.28 38.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.665 . . . . 0.0 109.397 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -94.29 12.56 26.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.557 -0.715 . . . . 0.0 110.345 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.12 169.43 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -91.03 76.99 6.13 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.63 89.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.596 -0.69 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.87 123.84 42.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 109.7 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 tt -89.51 108.3 19.58 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -89.13 123.72 33.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.703 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.16 72.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 t30 48.45 85.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.513 -0.742 . . . . 0.0 111.32 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 -38.69 3.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.36 159.47 17.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -1.119 . . . . 0.0 109.621 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.78 85.1 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.71 145.44 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 139.87 41.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.6 tp -58.99 -16.2 16.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -86.92 49.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.774 -1.204 . . . . 0.0 108.197 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 t -151.0 93.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 0.0 109.074 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.3 mt -71.11 -39.07 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.624 -0.672 . . . . 0.0 109.621 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -72.46 -28.52 62.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.585 -0.697 . . . . 0.0 109.614 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.72 -28.62 64.8 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.62 -26.25 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.475 -1.015 . . . . 0.0 109.679 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -78.95 -26.98 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -0.791 . . . . 0.0 109.794 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p -68.42 -34.69 76.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 109.564 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 mt -63.38 -45.92 88.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.461 -0.774 . . . . 0.0 109.344 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.83 61.59 1.84 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.8 mt -88.96 149.17 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.562 -0.964 . . . . 0.0 109.142 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.98 -168.98 3.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.562 -0.711 . . . . 0.0 109.772 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -64.62 130.29 43.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.682 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.16 55.66 2.06 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.36 30.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.61 -0.935 . . . . 0.0 109.577 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -95.08 145.82 24.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.266 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -136.71 152.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 109.522 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 m -127.35 152.53 47.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.409 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.37 143.58 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.449 -0.782 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -147.85 107.84 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.971 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.53 130.97 36.52 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.31 97.1 3.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.88 -131.51 1.47 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.58 -71.23 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.933 . . . . 0.0 109.73 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -99.01 61.38 1.25 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.527 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.67 -27.55 66.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.537 -0.727 . . . . 0.0 109.995 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.94 -35.07 43.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.47 -0.769 . . . . 0.0 109.975 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.73 -22.26 59.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.741 . . . . 0.0 110.344 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.416 ' HA ' ' CD2' ' A' ' 29' ' ' TYR . . . -81.6 -43.67 18.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.4 pp -68.7 -39.82 80.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.479 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 45.0 p30 -79.13 -20.48 48.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 109.795 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.73 -56.05 5.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.326 -0.859 . . . . 0.0 108.838 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.65 -34.19 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.545 -0.722 . . . . 0.0 109.51 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.63 -52.73 64.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.94 -26.74 68.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.373 -0.83 . . . . 0.0 109.709 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.5 m -70.22 -32.94 71.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.072 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.46 -27.12 63.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.725 -0.61 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -25.6 26.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 110.148 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 p -66.63 -54.33 24.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.535 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.49 -29.8 22.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.48 -0.763 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 48.99 4.53 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.6 mt -82.43 -42.66 18.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.979 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.38 142.87 8.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.497 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.89 153.79 19.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.728 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -141.8 133.79 27.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -89.98 130.37 36.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.287 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CE1' HD11 ' A' ' 63' ' ' ILE . 93.5 m-85 -116.02 154.2 30.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.604 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.37 127.82 54.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.635 -0.666 . . . . 0.0 109.235 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.73 114.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -121.12 -5.13 9.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.568 -0.707 . . . . 0.0 110.57 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.66 150.43 40.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.21 -57.46 11.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.467 -0.77 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -65.81 -33.4 75.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.59 -132.8 11.06 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.7 mt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.954 . . . . 0.0 109.387 179.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 2.4 ttt85 -53.75 -53.93 52.09 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.961 -1.087 . . . . 0.0 111.377 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.7 Cg_endo -73.87 -24.66 15.14 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.192 1.262 . . . . 0.0 110.523 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.42 61.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.413 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.5 -31.95 24.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.007 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.67 -39.38 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.5 mt -74.84 -51.84 12.93 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.553 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.33 -28.44 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.252 -0.905 . . . . 0.0 110.149 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -74.84 -42.65 57.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -68.55 -65.62 0.68 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.775 . . . . 0.0 109.935 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.38 -24.64 12.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.473 -0.767 . . . . 0.0 110.581 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.22 -45.97 90.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 109.469 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -63.87 -25.52 68.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.645 -0.66 . . . . 0.0 109.822 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -89.57 124.39 34.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 109.576 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.79 -21.24 65.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.072 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 147.88 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -89.88 88.96 7.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.608 -0.682 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.8 129.85 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -129.36 140.33 51.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.975 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 tt -92.3 149.09 21.64 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -115.18 141.8 47.53 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.426 ' CD2' HG12 ' A' ' 55' ' ' ILE . 35.2 t80 -160.28 115.82 2.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.0 109.983 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 t30 63.9 23.47 13.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.557 -0.714 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.71 -18.21 51.25 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.788 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -88.97 118.55 28.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -1.172 . . . . 0.0 109.158 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -95.08 117.5 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.709 -0.619 . . . . 0.0 109.886 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.07 147.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.8 135.45 51.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.07 -29.12 28.37 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.369 -0.832 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 62.05 4.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.92 87.09 1.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.3 mt -71.45 -38.76 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.733 -0.604 . . . . 0.0 109.873 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.1 ttp -77.7 -27.51 50.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.532 -0.73 . . . . 0.0 109.987 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.16 49.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.35 -33.36 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.471 -1.017 . . . . 0.0 109.759 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 t -75.59 -30.71 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 109.614 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.7 p -63.3 -28.02 69.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.692 . . . . 0.0 109.854 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 mp -69.15 -76.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.761 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.02 51.79 0.23 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.426 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.0 mt -78.93 158.33 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.576 -0.955 . . . . 0.0 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.18 -168.15 2.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 109.639 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -73.9 146.44 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.757 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.63 57.32 3.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.14 170.64 15.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.946 . . . . 0.0 109.538 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -126.85 129.93 49.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.594 -0.692 . . . . 0.0 109.469 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.4 pt -119.88 146.41 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.671 -0.643 . . . . 0.0 109.305 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.06 107.33 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.747 . . . . 0.0 109.646 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.406 HD11 ' CE1' ' A' ' 6' ' ' PHE . 75.3 mt -92.54 154.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.282 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -150.12 105.95 3.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.78 124.34 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.36 107.4 7.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.463 -0.773 . . . . 0.0 109.79 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -138.84 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.25 -64.7 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.965 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.08 42.07 1.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.96 -28.6 67.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -0.75 . . . . 0.0 109.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.21 -35.49 63.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.26 -25.37 59.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.675 . . . . 0.0 110.03 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -43.67 20.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.397 -0.814 . . . . 0.0 110.689 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -62.09 -41.62 98.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.327 -0.858 . . . . 0.0 110.69 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 17.8 p-10 -74.46 -27.07 60.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.246 -0.909 . . . . 0.0 109.764 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.24 -57.67 8.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.805 . . . . 0.0 109.266 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.59 -27.35 69.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.493 -0.755 . . . . 0.0 109.876 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.71 -58.01 9.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 109.682 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.85 -26.59 65.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -71.98 -34.02 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 0.0 109.015 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.6 -29.91 65.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -85.81 -21.19 28.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.69 . . . . 0.0 110.305 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -80.75 -55.07 5.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -73.45 -27.07 61.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.825 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.25 39.79 6.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.7 mt -81.74 -52.76 6.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.687 -0.89 . . . . 0.0 109.651 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.24 145.8 12.59 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.593 -0.945 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.79 158.12 44.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.583 -0.698 . . . . 0.0 109.294 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -142.78 132.73 24.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.2 m -95.07 139.05 31.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.543 -0.723 . . . . 0.0 109.297 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 91.3 m-85 -122.69 162.76 21.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.524 -0.735 . . . . 0.0 109.709 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.76 125.23 50.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 t -77.81 123.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.522 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 m -129.92 3.37 4.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.588 -0.695 . . . . 0.0 110.544 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.39 46.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.039 -1.038 . . . . 0.0 109.47 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.18 -37.71 88.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.693 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -80.01 -30.19 39.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.81 -148.6 18.88 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 14' ' ' ILE . 58.8 mt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.945 . . . . 0.0 109.562 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -57.39 -60.66 9.07 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.856 -1.153 . . . . 0.0 110.598 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.8 -15.1 36.79 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.302 1.335 . . . . 0.0 110.787 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.71 -24.99 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 m -82.99 -29.59 28.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.187 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.36 -40.49 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.669 0.747 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.09 -46.35 57.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.967 -0.458 . . . . 0.0 110.397 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.03 -29.01 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.791 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.61 -43.57 72.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.475 -0.766 . . . . 0.0 109.975 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -68.04 -60.83 2.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.049 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.2 -23.6 48.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.411 -0.806 . . . . 0.0 110.41 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -59.83 -41.3 91.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -26.39 67.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.743 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 90.8 m-85 -89.66 127.95 36.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.4 -0.813 . . . . 0.0 109.604 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -71.82 -21.62 61.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.806 -0.559 . . . . 0.0 110.075 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 149.1 23.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.67 92.46 9.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.63 -0.669 . . . . 0.0 109.449 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.8 102.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 109.195 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.72 137.68 41.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.777 . . . . 0.0 110.096 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 tt -90.77 150.56 21.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.72 135.43 55.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.481 -0.762 . . . . 0.0 109.601 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.426 ' CD2' HG12 ' A' ' 55' ' ' ILE . 57.9 t80 -160.21 125.9 4.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 64.09 21.44 12.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.523 -0.735 . . . . 0.0 110.519 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.01 55.37 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.908 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -89.07 122.78 32.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -1.187 . . . . 0.0 109.307 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 m -105.22 103.65 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.768 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.7 146.97 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -67.04 143.19 56.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 7.0 tp -63.37 -15.09 56.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.056 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -87.63 48.93 1.71 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.86 -1.15 . . . . 0.0 107.973 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 t -150.61 84.09 1.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 108.992 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.5 -37.89 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.7 ttm -74.39 -30.3 61.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.377 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.66 -35.93 92.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.4 t -68.38 -29.01 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.937 . . . . 0.0 109.386 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 t -65.47 -34.48 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.488 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.9 p -63.17 -32.0 73.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mp -70.54 -50.58 36.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.701 . . . . 0.0 109.393 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.84 59.46 3.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.426 HG12 ' CD2' ' A' ' 37' ' ' TYR . 49.0 mt -72.58 162.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.6 175.56 9.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.591 -0.693 . . . . 0.0 109.572 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -61.34 152.82 28.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.588 -0.695 . . . . 0.0 109.767 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.04 64.24 3.94 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.33 172.02 13.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.545 -0.973 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -124.76 129.8 51.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 pt -128.12 152.16 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.582 -0.699 . . . . 0.0 109.364 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -131.67 109.43 10.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.416 HD11 ' CE1' ' A' ' 6' ' ' PHE . 88.1 mt -93.69 155.97 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.219 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -150.09 110.56 4.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.64 -0.662 . . . . 0.0 109.808 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.69 131.74 35.52 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.03 107.04 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.499 -0.751 . . . . 0.0 109.662 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.5 -133.41 2.4 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.15 -61.99 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.574 -0.957 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -98.39 44.44 1.03 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.686 -0.633 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.71 -31.29 71.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.707 . . . . 0.0 109.857 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.69 -36.47 70.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.565 -0.709 . . . . 0.0 109.616 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.44 -19.55 52.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.306 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 -44.85 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.165 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.79 -41.78 91.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.247 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 45.6 p30 -77.65 -19.89 54.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 0.0 109.501 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.18 -57.16 5.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -30.11 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.575 -0.703 . . . . 0.0 109.432 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -54.02 51.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.999 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.29 -26.69 66.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 109.888 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.8 m -70.18 -35.82 74.22 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.8 mmm -71.45 -30.48 66.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -83.91 -18.49 37.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.676 . . . . 0.0 110.318 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.2 p -74.81 -52.84 10.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.3 -27.49 24.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.756 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.93 48.71 4.04 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.78 -64.44 1.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.676 -0.896 . . . . 0.0 109.607 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.72 11.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.982 . . . . 0.0 109.518 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.94 153.4 33.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.43 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 7.6 tttp -135.55 140.52 44.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.702 -0.624 . . . . 0.0 109.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 m -96.63 130.49 43.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.591 -0.693 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 4' ' ' LYS . 97.2 m-85 -118.0 149.01 41.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.593 -0.692 . . . . 0.0 109.604 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.14 125.89 52.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.4 119.6 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.598 -0.689 . . . . 0.0 109.593 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -140.49 22.27 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.571 -0.706 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.68 36.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.518 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.09 -41.18 97.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -78.72 -30.89 46.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.613 -0.679 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.18 -143.77 16.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.0 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.7 mmt180 -62.68 -61.35 7.69 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.812 -1.18 . . . . 0.0 109.782 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.07 -13.71 36.92 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.198 1.265 . . . . 0.0 110.509 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.0 -30.3 50.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 108.784 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -79.5 -27.97 41.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.67 . . . . 0.0 109.572 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.79 -48.59 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.747 0.784 . . . . 0.0 109.084 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.77 -42.7 90.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 122.004 -0.435 . . . . 0.0 110.614 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.22 -30.46 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -70.92 -29.77 65.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.074 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.53 -58.5 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.508 -0.745 . . . . 0.0 110.434 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.7 68.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.462 -0.774 . . . . 0.0 110.427 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 p -59.85 -32.77 70.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.354 -0.841 . . . . 0.0 109.708 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -73.39 -29.67 62.77 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.87 127.57 36.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.448 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.34 -2.99 44.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.684 -0.635 . . . . 0.0 110.681 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.14 167.6 3.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.67 82.18 3.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.606 -0.684 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 m -89.69 100.75 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.353 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -104.54 128.97 52.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.708 . . . . 0.0 109.921 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.9 tt -89.46 142.95 27.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -117.01 143.03 46.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -139.87 71.19 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.566 -0.709 . . . . 0.0 109.772 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.45 62.69 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.564 -0.71 . . . . 0.0 110.852 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 -29.8 8.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -89.54 88.14 7.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -1.078 . . . . 0.0 109.402 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.2 m -93.04 94.7 9.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.695 -0.628 . . . . 0.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.07 145.83 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -70.08 146.83 50.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.7 tp -65.87 -12.01 51.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -88.28 48.56 1.66 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.775 -1.203 . . . . 0.0 108.03 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 t -149.93 99.3 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.3 mm -70.47 -59.41 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.731 -0.606 . . . . 0.0 109.464 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.68 -22.19 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.711 -0.618 . . . . 0.0 110.163 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.87 63.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.8 t -68.78 -34.42 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.95 . . . . 0.0 109.616 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.3 t -71.83 -26.5 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.9 p -70.31 -33.93 72.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.473 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.1 -37.4 87.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.281 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.6 5.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 mt -78.44 152.36 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.992 . . . . 0.0 109.097 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.97 -168.58 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.547 -0.721 . . . . 0.0 109.8 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.49 131.93 50.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.672 -0.643 . . . . 0.0 109.704 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.93 55.58 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.41 172.96 12.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.548 -0.971 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -131.99 156.16 46.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.656 . . . . 0.0 109.296 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 pt -149.61 139.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.49 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 m -117.87 109.28 16.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.534 -0.729 . . . . 0.0 109.561 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.8 mt -96.85 150.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.589 -0.694 . . . . 0.0 109.401 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.24 109.88 4.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.653 -0.654 . . . . 0.0 109.609 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.73 131.49 35.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.11 101.72 4.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.802 . . . . 0.0 109.76 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.9 -123.67 0.85 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.95 -62.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.949 . . . . 0.0 109.314 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -96.64 51.51 1.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.293 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -27.39 66.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -80.69 -33.15 35.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.38 -21.61 52.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.73 . . . . 0.0 110.23 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.21 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.342 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.55 -42.76 91.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.318 -0.864 . . . . 0.0 110.438 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.419 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 33.3 p-10 -75.9 -21.95 56.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -0.873 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.401 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.81 -56.88 7.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -30.58 71.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.682 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -53.28 60.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.14 -29.22 69.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -66.73 -35.31 79.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.6 mmm -71.59 -28.21 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -69.99 -47.49 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 109.908 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 p -66.91 -59.12 3.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -59.28 -23.44 62.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.505 -0.747 . . . . 0.0 110.154 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.89 34.97 88.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.92 -44.61 16.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.97 . . . . 0.0 109.616 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -176.19 28.67 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.494 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -51.46 152.53 2.58 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.378 -0.826 . . . . 0.0 110.501 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -140.91 167.93 21.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 109.517 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -112.4 150.75 30.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.341 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.57 148.58 41.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 121.47 45.4 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.02 125.56 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.564 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -143.93 22.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.712 . . . . 0.0 109.861 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 145.29 36.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.488 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.11 -43.18 95.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 0.0 109.674 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -77.44 -29.25 52.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.36 -155.83 24.53 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 14' ' ' ILE . 61.4 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.537 -0.978 . . . . 0.0 109.415 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.11 -55.59 29.65 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.853 -1.154 . . . . 0.0 111.196 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.74 -23.32 22.81 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.233 1.288 . . . . 0.0 110.212 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.14 -22.33 61.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 0.0 109.309 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.404 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -84.33 -31.64 24.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.074 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.72 -40.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.614 0.721 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.57 -51.77 13.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.008 -0.433 . . . . 0.0 110.357 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 20' ' ' THR . 12.4 p -51.83 -30.69 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.09 -39.76 63.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.605 -0.684 . . . . 0.0 109.75 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -66.53 -64.43 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.51 -0.743 . . . . 0.0 109.894 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.51 -24.28 30.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -61.37 -43.44 98.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.359 -0.838 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -62.96 -26.73 68.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 109.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.445 ' CG ' ' CB ' ' A' ' 73' ' ' ALA . 93.2 m-85 -89.78 125.16 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.683 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -69.87 -22.97 63.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.81 25.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.373 -0.829 . . . . 0.0 109.858 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.06 95.83 10.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 109.759 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 m -97.04 120.41 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -116.88 123.92 48.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.554 -0.717 . . . . 0.0 110.326 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 tt -90.12 148.65 22.87 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -126.05 158.13 36.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.0 110.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -147.42 105.35 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -81.4 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.77 -0.581 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.87 26.56 1.46 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 114.88 19.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.468 -1.019 . . . . 0.0 109.175 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -89.79 90.07 8.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.586 -0.696 . . . . 0.0 110.025 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.83 148.04 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.43 139.75 36.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -53.54 -27.47 26.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.439 -0.788 . . . . 0.0 109.15 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.56 57.93 3.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 110.14 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mt -89.37 -42.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.251 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.2 ttt -79.15 -24.03 43.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.482 -0.761 . . . . 0.0 110.163 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.22 -29.5 53.35 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.5 t -84.3 -42.82 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -1.018 . . . . 0.0 109.742 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.94 -37.43 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -57.4 -29.48 64.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.699 -0.626 . . . . 0.0 110.107 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.41 -53.14 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 0.0 109.348 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.06 58.52 1.67 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.0 mt -78.12 162.91 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.647 -0.914 . . . . 0.0 109.211 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.95 -161.21 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.827 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 66.2 9.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.88 53.99 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.15 168.34 20.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.92 . . . . 0.0 109.554 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -126.14 133.26 51.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.8 pt -124.84 136.75 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.616 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -112.63 112.4 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.0 mt -93.71 155.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.644 -0.66 . . . . 0.0 109.343 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -149.45 104.68 3.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.717 -0.615 . . . . 0.0 109.349 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.56 135.04 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 106.94 4.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.44 -144.24 7.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.2 -73.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.958 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -95.32 45.47 1.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.308 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.42 -43.22 83.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.448 -0.782 . . . . 0.0 110.28 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.35 -37.15 84.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.881 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.45 -33.26 74.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.694 -0.629 . . . . 0.0 110.984 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.445 ' CB ' ' CG ' ' A' ' 29' ' ' TYR . . . -73.44 -53.57 10.36 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.319 -0.863 . . . . 0.0 111.615 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -54.6 -45.64 73.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.241 -0.912 . . . . 0.0 111.297 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -67.1 -27.82 67.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 109.079 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.64 -52.36 63.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.072 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -31.07 72.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 109.84 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.82 -52.2 66.09 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.87 . . . . 0.0 109.996 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.28 -27.62 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.6 m -70.62 -33.88 71.5 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmt -71.54 -31.13 66.69 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -86.24 -17.27 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -60.52 -49.93 75.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 109.81 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.42 -54.88 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.494 -0.754 . . . . 0.0 109.518 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.78 52.45 0.08 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.0 -63.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.562 -0.963 . . . . 0.0 109.566 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.49 134.89 4.7 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.534 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -60.92 153.66 24.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.425 -0.797 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -138.22 165.01 27.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m -115.83 138.21 51.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.693 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -125.02 144.85 50.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.718 . . . . 0.0 109.369 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.52 129.99 54.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 t -90.5 112.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.429 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -116.69 -14.31 10.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.686 -0.634 . . . . 0.0 110.292 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.94 140.33 56.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.877 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -68.56 -34.66 76.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.654 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -64.96 -28.72 69.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.763 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.15 -157.04 36.56 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 14' ' ' ILE . 9.1 mm . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.974 . . . . 0.0 109.157 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.91 -54.98 37.83 Favored Pre-proline 0 N--CA 1.507 2.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.563 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 31.1 Cg_endo -70.11 -23.0 29.68 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.052 1.168 . . . . 0.0 110.283 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.14 60.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.746 . . . . 0.0 109.134 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -28.82 31.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.772 . . . . 0.0 109.158 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -70.26 -37.79 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.97 -50.9 15.12 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.538 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.49 -28.91 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.5 -37.98 55.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.486 -0.759 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.1 m -71.95 -65.85 0.72 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.425 -0.797 . . . . 0.0 109.784 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.27 -27.33 14.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.674 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -61.71 -46.17 90.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -63.24 -21.87 66.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.685 . . . . 0.0 110.003 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.445 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 84.9 m-85 -89.53 127.1 35.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.16 -28.19 69.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.66 -0.65 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.39 53.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -89.93 94.38 9.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 0.0 109.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.89 135.06 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.64 -0.663 . . . . 0.0 109.248 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -132.08 138.25 48.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 0.0 110.171 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.07 156.02 19.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.51 129.52 35.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.37 57.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 55.63 22.63 5.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.86 -41.16 0.61 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -89.96 87.79 7.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.523 -0.986 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.7 m -91.74 112.6 24.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.05 148.24 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -64.92 138.96 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -54.54 -29.61 51.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -90.76 61.75 4.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.19 87.71 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 mt -70.33 -39.79 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.668 -0.645 . . . . 0.0 109.68 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.78 -28.56 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.22 57.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.45 -33.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.485 -1.009 . . . . 0.0 109.337 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -69.36 -34.29 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 109.194 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.5 p -63.08 -34.65 78.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.607 -0.683 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.89 -38.96 66.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.423 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.47 73.35 0.58 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.9 mt -81.78 151.06 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.968 . . . . 0.0 109.161 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.4 172.14 13.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.642 -0.662 . . . . 0.0 109.839 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 159.27 1.43 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.56 40.79 99.08 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.63 121.14 34.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -84.8 132.69 34.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.608 -0.683 . . . . 0.0 109.354 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 pt -127.22 163.44 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 109.383 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 m -140.14 111.4 7.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.2 mt -92.35 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -150.18 103.03 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.822 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 121.7 32.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.96 109.88 10.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 109.669 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.35 -150.21 10.8 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.51 -65.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.517 -0.99 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.73 47.5 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.637 -0.664 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -58.65 -41.46 86.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.727 . . . . 0.0 110.139 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -62.26 -30.13 70.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.91 -25.26 58.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.83 -39.97 25.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.816 . . . . 0.0 110.982 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.2 -42.46 93.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 0.0 110.459 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 17.7 p-10 -72.08 -28.44 63.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.0 109.187 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -61.0 -64.08 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.45 -0.781 . . . . 0.0 109.555 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.67 -25.54 66.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -0.828 . . . . 0.0 109.872 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -54.56 44.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.437 -0.789 . . . . 0.0 110.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 -28.26 69.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -66.22 -35.78 81.33 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -28.5 64.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.783 -0.573 . . . . 0.0 109.558 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -80.52 -25.19 38.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.782 . . . . 0.0 110.042 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 p -81.53 -63.14 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -0.766 . . . . 0.0 109.786 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.15 -29.11 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 109.731 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.2 6.24 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.77 -34.69 30.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.627 -0.925 . . . . 0.0 109.563 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.16 -179.42 41.83 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.58 150.58 31.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.045 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -134.64 163.03 30.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.708 -0.62 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 134.75 54.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.733 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -119.91 161.58 20.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.715 . . . . 0.0 109.547 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -120.2 123.68 43.85 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -83.66 120.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -131.95 16.19 4.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.738 . . . . 0.0 110.183 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 144.86 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.46 -29.2 70.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -90.0 -30.87 17.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 109.496 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.56 -150.03 19.7 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.987 . . . . 0.0 109.424 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.096 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 9.2 ttp180 -54.17 -55.45 36.58 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 31.0 Cg_endo -69.72 -22.17 32.64 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 120.922 1.081 . . . . 0.0 110.443 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.46 -21.66 57.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.259 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -82.12 -30.69 31.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.46 -0.775 . . . . 0.0 109.071 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 t -70.08 -34.49 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mt -76.85 -49.1 16.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.02 -0.425 . . . . 0.0 110.5 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.54 -27.26 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -54.13 8.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.441 -0.787 . . . . 0.0 110.328 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -61.16 -60.55 3.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.524 -0.735 . . . . 0.0 110.419 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.49 -26.52 43.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.466 -0.771 . . . . 0.0 110.745 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.48 -42.12 99.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.408 -0.807 . . . . 0.0 109.474 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -64.25 -21.03 66.44 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -89.4 133.88 34.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 0.0 109.696 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -77.32 -22.97 51.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.615 -0.678 . . . . 0.0 110.081 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.54 150.97 17.79 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.61 87.79 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.651 -0.656 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.02 118.16 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -120.25 124.9 46.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.75 142.55 27.64 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -129.98 155.76 45.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -145.8 105.27 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 -81.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.35 26.58 1.85 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -124.26 99.92 6.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.511 -0.994 . . . . 0.0 108.928 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -89.85 87.27 6.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.578 -0.702 . . . . 0.0 109.957 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.53 146.48 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -69.89 142.85 52.93 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -53.95 -28.88 40.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.403 -0.811 . . . . 0.0 109.02 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.92 59.45 4.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -150.1 89.53 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.2 mt -71.9 -51.8 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 109.519 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.0 tpt -61.49 -28.59 69.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.748 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.62 -40.53 53.38 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -64.56 -28.11 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.97 . . . . 0.0 109.601 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.4 t -74.03 -31.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.8 . . . . 0.0 109.422 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.6 p -64.3 -27.29 68.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mp -75.0 -46.76 32.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.798 . . . . 0.0 109.542 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.32 63.04 2.74 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.3 mt -74.21 162.58 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.922 . . . . 0.0 109.29 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.84 -164.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 109.759 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -72.98 135.23 44.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.778 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 45.16 7.43 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.03 161.72 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.598 -0.942 . . . . 0.0 109.408 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -124.5 118.59 26.96 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 151.99 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.744 . . . . 0.0 109.491 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.8 m -136.16 107.87 7.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.58 -0.7 . . . . 0.0 109.483 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.6 mt -92.25 159.28 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.614 -0.679 . . . . 0.0 109.275 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 p -144.98 102.47 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.715 -0.616 . . . . 0.0 109.667 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.88 121.48 32.04 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.75 105.33 6.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.354 -0.841 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.45 -140.68 4.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.67 -53.27 5.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.582 -0.952 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.3 45.59 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 109.418 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -66.16 -33.62 76.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 109.94 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.28 -35.29 61.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.448 -0.782 . . . . 0.0 109.839 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.75 -20.75 58.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.464 -0.773 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.41 -43.14 19.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.267 -0.895 . . . . 0.0 110.477 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.96 -41.7 95.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.324 -0.86 . . . . 0.0 110.694 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.436 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 26.3 p-10 -74.84 -25.92 59.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.59 -60.47 2.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.35 -28.41 69.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 109.771 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.15 -54.95 39.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.12 -29.14 68.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.372 -0.83 . . . . 0.0 109.978 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.8 m -69.03 -34.2 74.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.2 mmt -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.794 -0.567 . . . . 0.0 109.607 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -75.53 -28.6 59.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.783 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.3 p -66.23 -49.76 66.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.696 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -10.83 54.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.585 -0.697 . . . . 0.0 110.46 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.77 94.24 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.85 -62.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.583 -0.951 . . . . 0.0 109.648 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.67 120.76 1.38 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -49.94 155.2 0.94 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 110.771 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.37 162.64 38.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.318 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -101.34 165.98 10.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -149.52 145.55 26.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.691 . . . . 0.0 109.288 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -107.78 127.27 53.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.556 -0.715 . . . . 0.0 109.073 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.5 t -90.72 120.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.753 -0.592 . . . . 0.0 109.634 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -134.12 23.5 3.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.702 -0.624 . . . . 0.0 109.929 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 144.12 37.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -56.6 -49.47 74.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.388 -0.82 . . . . 0.0 109.882 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -80.44 -29.5 37.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.371 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.63 -161.39 19.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.613 -0.934 . . . . 0.0 109.187 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -57.44 13.36 Favored Pre-proline 0 N--CA 1.507 2.405 0 O-C-N 120.829 -1.169 . . . . 0.0 111.184 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -71.94 -18.31 27.97 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.333 1.355 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.78 -21.69 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.787 . . . . 0.0 109.385 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.33 -33.87 21.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -72.5 -35.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.699 0.762 . . . . 0.0 109.068 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.8 mt -77.17 -45.36 26.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.998 -0.439 . . . . 0.0 110.431 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.4 p -60.1 -27.47 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -73.44 -52.56 13.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.5 -0.75 . . . . 0.0 110.468 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.27 -54.39 46.33 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.422 -0.799 . . . . 0.0 110.344 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.68 -25.16 62.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.3 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.6 t -62.55 -38.6 90.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.348 -0.845 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.624 . . . . 0.0 109.931 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 88.3 m-85 -89.56 125.32 35.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 109.676 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -68.58 -24.73 64.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.874 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.62 144.63 42.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 109.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.67 96.14 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -89.96 131.39 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -122.08 130.61 53.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 110.379 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.1 tp -89.91 146.71 24.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.48 126.95 46.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.391 -0.818 . . . . 0.0 109.903 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 55' ' ' ILE . 42.0 t80 -160.33 137.65 9.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.61 37.35 19.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.037 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.85 29.5 67.71 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -129.33 113.36 14.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.595 -0.944 . . . . 0.0 109.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.6 m -93.39 91.52 7.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.538 -0.726 . . . . 0.0 109.794 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.514 -0.741 . . . . 0.0 109.065 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -69.4 145.03 53.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 7.0 tp -63.38 -13.25 37.49 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -87.17 50.51 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.77 -1.206 . . . . 0.0 108.113 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.0 t -150.24 86.2 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.83 -41.36 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.768 -0.582 . . . . 0.0 109.658 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.6 tpt -72.74 -27.23 61.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.526 -0.734 . . . . 0.0 109.762 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -24.13 72.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.67 -31.36 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -1.058 . . . . 0.0 109.574 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 t -75.43 -28.54 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.839 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.2 p -62.08 -27.97 69.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.77 . . . . 0.0 109.776 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.53 -76.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.475 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.89 55.42 0.27 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 37' ' ' TYR . 17.9 mt -73.85 150.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.607 -0.937 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.03 -158.68 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.671 -0.643 . . . . 0.0 109.722 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -86.55 63.57 8.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.6 56.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -132.52 129.72 39.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.93 . . . . 0.0 109.488 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -84.65 129.45 34.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.7 pt -123.21 134.56 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.639 -0.663 . . . . 0.0 109.347 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -105.16 117.07 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.8 mt -102.14 153.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -149.94 103.35 3.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.658 -0.651 . . . . 0.0 109.597 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.31 127.97 35.83 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.84 106.6 7.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.88 -145.67 7.17 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.09 -71.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.896 . . . . 0.0 109.594 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -98.91 52.73 0.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.535 -0.728 . . . . 0.0 109.416 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.92 -42.81 90.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.435 -0.79 . . . . 0.0 110.114 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -62.0 -28.58 69.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 0.0 109.85 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -23.53 50.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.433 -0.792 . . . . 0.0 110.454 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . . . -81.06 -47.11 14.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -62.26 -45.61 92.53 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.35 -0.844 . . . . 0.0 110.66 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 36.4 p-10 -70.81 -25.26 62.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.1 -62.72 1.58 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -62.76 -22.95 66.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.593 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.93 -52.39 65.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.49 -29.45 70.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -66.24 -33.85 76.68 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mmt -71.75 -28.24 63.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.749 -0.595 . . . . 0.0 109.665 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -86.89 -18.96 29.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 110.47 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -74.22 -67.59 0.6 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.34 -28.56 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.68 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.5 35.46 5.68 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.7 -49.7 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.748 -0.854 . . . . 0.0 109.696 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.1 -179.51 36.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.49 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -172.95 153.57 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.628 -0.67 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -144.58 148.16 34.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.679 -0.638 . . . . 0.0 109.632 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.5 m -92.61 159.08 15.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.712 -0.617 . . . . 0.0 109.438 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -143.08 172.68 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.171 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -136.68 122.74 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -75.11 111.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.638 . . . . 0.0 109.305 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -16.67 13.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.728 -0.608 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.05 139.88 56.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.24 -0.912 . . . . 0.0 109.841 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.73 -42.71 90.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.1 p -63.09 -29.82 71.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.46 -157.07 24.46 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.7 mt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.601 -0.941 . . . . 0.0 109.599 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.404 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.42 -60.7 7.67 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 120.852 -1.155 . . . . 0.0 111.001 -178.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.3 Cg_endo -69.7 -14.97 37.06 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.378 1.386 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.85 -23.96 38.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -0.831 . . . . 0.0 109.199 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.91 -30.04 26.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.192 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -74.31 -36.46 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.625 0.726 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.13 -43.86 27.69 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.92 -0.488 . . . . 0.0 110.367 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.8 -29.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 0.0 109.804 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -74.27 -42.49 59.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -65.42 -61.39 2.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.499 -0.751 . . . . 0.0 110.158 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.94 -25.38 63.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 0.0 110.303 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.0 t -60.92 -39.02 87.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.279 -0.888 . . . . 0.0 109.155 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -66.95 -27.72 67.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.452 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 98.7 m-85 -89.72 119.53 30.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.723 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -65.61 -15.74 63.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.774 -0.579 . . . . 0.0 110.278 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.51 172.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.82 88.67 2.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.638 . . . . 0.0 109.441 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.72 111.19 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.392 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -110.43 133.43 53.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.458 -0.777 . . . . 0.0 109.876 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.22 148.63 22.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.68 . . . . 0.0 109.268 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.39 107.55 12.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.51 -0.744 . . . . 0.0 109.445 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -92.88 71.69 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.441 -0.787 . . . . 0.0 110.003 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.66 85.57 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.656 -0.652 . . . . 0.0 111.592 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 -42.65 2.83 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -89.33 160.39 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.456 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -150.14 105.84 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.775 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.23 148.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 109.165 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.13 132.45 49.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -50.24 -28.22 7.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -90.76 61.18 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -150.44 86.79 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mt -63.93 -61.81 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.982 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 ttm -64.35 -21.66 66.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.465 -0.772 . . . . 0.0 110.167 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.57 60.29 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.18 -32.21 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.411 -1.053 . . . . 0.0 109.718 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.3 t -64.33 -28.4 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.781 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -69.48 -25.65 64.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 0.0 110.022 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 4.2 mm? -64.71 -37.12 86.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.486 -0.759 . . . . 0.0 109.592 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.88 38.02 28.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -69.59 144.24 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.54 -0.976 . . . . 0.0 109.264 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.59 -165.76 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.49 42.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.61 72.93 0.58 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.82 170.1 16.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.977 . . . . 0.0 109.602 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.77 143.41 48.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.693 . . . . 0.0 109.236 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.3 pt -145.79 126.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.539 -0.726 . . . . 0.0 109.524 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -101.64 118.39 36.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.0 mt -102.13 151.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -150.25 109.91 4.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.515 -0.74 . . . . 0.0 110.131 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.85 134.98 33.9 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.71 107.67 4.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.77 -127.32 1.36 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.2 -70.07 0.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.973 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -93.14 49.54 1.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.632 -0.668 . . . . 0.0 109.326 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -64.2 -40.9 97.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 0.0 110.039 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -68.48 -43.09 77.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.0 -23.9 65.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 0.0 110.314 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.22 -46.65 15.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.285 -0.885 . . . . 0.0 111.391 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -59.21 -41.74 89.31 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.88 -26.36 60.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.903 . . . . 0.0 109.221 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.452 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -60.27 -61.57 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.78 . . . . 0.0 109.24 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.64 -29.25 69.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.404 -0.81 . . . . 0.0 109.793 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.23 -37.73 86.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.487 -0.758 . . . . 0.0 109.919 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.75 -28.56 62.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.4 m -68.2 -37.6 81.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -27.89 63.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.777 -0.577 . . . . 0.0 109.567 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -86.87 -17.64 32.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 110.453 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -75.04 -52.12 11.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.886 . . . . 0.0 109.806 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.48 -35.1 14.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.653 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 44.81 1.52 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.6 mt -81.71 -29.33 33.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -1.006 . . . . 0.0 109.635 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.15 169.09 41.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.569 -179.859 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.87 153.96 36.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.558 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -142.9 144.64 32.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.678 -0.639 . . . . 0.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -90.15 146.3 24.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.675 -0.641 . . . . 0.0 109.402 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.416 ' CE1' HD11 ' A' ' 63' ' ' ILE . 36.0 m-85 -126.86 161.32 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.576 -0.703 . . . . 0.0 109.561 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.02 133.77 55.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.25 106.5 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.371 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -124.48 14.78 8.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 110.177 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 148.67 34.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -54.49 17.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.354 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -66.09 -29.3 69.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.565 -0.709 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.77 -159.31 20.27 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.995 . . . . 0.0 109.362 179.956 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -60.34 10.24 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.952 -1.093 . . . . 0.0 110.845 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -70.39 -13.54 33.18 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.341 1.36 . . . . 0.0 110.983 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.19 -28.65 38.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 108.914 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.84 -27.25 36.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.4 t -71.57 -40.84 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.8 mt -69.25 -53.98 17.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.161 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -53.14 -28.17 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 110.434 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -71.41 -43.12 67.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.935 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -69.18 -59.64 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.389 -0.819 . . . . 0.0 109.947 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.0 -21.59 31.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.465 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.7 t -58.9 -41.84 88.15 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -65.94 -29.51 69.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.438 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 68.9 m-85 -93.67 128.52 39.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.26 8.94 21.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.87 -178.44 1.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.96 75.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -89.71 124.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 109.395 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -135.03 142.8 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.612 -0.68 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.6 tt -89.62 159.16 17.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -127.12 125.67 41.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.409 ' CD2' HG12 ' A' ' 55' ' ' ILE . 73.8 t80 -160.39 145.5 14.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.504 -0.748 . . . . 0.0 109.784 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 61.3 34.82 18.37 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.631 -0.668 . . . . 0.0 110.018 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 29.5 70.21 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -135.33 178.92 6.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.59 -0.947 . . . . 0.0 109.083 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 m -143.74 114.12 7.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.23 147.71 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -68.11 134.74 51.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -53.39 -26.95 21.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.456 -0.778 . . . . 0.0 109.293 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.63 57.07 3.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -146.38 88.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 mt -69.21 -39.23 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 0.0 109.993 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.5 ttm -82.59 -29.5 30.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.755 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.03 -43.15 96.22 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.76 -34.01 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.49 -1.006 . . . . 0.0 109.385 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.4 -28.65 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.707 . . . . 0.0 109.561 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -62.03 -34.14 75.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.505 -0.747 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mp -70.83 -46.84 62.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.583 -0.698 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.68 65.57 2.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.5 mt -77.09 162.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.603 -0.939 . . . . 0.0 109.269 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.5 -175.06 3.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.655 -0.653 . . . . 0.0 109.618 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 153.23 42.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.598 -0.689 . . . . 0.0 109.496 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.3 55.45 10.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.68 179.49 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.557 -0.967 . . . . 0.0 109.535 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -132.82 140.86 48.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 pt -138.78 161.3 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.459 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.37 121.58 21.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 109.644 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.416 HD11 ' CE1' ' A' ' 6' ' ' PHE . 90.8 mt -105.01 149.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 p -150.3 112.83 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.79 134.59 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.01 102.87 3.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.394 -0.816 . . . . 0.0 109.821 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.88 -125.23 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.06 -72.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.956 . . . . 0.0 109.666 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.26 55.84 1.55 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.72 . . . . 0.0 109.385 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.18 -28.26 69.93 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -74.78 -44.4 49.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.44 -0.788 . . . . 0.0 109.946 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.5 -46.27 14.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.01 -1.056 . . . . 0.0 110.49 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.12 -42.42 96.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.348 -0.845 . . . . 0.0 110.669 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.416 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 45.7 p-10 -75.77 -22.41 56.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 109.391 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -66.86 -59.13 3.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.339 -0.851 . . . . 0.0 108.707 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.69 -28.39 69.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.527 -0.733 . . . . 0.0 109.848 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' OE2' ' CE2' ' A' ' 6' ' ' PHE . 4.8 tt0 -61.18 -56.28 22.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.477 -0.764 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.68 -30.67 70.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -68.56 -32.48 72.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -0.822 . . . . 0.0 108.915 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 30.6 mmm -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -76.0 -22.59 55.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.731 -0.605 . . . . 0.0 110.03 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 p -66.1 -50.04 65.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.399 -0.813 . . . . 0.0 109.675 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -97.84 10.1 41.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.565 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.5 89.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.3 mt -132.46 -60.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.628 -0.924 . . . . 0.0 109.401 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.22 150.4 22.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -64.6 152.71 41.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -150.44 137.73 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.652 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.4 m -89.85 139.71 30.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.632 -0.667 . . . . 0.0 109.357 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CD1' HD13 ' A' ' 63' ' ' ILE . 18.8 m-85 -123.02 169.5 11.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 109.868 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 137.88 52.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.592 -0.693 . . . . 0.0 109.342 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 21.3 t -90.51 108.09 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.59 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -129.1 22.25 5.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.59 -0.694 . . . . 0.0 109.884 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.68 159.06 29.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.07 -61.75 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.562 -0.711 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -71.04 -29.36 65.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.718 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.18 -139.55 14.98 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 14' ' ' ILE . 55.4 mt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.597 -0.943 . . . . 0.0 109.391 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.99 -54.07 51.15 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.906 -1.121 . . . . 0.0 111.092 -178.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -73.13 -21.44 20.44 Favored 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 121.115 1.21 . . . . 0.0 110.293 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.43 -21.43 58.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.33 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.52 -31.89 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.129 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.2 -45.21 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.7 -49.57 57.88 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -55.93 -29.64 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.83 -36.16 70.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.913 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -72.43 -59.25 2.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.473 -0.767 . . . . 0.0 110.148 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.14 31.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.478 -0.764 . . . . 0.0 110.738 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.1 p -59.94 -42.61 94.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.289 -0.882 . . . . 0.0 109.645 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -28.02 69.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.609 -0.682 . . . . 0.0 109.622 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 78.5 m-85 -94.8 131.48 40.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.429 -0.794 . . . . 0.0 109.633 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.23 -11.46 57.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.668 -0.645 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.3 155.73 8.55 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.039 -1.038 . . . . 0.0 109.82 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.62 82.0 6.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.581 -0.699 . . . . 0.0 109.528 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -89.68 121.97 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -124.5 126.24 45.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 110.105 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.4 tt -89.97 155.45 19.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -122.16 158.53 29.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 110.053 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 55' ' ' ILE . 34.3 t80 -145.48 98.46 3.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.04 -81.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.24 26.85 1.56 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -125.24 121.07 33.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.569 -0.96 . . . . 0.0 109.116 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.31 100.85 12.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.539 -0.726 . . . . 0.0 110.057 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.06 147.65 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -71.67 142.21 49.87 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -58.02 -30.43 66.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 109.105 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.74 60.8 4.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.79 81.23 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.6 mt -64.81 -38.66 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.697 -0.627 . . . . 0.0 109.662 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.81 -24.34 59.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.546 -0.721 . . . . 0.0 110.04 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 -31.24 46.08 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -79.92 -38.44 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -1.047 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.9 -30.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.7 p -67.52 -32.64 73.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.0 -55.78 5.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.544 -0.722 . . . . 0.0 109.533 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.43 63.77 1.69 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.426 HG21 ' CE1' ' A' ' 37' ' ' TYR . 61.8 mt -76.2 159.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.974 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.13 -175.04 4.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.707 -0.621 . . . . 0.0 109.558 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -70.46 146.96 49.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.628 -0.67 . . . . 0.0 109.603 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.42 61.88 2.39 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.33 -178.58 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.582 -0.952 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -128.49 148.48 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 61' ' ' ILE . 19.3 pt -139.81 154.63 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.76 113.11 11.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 6' ' ' PHE . 77.1 mt -99.12 155.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.25 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 p -150.22 101.04 2.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.841 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.76 122.38 32.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.4 104.78 4.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 109.707 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.4 -125.2 0.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.58 -69.74 0.71 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.642 -0.917 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.67 49.17 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.78 -32.41 70.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.475 -0.766 . . . . 0.0 110.023 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.35 -33.18 72.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -77.47 -23.25 50.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 110.051 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.401 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -68.16 -42.12 80.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 39.5 p30 -78.39 -18.86 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.31 -58.8 3.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.195 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -24.96 62.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.82 -59.11 4.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.91 -28.55 67.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.355 -0.84 . . . . 0.0 109.771 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 40.6 m -67.25 -35.89 80.48 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.33 -28.4 64.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.699 -0.626 . . . . 0.0 109.422 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -83.0 -21.55 33.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.113 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 p -75.08 -53.61 8.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -80.17 -29.1 38.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 109.562 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.57 37.32 7.02 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.02 -37.38 26.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.691 -0.887 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.39 163.06 34.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.415 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.7 155.74 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.423 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -140.1 141.19 36.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.685 . . . . 0.0 109.645 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 m -99.13 158.99 15.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -143.87 161.79 37.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.0 109.531 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -121.6 118.72 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.134 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.59 116.42 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.652 -0.655 . . . . 0.0 109.588 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -117.44 -16.03 10.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.726 -0.608 . . . . 0.0 110.357 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 151.97 36.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.68 -43.53 72.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -64.3 -32.5 74.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.589 -0.694 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.66 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.9 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.594 -0.944 . . . . 0.0 109.428 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.4 ttt180 -53.77 -52.98 62.66 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.046 -1.034 . . . . 0.0 111.109 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -74.27 -24.6 14.3 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.137 1.225 . . . . 0.0 110.332 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.36 -20.88 61.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.55 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.77 -34.16 21.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 108.979 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -69.95 -34.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.38 -51.5 11.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.397 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.17 -27.38 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.292 -0.88 . . . . 0.0 109.918 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.76 -45.63 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.676 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 m -61.05 -59.37 5.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 109.822 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.52 -26.43 67.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.041 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -59.86 -33.3 71.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -77.09 -26.32 53.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.619 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.3 m-85 -89.81 123.8 34.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.57 -24.21 67.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.692 -0.63 . . . . 0.0 109.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 141.76 53.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.401 -0.812 . . . . 0.0 109.789 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -89.51 98.56 11.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.587 -0.696 . . . . 0.0 109.235 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -89.96 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.575 -0.703 . . . . 0.0 109.351 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -131.96 132.84 43.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -121.27 128.73 52.65 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.477 -0.764 . . . . 0.0 109.903 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' A' ' 55' ' ' ILE . 51.9 t80 -160.49 138.49 9.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.718 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.87 37.08 15.58 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.536 -0.727 . . . . 0.0 109.754 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.76 27.98 64.93 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -123.35 168.98 11.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.943 . . . . 0.0 109.026 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.8 m -142.22 103.52 4.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 109.95 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.83 146.2 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -69.19 142.79 54.2 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.8 tp -64.05 -13.45 47.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.33 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -88.1 48.72 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.85 -1.157 . . . . 0.0 107.984 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 t -150.54 82.36 1.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.0 109.049 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.1 mt -63.63 -41.31 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.725 -0.61 . . . . 0.0 109.543 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.44 -29.98 66.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.29 -30.06 69.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.56 -31.13 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.97 . . . . 0.0 109.343 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.21 -31.68 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.616 -0.677 . . . . 0.0 109.397 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 p -63.89 -37.2 86.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.38 -46.62 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.605 -0.684 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.55 71.54 1.09 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 37' ' ' TYR . 59.5 mt -84.36 162.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.624 -0.927 . . . . 0.0 109.389 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.11 -174.14 4.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.602 -0.686 . . . . 0.0 109.617 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.9 150.31 42.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.712 -0.617 . . . . 0.0 109.686 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 62.7 3.14 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.63 164.88 29.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.942 . . . . 0.0 109.62 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -126.2 123.04 37.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 pt -117.56 130.52 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.687 . . . . 0.0 109.293 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.07 115.27 29.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.52 -0.738 . . . . 0.0 109.804 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.6 mt -101.93 149.85 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.581 -0.699 . . . . 0.0 109.183 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 p -147.22 108.89 4.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.637 -0.664 . . . . 0.0 109.675 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.75 131.16 35.85 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.61 107.18 7.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -145.72 8.16 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -64.4 1.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.943 . . . . 0.0 109.65 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.14 44.34 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.03 -32.21 72.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.35 -33.29 69.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 109.578 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.19 -24.13 54.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.761 . . . . 0.0 110.07 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -41.51 23.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 110.457 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.22 -41.84 96.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.294 -0.878 . . . . 0.0 110.4 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 40.8 p30 -76.54 -21.04 56.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.25 -0.907 . . . . 0.0 109.763 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.78 -56.49 9.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.747 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -28.24 69.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -54.31 47.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.462 -0.774 . . . . 0.0 109.66 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.68 -27.48 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.643 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 m -67.9 -33.89 75.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -28.74 64.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.68 -0.638 . . . . 0.0 109.293 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -81.51 -25.29 36.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.602 -0.686 . . . . 0.0 110.116 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 p -72.32 -58.89 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 109.69 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -75.17 -41.23 58.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 109.451 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.6 44.33 1.98 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.77 -38.57 25.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.578 -0.954 . . . . 0.0 109.463 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.57 150.38 14.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.454 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -160.24 155.57 25.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.69 -0.631 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -140.06 147.61 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.631 -0.668 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -99.38 146.53 26.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 80.4 m-85 -138.53 162.58 34.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -123.15 138.2 54.71 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.68 118.89 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.729 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -128.36 9.61 6.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 144.13 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.525 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.52 -34.41 74.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 p -71.14 -29.83 65.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.485 -0.759 . . . . 0.0 109.582 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.32 -150.62 19.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 14' ' ' ILE . 15.6 mm . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.54 -0.977 . . . . 0.0 109.215 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.076 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -56.02 -52.59 71.39 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.954 -1.091 . . . . 0.0 111.112 -178.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.3 Cg_endo -71.84 -25.15 20.4 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.189 1.26 . . . . 0.0 110.497 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.09 -26.08 62.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 108.96 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 m -79.21 -30.2 43.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.477 -0.764 . . . . 0.0 109.27 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.67 -48.99 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.107 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.8 -54.38 27.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.85 -30.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.388 -0.82 . . . . 0.0 110.739 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.33 -47.63 63.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.74 . . . . 0.0 110.339 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -65.96 -56.53 11.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.27 -17.78 59.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.442 -0.787 . . . . 0.0 110.437 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -64.66 -29.48 70.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.71 23.72 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.734 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -131.79 120.14 22.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -22.19 66.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.655 -0.653 . . . . 0.0 109.958 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 147.52 34.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.0 109.818 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.75 89.74 7.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.616 -0.678 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.89 138.65 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -133.77 135.47 43.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tp -95.78 131.29 42.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -108.73 119.4 39.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 110.449 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 28.7 t80 -103.82 97.52 7.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 72.37 -81.27 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.828 -0.545 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.04 26.76 2.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -124.52 116.06 21.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -1.014 . . . . 0.0 109.012 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -91.5 104.15 16.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.428 -0.795 . . . . 0.0 110.321 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.25 147.86 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -68.2 140.37 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.96 -27.32 63.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.429 -0.795 . . . . 0.0 109.035 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -90.02 51.5 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.805 . . . . 0.0 109.118 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -137.87 91.96 2.63 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 mm -68.11 -62.54 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.682 -0.636 . . . . 0.0 109.641 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -66.5 -25.76 66.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 109.91 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.6 -30.13 75.89 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.69 -30.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.513 -0.992 . . . . 0.0 109.442 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.05 -29.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.484 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -66.52 -30.41 70.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.717 . . . . 0.0 109.589 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.93 -66.43 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.723 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.71 52.33 0.86 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.417 HG12 ' CZ ' ' A' ' 37' ' ' TYR . 38.7 mt -78.5 150.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.548 -0.972 . . . . 0.0 109.041 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.96 -164.28 1.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.573 -0.705 . . . . 0.0 109.804 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -66.64 153.89 41.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 109.703 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.15 57.85 13.96 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.1 173.97 8.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.667 -0.902 . . . . 0.0 109.515 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -128.37 141.13 51.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 pt -142.76 126.02 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.54 -0.725 . . . . 0.0 109.373 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 m -106.89 110.07 22.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.532 -0.73 . . . . 0.0 109.828 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 63' ' ' ILE . 79.2 mt -94.19 150.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -150.1 109.75 4.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.67 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.82 132.52 35.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.38 102.67 4.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.362 -0.836 . . . . 0.0 109.748 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.45 -134.38 2.57 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.49 -58.82 2.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.95 . . . . 0.0 109.476 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.13 47.96 1.04 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.9 -40.35 87.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 110.114 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -70.31 -35.64 73.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.897 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.88 -24.18 59.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 110.105 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.65 -44.07 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.823 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -61.79 -42.8 99.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.293 -0.88 . . . . 0.0 110.635 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.421 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 17.0 p-10 -72.48 -27.51 62.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 0.0 109.151 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.19 -58.36 8.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 109.254 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.72 -22.66 66.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -62.71 1.46 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.34 -34.51 73.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.313 -0.867 . . . . 0.0 109.906 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.8 m -63.15 -32.87 74.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.408 -0.807 . . . . 0.0 108.971 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.33 -30.95 66.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -82.02 -19.18 40.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.655 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.7 p -80.66 -45.51 17.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 109.739 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -81.06 -28.74 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.729 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 32.26 8.02 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.72 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.665 -0.903 . . . . 0.0 109.478 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.19 -173.08 13.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -107.32 150.12 27.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -142.18 150.78 41.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.7 -0.625 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 m -105.3 151.09 24.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 109.291 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.64 166.03 24.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.493 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -113.1 134.57 54.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.618 -0.676 . . . . 0.0 109.301 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 t -89.27 99.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 109.564 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -123.37 27.15 7.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 155.2 31.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -65.46 -43.71 89.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.265 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -101.15 21.77 13.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 109.851 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.34 -136.79 47.64 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.3 mt . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.573 -0.957 . . . . 0.0 109.426 -179.993 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.43 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -54.1 -52.46 68.28 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 111.521 -178.398 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -72.89 -23.89 18.29 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.19 1.26 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.36 -22.26 57.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 109.526 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.72 -31.19 26.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.225 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -71.53 -42.95 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.722 0.772 . . . . 0.0 108.998 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.47 -50.31 39.4 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.463 -179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 p -55.3 -28.88 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -73.01 -36.83 67.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.485 -0.759 . . . . 0.0 109.861 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -73.94 -63.78 1.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.456 -0.777 . . . . 0.0 110.202 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -25.08 50.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -61.3 -40.9 95.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -68.36 -26.47 65.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.442 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.1 m-85 -89.85 128.32 36.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.342 -0.849 . . . . 0.0 109.725 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.29 -23.44 62.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.666 -0.646 . . . . 0.0 110.291 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 146.06 26.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.305 -0.872 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 91.05 8.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.538 -0.726 . . . . 0.0 109.263 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.9 m -89.91 113.93 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.673 -0.642 . . . . 0.0 109.335 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -105.93 137.25 44.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 tt -100.72 116.27 32.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -89.61 143.21 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.843 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CE2' HG12 ' A' ' 55' ' ' ILE . 15.1 t80 -132.38 68.9 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.7 . . . . 0.0 109.547 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.56 62.26 2.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.3 -38.85 2.95 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -89.15 90.88 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -1.031 . . . . 0.0 109.195 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.4 m -95.91 112.55 24.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 110.11 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.1 147.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -65.59 141.81 58.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -56.87 -29.58 63.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 109.139 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 61.02 4.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -148.78 88.74 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.1 mt -71.72 -40.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.618 -0.676 . . . . 0.0 109.937 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -30.2 45.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 109.691 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.4 92.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.06 -28.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.54 -0.976 . . . . 0.0 109.52 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.18 -31.3 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 109.401 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -62.89 -41.02 99.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.768 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.11 -33.51 75.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 109.431 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.84 23.65 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 37' ' ' TYR . 54.6 mt -75.92 147.46 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.615 -0.933 . . . . 0.0 109.327 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.68 -167.52 1.84 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.52 150.34 32.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.577 -0.702 . . . . 0.0 109.538 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.84 3.7 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 179.97 6.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.941 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.16 136.19 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 pt -124.38 162.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.668 . . . . 0.0 109.677 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.0 m -136.34 161.26 36.3 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.2 mt -146.26 150.95 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.409 -0.807 . . . . 0.0 109.768 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -150.52 108.13 3.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.67 -0.643 . . . . 0.0 109.578 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.63 130.43 35.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 109.08 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 102.22 5.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.2 -142.24 5.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.16 -57.96 2.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.588 -0.948 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -96.72 48.3 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.688 . . . . 0.0 109.359 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -66.89 -29.08 68.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 109.744 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -77.74 -36.23 51.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.497 -0.752 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -76.16 -20.72 57.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.117 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.36 -44.26 17.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.906 . . . . 0.0 110.296 -179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.83 -42.45 94.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.466 -0.771 . . . . 0.0 110.285 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 23.8 p30 -78.55 -19.8 52.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.462 -0.774 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.442 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.76 -54.32 20.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.56 -30.9 71.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.665 -0.647 . . . . 0.0 109.6 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.18 -52.19 66.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.43 -0.794 . . . . 0.0 110.122 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.83 -29.44 70.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.2 m -67.67 -33.26 74.58 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.8 mtt -67.87 -29.29 68.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -84.64 -23.49 29.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.569 -0.707 . . . . 0.0 110.184 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -73.54 -55.33 6.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -85.06 -27.92 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.524 -0.735 . . . . 0.0 109.679 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.18 1.48 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.78 -37.8 6.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.957 . . . . 0.0 109.685 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.84 158.34 30.83 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.245 0.545 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -99.91 157.06 16.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.782 . . . . 0.0 109.234 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -146.32 137.78 24.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 m -89.69 159.48 17.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.674 . . . . 0.0 109.244 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -145.4 143.31 30.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.6 -0.687 . . . . 0.0 109.69 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.57 127.92 46.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.214 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.5 t -85.96 134.21 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.586 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -149.6 27.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.583 -0.698 . . . . 0.0 109.587 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.58 146.7 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -58.87 5.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.1 p -69.67 -31.31 69.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.687 . . . . 0.0 109.408 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.06 -154.22 16.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 14' ' ' ILE . 38.7 mm . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.973 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.074 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.8 ttp85 -59.06 -55.17 49.1 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.77 -1.206 . . . . 0.0 111.094 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.0 Cg_endo -69.93 -21.51 32.59 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.04 1.16 . . . . 0.0 110.417 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.69 -22.53 50.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 109.272 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 m -81.13 -29.38 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.81 . . . . 0.0 109.152 179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.24 -41.1 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.52 -51.78 32.53 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.297 -179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.55 -28.26 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.389 -0.819 . . . . 0.0 109.816 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -69.96 -36.64 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -60.22 2.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.627 -0.67 . . . . 0.0 110.13 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.83 -24.83 62.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.473 -0.767 . . . . 0.0 110.359 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 t -60.84 -39.23 88.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -23.21 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.671 -0.643 . . . . 0.0 109.885 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 86.3 m-85 -89.46 127.72 35.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -0.865 . . . . 0.0 109.632 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.87 -22.8 62.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.72 -0.612 . . . . 0.0 109.905 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.17 45.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 109.715 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.67 93.9 9.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.56 -0.713 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -89.84 127.72 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -118.91 126.68 52.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 110.486 -178.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.79 133.73 34.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -113.35 130.16 56.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.448 -0.782 . . . . 0.0 110.167 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CE2' HG12 ' A' ' 55' ' ' ILE . 35.7 t80 -160.46 136.95 8.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.55 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.28 37.44 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.581 -0.7 . . . . 0.0 109.748 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.96 28.76 66.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -127.17 111.37 13.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.599 -0.942 . . . . 0.0 109.158 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -89.79 87.78 7.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.866 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.33 146.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -73.64 152.44 40.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.5 tp -69.61 -9.04 52.49 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.288 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -88.7 48.79 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.764 -1.21 . . . . 0.0 107.991 178.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 t -150.41 95.43 2.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.381 -0.825 . . . . 0.0 109.298 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.7 mt -76.97 -38.81 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.677 -0.639 . . . . 0.0 109.557 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpt -74.65 -34.03 62.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.59 99.24 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.11 -28.31 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.98 . . . . 0.0 109.424 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -63.2 -35.06 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 p -63.5 -34.58 78.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.643 -0.66 . . . . 0.0 109.365 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.01 -59.02 4.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 109.333 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.2 67.32 1.54 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 55' ' ' ILE . 50.2 mt -81.22 162.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.557 -0.967 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.98 178.57 9.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.572 -0.705 . . . . 0.0 109.463 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -62.02 137.97 58.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.48 39.96 9.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.47 179.59 4.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.604 -0.939 . . . . 0.0 109.468 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -137.95 153.2 49.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.678 -0.639 . . . . 0.0 109.365 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 pt -150.19 132.47 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.88 107.51 18.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.558 -0.714 . . . . 0.0 109.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.0 mt -94.11 153.81 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.211 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -148.04 107.96 4.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.67 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 125.92 35.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.526 -0.734 . . . . 0.0 109.06 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.85 107.12 8.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.32 8.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.61 -58.02 3.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 0.0 109.536 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.63 42.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.671 . . . . 0.0 109.361 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.01 -29.24 70.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.588 -0.695 . . . . 0.0 109.798 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -78.15 -33.46 50.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -76.42 -22.15 55.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.721 . . . . 0.0 110.125 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . . . -81.54 -42.52 20.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.08 -42.35 94.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.693 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.417 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 19.6 p30 -75.06 -22.53 58.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 109.622 -179.682 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.33 -59.5 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 108.745 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -28.88 70.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.52 -0.737 . . . . 0.0 109.781 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.33 -55.9 26.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.459 -0.776 . . . . 0.0 109.938 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -58.73 -27.24 64.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 110.038 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -70.91 -36.86 72.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 mmt -71.0 -29.85 65.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.754 -0.591 . . . . 0.0 109.459 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -83.5 -21.75 32.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.575 -0.703 . . . . 0.0 110.229 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -75.2 -70.22 0.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 109.781 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -62.2 -28.22 69.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.713 . . . . 0.0 109.753 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.79 39.91 5.41 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.81 -56.12 4.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.552 -0.97 . . . . 0.0 109.373 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.78 176.54 27.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.29 153.15 20.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.599 -0.688 . . . . 0.0 109.441 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 7.3 tttp -141.71 149.47 40.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 109.374 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -89.92 153.02 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.534 -0.729 . . . . 0.0 109.476 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 76.7 m-85 -142.27 145.49 34.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.624 -0.672 . . . . 0.0 109.398 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.97 126.93 52.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.2 t -81.61 116.1 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.589 -0.694 . . . . 0.0 109.552 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -134.34 26.37 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.46 164.55 25.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 109.466 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.55 -34.22 73.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.572 -0.705 . . . . 0.0 109.316 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -114.48 24.25 12.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.73 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.65 -139.07 46.77 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.906 . . . . 0.0 109.307 179.996 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.416 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.63 -53.72 59.48 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.961 -1.087 . . . . 0.0 110.829 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -73.88 -21.67 18.34 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.113 1.208 . . . . 0.0 110.456 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.03 60.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.258 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.55 -31.12 24.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 109.16 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -73.03 -35.48 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.721 0.772 . . . . 0.0 109.047 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.87 -43.35 30.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.996 -0.44 . . . . 0.0 110.554 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.72 -27.94 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 109.681 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -72.43 -50.35 26.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.528 -0.733 . . . . 0.0 110.025 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -61.57 -59.07 5.77 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.51 -0.743 . . . . 0.0 109.991 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.51 60.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -38.98 83.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -29.06 69.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.483 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 96.5 m-85 -89.65 118.37 29.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.46 -15.68 62.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.657 -0.652 . . . . 0.0 110.243 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.35 29.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.7 86.95 6.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.391 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.73 119.98 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -112.12 132.82 54.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.732 . . . . 0.0 109.994 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.93 135.12 33.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -105.93 140.36 39.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.737 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 55' ' ' ILE . 27.5 t80 -140.82 84.54 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.667 -0.646 . . . . 0.0 109.532 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.42 52.06 6.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.614 -0.679 . . . . 0.0 110.089 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.86 -12.96 64.17 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.412 -0.899 . . . . 0.0 110.874 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -89.48 86.91 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -1.175 . . . . 0.0 109.348 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 m -91.63 92.97 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.879 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.94 147.5 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.01 142.55 57.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 7.2 tp -64.14 -13.75 50.27 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.22 48.36 1.63 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.8 t -150.27 84.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.818 . . . . 0.0 109.139 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.1 mt -67.45 -46.31 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 0.0 109.255 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 ttm -64.35 -29.74 70.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.634 -0.667 . . . . 0.0 109.36 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.07 91.88 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.49 -39.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.972 . . . . 0.0 109.286 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.7 t -64.11 -30.63 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -68.14 -31.6 71.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.637 -0.664 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.91 -67.58 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.79 47.8 1.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.5 mt -63.73 157.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.953 . . . . 0.0 109.122 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.01 -170.49 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -84.13 150.66 25.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 109.474 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.02 46.95 14.53 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.33 178.46 6.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.481 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.78 147.75 49.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.679 . . . . 0.0 109.466 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.4 pt -142.5 157.36 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -131.37 109.63 10.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 109.639 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.416 HD11 ' CE1' ' A' ' 6' ' ' PHE . 90.0 mt -92.32 152.41 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.729 . . . . 0.0 109.145 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -150.2 109.54 3.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.78 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 126.64 35.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 103.86 5.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.475 -0.766 . . . . 0.0 109.618 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.54 -130.85 1.8 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.86 -74.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.629 -0.924 . . . . 0.0 109.59 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -90.34 53.0 2.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.8 -30.45 69.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.869 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.27 -37.81 60.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.712 . . . . 0.0 109.797 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.83 -24.88 58.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 110.19 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HA ' ' CD2' ' A' ' 29' ' ' TYR . . . -80.9 -43.18 20.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.832 . . . . 0.0 110.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -62.51 -42.01 99.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 17.9 p-10 -74.13 -26.93 60.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 -60.77 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.805 . . . . 0.0 109.28 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -28.07 69.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 109.969 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -56.61 19.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.919 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.79 -28.28 69.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -67.8 -32.59 73.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -30.78 66.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -81.17 -24.17 37.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.635 -0.666 . . . . 0.0 109.989 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -73.98 -69.33 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.61 -28.79 70.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.45 44.73 5.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.3 mt -81.87 -33.82 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.612 -0.934 . . . . 0.0 109.572 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.03 153.45 10.85 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.387 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -91.56 153.48 19.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 10.3 tttm -143.28 150.31 39.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.659 . . . . 0.0 109.631 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -97.16 152.42 18.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 4' ' ' LYS . 96.5 m-85 -142.08 148.2 38.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.627 -0.671 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -110.11 117.61 34.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.712 . . . . 0.0 109.145 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.15 112.97 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.736 -0.602 . . . . 0.0 109.503 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.6 17.62 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.701 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.25 38.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 109.373 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.12 91.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.552 -0.717 . . . . 0.0 109.716 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -75.17 -29.61 60.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.438 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 -166.38 24.87 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 14' ' ' ILE . 62.8 mt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.567 -0.96 . . . . 0.0 109.435 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -57.88 -60.96 8.36 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.875 -1.141 . . . . 0.0 110.575 -178.594 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.59 -13.67 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.265 1.31 . . . . 0.0 110.786 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.91 -26.12 40.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 108.974 179.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.09 -29.78 31.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -0.755 . . . . 0.0 109.056 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.38 -43.93 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.11 -51.6 36.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.465 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -53.44 -29.54 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -70.75 -40.68 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -69.52 -63.95 0.97 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.926 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.92 -24.91 25.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.468 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 t -60.06 -44.86 94.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 109.328 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -65.45 -28.85 69.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.623 -0.673 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -89.65 129.91 36.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 109.269 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.23 -7.98 58.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.618 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.4 168.93 1.87 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.98 . . . . 0.0 109.707 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.99 87.09 4.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.429 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -95.84 98.64 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -107.11 131.89 53.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 0.0 109.761 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.5 tt -89.99 153.19 20.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.328 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -126.07 145.25 50.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.759 . . . . 0.0 109.447 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -160.29 108.48 1.66 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.531 -0.731 . . . . 0.0 109.835 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.82 50.52 8.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 109.93 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.49 27.98 71.71 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.41 97.92 5.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 109.133 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -91.79 102.02 14.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.557 -0.714 . . . . 0.0 110.062 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.95 147.46 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.87 135.37 52.4 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -53.99 -25.62 21.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.373 -0.829 . . . . 0.0 109.338 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -90.61 54.58 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -145.64 85.22 1.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.7 mt -67.42 -40.32 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.708 -0.62 . . . . 0.0 110.118 -178.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.4 ttt -74.45 -27.68 60.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.48 -0.762 . . . . 0.0 109.835 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.89 59.14 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 37.4 t -67.39 -38.58 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -1.017 . . . . 0.0 109.72 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -29.17 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.47 -0.768 . . . . 0.0 109.626 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.9 p -65.77 -29.62 70.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.49 -56.09 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.561 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.18 43.65 3.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.88 158.0 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -1.003 . . . . 0.0 109.3 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.94 -164.47 1.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.551 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -66.94 130.14 42.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.586 -0.696 . . . . 0.0 109.568 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.65 79.7 0.94 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.97 167.35 25.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.611 -0.934 . . . . 0.0 109.437 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.51 119.85 23.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 109.27 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.5 pt -120.33 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.717 . . . . 0.0 109.556 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -112.25 111.84 23.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.603 -0.685 . . . . 0.0 109.738 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD13 ' CD2' ' A' ' 6' ' ' PHE . 90.1 mt -92.41 158.75 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 p -150.31 103.13 3.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.99 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.96 123.66 36.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.49 105.77 4.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.56 -124.89 0.93 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.02 -65.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.962 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -97.97 53.83 1.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.18 -29.76 68.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.531 -0.73 . . . . 0.0 109.816 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.43 -36.16 58.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.769 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.84 -23.9 58.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.703 . . . . 0.0 110.111 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.85 -43.6 19.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.825 . . . . 0.0 110.722 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -63.87 -41.53 97.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.23 -0.919 . . . . 0.0 110.542 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 24.5 p-10 -76.81 -22.49 53.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 -179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.98 -53.96 17.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.258 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.22 -26.34 61.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.513 -0.742 . . . . 0.0 109.995 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -58.47 6.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.416 -0.802 . . . . 0.0 109.76 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -29.11 68.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.449 -0.782 . . . . 0.0 109.702 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.0 m -68.49 -34.22 75.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmm -71.49 -32.25 68.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.636 -0.665 . . . . 0.0 109.455 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -77.28 -27.38 53.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.66 -0.65 . . . . 0.0 109.951 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 p -71.46 -70.66 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.485 -0.759 . . . . 0.0 109.637 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -64.43 -28.29 69.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.691 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.57 45.35 6.49 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.33 -37.9 22.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.579 -0.953 . . . . 0.0 109.845 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.67 114.4 0.5 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.994 . . . . 0.0 109.613 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 154.34 1.66 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.361 -0.837 . . . . 0.0 110.563 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -139.66 165.78 26.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.682 -0.636 . . . . 0.0 109.48 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -118.18 126.78 52.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -109.44 150.15 28.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.86 117.11 33.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.415 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.6 t -76.22 124.19 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.648 -0.657 . . . . 0.0 109.661 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 m -142.5 21.57 2.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.899 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 143.39 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.1 -43.56 70.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.533 -0.73 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -69.04 -35.59 76.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 0.0 109.462 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.73 -164.15 12.97 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.978 . . . . 0.0 109.307 179.997 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.43 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.9 mmm180 -59.58 -61.27 8.2 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.958 -1.088 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.9 Cg_endo -69.49 -17.48 38.78 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.296 1.33 . . . . 0.0 110.669 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.1 -25.95 52.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.483 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -82.98 -29.92 28.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.25 -41.85 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.669 0.747 . . . . 0.0 109.162 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.97 -47.02 55.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.978 -0.451 . . . . 0.0 110.587 -179.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -59.07 -28.92 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -44.22 70.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.648 -0.657 . . . . 0.0 110.011 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -66.67 -59.68 3.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.484 -0.76 . . . . 0.0 110.013 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.61 -22.14 43.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 110.499 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.2 t -59.13 -40.91 86.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.277 -0.89 . . . . 0.0 109.719 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -69.05 -26.62 65.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.73 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.415 ' CZ ' ' HB1' ' A' ' 76' ' ' ALA . 94.1 m-85 -89.82 121.6 32.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.64 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.36 -18.84 63.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.691 -0.631 . . . . 0.0 110.089 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.8 148.46 25.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.212 -0.93 . . . . 0.0 109.848 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -89.78 92.05 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -91.69 120.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -117.7 134.22 55.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.5 145.59 25.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.05 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.38 129.11 55.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.397 -0.815 . . . . 0.0 110.084 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 55' ' ' ILE . 54.1 t80 -160.33 141.42 12.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.533 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.79 33.78 17.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.722 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.76 30.16 74.19 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -125.32 175.29 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.626 -0.926 . . . . 0.0 108.989 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.5 m -148.65 101.2 3.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.11 146.49 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.644 -0.66 . . . . 0.0 109.227 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -70.22 140.82 52.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.8 tp -62.85 -15.51 54.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.203 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.26 49.68 1.84 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.0 t -150.07 90.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.1 mt -71.43 -45.48 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.824 -0.548 . . . . 0.0 109.773 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ttt -66.17 -27.22 67.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.771 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.91 -37.15 51.04 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.56 -35.8 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.516 -0.991 . . . . 0.0 109.45 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.72 -29.3 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.493 -0.754 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.0 p -62.76 -33.09 74.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.566 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mp -74.55 -55.01 6.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.489 -0.757 . . . . 0.0 109.277 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.03 64.99 2.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.2 mt -74.5 162.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.97 . . . . 0.0 109.165 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.33 -172.04 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.579 -0.7 . . . . 0.0 109.746 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 142.92 38.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.58 8.03 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.94 166.91 17.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.961 . . . . 0.0 109.434 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.25 123.03 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.677 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -113.87 138.68 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.551 -0.718 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.09 108.73 19.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.762 . . . . 0.0 109.692 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.7 mt -93.27 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -150.08 106.45 3.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.638 -0.664 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.99 124.99 35.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 108.93 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.439 -0.788 . . . . 0.0 109.831 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -142.44 6.37 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.53 -63.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.991 . . . . 0.0 109.381 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -97.63 41.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.662 -0.648 . . . . 0.0 109.334 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -49.15 78.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.659 -0.65 . . . . 0.0 110.794 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.89 -36.4 79.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.156 -0.965 . . . . 0.0 109.983 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.3 -22.88 60.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.587 -0.696 . . . . 0.0 110.651 -179.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 29' ' ' TYR . . . -80.04 -48.04 13.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.925 . . . . 0.0 110.852 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -60.65 -45.05 95.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.304 -0.872 . . . . 0.0 110.857 -178.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 21.1 p-10 -68.87 -27.34 65.72 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 29' ' ' TYR . . . -63.75 -54.7 31.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 108.758 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -28.72 70.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.643 -0.661 . . . . 0.0 109.783 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -62.31 -53.99 47.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -60.31 -27.9 67.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.813 . . . . 0.0 109.922 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -71.54 -33.79 69.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.4 mmm -71.66 -31.82 67.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -82.12 -21.37 36.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 110.155 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.0 p -59.54 -40.28 86.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.972 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -111.76 -50.74 2.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.575 -0.703 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.03 54.29 0.19 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.6 mt -85.56 -63.6 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.595 -0.944 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 118.82 1.14 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -178.97 153.52 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -151.88 139.39 19.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.615 -0.678 . . . . 0.0 109.848 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 m -89.92 121.15 31.77 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 71.6 m-85 -103.71 152.29 21.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.65 . . . . 0.0 109.694 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -100.71 131.25 46.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 t -90.04 114.49 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.74 . . . . 0.0 109.632 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -135.42 21.18 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.595 -0.691 . . . . 0.0 109.857 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.22 32.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.545 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -69.8 -50.53 42.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -73.45 -30.31 63.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -152.62 18.86 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.7 mm -109.52 58.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.98 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.417 ' CD2' ' CD ' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.62 76.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.873 -1.142 . . . . 0.0 112.563 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.18 -54.18 44.26 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 120.919 -1.113 . . . . 0.0 111.347 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.0 Cg_endo -72.56 -25.61 17.52 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 121.36 1.373 . . . . 0.0 110.313 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.45 -21.39 61.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.558 -0.714 . . . . 0.0 109.332 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.02 -31.23 23.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -71.29 -37.64 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.0 mt -75.01 -50.4 16.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.009 -0.432 . . . . 0.0 110.299 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.91 -29.12 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.241 -0.912 . . . . 0.0 109.95 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -73.6 -39.85 64.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.704 . . . . 0.0 109.472 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -68.49 -66.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.71 -23.25 16.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.52 -0.737 . . . . 0.0 110.47 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -45.0 92.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.809 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -62.7 -28.62 70.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.661 . . . . 0.0 109.479 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.95 129.17 36.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 -16.93 59.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.703 -0.623 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 150.96 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.21 -0.931 . . . . 0.0 109.91 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.01 83.38 6.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.696 -0.628 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 m -89.67 123.53 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.41 146.22 48.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 110.036 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tt -96.31 157.09 16.06 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.09 134.21 53.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CE1' HG21 ' A' ' 55' ' ' ILE . 67.2 t80 -160.17 129.33 5.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.0 109.785 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.34 30.89 20.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.631 -0.668 . . . . 0.0 109.975 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.26 30.46 71.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.38 116.46 17.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.954 . . . . 0.0 109.296 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -96.13 107.86 20.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.612 -0.68 . . . . 0.0 109.96 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.7 148.06 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -65.23 132.75 49.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -52.05 -26.78 11.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.92 53.83 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.47 84.78 1.82 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.8 mt -67.88 -40.11 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 tpt -76.52 -26.12 54.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.568 -0.708 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.03 -31.98 57.12 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -73.52 -27.8 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.97 . . . . 0.0 109.638 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.01 -33.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.376 -0.828 . . . . 0.0 109.491 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.0 p -63.26 -31.89 73.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.66 -45.51 61.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.86 62.31 5.61 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 37' ' ' TYR . 54.4 mt -75.74 153.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.985 . . . . 0.0 109.34 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.43 -166.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.0 109.702 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 142.07 34.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.649 -0.657 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 43.61 6.25 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.5 178.98 6.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.961 . . . . 0.0 109.474 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -132.77 153.5 51.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.488 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.1 pt -141.21 144.33 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.606 -0.684 . . . . 0.0 109.286 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.02 116.71 27.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 6' ' ' PHE . 85.8 mt -102.84 151.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 p -150.4 113.34 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.529 -0.732 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.81 130.48 36.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.4 99.88 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.81 -138.36 3.77 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.96 -74.14 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.975 . . . . 0.0 109.388 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.78 50.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.4 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.31 -31.44 70.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.95 -35.93 64.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.39 -0.819 . . . . 0.0 109.835 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 -26.38 63.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.428 -0.795 . . . . 0.0 110.31 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.93 -45.03 21.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 111.259 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -60.62 -41.8 95.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.935 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.97 -25.7 60.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -64.0 -57.04 10.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -28.44 70.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 109.842 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.24 -55.05 36.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.62 -26.64 65.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.4 m -72.07 -34.9 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -28.51 63.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.744 -0.597 . . . . 0.0 109.474 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -85.21 -23.32 28.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.709 . . . . 0.0 110.107 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -67.3 -50.64 59.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.396 -0.815 . . . . 0.0 109.657 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.49 -42.55 9.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 43.41 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.84 -31.33 31.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.981 . . . . 0.0 109.463 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.16 168.88 42.01 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.05 153.37 48.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 129.09 26.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 109.657 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.9 m -99.13 136.55 38.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.611 -0.681 . . . . 0.0 109.374 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 78' ' ' GLU . 76.7 m-85 -119.54 174.49 6.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.564 -0.71 . . . . 0.0 109.718 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.6 129.72 54.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.612 -0.68 . . . . 0.0 109.217 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.74 113.34 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.577 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 16.31 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.704 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.14 34.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.289 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -62.1 -49.92 73.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -69.12 -28.81 66.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.576 -0.702 . . . . 0.0 109.554 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.35 -152.01 23.11 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.8 mt -113.76 77.81 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.979 . . . . 0.0 109.394 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.403 ' CD2' ' CD ' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.07 80.5 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.822 -1.174 . . . . 0.0 112.256 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -54.58 -54.96 43.02 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.929 -1.107 . . . . 0.0 111.285 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.64 -22.74 23.82 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.114 1.21 . . . . 0.0 110.347 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.86 -22.63 59.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.13 -29.75 28.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.256 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.17 -40.16 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 109.178 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.25 -43.81 60.48 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.954 -0.467 . . . . 0.0 110.394 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.52 -29.83 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.873 . . . . 0.0 109.479 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -45.42 74.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.556 -0.715 . . . . 0.0 109.753 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -64.3 -60.48 3.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.465 -0.772 . . . . 0.0 109.758 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.8 -20.92 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.608 -0.683 . . . . 0.0 110.624 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -60.45 -40.6 91.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -66.58 -32.11 73.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 109.374 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 71.9 m-85 -90.96 130.34 36.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.2 14.13 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 177.65 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.71 78.21 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.5 m -89.39 85.86 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.677 -0.639 . . . . 0.0 109.285 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.0 123.71 34.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.738 -0.602 . . . . 0.0 109.956 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.0 tp -91.51 133.57 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -119.42 129.53 54.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.627 -0.671 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -116.4 74.16 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 109.834 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 48.3 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.574 -0.704 . . . . 0.0 111.409 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.95 -37.72 3.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -89.64 161.56 16.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -1.061 . . . . 0.0 109.597 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 m -150.1 75.93 1.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.613 -0.679 . . . . 0.0 109.708 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -92.52 145.14 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -71.87 141.79 49.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -54.9 -27.62 44.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.408 -0.808 . . . . 0.0 109.168 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 56.1 3.17 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -150.21 89.87 1.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 mt -66.43 -37.15 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.796 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 ttm -75.28 -24.93 57.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.69 -0.631 . . . . 0.0 109.906 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.12 44.68 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.33 -43.94 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.997 . . . . 0.0 109.209 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.59 -29.33 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 p -70.96 -26.27 63.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.802 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.5 mt -59.67 -33.88 72.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.466 -0.771 . . . . 0.0 109.958 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.03 38.41 35.45 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.6 mt -75.45 163.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.968 . . . . 0.0 109.123 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.56 -162.38 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.902 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.99 68.83 10.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.63 63.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.88 -175.72 4.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.884 . . . . 0.0 109.63 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -132.32 132.52 43.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.53 151.1 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.545 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.3 m -139.95 108.43 5.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -91.43 161.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.582 -0.699 . . . . 0.0 109.85 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 p -150.62 105.95 3.36 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.88 135.14 33.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.96 92.42 1.72 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -0.778 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.27 129.14 1.15 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 55.88 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.677 -0.896 . . . . 0.0 111.031 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -122.81 64.13 0.97 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 110.003 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -57.84 -35.24 70.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 110.342 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 -32.94 73.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.73 -25.31 53.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.453 -0.779 . . . . 0.0 110.457 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.93 -40.8 23.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.814 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -66.35 -42.21 88.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 0.0 110.451 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 22.2 p-10 -75.09 -22.99 57.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.385 -0.822 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -65.81 -58.68 5.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.091 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.74 -25.15 63.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -0.772 . . . . 0.0 110.064 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HA ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -62.81 -59.57 4.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.311 -0.868 . . . . 0.0 109.965 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -60.17 -28.97 68.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 109.774 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -66.46 -35.58 80.63 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.713 -0.617 . . . . 0.0 109.641 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -85.33 -21.59 28.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 110.283 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.8 p -70.66 -52.59 20.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.79 -29.07 22.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.726 . . . . 0.0 109.549 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.18 5.56 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.58 -44.72 16.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.644 -0.915 . . . . 0.0 109.53 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.47 141.92 7.19 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.399 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.17 153.57 25.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -140.09 164.91 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.569 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -112.12 128.78 56.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.608 -0.682 . . . . 0.0 109.329 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -117.53 150.19 39.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.418 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.72 129.49 51.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.78 118.46 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.731 -0.606 . . . . 0.0 109.554 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.5 m -140.24 24.81 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 109.755 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.28 34.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.457 -0.777 . . . . 0.0 109.47 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.16 -45.53 69.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.605 -0.685 . . . . 0.0 109.499 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -76.02 -31.66 59.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.618 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.25 -148.17 17.96 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.66 79.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.989 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.418 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.29 -42.58 81.99 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.161 -0.962 . . . . 0.0 112.943 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.413 ' HB2' ' CE1' ' A' ' 15' ' ' HIP . 1.9 ttt85 -56.52 -57.16 25.13 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.744 -1.223 . . . . 0.0 111.082 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HD2' ' C ' ' A' ' 15' ' ' HIP . 31.7 Cg_endo -70.11 -17.81 35.74 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.076 1.184 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.65 -21.98 40.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.539 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 m -83.41 -31.32 26.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.58 -39.23 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.799 0.809 . . . . 0.0 108.933 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.95 -49.78 27.33 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.539 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.74 -29.44 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.87 -43.09 72.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.465 -0.772 . . . . 0.0 109.835 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -66.48 -59.84 3.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.934 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -23.62 63.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.542 -0.724 . . . . 0.0 110.373 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 t -61.73 -37.53 84.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.372 -0.83 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.34 -20.67 60.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.719 -0.613 . . . . 0.0 110.169 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.45 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.54 128.02 35.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.27 -0.893 . . . . 0.0 109.597 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -70.13 -24.93 63.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.646 . . . . 0.0 109.711 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.8 39.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.803 . . . . 0.0 109.852 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.72 95.57 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.672 -0.642 . . . . 0.0 109.565 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.85 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -132.6 130.59 40.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.29 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 tt -89.83 139.11 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -113.96 113.97 25.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 109.842 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.404 ' CE1' HG12 ' A' ' 55' ' ' ILE . 13.6 t80 -95.47 68.02 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.511 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m120 48.13 85.07 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.551 -0.718 . . . . 0.0 111.178 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.12 -39.82 2.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -89.53 159.01 17.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.398 -1.06 . . . . 0.0 109.37 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -150.18 91.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.585 -0.697 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -65.48 146.08 55.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.8 tp -65.54 -12.06 49.44 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.47 48.73 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.7 t -150.14 95.54 2.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.828 . . . . 0.0 109.164 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 mt -77.12 -40.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 109.589 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.65 -29.1 63.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.52 -29.43 67.96 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.8 t -73.65 -43.47 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -1.046 . . . . 0.0 109.452 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.42 -29.81 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.618 -0.676 . . . . 0.0 109.588 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.8 p -66.57 -30.65 71.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.67 -51.32 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.37 50.33 2.41 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 55' ' ' ILE . 55.2 mt -77.0 159.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.59 -0.947 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.82 179.38 7.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.852 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -61.84 147.17 47.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.529 -0.732 . . . . 0.0 109.78 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 64.07 2.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.37 125.11 9.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.991 . . . . 0.0 109.486 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.04 124.58 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.709 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.3 pt -112.48 160.85 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.249 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 m -136.0 111.5 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.645 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.2 mt -91.9 160.28 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 p -149.91 101.21 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.104 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.97 126.87 35.9 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.88 111.4 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 -135.1 2.91 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -57.08 3.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.583 -0.951 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -104.83 45.86 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.571 -0.706 . . . . 0.0 109.302 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.44 -37.01 79.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.571 -0.705 . . . . 0.0 110.191 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -67.77 -37.77 82.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 109.985 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.66 -25.28 62.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 110.138 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.87 -42.1 24.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 111.21 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -62.02 -41.59 98.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -76.17 -23.58 54.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.333 -0.854 . . . . 0.0 109.788 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -63.89 -60.09 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.306 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -28.82 69.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.007 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.31 -52.64 64.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 109.841 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.3 -27.53 69.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -68.89 -31.59 70.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.7 mmt -71.35 -30.8 66.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -86.22 -17.43 34.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 110.316 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 p -73.11 -52.95 12.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -100.9 10.71 40.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.45 99.01 0.01 OUTLIER Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 mt -140.5 -50.71 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.519 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.04 139.36 6.42 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.996 . . . . 0.0 109.522 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.72 152.34 26.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.655 -0.653 . . . . 0.0 109.589 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -142.69 142.7 32.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.566 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 m -95.14 128.58 42.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.687 -0.633 . . . . 0.0 109.373 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD2' ' HE2' ' A' ' 81' ' ' MET . 85.4 m-85 -112.88 152.62 29.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.619 -0.676 . . . . 0.0 109.583 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -116.06 116.34 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.623 -0.673 . . . . 0.0 109.203 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 t -75.5 118.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -116.63 -15.26 10.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.618 -0.676 . . . . 0.0 110.333 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.18 146.3 39.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.149 -0.97 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -49.76 71.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.657 . . . . 0.0 109.574 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -63.26 -30.96 72.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.86 -138.39 14.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.1 mt -122.48 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.937 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.401 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.69 -35.64 72.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.153 -0.967 . . . . 0.0 112.264 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.405 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 9.8 mtm180 -58.24 -60.13 11.17 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.879 -1.138 . . . . 0.0 110.527 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -70.7 -15.94 33.59 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.318 1.345 . . . . 0.0 110.681 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.56 -25.92 50.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.212 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.54 -30.47 27.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.22 -36.79 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.672 0.748 . . . . 0.0 109.044 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.26 -44.81 43.87 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.999 -0.438 . . . . 0.0 110.366 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.7 -29.07 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.31 -36.91 63.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -67.33 -60.07 2.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.48 -0.762 . . . . 0.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -21.79 59.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.446 -0.784 . . . . 0.0 110.107 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.8 t -57.2 -38.9 74.38 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.285 -0.884 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.98 -30.01 66.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.585 -0.697 . . . . 0.0 109.42 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 77.4 m-85 -92.65 124.97 37.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -82.24 2.8 30.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 110.625 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.2 -179.78 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.544 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.34 80.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 0.0 109.41 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.61 111.84 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.671 . . . . 0.0 109.248 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -120.64 134.12 55.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.551 -0.718 . . . . 0.0 110.028 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 tt -92.35 154.95 18.24 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -134.4 129.93 36.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.459 -0.776 . . . . 0.0 109.865 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CD2' HG12 ' A' ' 55' ' ' ILE . 39.3 t80 -160.31 132.47 6.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 109.687 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.16 40.71 17.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.737 . . . . 0.0 109.978 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.78 28.09 65.16 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.24 102.79 7.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.582 -0.952 . . . . 0.0 109.129 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 m -93.5 99.85 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.593 -0.692 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.65 146.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -67.79 143.02 56.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 7.4 tp -62.99 -14.98 54.54 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.164 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -87.67 49.98 1.91 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.3 t -150.24 99.23 2.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.0 mt -79.39 -39.94 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 109.858 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 ttt -75.75 -17.72 59.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.03 -44.55 4.73 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.32 -29.44 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.444 -1.033 . . . . 0.0 109.788 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.6 t -75.93 -30.68 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.48 -0.763 . . . . 0.0 109.285 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -62.23 -26.66 68.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.7 mp -62.06 -52.73 62.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.87 54.74 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 37' ' ' TYR . 46.7 mt -77.44 157.67 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.539 -0.977 . . . . 0.0 109.337 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.2 -171.22 3.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.567 -0.708 . . . . 0.0 109.421 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -68.19 144.75 54.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.641 -0.662 . . . . 0.0 109.625 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.79 54.76 7.0 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.14 155.89 48.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.956 . . . . 0.0 109.472 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.37 122.06 43.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.565 -0.71 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 pt -118.23 133.23 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -104.65 120.34 41.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.528 -0.732 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.3 mt -110.5 148.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.46 112.55 4.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 0.0 110.194 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.14 130.07 37.07 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.89 105.29 5.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.854 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.92 -136.05 3.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.9 -73.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.988 . . . . 0.0 109.659 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -90.31 51.9 2.12 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.682 -0.636 . . . . 0.0 109.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.66 -28.33 67.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.5 -0.75 . . . . 0.0 109.81 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -77.57 -35.22 53.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 109.561 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -76.8 -20.47 56.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.0 110.107 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.65 -43.65 18.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.49 -42.91 91.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.349 -0.845 . . . . 0.0 110.547 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 44.7 p-10 -75.87 -22.11 56.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.25 -57.58 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -31.18 72.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.569 -0.707 . . . . 0.0 109.648 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.55 -52.62 64.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.174 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.22 -27.58 69.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 m -69.11 -32.76 72.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.405 ' HE2' ' CD2' ' A' ' 6' ' ' PHE . 1.1 mtt -70.83 -31.5 68.24 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -77.89 -27.85 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.727 -0.608 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -77.41 -66.33 0.85 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.75 . . . . 0.0 109.651 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.87 -28.71 69.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.571 -0.706 . . . . 0.0 109.713 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 34.99 15.86 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.7 mt -81.95 -39.49 23.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.647 -0.914 . . . . 0.0 109.571 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.52 30.1 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.548 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.71 152.62 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -143.99 149.33 36.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.623 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 m -99.48 119.01 37.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -98.61 162.15 13.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.675 -0.641 . . . . 0.0 109.336 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 135.0 52.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.345 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.87 107.33 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.596 -0.69 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -122.3 -1.43 9.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.547 -0.721 . . . . 0.0 110.562 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.57 136.42 57.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.131 -0.98 . . . . 0.0 109.577 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.49 -38.97 92.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -72.48 -30.94 64.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.531 -0.731 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -151.59 20.04 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 14' ' ' ILE . 23.8 mm -109.27 82.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.946 . . . . 0.0 109.335 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.432 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.69 -32.11 67.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.91 -1.119 . . . . 0.0 112.423 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.504 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -60.51 -51.34 80.62 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.752 -1.217 . . . . 0.0 111.291 -178.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -73.08 -23.67 17.99 Favored 'Trans proline' 0 C--N 1.326 -0.637 0 C-N-CA 121.036 1.157 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.25 -27.76 62.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.352 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 m -81.83 -29.51 32.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.522 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.9 t -71.76 -40.05 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.829 0.823 . . . . 0.0 108.858 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.43 -51.4 24.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.941 -0.474 . . . . 0.0 110.208 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.79 -27.65 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.38 -0.825 . . . . 0.0 110.037 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -74.12 -37.86 63.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.709 . . . . 0.0 109.959 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -72.8 -62.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.71 -20.71 36.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.13 -40.85 91.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -71.06 -22.57 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.624 -0.672 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.421 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.4 130.21 35.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 0.0 109.647 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -73.61 -25.96 60.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.676 -0.64 . . . . 0.0 109.754 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 145.26 44.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.448 -0.783 . . . . 0.0 109.639 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.63 97.09 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.608 -0.683 . . . . 0.0 109.602 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -92.56 138.68 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -132.48 142.16 49.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.456 -0.778 . . . . 0.0 110.332 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.8 tt -102.47 122.61 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.44 150.75 21.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.474 -0.766 . . . . 0.0 110.026 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 55' ' ' ILE . 26.9 t80 -160.38 115.27 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.733 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 64.04 27.1 14.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.673 -0.642 . . . . 0.0 110.285 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.7 -18.13 51.55 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.338 -0.934 . . . . 0.0 110.892 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 112.28 23.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.228 -1.16 . . . . 0.0 109.169 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 m -95.84 114.19 25.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.625 . . . . 0.0 109.842 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.95 147.68 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -70.27 136.39 49.82 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.03 -25.15 28.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.429 -0.795 . . . . 0.0 109.405 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -90.28 56.57 3.42 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.37 86.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 mt -61.28 -60.73 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.739 -0.601 . . . . 0.0 109.723 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 ttp -66.64 -27.2 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.7 74.87 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.93 -32.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -1.067 . . . . 0.0 109.529 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 t -71.85 -23.8 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.471 -0.768 . . . . 0.0 109.861 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.3 p -59.24 -39.62 83.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mp -63.82 -34.02 76.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.211 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.07 4.74 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 55' ' ' ILE . 51.3 mt -75.41 153.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.963 . . . . 0.0 109.175 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.19 -179.0 6.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.701 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -62.47 136.08 57.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.756 -0.59 . . . . 0.0 109.652 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.77 56.86 1.69 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.37 -178.52 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.995 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -136.5 159.55 41.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.68 . . . . 0.0 109.277 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.3 pt -150.22 138.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -115.63 105.66 13.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.695 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 88.8 mt -92.4 148.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 p -150.52 112.92 4.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.631 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.26 134.47 34.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.66 104.66 6.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.7 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.22 -145.21 8.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -59.55 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.92 . . . . 0.0 109.584 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -96.28 42.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.602 -0.686 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.15 -32.81 73.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.707 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -72.04 -50.0 32.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 109.461 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -61.9 -21.81 65.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 0.0 110.339 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.03 -51.8 9.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.363 -0.836 . . . . 0.0 111.557 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -56.34 -42.34 77.56 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.006 . . . . 0.0 110.809 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.405 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -72.14 -27.08 62.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.0 109.106 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -60.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.378 -0.826 . . . . 0.0 109.148 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -60.56 -25.89 66.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 109.86 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.55 -54.45 45.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.961 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -61.79 -27.37 68.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.303 -0.873 . . . . 0.0 109.714 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.408 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 54.2 m -68.66 -34.51 75.82 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mmt -71.58 -31.87 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -91.52 -6.17 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.702 -0.624 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 p -78.09 -50.24 12.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -98.2 -59.52 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.553 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 139.55 69.22 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.39 -50.41 3.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.923 . . . . 0.0 109.662 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.55 154.24 25.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.445 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -178.01 151.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.671 -0.643 . . . . 0.0 109.28 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -146.41 148.76 32.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.618 -0.676 . . . . 0.0 109.58 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -89.59 133.12 34.77 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 63' ' ' ILE . 67.5 m-85 -117.57 148.58 41.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.954 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.72 115.75 29.6 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.9 t -68.86 109.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.687 -0.633 . . . . 0.0 109.402 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -117.03 -8.81 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 110.466 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.53 142.07 57.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.096 -1.003 . . . . 0.0 109.63 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.54 -40.75 97.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -74.83 -30.19 61.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.626 -0.671 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.71 -145.54 17.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -114.69 59.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.632 -0.922 . . . . 0.0 109.292 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.416 ' CD2' ' CD ' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.25 -46.0 57.84 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.757 -1.215 . . . . 0.0 112.191 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -50.34 -53.13 48.03 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 120.965 -1.084 . . . . 0.0 111.542 -178.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -73.38 -25.2 15.68 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.389 1.392 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.83 -18.6 60.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.526 -0.734 . . . . 0.0 109.615 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.03 -32.99 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 108.941 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.57 -35.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.38 -51.24 12.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.248 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -54.8 -27.78 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.32 -0.862 . . . . 0.0 109.976 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -44.81 55.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -62.06 -62.23 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.546 -0.721 . . . . 0.0 109.845 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.22 -22.67 18.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.443 -0.786 . . . . 0.0 110.715 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -43.39 90.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.258 -0.901 . . . . 0.0 109.884 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -66.61 -29.32 69.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -90.05 126.9 35.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.487 -0.758 . . . . 0.0 109.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.84 -17.66 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.741 -0.599 . . . . 0.0 110.283 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.87 147.14 29.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.203 -0.936 . . . . 0.0 109.922 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.34 90.59 8.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.75 128.21 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.98 135.09 52.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.558 -0.714 . . . . 0.0 109.869 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tt -89.72 155.07 19.45 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.12 142.55 51.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.867 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 55' ' ' ILE . 59.3 t80 -160.37 128.09 4.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.68 36.66 19.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.477 -0.764 . . . . 0.0 110.012 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.62 22.9 78.05 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -116.2 169.28 9.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -1.059 . . . . 0.0 108.89 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 m -145.58 97.58 3.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.76 146.37 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -68.67 146.17 53.23 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.8 tp -67.0 -10.71 52.59 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -88.55 48.26 1.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.831 -1.168 . . . . 0.0 107.91 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.2 t -149.54 85.08 1.43 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.847 . . . . 0.0 109.009 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.5 mt -69.06 -39.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.801 -0.562 . . . . 0.0 109.541 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ttt -73.53 -29.37 62.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.563 -0.71 . . . . 0.0 109.606 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.27 -38.07 81.39 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.67 -27.72 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.995 . . . . 0.0 109.691 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.4 t -83.91 -25.74 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.815 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -60.37 -38.92 85.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.443 -0.786 . . . . 0.0 109.799 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.42 -55.59 15.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.454 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.27 51.93 0.85 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 37' ' ' TYR . 42.9 mt -75.62 162.16 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.562 -0.964 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.9 -163.16 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -78.85 157.0 28.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.712 . . . . 0.0 109.557 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.97 61.03 6.82 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.39 173.21 11.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.931 . . . . 0.0 109.51 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -127.98 141.45 51.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.709 . . . . 0.0 109.208 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 61' ' ' ILE . 20.2 pt -141.97 164.12 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.559 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -132.58 117.24 17.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.67 . . . . 0.0 109.836 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.401 HD11 ' CE1' ' A' ' 6' ' ' PHE . 89.6 mt -99.2 152.07 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -150.4 110.16 4.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.508 -0.745 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.35 130.09 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.99 103.19 4.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.453 -0.779 . . . . 0.0 109.98 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.27 -132.31 2.06 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.81 -67.18 0.85 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.963 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 46.53 1.19 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.548 -0.72 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.04 -37.25 86.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.49 -0.756 . . . . 0.0 110.21 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.25 -36.74 77.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.64 -20.59 56.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.457 -0.777 . . . . 0.0 110.284 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.16 -42.8 20.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.49 -41.64 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.438 -0.789 . . . . 0.0 110.047 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.415 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 15.9 p30 -79.27 -16.9 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.783 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.45 -52.37 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.28 -33.14 75.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.567 -0.708 . . . . 0.0 109.466 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.66 -52.81 63.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.551 -0.718 . . . . 0.0 109.987 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.12 -27.62 65.77 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.133 -0.98 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.2 m -69.86 -37.22 76.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mtt -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -76.15 -26.0 55.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 0.0 109.734 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -82.57 -67.03 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.729 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -66.71 -29.87 69.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.53 -0.731 . . . . 0.0 109.581 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.73 2.93 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.83 -30.37 20.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.654 -0.909 . . . . 0.0 109.743 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.7 146.94 5.91 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.479 -1.012 . . . . 0.0 109.469 -179.925 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -173.74 154.98 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.716 . . . . 0.0 109.543 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.52 139.92 19.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.561 -0.712 . . . . 0.0 109.651 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -89.96 143.15 27.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.205 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 63' ' ' ILE . 27.0 m-85 -125.92 169.76 12.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.7 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.76 135.82 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.582 -0.699 . . . . 0.0 109.332 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 t -81.43 112.08 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 109.319 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 m -114.12 -12.08 12.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 141.74 50.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -0.966 . . . . 0.0 109.985 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.71 -43.11 94.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.9 p -74.07 -32.78 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.53 -0.731 . . . . 0.0 109.366 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.54 -139.58 15.38 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.1 mt -122.96 82.33 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.593 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.18 -36.3 63.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.34 -0.85 . . . . 0.0 112.305 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -60.16 -61.31 8.18 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 120.943 -1.098 . . . . 0.0 110.589 -178.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.9 Cg_endo -69.59 -12.36 33.07 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 121.283 1.322 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.88 -28.89 32.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.867 . . . . 0.0 109.008 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -78.89 -30.02 44.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -68.78 -49.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.809 . . . . 0.0 108.979 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.91 -54.69 30.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.6 -28.58 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.307 -0.871 . . . . 0.0 110.506 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.01 -54.59 17.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.525 -0.735 . . . . 0.0 110.245 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 m -59.94 -53.35 58.87 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -0.813 . . . . 0.0 110.411 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.33 62.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.412 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.49 -37.74 79.04 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -71.57 -28.75 64.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.775 -0.578 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 81.7 m-85 -94.58 125.45 39.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.85 9.31 19.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.671 -0.643 . . . . 0.0 110.716 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.8 179.22 1.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.092 -1.005 . . . . 0.0 109.478 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -102.75 76.03 1.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.639 -0.663 . . . . 0.0 109.237 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -89.62 108.91 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -117.09 134.31 54.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.47 160.82 16.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -128.43 152.75 47.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.36 87.54 1.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.758 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 61.84 48.65 5.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.565 -0.709 . . . . 0.0 109.681 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.06 -7.47 74.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -91.09 101.32 14.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -1.204 . . . . 0.0 109.333 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.35 98.03 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.558 -0.714 . . . . 0.0 109.746 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.77 148.1 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.7 140.95 56.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.22 -28.95 63.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 0.0 109.132 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 60.52 4.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -147.67 83.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.6 mt -66.21 -40.55 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.607 . . . . 0.0 109.657 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -77.6 -27.39 51.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.56 -0.713 . . . . 0.0 109.96 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.26 -29.72 63.87 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.52 -31.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -1.011 . . . . 0.0 109.579 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.28 -28.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.6 p -63.41 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.31 -72.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.563 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.4 48.93 0.3 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.5 mt -75.97 162.05 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.981 . . . . 0.0 109.415 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.06 -177.42 5.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 109.36 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 148.26 52.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.588 -0.695 . . . . 0.0 109.398 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.07 70.94 1.0 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -175.49 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.494 -1.004 . . . . 0.0 109.569 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -131.39 148.49 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 pt -149.8 153.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.621 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -127.75 127.07 42.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.713 . . . . 0.0 109.664 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HD11 ' CE1' ' A' ' 6' ' ' PHE . 78.0 mt -112.31 148.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 p -150.77 112.11 4.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.93 134.41 35.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.83 103.3 3.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 0.0 109.661 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.73 -128.71 1.37 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.22 -59.47 2.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -104.44 52.65 0.75 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.533 -0.73 . . . . 0.0 109.637 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.5 -38.75 90.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.49 -0.756 . . . . 0.0 109.96 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.98 -37.97 75.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 110.115 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -76.71 -19.42 57.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.0 -43.9 17.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.16 -41.94 94.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.489 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 42.1 p-10 -78.08 -20.33 52.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 109.727 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.26 -55.91 9.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.903 . . . . 0.0 108.593 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -29.13 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.498 -0.751 . . . . 0.0 109.782 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -54.58 42.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.397 -0.815 . . . . 0.0 110.192 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.59 -33.54 71.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.807 . . . . 0.0 109.774 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -65.67 -34.06 77.33 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 mmm -71.94 -28.07 63.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.736 -0.603 . . . . 0.0 109.65 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -82.47 -23.8 34.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.591 -0.693 . . . . 0.0 110.177 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -85.85 -31.56 22.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 109.918 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -93.78 -21.8 19.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.725 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.06 33.3 29.75 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.94 -60.45 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.946 . . . . 0.0 109.615 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.31 156.04 26.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.423 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -117.14 150.79 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.414 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.74 142.09 31.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.754 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.5 m -96.51 143.56 27.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -127.21 174.04 9.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.547 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.86 124.39 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.596 -0.69 . . . . 0.0 109.416 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.32 123.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.382 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.84 10.95 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 110.258 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 147.13 35.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.429 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.19 -31.21 71.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.684 . . . . 0.0 109.584 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -80.68 -30.44 36.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 109.466 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.25 37.01 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 14' ' ' ILE . 65.8 mt -106.76 80.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.558 -0.966 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.418 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.21 80.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.175 -0.953 . . . . 0.0 112.734 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -51.48 -54.51 38.29 Favored Pre-proline 0 N--CA 1.508 2.462 0 O-C-N 120.801 -1.187 . . . . 0.0 111.55 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HD2' ' C ' ' A' ' 15' ' ' HIP . 31.2 Cg_endo -71.28 -23.2 24.49 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.122 1.214 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.94 -19.97 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.484 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.73 -32.66 23.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 108.815 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.58 -35.37 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.656 0.741 . . . . 0.0 109.039 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.57 -43.79 37.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.0 -0.437 . . . . 0.0 110.28 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -62.63 -28.31 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.77 -48.05 60.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.529 -0.732 . . . . 0.0 109.954 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -62.1 -57.35 11.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.903 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.53 -23.18 48.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.542 -0.724 . . . . 0.0 110.372 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -59.75 -41.1 90.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.667 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -64.62 -32.04 73.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 54.4 m-85 -93.49 131.28 38.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.665 . . . . 0.0 109.397 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -94.29 12.56 26.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.557 -0.715 . . . . 0.0 110.345 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.12 169.43 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -91.03 76.99 6.13 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.63 89.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.596 -0.69 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.87 123.84 42.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 109.7 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 tt -89.51 108.3 19.58 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -89.13 123.72 33.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.703 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.16 72.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 t30 48.45 85.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.513 -0.742 . . . . 0.0 111.32 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 -38.69 3.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.36 159.47 17.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -1.119 . . . . 0.0 109.621 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.78 85.1 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.71 145.44 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 139.87 41.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.6 tp -58.99 -16.2 16.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -86.92 49.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.774 -1.204 . . . . 0.0 108.197 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 t -151.0 93.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 0.0 109.074 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.3 mt -71.11 -39.07 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.624 -0.672 . . . . 0.0 109.621 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -72.46 -28.52 62.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.585 -0.697 . . . . 0.0 109.614 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.72 -28.62 64.8 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.62 -26.25 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.475 -1.015 . . . . 0.0 109.679 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -78.95 -26.98 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -0.791 . . . . 0.0 109.794 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p -68.42 -34.69 76.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 109.564 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 mt -63.38 -45.92 88.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.461 -0.774 . . . . 0.0 109.344 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.83 61.59 1.84 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.8 mt -88.96 149.17 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.562 -0.964 . . . . 0.0 109.142 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.98 -168.98 3.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.562 -0.711 . . . . 0.0 109.772 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -64.62 130.29 43.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.682 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.16 55.66 2.06 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.36 30.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.61 -0.935 . . . . 0.0 109.577 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -95.08 145.82 24.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.266 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -136.71 152.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 109.522 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 m -127.35 152.53 47.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.409 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.37 143.58 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.449 -0.782 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -147.85 107.84 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.971 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.53 130.97 36.52 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.31 97.1 3.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.88 -131.51 1.47 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.58 -71.23 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.933 . . . . 0.0 109.73 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -99.01 61.38 1.25 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.527 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.67 -27.55 66.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.537 -0.727 . . . . 0.0 109.995 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.94 -35.07 43.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.47 -0.769 . . . . 0.0 109.975 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.73 -22.26 59.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.741 . . . . 0.0 110.344 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.416 ' HA ' ' CD2' ' A' ' 29' ' ' TYR . . . -81.6 -43.67 18.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.4 pp -68.7 -39.82 80.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.479 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 45.0 p30 -79.13 -20.48 48.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 109.795 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.73 -56.05 5.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.326 -0.859 . . . . 0.0 108.838 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.65 -34.19 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.545 -0.722 . . . . 0.0 109.51 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.63 -52.73 64.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.94 -26.74 68.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.373 -0.83 . . . . 0.0 109.709 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.5 m -70.22 -32.94 71.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.072 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.46 -27.12 63.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.725 -0.61 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -25.6 26.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 110.148 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 p -66.63 -54.33 24.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.535 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.49 -29.8 22.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.48 -0.763 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 48.99 4.53 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.6 mt -82.43 -42.66 18.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.979 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.38 142.87 8.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.497 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.89 153.79 19.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.728 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -141.8 133.79 27.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -89.98 130.37 36.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.287 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CE1' HD11 ' A' ' 63' ' ' ILE . 93.5 m-85 -116.02 154.2 30.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.604 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.37 127.82 54.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.635 -0.666 . . . . 0.0 109.235 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.73 114.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -121.12 -5.13 9.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.568 -0.707 . . . . 0.0 110.57 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.66 150.43 40.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.21 -57.46 11.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.467 -0.77 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -65.81 -33.4 75.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.59 -132.8 11.06 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.7 mt -116.24 83.58 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.954 . . . . 0.0 109.387 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.36 67.18 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.634 -1.291 . . . . 0.0 112.153 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 2.4 ttt85 -53.75 -53.93 52.09 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.961 -1.087 . . . . 0.0 111.377 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.7 Cg_endo -73.87 -24.66 15.14 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.192 1.262 . . . . 0.0 110.523 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.99 -22.42 61.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.413 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.5 -31.95 24.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.007 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.67 -39.38 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.5 mt -74.84 -51.84 12.93 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.553 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.33 -28.44 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.252 -0.905 . . . . 0.0 110.149 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -74.84 -42.65 57.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -68.55 -65.62 0.68 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.775 . . . . 0.0 109.935 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.38 -24.64 12.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.473 -0.767 . . . . 0.0 110.581 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.22 -45.97 90.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 109.469 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -63.87 -25.52 68.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.645 -0.66 . . . . 0.0 109.822 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -89.57 124.39 34.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 109.576 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.79 -21.24 65.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.072 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 147.88 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -89.88 88.96 7.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.608 -0.682 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.8 129.85 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -129.36 140.33 51.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.975 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 tt -92.3 149.09 21.64 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -115.18 141.8 47.53 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' CD2' HG12 ' A' ' 55' ' ' ILE . 35.2 t80 -160.28 115.82 2.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.0 109.983 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 t30 63.9 23.47 13.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.557 -0.714 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.71 -18.21 51.25 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.788 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -88.97 118.55 28.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -1.172 . . . . 0.0 109.158 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -95.08 117.5 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.709 -0.619 . . . . 0.0 109.886 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.07 147.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.8 135.45 51.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.07 -29.12 28.37 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.369 -0.832 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 62.05 4.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.92 87.09 1.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.3 mt -71.45 -38.76 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.733 -0.604 . . . . 0.0 109.873 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.1 ttp -77.7 -27.51 50.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.532 -0.73 . . . . 0.0 109.987 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.16 49.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.35 -33.36 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.471 -1.017 . . . . 0.0 109.759 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 t -75.59 -30.71 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 109.614 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.7 p -63.3 -28.02 69.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.692 . . . . 0.0 109.854 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 mp -69.15 -76.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.761 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.02 51.79 0.23 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.426 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.0 mt -78.93 158.33 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.576 -0.955 . . . . 0.0 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.18 -168.15 2.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 109.639 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -73.9 146.44 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.757 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.63 57.32 3.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.14 170.64 15.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.946 . . . . 0.0 109.538 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -126.85 129.93 49.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.594 -0.692 . . . . 0.0 109.469 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.4 pt -119.88 146.41 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.671 -0.643 . . . . 0.0 109.305 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.06 107.33 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.747 . . . . 0.0 109.646 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.406 HD11 ' CE1' ' A' ' 6' ' ' PHE . 75.3 mt -92.54 154.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.282 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -150.12 105.95 3.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.78 124.34 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.36 107.4 7.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.463 -0.773 . . . . 0.0 109.79 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -138.84 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.25 -64.7 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.965 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.08 42.07 1.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.96 -28.6 67.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -0.75 . . . . 0.0 109.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.21 -35.49 63.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.26 -25.37 59.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.675 . . . . 0.0 110.03 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.6 -43.67 20.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.397 -0.814 . . . . 0.0 110.689 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -62.09 -41.62 98.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.327 -0.858 . . . . 0.0 110.69 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 17.8 p-10 -74.46 -27.07 60.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.246 -0.909 . . . . 0.0 109.764 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.24 -57.67 8.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.805 . . . . 0.0 109.266 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.59 -27.35 69.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.493 -0.755 . . . . 0.0 109.876 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.71 -58.01 9.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 109.682 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.85 -26.59 65.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -71.98 -34.02 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 0.0 109.015 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.6 -29.91 65.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -85.81 -21.19 28.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.69 . . . . 0.0 110.305 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -80.75 -55.07 5.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -73.45 -27.07 61.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.825 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.25 39.79 6.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.7 mt -81.74 -52.76 6.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.687 -0.89 . . . . 0.0 109.651 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.24 145.8 12.59 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.593 -0.945 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.79 158.12 44.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.583 -0.698 . . . . 0.0 109.294 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -142.78 132.73 24.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.2 m -95.07 139.05 31.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.543 -0.723 . . . . 0.0 109.297 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 91.3 m-85 -122.69 162.76 21.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.524 -0.735 . . . . 0.0 109.709 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.76 125.23 50.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 t -77.81 123.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.522 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 m -129.92 3.37 4.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.588 -0.695 . . . . 0.0 110.544 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.39 46.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.039 -1.038 . . . . 0.0 109.47 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.18 -37.71 88.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.693 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -80.01 -30.19 39.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.81 -148.6 18.88 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 14' ' ' ILE . 58.8 mt -114.42 86.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.945 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.54 70.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.181 -0.949 . . . . 0.0 112.241 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -57.39 -60.66 9.07 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.856 -1.153 . . . . 0.0 110.598 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.8 -15.1 36.79 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.302 1.335 . . . . 0.0 110.787 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.71 -24.99 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 m -82.99 -29.59 28.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.187 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.36 -40.49 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.669 0.747 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.09 -46.35 57.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.967 -0.458 . . . . 0.0 110.397 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.03 -29.01 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.791 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.61 -43.57 72.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.475 -0.766 . . . . 0.0 109.975 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -68.04 -60.83 2.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.049 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.2 -23.6 48.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.411 -0.806 . . . . 0.0 110.41 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -59.83 -41.3 91.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -26.39 67.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.743 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 90.8 m-85 -89.66 127.95 36.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.4 -0.813 . . . . 0.0 109.604 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -71.82 -21.62 61.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.806 -0.559 . . . . 0.0 110.075 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 149.1 23.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.67 92.46 9.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.63 -0.669 . . . . 0.0 109.449 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.8 102.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 109.195 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.72 137.68 41.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.777 . . . . 0.0 110.096 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.3 tt -90.77 150.56 21.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.72 135.43 55.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.481 -0.762 . . . . 0.0 109.601 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' CD2' HG12 ' A' ' 55' ' ' ILE . 57.9 t80 -160.21 125.9 4.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 64.09 21.44 12.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.523 -0.735 . . . . 0.0 110.519 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.01 55.37 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.908 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -89.07 122.78 32.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -1.187 . . . . 0.0 109.307 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 m -105.22 103.65 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.768 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.7 146.97 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -67.04 143.19 56.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 7.0 tp -63.37 -15.09 56.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.056 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -87.63 48.93 1.71 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.86 -1.15 . . . . 0.0 107.973 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 t -150.61 84.09 1.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 108.992 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.5 -37.89 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.7 ttm -74.39 -30.3 61.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.377 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.66 -35.93 92.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.4 t -68.38 -29.01 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.937 . . . . 0.0 109.386 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 t -65.47 -34.48 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.488 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.9 p -63.17 -32.0 73.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mp -70.54 -50.58 36.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.701 . . . . 0.0 109.393 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.84 59.46 3.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.426 HG12 ' CD2' ' A' ' 37' ' ' TYR . 49.0 mt -72.58 162.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.6 175.56 9.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.591 -0.693 . . . . 0.0 109.572 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -61.34 152.82 28.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.588 -0.695 . . . . 0.0 109.767 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.04 64.24 3.94 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.33 172.02 13.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.545 -0.973 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -124.76 129.8 51.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 pt -128.12 152.16 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.582 -0.699 . . . . 0.0 109.364 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -131.67 109.43 10.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 HD11 ' CE1' ' A' ' 6' ' ' PHE . 88.1 mt -93.69 155.97 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.219 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -150.09 110.56 4.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.64 -0.662 . . . . 0.0 109.808 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.69 131.74 35.52 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.03 107.04 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.499 -0.751 . . . . 0.0 109.662 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.5 -133.41 2.4 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.15 -61.99 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.574 -0.957 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -98.39 44.44 1.03 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.686 -0.633 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.71 -31.29 71.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.707 . . . . 0.0 109.857 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.69 -36.47 70.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.565 -0.709 . . . . 0.0 109.616 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.44 -19.55 52.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.306 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 -44.85 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.165 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.79 -41.78 91.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.247 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 45.6 p30 -77.65 -19.89 54.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 0.0 109.501 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.18 -57.16 5.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -30.11 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.575 -0.703 . . . . 0.0 109.432 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -54.02 51.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.999 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.29 -26.69 66.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 109.888 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.8 m -70.18 -35.82 74.22 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.8 mmm -71.45 -30.48 66.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -83.91 -18.49 37.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.676 . . . . 0.0 110.318 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.2 p -74.81 -52.84 10.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.3 -27.49 24.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.756 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.93 48.71 4.04 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.78 -64.44 1.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.676 -0.896 . . . . 0.0 109.607 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.72 11.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.982 . . . . 0.0 109.518 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.94 153.4 33.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.43 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 7.6 tttp -135.55 140.52 44.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.702 -0.624 . . . . 0.0 109.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 m -96.63 130.49 43.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.591 -0.693 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 4' ' ' LYS . 97.2 m-85 -118.0 149.01 41.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.593 -0.692 . . . . 0.0 109.604 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.14 125.89 52.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.4 119.6 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.598 -0.689 . . . . 0.0 109.593 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -140.49 22.27 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.571 -0.706 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.68 36.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.518 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.09 -41.18 97.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -78.72 -30.89 46.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.613 -0.679 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.18 -143.77 16.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.0 mt -126.18 82.16 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.413 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.44 63.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.253 -0.904 . . . . 0.0 111.974 -177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.7 mmt180 -62.68 -61.35 7.69 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.812 -1.18 . . . . 0.0 109.782 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.07 -13.71 36.92 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.198 1.265 . . . . 0.0 110.509 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.0 -30.3 50.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 108.784 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -79.5 -27.97 41.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.67 . . . . 0.0 109.572 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.79 -48.59 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.747 0.784 . . . . 0.0 109.084 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.77 -42.7 90.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 122.004 -0.435 . . . . 0.0 110.614 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.22 -30.46 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -70.92 -29.77 65.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.074 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.53 -58.5 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.508 -0.745 . . . . 0.0 110.434 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.7 68.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.462 -0.774 . . . . 0.0 110.427 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 p -59.85 -32.77 70.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.354 -0.841 . . . . 0.0 109.708 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -73.39 -29.67 62.77 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.87 127.57 36.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.448 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.34 -2.99 44.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.684 -0.635 . . . . 0.0 110.681 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.14 167.6 3.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.67 82.18 3.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.606 -0.684 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 m -89.69 100.75 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.353 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -104.54 128.97 52.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.708 . . . . 0.0 109.921 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.9 tt -89.46 142.95 27.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -117.01 143.03 46.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -139.87 71.19 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.566 -0.709 . . . . 0.0 109.772 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.45 62.69 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.564 -0.71 . . . . 0.0 110.852 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 -29.8 8.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -89.54 88.14 7.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -1.078 . . . . 0.0 109.402 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.2 m -93.04 94.7 9.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.695 -0.628 . . . . 0.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.07 145.83 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -70.08 146.83 50.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.7 tp -65.87 -12.01 51.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -88.28 48.56 1.66 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.775 -1.203 . . . . 0.0 108.03 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 t -149.93 99.3 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.3 mm -70.47 -59.41 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.731 -0.606 . . . . 0.0 109.464 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.68 -22.19 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.711 -0.618 . . . . 0.0 110.163 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.87 63.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.8 t -68.78 -34.42 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.95 . . . . 0.0 109.616 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.3 t -71.83 -26.5 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.9 p -70.31 -33.93 72.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.473 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.1 -37.4 87.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.281 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.6 5.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 mt -78.44 152.36 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.992 . . . . 0.0 109.097 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.97 -168.58 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.547 -0.721 . . . . 0.0 109.8 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.49 131.93 50.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.672 -0.643 . . . . 0.0 109.704 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.93 55.58 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.41 172.96 12.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.548 -0.971 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -131.99 156.16 46.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.656 . . . . 0.0 109.296 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 pt -149.61 139.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.49 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 m -117.87 109.28 16.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.534 -0.729 . . . . 0.0 109.561 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.8 mt -96.85 150.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.589 -0.694 . . . . 0.0 109.401 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.24 109.88 4.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.653 -0.654 . . . . 0.0 109.609 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.73 131.49 35.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.11 101.72 4.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.802 . . . . 0.0 109.76 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.9 -123.67 0.85 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.95 -62.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.949 . . . . 0.0 109.314 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -96.64 51.51 1.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.293 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -27.39 66.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -80.69 -33.15 35.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.38 -21.61 52.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.73 . . . . 0.0 110.23 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.21 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.342 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.55 -42.76 91.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.318 -0.864 . . . . 0.0 110.438 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.419 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 33.3 p-10 -75.9 -21.95 56.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -0.873 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.401 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.81 -56.88 7.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -30.58 71.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.682 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -53.28 60.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.14 -29.22 69.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -66.73 -35.31 79.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.6 mmm -71.59 -28.21 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -69.99 -47.49 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 109.908 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 p -66.91 -59.12 3.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -59.28 -23.44 62.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.505 -0.747 . . . . 0.0 110.154 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.89 34.97 88.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.92 -44.61 16.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.97 . . . . 0.0 109.616 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -176.19 28.67 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.494 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -51.46 152.53 2.58 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.378 -0.826 . . . . 0.0 110.501 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -140.91 167.93 21.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 109.517 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -112.4 150.75 30.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.341 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.57 148.58 41.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 121.47 45.4 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.02 125.56 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.564 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -143.93 22.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.712 . . . . 0.0 109.861 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 145.29 36.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.488 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.11 -43.18 95.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 0.0 109.674 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -77.44 -29.25 52.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.36 -155.83 24.53 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 14' ' ' ILE . 61.4 mt -109.02 66.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.537 -0.978 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.408 ' CD2' ' CD ' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.22 84.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.949 -1.095 . . . . 0.0 112.359 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.11 -55.59 29.65 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.853 -1.154 . . . . 0.0 111.196 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.74 -23.32 22.81 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.233 1.288 . . . . 0.0 110.212 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.14 -22.33 61.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 0.0 109.309 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.404 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -84.33 -31.64 24.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.074 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.72 -40.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.614 0.721 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.57 -51.77 13.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.008 -0.433 . . . . 0.0 110.357 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 20' ' ' THR . 12.4 p -51.83 -30.69 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.09 -39.76 63.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.605 -0.684 . . . . 0.0 109.75 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -66.53 -64.43 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.51 -0.743 . . . . 0.0 109.894 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.51 -24.28 30.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -61.37 -43.44 98.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.359 -0.838 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -62.96 -26.73 68.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 109.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.445 ' CG ' ' CB ' ' A' ' 73' ' ' ALA . 93.2 m-85 -89.78 125.16 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.683 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -69.87 -22.97 63.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.81 25.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.373 -0.829 . . . . 0.0 109.858 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.06 95.83 10.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 109.759 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 m -97.04 120.41 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -116.88 123.92 48.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.554 -0.717 . . . . 0.0 110.326 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 tt -90.12 148.65 22.87 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -126.05 158.13 36.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.0 110.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -147.42 105.35 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -81.4 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.77 -0.581 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.87 26.56 1.46 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 114.88 19.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.468 -1.019 . . . . 0.0 109.175 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -89.79 90.07 8.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.586 -0.696 . . . . 0.0 110.025 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.83 148.04 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.43 139.75 36.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -53.54 -27.47 26.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.439 -0.788 . . . . 0.0 109.15 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.56 57.93 3.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 110.14 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.9 mt -89.37 -42.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.251 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.2 ttt -79.15 -24.03 43.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.482 -0.761 . . . . 0.0 110.163 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.22 -29.5 53.35 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.5 t -84.3 -42.82 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -1.018 . . . . 0.0 109.742 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.94 -37.43 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -57.4 -29.48 64.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.699 -0.626 . . . . 0.0 110.107 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.41 -53.14 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 0.0 109.348 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.06 58.52 1.67 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.0 mt -78.12 162.91 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.647 -0.914 . . . . 0.0 109.211 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.95 -161.21 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.827 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 66.2 9.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.88 53.99 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.15 168.34 20.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.92 . . . . 0.0 109.554 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -126.14 133.26 51.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.8 pt -124.84 136.75 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.616 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -112.63 112.4 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.0 mt -93.71 155.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.644 -0.66 . . . . 0.0 109.343 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -149.45 104.68 3.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.717 -0.615 . . . . 0.0 109.349 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.56 135.04 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 106.94 4.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.44 -144.24 7.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.2 -73.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.958 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -95.32 45.47 1.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.308 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.42 -43.22 83.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.448 -0.782 . . . . 0.0 110.28 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.35 -37.15 84.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.881 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.45 -33.26 74.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.694 -0.629 . . . . 0.0 110.984 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.445 ' CB ' ' CG ' ' A' ' 29' ' ' TYR . . . -73.44 -53.57 10.36 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.319 -0.863 . . . . 0.0 111.615 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -54.6 -45.64 73.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.241 -0.912 . . . . 0.0 111.297 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -67.1 -27.82 67.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 109.079 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.64 -52.36 63.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.072 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -31.07 72.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 109.84 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.82 -52.2 66.09 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.87 . . . . 0.0 109.996 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.28 -27.62 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.6 m -70.62 -33.88 71.5 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmt -71.54 -31.13 66.69 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -86.24 -17.27 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -60.52 -49.93 75.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 109.81 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.42 -54.88 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.494 -0.754 . . . . 0.0 109.518 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.78 52.45 0.08 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.0 -63.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.562 -0.963 . . . . 0.0 109.566 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.49 134.89 4.7 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.534 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -60.92 153.66 24.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.425 -0.797 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -138.22 165.01 27.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m -115.83 138.21 51.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.693 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -125.02 144.85 50.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.718 . . . . 0.0 109.369 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.52 129.99 54.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 t -90.5 112.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.429 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -116.69 -14.31 10.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.686 -0.634 . . . . 0.0 110.292 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.94 140.33 56.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.877 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -68.56 -34.66 76.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.654 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -64.96 -28.72 69.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.763 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.15 -157.04 36.56 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 14' ' ' ILE . 9.1 mm -110.81 89.66 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.974 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.427 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.61 -46.35 89.24 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.305 -0.872 . . . . 0.0 112.912 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.91 -54.98 37.83 Favored Pre-proline 0 N--CA 1.507 2.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.563 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' C ' ' A' ' 15' ' ' HIP . 31.1 Cg_endo -70.11 -23.0 29.68 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.052 1.168 . . . . 0.0 110.283 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.14 60.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.746 . . . . 0.0 109.134 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -28.82 31.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.772 . . . . 0.0 109.158 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -70.26 -37.79 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.97 -50.9 15.12 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.538 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.49 -28.91 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.5 -37.98 55.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.486 -0.759 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.1 m -71.95 -65.85 0.72 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.425 -0.797 . . . . 0.0 109.784 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.27 -27.33 14.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.674 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -61.71 -46.17 90.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -63.24 -21.87 66.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.685 . . . . 0.0 110.003 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.445 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 84.9 m-85 -89.53 127.1 35.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.16 -28.19 69.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.66 -0.65 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.39 53.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -89.93 94.38 9.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 0.0 109.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.89 135.06 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.64 -0.663 . . . . 0.0 109.248 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -132.08 138.25 48.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 0.0 110.171 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.07 156.02 19.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.51 129.52 35.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.37 57.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 55.63 22.63 5.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.86 -41.16 0.61 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -89.96 87.79 7.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.523 -0.986 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.7 m -91.74 112.6 24.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.05 148.24 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -64.92 138.96 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -54.54 -29.61 51.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -90.76 61.75 4.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.19 87.71 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 mt -70.33 -39.79 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.668 -0.645 . . . . 0.0 109.68 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.78 -28.56 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.22 57.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.45 -33.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.485 -1.009 . . . . 0.0 109.337 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -69.36 -34.29 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 109.194 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.5 p -63.08 -34.65 78.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.607 -0.683 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.89 -38.96 66.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.423 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.47 73.35 0.58 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.9 mt -81.78 151.06 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.968 . . . . 0.0 109.161 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.4 172.14 13.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.642 -0.662 . . . . 0.0 109.839 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 159.27 1.43 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.56 40.79 99.08 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.63 121.14 34.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -84.8 132.69 34.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.608 -0.683 . . . . 0.0 109.354 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 pt -127.22 163.44 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 109.383 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 m -140.14 111.4 7.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.2 mt -92.35 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -150.18 103.03 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.822 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 121.7 32.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.96 109.88 10.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 109.669 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.35 -150.21 10.8 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.51 -65.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.517 -0.99 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.73 47.5 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.637 -0.664 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -58.65 -41.46 86.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.727 . . . . 0.0 110.139 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -62.26 -30.13 70.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.91 -25.26 58.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.83 -39.97 25.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.816 . . . . 0.0 110.982 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.2 -42.46 93.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 0.0 110.459 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 17.7 p-10 -72.08 -28.44 63.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.0 109.187 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -61.0 -64.08 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.45 -0.781 . . . . 0.0 109.555 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.67 -25.54 66.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -0.828 . . . . 0.0 109.872 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -54.56 44.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.437 -0.789 . . . . 0.0 110.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 -28.26 69.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -66.22 -35.78 81.33 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -28.5 64.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.783 -0.573 . . . . 0.0 109.558 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -80.52 -25.19 38.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.782 . . . . 0.0 110.042 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 p -81.53 -63.14 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -0.766 . . . . 0.0 109.786 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.15 -29.11 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 109.731 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.2 6.24 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.77 -34.69 30.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.627 -0.925 . . . . 0.0 109.563 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.16 -179.42 41.83 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.58 150.58 31.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.045 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -134.64 163.03 30.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.708 -0.62 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 134.75 54.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.733 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -119.91 161.58 20.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.715 . . . . 0.0 109.547 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -120.2 123.68 43.85 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -83.66 120.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -131.95 16.19 4.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.738 . . . . 0.0 110.183 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 144.86 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.46 -29.2 70.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -90.0 -30.87 17.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 109.496 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.56 -150.03 19.7 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.8 mt -112.29 91.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.987 . . . . 0.0 109.424 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.424 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.94 -45.12 91.21 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.214 -0.929 . . . . 0.0 112.972 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 9.2 ttp180 -54.17 -55.45 36.58 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD2' ' C ' ' A' ' 15' ' ' HIP . 31.0 Cg_endo -69.72 -22.17 32.64 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 120.922 1.081 . . . . 0.0 110.443 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.46 -21.66 57.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.259 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -82.12 -30.69 31.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.46 -0.775 . . . . 0.0 109.071 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 t -70.08 -34.49 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mt -76.85 -49.1 16.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.02 -0.425 . . . . 0.0 110.5 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.54 -27.26 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -54.13 8.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.441 -0.787 . . . . 0.0 110.328 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -61.16 -60.55 3.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.524 -0.735 . . . . 0.0 110.419 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.49 -26.52 43.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.466 -0.771 . . . . 0.0 110.745 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.48 -42.12 99.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.408 -0.807 . . . . 0.0 109.474 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -64.25 -21.03 66.44 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -89.4 133.88 34.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 0.0 109.696 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -77.32 -22.97 51.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.615 -0.678 . . . . 0.0 110.081 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.54 150.97 17.79 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.61 87.79 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.651 -0.656 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.02 118.16 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -120.25 124.9 46.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.75 142.55 27.64 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -129.98 155.76 45.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -145.8 105.27 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 -81.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.35 26.58 1.85 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -124.26 99.92 6.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.511 -0.994 . . . . 0.0 108.928 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -89.85 87.27 6.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.578 -0.702 . . . . 0.0 109.957 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.53 146.48 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -69.89 142.85 52.93 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -53.95 -28.88 40.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.403 -0.811 . . . . 0.0 109.02 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.92 59.45 4.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -150.1 89.53 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.2 mt -71.9 -51.8 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 109.519 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.0 tpt -61.49 -28.59 69.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.748 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.62 -40.53 53.38 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -64.56 -28.11 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.97 . . . . 0.0 109.601 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.4 t -74.03 -31.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.8 . . . . 0.0 109.422 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.6 p -64.3 -27.29 68.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mp -75.0 -46.76 32.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.798 . . . . 0.0 109.542 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.32 63.04 2.74 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.3 mt -74.21 162.58 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.922 . . . . 0.0 109.29 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.84 -164.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 109.759 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -72.98 135.23 44.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.778 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 45.16 7.43 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.03 161.72 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.598 -0.942 . . . . 0.0 109.408 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -124.5 118.59 26.96 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 151.99 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.744 . . . . 0.0 109.491 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.8 m -136.16 107.87 7.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.58 -0.7 . . . . 0.0 109.483 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.6 mt -92.25 159.28 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.614 -0.679 . . . . 0.0 109.275 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 p -144.98 102.47 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.715 -0.616 . . . . 0.0 109.667 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.88 121.48 32.04 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.75 105.33 6.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.354 -0.841 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.45 -140.68 4.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.67 -53.27 5.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.582 -0.952 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.3 45.59 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 109.418 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -66.16 -33.62 76.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 109.94 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.28 -35.29 61.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.448 -0.782 . . . . 0.0 109.839 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.75 -20.75 58.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.464 -0.773 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.41 -43.14 19.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.267 -0.895 . . . . 0.0 110.477 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.96 -41.7 95.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.324 -0.86 . . . . 0.0 110.694 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.436 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 26.3 p-10 -74.84 -25.92 59.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.59 -60.47 2.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.35 -28.41 69.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 109.771 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.15 -54.95 39.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.12 -29.14 68.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.372 -0.83 . . . . 0.0 109.978 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.8 m -69.03 -34.2 74.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.2 mmt -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.794 -0.567 . . . . 0.0 109.607 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -75.53 -28.6 59.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.783 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.3 p -66.23 -49.76 66.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.696 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -10.83 54.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.585 -0.697 . . . . 0.0 110.46 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.77 94.24 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.85 -62.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.583 -0.951 . . . . 0.0 109.648 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.67 120.76 1.38 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -49.94 155.2 0.94 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 110.771 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.37 162.64 38.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.318 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -101.34 165.98 10.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -149.52 145.55 26.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.691 . . . . 0.0 109.288 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -107.78 127.27 53.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.556 -0.715 . . . . 0.0 109.073 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.5 t -90.72 120.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.753 -0.592 . . . . 0.0 109.634 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -134.12 23.5 3.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.702 -0.624 . . . . 0.0 109.929 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 144.12 37.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -56.6 -49.47 74.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.388 -0.82 . . . . 0.0 109.882 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -80.44 -29.5 37.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.371 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.63 -161.39 19.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.4 mt -99.46 63.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.613 -0.934 . . . . 0.0 109.187 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.71 -47.8 84.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.052 -1.03 . . . . 0.0 112.608 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -57.44 13.36 Favored Pre-proline 0 N--CA 1.507 2.405 0 O-C-N 120.829 -1.169 . . . . 0.0 111.184 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -71.94 -18.31 27.97 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.333 1.355 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.78 -21.69 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.787 . . . . 0.0 109.385 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.33 -33.87 21.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -72.5 -35.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.699 0.762 . . . . 0.0 109.068 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.8 mt -77.17 -45.36 26.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.998 -0.439 . . . . 0.0 110.431 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.4 p -60.1 -27.47 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -73.44 -52.56 13.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.5 -0.75 . . . . 0.0 110.468 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.27 -54.39 46.33 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.422 -0.799 . . . . 0.0 110.344 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.68 -25.16 62.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.3 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.6 t -62.55 -38.6 90.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.348 -0.845 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.624 . . . . 0.0 109.931 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 88.3 m-85 -89.56 125.32 35.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 109.676 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -68.58 -24.73 64.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.874 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.62 144.63 42.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 109.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.67 96.14 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -89.96 131.39 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -122.08 130.61 53.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 110.379 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.1 tp -89.91 146.71 24.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.48 126.95 46.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.391 -0.818 . . . . 0.0 109.903 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 55' ' ' ILE . 42.0 t80 -160.33 137.65 9.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.61 37.35 19.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.037 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.85 29.5 67.71 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -129.33 113.36 14.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.595 -0.944 . . . . 0.0 109.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.6 m -93.39 91.52 7.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.538 -0.726 . . . . 0.0 109.794 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.514 -0.741 . . . . 0.0 109.065 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -69.4 145.03 53.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 7.0 tp -63.38 -13.25 37.49 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -87.17 50.51 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.77 -1.206 . . . . 0.0 108.113 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.0 t -150.24 86.2 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.83 -41.36 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.768 -0.582 . . . . 0.0 109.658 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.6 tpt -72.74 -27.23 61.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.526 -0.734 . . . . 0.0 109.762 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -24.13 72.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.67 -31.36 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -1.058 . . . . 0.0 109.574 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 t -75.43 -28.54 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.839 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.2 p -62.08 -27.97 69.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.77 . . . . 0.0 109.776 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.53 -76.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.475 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.89 55.42 0.27 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 37' ' ' TYR . 17.9 mt -73.85 150.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.607 -0.937 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.03 -158.68 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.671 -0.643 . . . . 0.0 109.722 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -86.55 63.57 8.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.6 56.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . . . -132.52 129.72 39.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.93 . . . . 0.0 109.488 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -84.65 129.45 34.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.7 pt -123.21 134.56 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.639 -0.663 . . . . 0.0 109.347 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -105.16 117.07 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.8 mt -102.14 153.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -149.94 103.35 3.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.658 -0.651 . . . . 0.0 109.597 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.31 127.97 35.83 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.84 106.6 7.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.88 -145.67 7.17 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.09 -71.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.896 . . . . 0.0 109.594 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -98.91 52.73 0.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.535 -0.728 . . . . 0.0 109.416 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.92 -42.81 90.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.435 -0.79 . . . . 0.0 110.114 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -62.0 -28.58 69.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 0.0 109.85 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -23.53 50.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.433 -0.792 . . . . 0.0 110.454 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . . . -81.06 -47.11 14.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -62.26 -45.61 92.53 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.35 -0.844 . . . . 0.0 110.66 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 36.4 p-10 -70.81 -25.26 62.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.1 -62.72 1.58 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -62.76 -22.95 66.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.593 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.93 -52.39 65.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.49 -29.45 70.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -66.24 -33.85 76.68 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mmt -71.75 -28.24 63.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.749 -0.595 . . . . 0.0 109.665 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -86.89 -18.96 29.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 110.47 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -74.22 -67.59 0.6 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.34 -28.56 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.68 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.5 35.46 5.68 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.7 -49.7 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.748 -0.854 . . . . 0.0 109.696 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.1 -179.51 36.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.49 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -172.95 153.57 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.628 -0.67 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -144.58 148.16 34.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.679 -0.638 . . . . 0.0 109.632 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.5 m -92.61 159.08 15.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.712 -0.617 . . . . 0.0 109.438 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -143.08 172.68 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.171 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -136.68 122.74 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -75.11 111.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.638 . . . . 0.0 109.305 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -16.67 13.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.728 -0.608 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.05 139.88 56.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.24 -0.912 . . . . 0.0 109.841 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.73 -42.71 90.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.1 p -63.09 -29.82 71.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.46 -157.07 24.46 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.7 mt -107.44 78.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.601 -0.941 . . . . 0.0 109.599 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.24 -41.66 69.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.269 -0.894 . . . . 0.0 112.336 -177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.404 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.42 -60.7 7.67 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 120.852 -1.155 . . . . 0.0 111.001 -178.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.3 Cg_endo -69.7 -14.97 37.06 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.378 1.386 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.85 -23.96 38.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -0.831 . . . . 0.0 109.199 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.91 -30.04 26.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.192 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -74.31 -36.46 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.625 0.726 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.13 -43.86 27.69 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.92 -0.488 . . . . 0.0 110.367 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.8 -29.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 0.0 109.804 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -74.27 -42.49 59.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -65.42 -61.39 2.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.499 -0.751 . . . . 0.0 110.158 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.94 -25.38 63.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 0.0 110.303 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.0 t -60.92 -39.02 87.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.279 -0.888 . . . . 0.0 109.155 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -66.95 -27.72 67.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.452 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 98.7 m-85 -89.72 119.53 30.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.723 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -65.61 -15.74 63.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.774 -0.579 . . . . 0.0 110.278 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.51 172.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.82 88.67 2.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.638 . . . . 0.0 109.441 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.72 111.19 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.392 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -110.43 133.43 53.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.458 -0.777 . . . . 0.0 109.876 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.22 148.63 22.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.68 . . . . 0.0 109.268 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.39 107.55 12.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.51 -0.744 . . . . 0.0 109.445 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -92.88 71.69 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.441 -0.787 . . . . 0.0 110.003 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.66 85.57 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.656 -0.652 . . . . 0.0 111.592 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 -42.65 2.83 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -89.33 160.39 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.456 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -150.14 105.84 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.775 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.23 148.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 109.165 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.13 132.45 49.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -50.24 -28.22 7.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -90.76 61.18 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -150.44 86.79 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mt -63.93 -61.81 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.982 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 ttm -64.35 -21.66 66.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.465 -0.772 . . . . 0.0 110.167 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.57 60.29 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.18 -32.21 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.411 -1.053 . . . . 0.0 109.718 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.3 t -64.33 -28.4 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.781 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -69.48 -25.65 64.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 0.0 110.022 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 4.2 mm? -64.71 -37.12 86.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.486 -0.759 . . . . 0.0 109.592 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.88 38.02 28.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -69.59 144.24 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.54 -0.976 . . . . 0.0 109.264 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.59 -165.76 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.49 42.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.61 72.93 0.58 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.82 170.1 16.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.977 . . . . 0.0 109.602 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.77 143.41 48.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.693 . . . . 0.0 109.236 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.3 pt -145.79 126.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.539 -0.726 . . . . 0.0 109.524 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -101.64 118.39 36.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.0 mt -102.13 151.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -150.25 109.91 4.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.515 -0.74 . . . . 0.0 110.131 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.85 134.98 33.9 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.71 107.67 4.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.77 -127.32 1.36 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.2 -70.07 0.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.973 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -93.14 49.54 1.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.632 -0.668 . . . . 0.0 109.326 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -64.2 -40.9 97.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 0.0 110.039 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -68.48 -43.09 77.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.0 -23.9 65.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 0.0 110.314 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.22 -46.65 15.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.285 -0.885 . . . . 0.0 111.391 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -59.21 -41.74 89.31 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.407 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.88 -26.36 60.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.903 . . . . 0.0 109.221 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.452 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -60.27 -61.57 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.78 . . . . 0.0 109.24 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.64 -29.25 69.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.404 -0.81 . . . . 0.0 109.793 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.23 -37.73 86.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.487 -0.758 . . . . 0.0 109.919 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.75 -28.56 62.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.4 m -68.2 -37.6 81.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -27.89 63.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.777 -0.577 . . . . 0.0 109.567 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -86.87 -17.64 32.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 110.453 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -75.04 -52.12 11.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.886 . . . . 0.0 109.806 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.48 -35.1 14.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.653 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 44.81 1.52 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.6 mt -81.71 -29.33 33.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -1.006 . . . . 0.0 109.635 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.15 169.09 41.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.569 -179.859 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.87 153.96 36.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.558 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -142.9 144.64 32.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.678 -0.639 . . . . 0.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -90.15 146.3 24.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.675 -0.641 . . . . 0.0 109.402 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.416 ' CE1' HD11 ' A' ' 63' ' ' ILE . 36.0 m-85 -126.86 161.32 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.576 -0.703 . . . . 0.0 109.561 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.02 133.77 55.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.25 106.5 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.371 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -124.48 14.78 8.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 110.177 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 148.67 34.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -54.49 17.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.354 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -66.09 -29.3 69.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.565 -0.709 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.77 -159.31 20.27 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.74 78.23 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.995 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.279 -0.888 . . . . 0.0 112.603 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -60.34 10.24 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.952 -1.093 . . . . 0.0 110.845 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -70.39 -13.54 33.18 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.341 1.36 . . . . 0.0 110.983 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.19 -28.65 38.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 108.914 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.84 -27.25 36.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.4 t -71.57 -40.84 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.8 mt -69.25 -53.98 17.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.161 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -53.14 -28.17 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 110.434 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -71.41 -43.12 67.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.935 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -69.18 -59.64 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.389 -0.819 . . . . 0.0 109.947 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.0 -21.59 31.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.465 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.7 t -58.9 -41.84 88.15 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -65.94 -29.51 69.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.438 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 68.9 m-85 -93.67 128.52 39.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.26 8.94 21.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.87 -178.44 1.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.96 75.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -89.71 124.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 109.395 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -135.03 142.8 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.612 -0.68 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.6 tt -89.62 159.16 17.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -127.12 125.67 41.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.409 ' CD2' HG12 ' A' ' 55' ' ' ILE . 73.8 t80 -160.39 145.5 14.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.504 -0.748 . . . . 0.0 109.784 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 61.3 34.82 18.37 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.631 -0.668 . . . . 0.0 110.018 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 29.5 70.21 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -135.33 178.92 6.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.59 -0.947 . . . . 0.0 109.083 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 m -143.74 114.12 7.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.23 147.71 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -68.11 134.74 51.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -53.39 -26.95 21.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.456 -0.778 . . . . 0.0 109.293 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.63 57.07 3.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -146.38 88.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 mt -69.21 -39.23 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 0.0 109.993 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.5 ttm -82.59 -29.5 30.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.755 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.03 -43.15 96.22 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.76 -34.01 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.49 -1.006 . . . . 0.0 109.385 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.4 -28.65 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.707 . . . . 0.0 109.561 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -62.03 -34.14 75.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.505 -0.747 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mp -70.83 -46.84 62.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.583 -0.698 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.68 65.57 2.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.5 mt -77.09 162.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.603 -0.939 . . . . 0.0 109.269 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.5 -175.06 3.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.655 -0.653 . . . . 0.0 109.618 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 153.23 42.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.598 -0.689 . . . . 0.0 109.496 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.3 55.45 10.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.68 179.49 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.557 -0.967 . . . . 0.0 109.535 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -132.82 140.86 48.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 pt -138.78 161.3 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.459 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.37 121.58 21.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 109.644 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 HD11 ' CE1' ' A' ' 6' ' ' PHE . 90.8 mt -105.01 149.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 p -150.3 112.83 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.79 134.59 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.01 102.87 3.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.394 -0.816 . . . . 0.0 109.821 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.88 -125.23 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.06 -72.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.956 . . . . 0.0 109.666 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.26 55.84 1.55 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.72 . . . . 0.0 109.385 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.18 -28.26 69.93 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -74.78 -44.4 49.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.44 -0.788 . . . . 0.0 109.946 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.5 -46.27 14.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.01 -1.056 . . . . 0.0 110.49 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.12 -42.42 96.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.348 -0.845 . . . . 0.0 110.669 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.416 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 45.7 p-10 -75.77 -22.41 56.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 109.391 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -66.86 -59.13 3.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.339 -0.851 . . . . 0.0 108.707 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.69 -28.39 69.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.527 -0.733 . . . . 0.0 109.848 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' OE2' ' CE2' ' A' ' 6' ' ' PHE . 4.8 tt0 -61.18 -56.28 22.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.477 -0.764 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.68 -30.67 70.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -68.56 -32.48 72.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -0.822 . . . . 0.0 108.915 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 30.6 mmm -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -76.0 -22.59 55.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.731 -0.605 . . . . 0.0 110.03 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 p -66.1 -50.04 65.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.399 -0.813 . . . . 0.0 109.675 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -97.84 10.1 41.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.565 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.5 89.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.3 mt -132.46 -60.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.628 -0.924 . . . . 0.0 109.401 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.22 150.4 22.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -64.6 152.71 41.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -150.44 137.73 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.652 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.4 m -89.85 139.71 30.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.632 -0.667 . . . . 0.0 109.357 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CD1' HD13 ' A' ' 63' ' ' ILE . 18.8 m-85 -123.02 169.5 11.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 109.868 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 137.88 52.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.592 -0.693 . . . . 0.0 109.342 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 21.3 t -90.51 108.09 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.59 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -129.1 22.25 5.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.59 -0.694 . . . . 0.0 109.884 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.68 159.06 29.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.07 -61.75 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.562 -0.711 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -71.04 -29.36 65.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.718 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.18 -139.55 14.98 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 14' ' ' ILE . 55.4 mt -122.15 73.15 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.597 -0.943 . . . . 0.0 109.391 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.405 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.7 69.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.712 -1.243 . . . . 0.0 112.247 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.99 -54.07 51.15 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.906 -1.121 . . . . 0.0 111.092 -178.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -73.13 -21.44 20.44 Favored 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 121.115 1.21 . . . . 0.0 110.293 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.43 -21.43 58.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.33 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.52 -31.89 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.129 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.2 -45.21 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.7 -49.57 57.88 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -55.93 -29.64 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.83 -36.16 70.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.913 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -72.43 -59.25 2.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.473 -0.767 . . . . 0.0 110.148 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.14 31.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.478 -0.764 . . . . 0.0 110.738 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.1 p -59.94 -42.61 94.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.289 -0.882 . . . . 0.0 109.645 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -28.02 69.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.609 -0.682 . . . . 0.0 109.622 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 78.5 m-85 -94.8 131.48 40.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.429 -0.794 . . . . 0.0 109.633 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.23 -11.46 57.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.668 -0.645 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.3 155.73 8.55 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.039 -1.038 . . . . 0.0 109.82 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.62 82.0 6.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.581 -0.699 . . . . 0.0 109.528 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -89.68 121.97 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -124.5 126.24 45.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 110.105 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.4 tt -89.97 155.45 19.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -122.16 158.53 29.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 110.053 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 55' ' ' ILE . 34.3 t80 -145.48 98.46 3.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.04 -81.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.24 26.85 1.56 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -125.24 121.07 33.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.569 -0.96 . . . . 0.0 109.116 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.31 100.85 12.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.539 -0.726 . . . . 0.0 110.057 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.06 147.65 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -71.67 142.21 49.87 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -58.02 -30.43 66.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 109.105 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.74 60.8 4.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.79 81.23 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.6 mt -64.81 -38.66 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.697 -0.627 . . . . 0.0 109.662 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.81 -24.34 59.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.546 -0.721 . . . . 0.0 110.04 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 -31.24 46.08 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -79.92 -38.44 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -1.047 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.9 -30.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.7 p -67.52 -32.64 73.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.0 -55.78 5.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.544 -0.722 . . . . 0.0 109.533 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.43 63.77 1.69 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.426 HG21 ' CE1' ' A' ' 37' ' ' TYR . 61.8 mt -76.2 159.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.974 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.13 -175.04 4.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.707 -0.621 . . . . 0.0 109.558 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -70.46 146.96 49.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.628 -0.67 . . . . 0.0 109.603 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.42 61.88 2.39 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.33 -178.58 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.582 -0.952 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -128.49 148.48 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 61' ' ' ILE . 19.3 pt -139.81 154.63 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.76 113.11 11.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 6' ' ' PHE . 77.1 mt -99.12 155.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.25 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 p -150.22 101.04 2.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.841 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.76 122.38 32.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.4 104.78 4.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 109.707 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.4 -125.2 0.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.58 -69.74 0.71 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.642 -0.917 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.67 49.17 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.78 -32.41 70.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.475 -0.766 . . . . 0.0 110.023 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.35 -33.18 72.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -77.47 -23.25 50.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 110.051 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.401 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -68.16 -42.12 80.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 39.5 p30 -78.39 -18.86 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.31 -58.8 3.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.195 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -24.96 62.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.82 -59.11 4.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.91 -28.55 67.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.355 -0.84 . . . . 0.0 109.771 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 40.6 m -67.25 -35.89 80.48 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.33 -28.4 64.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.699 -0.626 . . . . 0.0 109.422 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -83.0 -21.55 33.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.113 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 p -75.08 -53.61 8.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -80.17 -29.1 38.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 109.562 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.57 37.32 7.02 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.02 -37.38 26.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.691 -0.887 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.39 163.06 34.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.415 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.7 155.74 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.423 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -140.1 141.19 36.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.685 . . . . 0.0 109.645 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 m -99.13 158.99 15.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -143.87 161.79 37.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.0 109.531 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -121.6 118.72 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.134 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.59 116.42 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.652 -0.655 . . . . 0.0 109.588 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -117.44 -16.03 10.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.726 -0.608 . . . . 0.0 110.357 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 151.97 36.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.68 -43.53 72.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -64.3 -32.5 74.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.589 -0.694 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.66 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.9 mt -132.04 87.72 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.594 -0.944 . . . . 0.0 109.428 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.65 60.54 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.743 -1.223 . . . . 0.0 111.968 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.4 ttt180 -53.77 -52.98 62.66 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.046 -1.034 . . . . 0.0 111.109 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -74.27 -24.6 14.3 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.137 1.225 . . . . 0.0 110.332 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.36 -20.88 61.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.55 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.77 -34.16 21.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 108.979 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -69.95 -34.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.38 -51.5 11.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.397 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.17 -27.38 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.292 -0.88 . . . . 0.0 109.918 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.76 -45.63 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.676 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 m -61.05 -59.37 5.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 109.822 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.52 -26.43 67.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.041 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -59.86 -33.3 71.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -77.09 -26.32 53.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.619 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.3 m-85 -89.81 123.8 34.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.57 -24.21 67.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.692 -0.63 . . . . 0.0 109.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 141.76 53.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.401 -0.812 . . . . 0.0 109.789 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -89.51 98.56 11.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.587 -0.696 . . . . 0.0 109.235 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -89.96 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.575 -0.703 . . . . 0.0 109.351 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -131.96 132.84 43.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -121.27 128.73 52.65 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.477 -0.764 . . . . 0.0 109.903 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' A' ' 55' ' ' ILE . 51.9 t80 -160.49 138.49 9.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.718 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.87 37.08 15.58 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.536 -0.727 . . . . 0.0 109.754 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.76 27.98 64.93 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -123.35 168.98 11.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.943 . . . . 0.0 109.026 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.8 m -142.22 103.52 4.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 109.95 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.83 146.2 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -69.19 142.79 54.2 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.8 tp -64.05 -13.45 47.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.33 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -88.1 48.72 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.85 -1.157 . . . . 0.0 107.984 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 t -150.54 82.36 1.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.0 109.049 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.1 mt -63.63 -41.31 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.725 -0.61 . . . . 0.0 109.543 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.44 -29.98 66.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.29 -30.06 69.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.56 -31.13 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.97 . . . . 0.0 109.343 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.1 t -70.21 -31.68 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.616 -0.677 . . . . 0.0 109.397 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 p -63.89 -37.2 86.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.38 -46.62 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.605 -0.684 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.55 71.54 1.09 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 37' ' ' TYR . 59.5 mt -84.36 162.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.624 -0.927 . . . . 0.0 109.389 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.11 -174.14 4.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.602 -0.686 . . . . 0.0 109.617 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.9 150.31 42.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.712 -0.617 . . . . 0.0 109.686 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 62.7 3.14 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.63 164.88 29.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.942 . . . . 0.0 109.62 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -126.2 123.04 37.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 pt -117.56 130.52 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.687 . . . . 0.0 109.293 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.07 115.27 29.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.52 -0.738 . . . . 0.0 109.804 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.6 mt -101.93 149.85 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.581 -0.699 . . . . 0.0 109.183 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 p -147.22 108.89 4.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.637 -0.664 . . . . 0.0 109.675 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.75 131.16 35.85 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.61 107.18 7.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -145.72 8.16 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -64.4 1.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.943 . . . . 0.0 109.65 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.14 44.34 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.03 -32.21 72.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.35 -33.29 69.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 109.578 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.19 -24.13 54.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.761 . . . . 0.0 110.07 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.78 -41.51 23.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 110.457 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.22 -41.84 96.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.294 -0.878 . . . . 0.0 110.4 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 40.8 p30 -76.54 -21.04 56.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.25 -0.907 . . . . 0.0 109.763 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.78 -56.49 9.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.747 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -28.24 69.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -54.31 47.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.462 -0.774 . . . . 0.0 109.66 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.68 -27.48 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.643 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 m -67.9 -33.89 75.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -28.74 64.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.68 -0.638 . . . . 0.0 109.293 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -81.51 -25.29 36.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.602 -0.686 . . . . 0.0 110.116 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 p -72.32 -58.89 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 109.69 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -75.17 -41.23 58.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 109.451 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.6 44.33 1.98 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.77 -38.57 25.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.578 -0.954 . . . . 0.0 109.463 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.57 150.38 14.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.454 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -160.24 155.57 25.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.69 -0.631 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -140.06 147.61 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.631 -0.668 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -99.38 146.53 26.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 80.4 m-85 -138.53 162.58 34.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -123.15 138.2 54.71 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.68 118.89 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.729 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -128.36 9.61 6.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 144.13 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.525 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.52 -34.41 74.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 p -71.14 -29.83 65.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.485 -0.759 . . . . 0.0 109.582 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.32 -150.62 19.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 14' ' ' ILE . 15.6 mm -114.15 56.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.54 -0.977 . . . . 0.0 109.215 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.403 ' CD2' ' CD ' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.38 65.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.73 -1.231 . . . . 0.0 112.404 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -56.02 -52.59 71.39 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.954 -1.091 . . . . 0.0 111.112 -178.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.3 Cg_endo -71.84 -25.15 20.4 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.189 1.26 . . . . 0.0 110.497 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.09 -26.08 62.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 108.96 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 m -79.21 -30.2 43.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.477 -0.764 . . . . 0.0 109.27 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.67 -48.99 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.107 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.8 -54.38 27.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.85 -30.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.388 -0.82 . . . . 0.0 110.739 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.33 -47.63 63.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.74 . . . . 0.0 110.339 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -65.96 -56.53 11.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.27 -17.78 59.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.442 -0.787 . . . . 0.0 110.437 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -64.66 -29.48 70.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.71 23.72 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.734 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -131.79 120.14 22.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -22.19 66.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.655 -0.653 . . . . 0.0 109.958 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 147.52 34.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.0 109.818 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.75 89.74 7.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.616 -0.678 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.89 138.65 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -133.77 135.47 43.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tp -95.78 131.29 42.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -108.73 119.4 39.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 110.449 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 28.7 t80 -103.82 97.52 7.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 72.37 -81.27 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.828 -0.545 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.04 26.76 2.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -124.52 116.06 21.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -1.014 . . . . 0.0 109.012 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -91.5 104.15 16.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.428 -0.795 . . . . 0.0 110.321 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.25 147.86 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -68.2 140.37 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.96 -27.32 63.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.429 -0.795 . . . . 0.0 109.035 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -90.02 51.5 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.805 . . . . 0.0 109.118 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -137.87 91.96 2.63 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 mm -68.11 -62.54 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.682 -0.636 . . . . 0.0 109.641 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -66.5 -25.76 66.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 109.91 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.6 -30.13 75.89 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.69 -30.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.513 -0.992 . . . . 0.0 109.442 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.05 -29.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.484 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -66.52 -30.41 70.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.717 . . . . 0.0 109.589 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.93 -66.43 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.723 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.71 52.33 0.86 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.417 HG12 ' CZ ' ' A' ' 37' ' ' TYR . 38.7 mt -78.5 150.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.548 -0.972 . . . . 0.0 109.041 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.96 -164.28 1.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.573 -0.705 . . . . 0.0 109.804 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -66.64 153.89 41.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 109.703 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.15 57.85 13.96 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.1 173.97 8.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.667 -0.902 . . . . 0.0 109.515 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -128.37 141.13 51.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 pt -142.76 126.02 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.54 -0.725 . . . . 0.0 109.373 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 m -106.89 110.07 22.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.532 -0.73 . . . . 0.0 109.828 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 63' ' ' ILE . 79.2 mt -94.19 150.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -150.1 109.75 4.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.67 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.82 132.52 35.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.38 102.67 4.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.362 -0.836 . . . . 0.0 109.748 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.45 -134.38 2.57 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.49 -58.82 2.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.95 . . . . 0.0 109.476 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.13 47.96 1.04 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.9 -40.35 87.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 110.114 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -70.31 -35.64 73.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.897 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.88 -24.18 59.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 110.105 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.65 -44.07 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.823 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -61.79 -42.8 99.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.293 -0.88 . . . . 0.0 110.635 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.421 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 17.0 p-10 -72.48 -27.51 62.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 0.0 109.151 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.19 -58.36 8.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 109.254 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.72 -22.66 66.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -62.71 1.46 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.34 -34.51 73.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.313 -0.867 . . . . 0.0 109.906 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.8 m -63.15 -32.87 74.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.408 -0.807 . . . . 0.0 108.971 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.33 -30.95 66.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -82.02 -19.18 40.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.655 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.7 p -80.66 -45.51 17.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 109.739 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -81.06 -28.74 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.729 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 32.26 8.02 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.72 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.665 -0.903 . . . . 0.0 109.478 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.19 -173.08 13.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -107.32 150.12 27.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -142.18 150.78 41.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.7 -0.625 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 m -105.3 151.09 24.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 109.291 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.64 166.03 24.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.493 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -113.1 134.57 54.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.618 -0.676 . . . . 0.0 109.301 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 t -89.27 99.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 109.564 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -123.37 27.15 7.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 155.2 31.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -65.46 -43.71 89.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.265 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -101.15 21.77 13.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 109.851 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.34 -136.79 47.64 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.3 mt -119.44 88.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.573 -0.957 . . . . 0.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.414 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.65 63.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.75 -1.219 . . . . 0.0 112.044 -178.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.43 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -54.1 -52.46 68.28 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 111.521 -178.398 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -72.89 -23.89 18.29 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.19 1.26 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.36 -22.26 57.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 109.526 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.72 -31.19 26.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.225 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -71.53 -42.95 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.722 0.772 . . . . 0.0 108.998 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.47 -50.31 39.4 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.463 -179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 p -55.3 -28.88 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -73.01 -36.83 67.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.485 -0.759 . . . . 0.0 109.861 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -73.94 -63.78 1.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.456 -0.777 . . . . 0.0 110.202 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.54 -25.08 50.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -61.3 -40.9 95.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -68.36 -26.47 65.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.442 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.1 m-85 -89.85 128.32 36.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.342 -0.849 . . . . 0.0 109.725 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.29 -23.44 62.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.666 -0.646 . . . . 0.0 110.291 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 146.06 26.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.305 -0.872 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 91.05 8.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.538 -0.726 . . . . 0.0 109.263 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.9 m -89.91 113.93 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.673 -0.642 . . . . 0.0 109.335 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -105.93 137.25 44.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 tt -100.72 116.27 32.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -89.61 143.21 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.843 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' CE2' HG12 ' A' ' 55' ' ' ILE . 15.1 t80 -132.38 68.9 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.7 . . . . 0.0 109.547 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.56 62.26 2.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.3 -38.85 2.95 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -89.15 90.88 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -1.031 . . . . 0.0 109.195 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.4 m -95.91 112.55 24.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 110.11 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.1 147.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -65.59 141.81 58.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -56.87 -29.58 63.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 109.139 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 61.02 4.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -148.78 88.74 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.1 mt -71.72 -40.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.618 -0.676 . . . . 0.0 109.937 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -30.2 45.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 109.691 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.4 92.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.06 -28.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.54 -0.976 . . . . 0.0 109.52 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.18 -31.3 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 109.401 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -62.89 -41.02 99.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.768 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.11 -33.51 75.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 109.431 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.84 23.65 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 37' ' ' TYR . 54.6 mt -75.92 147.46 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.615 -0.933 . . . . 0.0 109.327 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.68 -167.52 1.84 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.52 150.34 32.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.577 -0.702 . . . . 0.0 109.538 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.84 3.7 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 179.97 6.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.941 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.16 136.19 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 pt -124.38 162.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.668 . . . . 0.0 109.677 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.0 m -136.34 161.26 36.3 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.2 mt -146.26 150.95 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.409 -0.807 . . . . 0.0 109.768 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -150.52 108.13 3.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.67 -0.643 . . . . 0.0 109.578 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.63 130.43 35.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 109.08 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 102.22 5.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.2 -142.24 5.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.16 -57.96 2.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.588 -0.948 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -96.72 48.3 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.688 . . . . 0.0 109.359 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -66.89 -29.08 68.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 109.744 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -77.74 -36.23 51.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.497 -0.752 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -76.16 -20.72 57.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.117 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.36 -44.26 17.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.906 . . . . 0.0 110.296 -179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.83 -42.45 94.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.466 -0.771 . . . . 0.0 110.285 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 23.8 p30 -78.55 -19.8 52.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.462 -0.774 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.442 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.76 -54.32 20.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.56 -30.9 71.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.665 -0.647 . . . . 0.0 109.6 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.18 -52.19 66.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.43 -0.794 . . . . 0.0 110.122 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.83 -29.44 70.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.2 m -67.67 -33.26 74.58 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.8 mtt -67.87 -29.29 68.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -84.64 -23.49 29.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.569 -0.707 . . . . 0.0 110.184 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -73.54 -55.33 6.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -85.06 -27.92 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.524 -0.735 . . . . 0.0 109.679 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.18 1.48 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.78 -37.8 6.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.957 . . . . 0.0 109.685 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.84 158.34 30.83 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.245 0.545 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -99.91 157.06 16.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.782 . . . . 0.0 109.234 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -146.32 137.78 24.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 m -89.69 159.48 17.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.674 . . . . 0.0 109.244 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -145.4 143.31 30.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.6 -0.687 . . . . 0.0 109.69 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.57 127.92 46.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.214 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.5 t -85.96 134.21 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.586 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -149.6 27.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.583 -0.698 . . . . 0.0 109.587 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.58 146.7 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -58.87 5.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.1 p -69.67 -31.31 69.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.687 . . . . 0.0 109.408 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.06 -154.22 16.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 14' ' ' ILE . 38.7 mm -104.7 85.3 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.973 . . . . 0.0 109.364 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.43 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.04 91.03 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.18 -0.95 . . . . 0.0 112.978 -177.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.8 ttp85 -59.06 -55.17 49.1 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.77 -1.206 . . . . 0.0 111.094 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD2' ' C ' ' A' ' 15' ' ' HIP . 31.0 Cg_endo -69.93 -21.51 32.59 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.04 1.16 . . . . 0.0 110.417 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.69 -22.53 50.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 109.272 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 m -81.13 -29.38 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.81 . . . . 0.0 109.152 179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.24 -41.1 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.52 -51.78 32.53 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.297 -179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.55 -28.26 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.389 -0.819 . . . . 0.0 109.816 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -69.96 -36.64 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -60.22 2.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.627 -0.67 . . . . 0.0 110.13 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.83 -24.83 62.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.473 -0.767 . . . . 0.0 110.359 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 t -60.84 -39.23 88.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -23.21 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.671 -0.643 . . . . 0.0 109.885 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 86.3 m-85 -89.46 127.72 35.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -0.865 . . . . 0.0 109.632 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.87 -22.8 62.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.72 -0.612 . . . . 0.0 109.905 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.17 45.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 109.715 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.67 93.9 9.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.56 -0.713 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -89.84 127.72 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -118.91 126.68 52.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 110.486 -178.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.79 133.73 34.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -113.35 130.16 56.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.448 -0.782 . . . . 0.0 110.167 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CE2' HG12 ' A' ' 55' ' ' ILE . 35.7 t80 -160.46 136.95 8.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.55 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.28 37.44 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.581 -0.7 . . . . 0.0 109.748 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.96 28.76 66.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -127.17 111.37 13.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.599 -0.942 . . . . 0.0 109.158 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -89.79 87.78 7.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.866 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.33 146.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -73.64 152.44 40.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.5 tp -69.61 -9.04 52.49 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.288 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -88.7 48.79 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.764 -1.21 . . . . 0.0 107.991 178.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 t -150.41 95.43 2.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.381 -0.825 . . . . 0.0 109.298 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.7 mt -76.97 -38.81 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.677 -0.639 . . . . 0.0 109.557 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpt -74.65 -34.03 62.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.59 99.24 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.11 -28.31 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.98 . . . . 0.0 109.424 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -63.2 -35.06 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 p -63.5 -34.58 78.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.643 -0.66 . . . . 0.0 109.365 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.01 -59.02 4.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 109.333 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.2 67.32 1.54 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 55' ' ' ILE . 50.2 mt -81.22 162.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.557 -0.967 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.98 178.57 9.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.572 -0.705 . . . . 0.0 109.463 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -62.02 137.97 58.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.48 39.96 9.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.47 179.59 4.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.604 -0.939 . . . . 0.0 109.468 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -137.95 153.2 49.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.678 -0.639 . . . . 0.0 109.365 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 pt -150.19 132.47 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.88 107.51 18.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.558 -0.714 . . . . 0.0 109.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.0 mt -94.11 153.81 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.211 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -148.04 107.96 4.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.67 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 125.92 35.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.526 -0.734 . . . . 0.0 109.06 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.85 107.12 8.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.32 8.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.61 -58.02 3.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 0.0 109.536 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.63 42.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.671 . . . . 0.0 109.361 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.01 -29.24 70.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.588 -0.695 . . . . 0.0 109.798 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -78.15 -33.46 50.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -76.42 -22.15 55.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.721 . . . . 0.0 110.125 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . . . -81.54 -42.52 20.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.08 -42.35 94.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.693 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.417 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 19.6 p30 -75.06 -22.53 58.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 109.622 -179.682 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.33 -59.5 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 108.745 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -28.88 70.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.52 -0.737 . . . . 0.0 109.781 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.33 -55.9 26.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.459 -0.776 . . . . 0.0 109.938 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -58.73 -27.24 64.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 110.038 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -70.91 -36.86 72.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 mmt -71.0 -29.85 65.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.754 -0.591 . . . . 0.0 109.459 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -83.5 -21.75 32.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.575 -0.703 . . . . 0.0 110.229 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -75.2 -70.22 0.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 109.781 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -62.2 -28.22 69.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.713 . . . . 0.0 109.753 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.79 39.91 5.41 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.81 -56.12 4.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.552 -0.97 . . . . 0.0 109.373 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.78 176.54 27.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.29 153.15 20.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.599 -0.688 . . . . 0.0 109.441 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 7.3 tttp -141.71 149.47 40.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 109.374 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -89.92 153.02 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.534 -0.729 . . . . 0.0 109.476 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 76.7 m-85 -142.27 145.49 34.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.624 -0.672 . . . . 0.0 109.398 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.97 126.93 52.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.2 t -81.61 116.1 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.589 -0.694 . . . . 0.0 109.552 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -134.34 26.37 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.46 164.55 25.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 109.466 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.55 -34.22 73.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.572 -0.705 . . . . 0.0 109.316 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -114.48 24.25 12.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.73 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.65 -139.07 46.77 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mt -121.69 87.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.906 . . . . 0.0 109.307 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.401 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.83 65.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.758 -1.214 . . . . 0.0 112.021 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.416 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.63 -53.72 59.48 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.961 -1.087 . . . . 0.0 110.829 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -73.88 -21.67 18.34 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.113 1.208 . . . . 0.0 110.456 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.03 60.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.258 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.55 -31.12 24.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 109.16 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -73.03 -35.48 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.721 0.772 . . . . 0.0 109.047 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.87 -43.35 30.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.996 -0.44 . . . . 0.0 110.554 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.72 -27.94 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 109.681 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -72.43 -50.35 26.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.528 -0.733 . . . . 0.0 110.025 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -61.57 -59.07 5.77 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.51 -0.743 . . . . 0.0 109.991 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.51 60.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -38.98 83.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -29.06 69.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.483 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 96.5 m-85 -89.65 118.37 29.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.46 -15.68 62.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.657 -0.652 . . . . 0.0 110.243 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.35 29.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.7 86.95 6.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.391 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.73 119.98 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -112.12 132.82 54.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.732 . . . . 0.0 109.994 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.93 135.12 33.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -105.93 140.36 39.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.737 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 55' ' ' ILE . 27.5 t80 -140.82 84.54 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.667 -0.646 . . . . 0.0 109.532 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.42 52.06 6.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.614 -0.679 . . . . 0.0 110.089 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.86 -12.96 64.17 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.412 -0.899 . . . . 0.0 110.874 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -89.48 86.91 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -1.175 . . . . 0.0 109.348 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 m -91.63 92.97 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.879 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.94 147.5 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.01 142.55 57.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 7.2 tp -64.14 -13.75 50.27 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.22 48.36 1.63 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.8 t -150.27 84.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.818 . . . . 0.0 109.139 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.1 mt -67.45 -46.31 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 0.0 109.255 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 ttm -64.35 -29.74 70.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.634 -0.667 . . . . 0.0 109.36 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.07 91.88 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.49 -39.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.972 . . . . 0.0 109.286 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.7 t -64.11 -30.63 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -68.14 -31.6 71.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.637 -0.664 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.91 -67.58 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.79 47.8 1.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.5 mt -63.73 157.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.953 . . . . 0.0 109.122 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.01 -170.49 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -84.13 150.66 25.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 109.474 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.02 46.95 14.53 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.33 178.46 6.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.481 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.78 147.75 49.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.679 . . . . 0.0 109.466 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.4 pt -142.5 157.36 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -131.37 109.63 10.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 109.639 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 HD11 ' CE1' ' A' ' 6' ' ' PHE . 90.0 mt -92.32 152.41 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.729 . . . . 0.0 109.145 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -150.2 109.54 3.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.78 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.84 126.64 35.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 103.86 5.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.475 -0.766 . . . . 0.0 109.618 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.54 -130.85 1.8 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.86 -74.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.629 -0.924 . . . . 0.0 109.59 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -90.34 53.0 2.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.8 -30.45 69.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.869 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.27 -37.81 60.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.712 . . . . 0.0 109.797 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.83 -24.88 58.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 110.19 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HA ' ' CD2' ' A' ' 29' ' ' TYR . . . -80.9 -43.18 20.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.832 . . . . 0.0 110.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -62.51 -42.01 99.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 17.9 p-10 -74.13 -26.93 60.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 -60.77 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.805 . . . . 0.0 109.28 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -28.07 69.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 109.969 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -56.61 19.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.919 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.79 -28.28 69.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -67.8 -32.59 73.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -30.78 66.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -81.17 -24.17 37.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.635 -0.666 . . . . 0.0 109.989 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -73.98 -69.33 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.61 -28.79 70.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.45 44.73 5.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.3 mt -81.87 -33.82 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.612 -0.934 . . . . 0.0 109.572 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.03 153.45 10.85 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.387 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -91.56 153.48 19.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 10.3 tttm -143.28 150.31 39.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.659 . . . . 0.0 109.631 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -97.16 152.42 18.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 4' ' ' LYS . 96.5 m-85 -142.08 148.2 38.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.627 -0.671 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -110.11 117.61 34.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.712 . . . . 0.0 109.145 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.15 112.97 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.736 -0.602 . . . . 0.0 109.503 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.6 17.62 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.701 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.25 38.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 109.373 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.12 91.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.552 -0.717 . . . . 0.0 109.716 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -75.17 -29.61 60.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.438 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 -166.38 24.87 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 14' ' ' ILE . 62.8 mt -100.59 82.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.567 -0.96 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.401 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.74 67.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.235 -0.916 . . . . 0.0 112.285 -177.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -57.88 -60.96 8.36 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.875 -1.141 . . . . 0.0 110.575 -178.594 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.59 -13.67 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.265 1.31 . . . . 0.0 110.786 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.91 -26.12 40.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 108.974 179.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.09 -29.78 31.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -0.755 . . . . 0.0 109.056 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.38 -43.93 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.11 -51.6 36.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.465 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -53.44 -29.54 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -70.75 -40.68 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -69.52 -63.95 0.97 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.926 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.92 -24.91 25.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.468 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 t -60.06 -44.86 94.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 109.328 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -65.45 -28.85 69.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.623 -0.673 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -89.65 129.91 36.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 109.269 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.23 -7.98 58.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.618 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.4 168.93 1.87 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.98 . . . . 0.0 109.707 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.99 87.09 4.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.429 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -95.84 98.64 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -107.11 131.89 53.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 0.0 109.761 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.5 tt -89.99 153.19 20.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.328 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -126.07 145.25 50.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.759 . . . . 0.0 109.447 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -160.29 108.48 1.66 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.531 -0.731 . . . . 0.0 109.835 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.82 50.52 8.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 109.93 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.49 27.98 71.71 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.41 97.92 5.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 109.133 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -91.79 102.02 14.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.557 -0.714 . . . . 0.0 110.062 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.95 147.46 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.87 135.37 52.4 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -53.99 -25.62 21.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.373 -0.829 . . . . 0.0 109.338 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -90.61 54.58 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 t -145.64 85.22 1.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.7 mt -67.42 -40.32 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.708 -0.62 . . . . 0.0 110.118 -178.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.4 ttt -74.45 -27.68 60.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.48 -0.762 . . . . 0.0 109.835 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.89 59.14 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 37.4 t -67.39 -38.58 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -1.017 . . . . 0.0 109.72 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -29.17 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.47 -0.768 . . . . 0.0 109.626 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.9 p -65.77 -29.62 70.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.49 -56.09 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.561 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.18 43.65 3.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.88 158.0 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -1.003 . . . . 0.0 109.3 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.94 -164.47 1.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.551 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -66.94 130.14 42.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.586 -0.696 . . . . 0.0 109.568 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.65 79.7 0.94 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.97 167.35 25.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.611 -0.934 . . . . 0.0 109.437 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.51 119.85 23.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 109.27 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.5 pt -120.33 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.717 . . . . 0.0 109.556 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -112.25 111.84 23.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.603 -0.685 . . . . 0.0 109.738 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD13 ' CD2' ' A' ' 6' ' ' PHE . 90.1 mt -92.41 158.75 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 p -150.31 103.13 3.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.99 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.96 123.66 36.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.49 105.77 4.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.56 -124.89 0.93 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.02 -65.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.962 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -97.97 53.83 1.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.18 -29.76 68.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.531 -0.73 . . . . 0.0 109.816 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.43 -36.16 58.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.769 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.84 -23.9 58.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.703 . . . . 0.0 110.111 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.85 -43.6 19.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.825 . . . . 0.0 110.722 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -63.87 -41.53 97.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.23 -0.919 . . . . 0.0 110.542 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 24.5 p-10 -76.81 -22.49 53.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 -179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.98 -53.96 17.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.258 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.22 -26.34 61.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.513 -0.742 . . . . 0.0 109.995 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -58.47 6.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.416 -0.802 . . . . 0.0 109.76 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -29.11 68.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.449 -0.782 . . . . 0.0 109.702 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.0 m -68.49 -34.22 75.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmm -71.49 -32.25 68.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.636 -0.665 . . . . 0.0 109.455 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -77.28 -27.38 53.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.66 -0.65 . . . . 0.0 109.951 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 p -71.46 -70.66 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.485 -0.759 . . . . 0.0 109.637 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -64.43 -28.29 69.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.691 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.57 45.35 6.49 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.33 -37.9 22.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.579 -0.953 . . . . 0.0 109.845 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.67 114.4 0.5 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.994 . . . . 0.0 109.613 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 154.34 1.66 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.361 -0.837 . . . . 0.0 110.563 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -139.66 165.78 26.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.682 -0.636 . . . . 0.0 109.48 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -118.18 126.78 52.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -109.44 150.15 28.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.584 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.86 117.11 33.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.415 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.6 t -76.22 124.19 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.648 -0.657 . . . . 0.0 109.661 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 m -142.5 21.57 2.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.899 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 143.39 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.1 -43.56 70.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.533 -0.73 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -69.04 -35.59 76.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 0.0 109.462 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.73 -164.15 12.97 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.94 78.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.978 . . . . 0.0 109.307 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . 0.415 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.95 -30.85 68.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 111.864 -177.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.43 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.9 mmm180 -59.58 -61.27 8.2 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.958 -1.088 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.9 Cg_endo -69.49 -17.48 38.78 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.296 1.33 . . . . 0.0 110.669 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.1 -25.95 52.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.483 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -82.98 -29.92 28.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.25 -41.85 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.669 0.747 . . . . 0.0 109.162 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.97 -47.02 55.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.978 -0.451 . . . . 0.0 110.587 -179.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -59.07 -28.92 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -44.22 70.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.648 -0.657 . . . . 0.0 110.011 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -66.67 -59.68 3.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.484 -0.76 . . . . 0.0 110.013 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.61 -22.14 43.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 110.499 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.2 t -59.13 -40.91 86.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.277 -0.89 . . . . 0.0 109.719 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -69.05 -26.62 65.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.73 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.415 ' CZ ' ' HB1' ' A' ' 76' ' ' ALA . 94.1 m-85 -89.82 121.6 32.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.64 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.36 -18.84 63.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.691 -0.631 . . . . 0.0 110.089 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.8 148.46 25.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.212 -0.93 . . . . 0.0 109.848 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -89.78 92.05 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.0 m -91.69 120.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -117.7 134.22 55.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.5 145.59 25.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.05 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.38 129.11 55.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.397 -0.815 . . . . 0.0 110.084 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 55' ' ' ILE . 54.1 t80 -160.33 141.42 12.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.533 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.79 33.78 17.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.722 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.76 30.16 74.19 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -125.32 175.29 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.626 -0.926 . . . . 0.0 108.989 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.5 m -148.65 101.2 3.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.11 146.49 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.644 -0.66 . . . . 0.0 109.227 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -70.22 140.82 52.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 6.8 tp -62.85 -15.51 54.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.203 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.26 49.68 1.84 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.0 t -150.07 90.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.1 mt -71.43 -45.48 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.824 -0.548 . . . . 0.0 109.773 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ttt -66.17 -27.22 67.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.771 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.91 -37.15 51.04 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.56 -35.8 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.516 -0.991 . . . . 0.0 109.45 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.72 -29.3 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.493 -0.754 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.0 p -62.76 -33.09 74.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.566 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mp -74.55 -55.01 6.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.489 -0.757 . . . . 0.0 109.277 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.03 64.99 2.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.2 mt -74.5 162.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.97 . . . . 0.0 109.165 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.33 -172.04 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.579 -0.7 . . . . 0.0 109.746 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 142.92 38.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.58 8.03 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.94 166.91 17.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.961 . . . . 0.0 109.434 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.25 123.03 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.677 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -113.87 138.68 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.551 -0.718 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.09 108.73 19.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.762 . . . . 0.0 109.692 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.7 mt -93.27 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -150.08 106.45 3.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.638 -0.664 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.99 124.99 35.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 108.93 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.439 -0.788 . . . . 0.0 109.831 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -142.44 6.37 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.53 -63.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.991 . . . . 0.0 109.381 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -97.63 41.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.662 -0.648 . . . . 0.0 109.334 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -49.15 78.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.659 -0.65 . . . . 0.0 110.794 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.89 -36.4 79.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.156 -0.965 . . . . 0.0 109.983 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.3 -22.88 60.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.587 -0.696 . . . . 0.0 110.651 -179.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 29' ' ' TYR . . . -80.04 -48.04 13.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.925 . . . . 0.0 110.852 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -60.65 -45.05 95.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.304 -0.872 . . . . 0.0 110.857 -178.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 21.1 p-10 -68.87 -27.34 65.72 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 29' ' ' TYR . . . -63.75 -54.7 31.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 108.758 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -28.72 70.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.643 -0.661 . . . . 0.0 109.783 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -62.31 -53.99 47.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -60.31 -27.9 67.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.813 . . . . 0.0 109.922 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -71.54 -33.79 69.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.4 mmm -71.66 -31.82 67.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -82.12 -21.37 36.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 110.155 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.0 p -59.54 -40.28 86.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.972 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -111.76 -50.74 2.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.575 -0.703 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.03 54.29 0.19 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.6 mt -85.56 -63.6 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.595 -0.944 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 118.82 1.14 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -178.97 153.52 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -151.88 139.39 19.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.615 -0.678 . . . . 0.0 109.848 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 m -89.92 121.15 31.77 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.72 ' CD1' HD12 ' A' ' 63' ' ' ILE . 71.6 m-85 -103.71 152.29 21.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.65 . . . . 0.0 109.694 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -100.71 131.25 46.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 55' ' ' ILE . 17.2 t -90.04 114.49 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.74 . . . . 0.0 109.632 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -135.42 21.18 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.595 -0.691 . . . . 0.0 109.857 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.22 32.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.545 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -69.8 -50.53 42.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -73.45 -30.31 63.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -152.62 18.86 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.764 ' HB ' HD12 ' A' ' 55' ' ' ILE . 17.7 mm . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.98 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.18 -54.18 44.26 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 120.919 -1.113 . . . . 0.0 111.347 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.0 Cg_endo -72.56 -25.61 17.52 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 121.36 1.373 . . . . 0.0 110.313 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -71.45 -21.39 61.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.558 -0.714 . . . . 0.0 109.332 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -85.02 -31.23 23.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 17' ' ' ARG . 17.1 t -71.29 -37.64 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.664 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.0 mt -75.01 -50.4 16.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.009 -0.432 . . . . 0.0 110.299 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.768 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.7 p -53.91 -29.12 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.241 -0.912 . . . . 0.0 109.95 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -73.6 -39.85 64.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.704 . . . . 0.0 109.472 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -68.49 -66.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -54.71 -23.25 16.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.52 -0.737 . . . . 0.0 110.47 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -45.0 92.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.809 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -62.7 -28.62 70.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.661 . . . . 0.0 109.479 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.95 129.17 36.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 -16.93 59.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.703 -0.623 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 150.96 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.21 -0.931 . . . . 0.0 109.91 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.01 83.38 6.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.696 -0.628 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.758 HG12 ' CB ' ' A' ' 65' ' ' ALA . 22.1 m -89.67 123.53 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.41 146.22 48.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 110.036 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.73 HD11 HD12 ' A' ' 61' ' ' ILE . 2.9 tt -96.31 157.09 16.06 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.519 ' N ' HD23 ' A' ' 35' ' ' LEU . 2.6 tt0 -124.09 134.21 53.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.615 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 67.2 t80 -160.17 129.33 5.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.0 109.785 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.34 30.89 20.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.631 -0.668 . . . . 0.0 109.975 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.26 30.46 71.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.38 116.46 17.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.954 . . . . 0.0 109.296 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -96.13 107.86 20.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.612 -0.68 . . . . 0.0 109.96 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.7 148.06 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -65.23 132.75 49.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.861 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.3 tm? -52.05 -26.78 11.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.768 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.92 53.83 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -143.47 84.78 1.82 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.686 HD11 HG11 ' A' ' 23' ' ' VAL . 26.8 mt -67.88 -40.11 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 tpt -76.52 -26.12 54.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.568 -0.708 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.03 -31.98 57.12 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 46' ' ' SER . 39.4 t -73.52 -27.8 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.97 . . . . 0.0 109.638 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 47' ' ' ILE . 25.2 t -62.01 -33.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.376 -0.828 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.0 p -63.26 -31.89 73.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.66 -45.51 61.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.86 62.31 5.61 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.764 HD12 ' HB ' ' A' ' 14' ' ' ILE . 54.4 mt -75.74 153.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.985 . . . . 0.0 109.34 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.43 -166.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.0 109.702 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 142.07 34.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.649 -0.657 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 43.61 6.25 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.615 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -137.5 178.98 6.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.961 . . . . 0.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -132.77 153.5 51.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.488 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 35' ' ' LEU . 27.1 pt -141.21 144.33 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.606 -0.684 . . . . 0.0 109.286 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.02 116.71 27.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' CD1' ' A' ' 6' ' ' PHE . 85.8 mt -102.84 151.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 p -150.4 113.34 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.529 -0.732 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.758 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.81 130.48 36.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.4 99.88 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.81 -138.36 3.77 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.96 -74.14 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.975 . . . . 0.0 109.388 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.78 50.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.4 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.31 -31.44 70.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -73.95 -35.93 64.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.39 -0.819 . . . . 0.0 109.835 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 -26.38 63.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.428 -0.795 . . . . 0.0 110.31 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -78.93 -45.03 21.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 111.259 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -60.62 -41.8 95.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.935 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.694 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.97 -25.7 60.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 29' ' ' TYR . . . -64.0 -57.04 10.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.04 -28.44 70.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 109.842 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.24 -55.05 36.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.62 -26.64 65.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.4 m -72.07 -34.9 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -28.51 63.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.744 -0.597 . . . . 0.0 109.474 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -85.21 -23.32 28.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.709 . . . . 0.0 110.107 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -67.3 -50.64 59.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.396 -0.815 . . . . 0.0 109.657 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.49 -42.55 9.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 43.41 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 86' ' ' LEU . 92.4 mt -81.84 -31.33 31.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.981 . . . . 0.0 109.463 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.16 168.88 42.01 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.654 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.05 153.37 48.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 129.09 26.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 109.657 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.869 ' OG1' HG23 ' A' ' 62' ' ' THR . 45.9 m -99.13 136.55 38.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.611 -0.681 . . . . 0.0 109.374 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 63' ' ' ILE . 76.7 m-85 -119.54 174.49 6.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.564 -0.71 . . . . 0.0 109.718 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.6 129.72 54.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.612 -0.68 . . . . 0.0 109.217 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HD11 ' A' ' 14' ' ' ILE . 21.5 t -89.74 113.34 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.577 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 16.31 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.704 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.14 34.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.289 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -62.1 -49.92 73.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -69.12 -28.81 66.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.576 -0.702 . . . . 0.0 109.554 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.35 -152.01 23.11 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 8' ' ' VAL . 61.8 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.979 . . . . 0.0 109.394 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -54.58 -54.96 43.02 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.929 -1.107 . . . . 0.0 111.285 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.64 -22.74 23.82 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.114 1.21 . . . . 0.0 110.347 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.493 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.86 -22.63 59.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.423 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -83.13 -29.75 28.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.256 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.17 -40.16 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 109.178 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 44' ' ' LEU . 96.1 mt -73.25 -43.81 60.48 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.954 -0.467 . . . . 0.0 110.394 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.3 p -61.52 -29.83 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.873 . . . . 0.0 109.479 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -45.42 74.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.556 -0.715 . . . . 0.0 109.753 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -64.3 -60.48 3.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.465 -0.772 . . . . 0.0 109.758 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 45' ' ' LYS . . . -57.8 -20.92 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.608 -0.683 . . . . 0.0 110.624 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -60.45 -40.6 91.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -66.58 -32.11 73.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 109.374 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 71.9 m-85 -90.96 130.34 36.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.2 14.13 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 177.65 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.71 78.21 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.772 HG12 ' HB2' ' A' ' 65' ' ' ALA . 17.5 m -89.39 85.86 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.677 -0.639 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.0 123.71 34.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.738 -0.602 . . . . 0.0 109.956 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 63' ' ' ILE . 42.0 tp -91.51 133.57 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -119.42 129.53 54.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.627 -0.671 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.755 ' HB3' HD22 ' A' ' 53' ' ' LEU . 16.2 t80 -116.4 74.16 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 109.834 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 48.3 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.574 -0.704 . . . . 0.0 111.409 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.95 -37.72 3.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB3' HD21 ' A' ' 53' ' ' LEU . 12.5 mmtt -89.64 161.56 16.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -1.061 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 m -150.1 75.93 1.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.613 -0.679 . . . . 0.0 109.708 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.764 ' CG2' HD11 ' A' ' 53' ' ' LEU . 3.6 m -92.52 145.14 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -71.87 141.79 49.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 22' ' ' LEU . 1.6 tm? -54.9 -27.62 44.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.408 -0.808 . . . . 0.0 109.168 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.71 56.1 3.17 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -150.21 89.87 1.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 19' ' ' ALA . 21.0 mt -66.43 -37.15 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.796 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 ttm -75.28 -24.93 57.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.69 -0.631 . . . . 0.0 109.906 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.12 44.68 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 46' ' ' SER . 53.1 t -68.33 -43.94 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.997 . . . . 0.0 109.209 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.59 -29.33 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 p -70.96 -26.27 63.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.802 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.764 HD11 ' CG2' ' A' ' 42' ' ' VAL . 61.5 mt -59.67 -33.88 72.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.466 -0.771 . . . . 0.0 109.958 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.03 38.41 35.45 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 56' ' ' ALA . 34.6 mt -75.45 163.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.968 . . . . 0.0 109.123 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.478 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -148.56 -162.38 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.99 68.83 10.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.63 63.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.474 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -141.88 -175.72 4.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.884 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -132.32 132.52 43.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.583 ' HB ' HD11 ' A' ' 35' ' ' LEU . 22.9 pt -122.53 151.1 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.545 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.869 HG23 ' OG1' ' A' ' 5' ' ' THR . 7.3 m -139.95 108.43 5.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.8 mp -91.43 161.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.582 -0.699 . . . . 0.0 109.85 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 63' ' ' ILE . 9.7 p -150.62 105.95 3.36 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.772 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -90.88 135.14 33.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.96 92.42 1.72 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -0.778 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.27 129.14 1.15 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 55.88 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.677 -0.896 . . . . 0.0 111.031 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -122.81 64.13 0.97 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 110.003 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.654 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 14.5 pt-20 -57.84 -35.24 70.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 110.342 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 -32.94 73.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.73 -25.31 53.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.453 -0.779 . . . . 0.0 110.457 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.792 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.93 -40.8 23.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.814 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -66.35 -42.21 88.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 0.0 110.451 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.709 ' N ' HD12 ' A' ' 74' ' ' LEU . 22.2 p-10 -75.09 -22.99 57.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.385 -0.822 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -65.81 -58.68 5.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.091 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.792 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -69.74 -25.15 63.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -0.772 . . . . 0.0 110.064 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HA ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -62.81 -59.57 4.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.311 -0.868 . . . . 0.0 109.965 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -60.17 -28.97 68.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 109.774 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -66.46 -35.58 80.63 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.713 -0.617 . . . . 0.0 109.641 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -85.33 -21.59 28.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 110.283 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.8 p -70.66 -52.59 20.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.79 -29.07 22.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.726 . . . . 0.0 109.549 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.18 5.56 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 86' ' ' LEU . 74.0 mt -81.58 -44.72 16.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.644 -0.915 . . . . 0.0 109.53 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.47 141.92 7.19 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.399 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.17 153.57 25.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -140.09 164.91 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.569 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -112.12 128.78 56.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.608 -0.682 . . . . 0.0 109.329 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 63' ' ' ILE . 78.0 m-85 -117.53 150.19 39.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.418 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.72 129.49 51.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 59' ' ' ALA . 21.5 t -90.78 118.46 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.731 -0.606 . . . . 0.0 109.554 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 9' ' ' THR . 19.5 m -140.24 24.81 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 109.755 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.28 34.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.457 -0.777 . . . . 0.0 109.47 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.16 -45.53 69.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.605 -0.685 . . . . 0.0 109.499 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -76.02 -31.66 59.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.618 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.25 -148.17 17.96 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.563 HD12 HG21 ' A' ' 55' ' ' ILE . 59.9 mt . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.989 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.038 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.9 ttt85 -56.52 -57.16 25.13 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.744 -1.223 . . . . 0.0 111.082 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -70.11 -17.81 35.74 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.076 1.184 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.646 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -80.65 -21.98 40.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.539 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 2.6 m -83.41 -31.32 26.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.58 -39.23 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.799 0.809 . . . . 0.0 108.933 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.5 mt -72.95 -49.78 27.33 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.539 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.3 p -57.74 -29.44 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.87 -43.09 72.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.465 -0.772 . . . . 0.0 109.835 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -66.48 -59.84 3.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.934 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -59.62 -23.62 63.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.542 -0.724 . . . . 0.0 110.373 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 t -61.73 -37.53 84.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.372 -0.83 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.34 -20.67 60.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.719 -0.613 . . . . 0.0 110.169 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.54 128.02 35.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.27 -0.893 . . . . 0.0 109.597 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -70.13 -24.93 63.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.646 . . . . 0.0 109.711 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.8 39.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.803 . . . . 0.0 109.852 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.72 95.57 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.672 -0.642 . . . . 0.0 109.565 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.628 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.8 m -89.85 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -132.6 130.59 40.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.29 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 36' ' ' GLU . 2.5 tt -89.83 139.11 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.709 ' N ' HD23 ' A' ' 35' ' ' LEU . 7.0 tt0 -113.96 113.97 25.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 109.842 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.702 ' CE1' HG23 ' A' ' 55' ' ' ILE . 13.6 t80 -95.47 68.02 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.511 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m120 48.13 85.07 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.551 -0.718 . . . . 0.0 111.178 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.12 -39.82 2.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -89.53 159.01 17.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.398 -1.06 . . . . 0.0 109.37 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -150.18 91.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.585 -0.697 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -65.48 146.08 55.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.618 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -65.54 -12.06 49.44 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.823 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -88.47 48.73 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.378 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 50' ' ' VAL . 46.7 t -150.14 95.54 2.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.828 . . . . 0.0 109.164 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 19' ' ' ALA . 28.8 mt -77.12 -40.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 109.589 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.65 -29.1 63.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.52 -29.43 67.96 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 46' ' ' SER . 43.8 t -73.65 -43.47 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -1.046 . . . . 0.0 109.452 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.42 -29.81 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.618 -0.676 . . . . 0.0 109.588 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.8 p -66.57 -30.65 71.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.67 -51.32 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.37 50.33 2.41 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.702 HG23 ' CE1' ' A' ' 37' ' ' TYR . 55.2 mt -77.0 159.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.59 -0.947 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -147.82 179.38 7.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.852 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -61.84 147.17 47.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.529 -0.732 . . . . 0.0 109.78 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 64.07 2.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -150.37 125.11 9.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.991 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.04 124.58 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.709 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' HB ' HD21 ' A' ' 35' ' ' LEU . 32.3 pt -112.48 160.85 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.249 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 m -136.0 111.5 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.645 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 6' ' ' PHE . 90.2 mt -91.9 160.28 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 63' ' ' ILE . 9.6 p -149.91 101.21 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.104 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.628 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.97 126.87 35.9 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.88 111.4 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 -135.1 2.91 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -57.08 3.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.583 -0.951 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -104.83 45.86 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.571 -0.706 . . . . 0.0 109.302 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.44 -37.01 79.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.571 -0.705 . . . . 0.0 110.191 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 74.7 m-80 -67.77 -37.77 82.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 109.985 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.66 -25.28 62.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 110.138 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -79.87 -42.1 24.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 111.21 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -62.02 -41.59 98.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.68 ' N ' HD12 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -76.17 -23.58 54.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.333 -0.854 . . . . 0.0 109.788 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -63.89 -60.09 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.306 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.91 -28.82 69.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.007 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.31 -52.64 64.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 109.841 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.3 -27.53 69.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -68.89 -31.59 70.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.7 mmt -71.35 -30.8 66.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -86.22 -17.43 34.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 110.316 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 p -73.11 -52.95 12.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -100.9 10.71 40.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.45 99.01 0.01 OUTLIER Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 mt -140.5 -50.71 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.519 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.04 139.36 6.42 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.996 . . . . 0.0 109.522 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.72 152.34 26.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.655 -0.653 . . . . 0.0 109.589 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -142.69 142.7 32.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.566 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 m -95.14 128.58 42.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.687 -0.633 . . . . 0.0 109.373 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.546 ' CD1' HD12 ' A' ' 63' ' ' ILE . 85.4 m-85 -112.88 152.62 29.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.619 -0.676 . . . . 0.0 109.583 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -116.06 116.34 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.623 -0.673 . . . . 0.0 109.203 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.715 HG22 HD11 ' A' ' 14' ' ' ILE . 11.4 t -75.5 118.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -116.63 -15.26 10.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.618 -0.676 . . . . 0.0 110.333 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.18 146.3 39.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.149 -0.97 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -49.76 71.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.657 . . . . 0.0 109.574 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -63.26 -30.96 72.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.86 -138.39 14.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 8' ' ' VAL . 57.1 mt . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.937 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 9.8 mtm180 -58.24 -60.13 11.17 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.879 -1.138 . . . . 0.0 110.527 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.669 ' HB3' HD13 ' A' ' 86' ' ' LEU . 32.4 Cg_endo -70.7 -15.94 33.59 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.318 1.345 . . . . 0.0 110.681 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.568 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.56 -25.92 50.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.212 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.417 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -83.54 -30.47 27.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.22 -36.79 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.672 0.748 . . . . 0.0 109.044 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB3' HD21 ' A' ' 44' ' ' LEU . 72.2 mt -75.26 -44.81 43.87 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.999 -0.438 . . . . 0.0 110.366 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.843 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.7 p -60.7 -29.07 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.31 -36.91 63.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -67.33 -60.07 2.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.48 -0.762 . . . . 0.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -59.1 -21.79 59.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.446 -0.784 . . . . 0.0 110.107 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.8 t -57.2 -38.9 74.38 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.285 -0.884 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.98 -30.01 66.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.585 -0.697 . . . . 0.0 109.42 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 77.4 m-85 -92.65 124.97 37.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -82.24 2.8 30.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 110.625 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.2 -179.78 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.544 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.34 80.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 0.0 109.41 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 65' ' ' ALA . 34.8 m -89.61 111.84 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.671 . . . . 0.0 109.248 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -120.64 134.12 55.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.551 -0.718 . . . . 0.0 110.028 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.3 tt -92.35 154.95 18.24 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.647 ' N ' HD23 ' A' ' 35' ' ' LEU . 23.1 tt0 -134.4 129.93 36.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.459 -0.776 . . . . 0.0 109.865 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.435 ' CD2' HG12 ' A' ' 55' ' ' ILE . 39.3 t80 -160.31 132.47 6.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 109.687 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.16 40.71 17.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.737 . . . . 0.0 109.978 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.78 28.09 65.16 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.24 102.79 7.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.582 -0.952 . . . . 0.0 109.129 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 m -93.5 99.85 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.593 -0.692 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.65 146.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -67.79 143.02 56.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 22' ' ' LEU . 7.4 tp -62.99 -14.98 54.54 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.164 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.843 ' HA ' HG23 ' A' ' 23' ' ' VAL . 2.4 mptt -87.67 49.98 1.91 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 50' ' ' VAL . 23.3 t -150.24 99.23 2.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.0 mt -79.39 -39.94 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 109.858 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 ttt -75.75 -17.72 59.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.426 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -90.03 -44.55 4.73 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 46' ' ' SER . 45.0 t -61.32 -29.44 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.444 -1.033 . . . . 0.0 109.788 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' ILE . 40.6 t -75.93 -30.68 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.48 -0.763 . . . . 0.0 109.285 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -62.23 -26.66 68.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 49' ' ' GLY . 1.7 mp -62.06 -52.73 62.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.87 54.74 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.525 HD12 ' HB ' ' A' ' 14' ' ' ILE . 46.7 mt -77.44 157.67 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.539 -0.977 . . . . 0.0 109.337 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.41 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.2 -171.22 3.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.567 -0.708 . . . . 0.0 109.421 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -68.19 144.75 54.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.641 -0.662 . . . . 0.0 109.625 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.79 54.76 7.0 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.14 155.89 48.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.956 . . . . 0.0 109.472 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.37 122.06 43.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.565 -0.71 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.612 HD12 HD11 ' A' ' 35' ' ' LEU . 22.6 pt -118.23 133.23 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -104.65 120.34 41.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.528 -0.732 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.546 HD12 ' CD1' ' A' ' 6' ' ' PHE . 82.3 mt -110.5 148.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.46 112.55 4.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 0.0 110.194 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.877 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -91.14 130.07 37.07 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.89 105.29 5.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.854 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.92 -136.05 3.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.9 -73.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.988 . . . . 0.0 109.659 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -90.31 51.9 2.12 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.682 -0.636 . . . . 0.0 109.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.579 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 10.4 pt-20 -67.66 -28.33 67.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.5 -0.75 . . . . 0.0 109.81 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -77.57 -35.22 53.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 109.561 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 38.6 m-20 -76.8 -20.47 56.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.0 110.107 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.804 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.65 -43.65 18.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.49 -42.91 91.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.349 -0.845 . . . . 0.0 110.547 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.71 ' N ' HD12 ' A' ' 74' ' ' LEU . 44.7 p-10 -75.87 -22.11 56.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.25 -57.58 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -64.34 -31.18 72.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.569 -0.707 . . . . 0.0 109.648 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.55 -52.62 64.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.174 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.22 -27.58 69.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 m -69.11 -32.76 72.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -70.83 -31.5 68.24 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -77.89 -27.85 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.727 -0.608 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -77.41 -66.33 0.85 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.75 . . . . 0.0 109.651 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.87 -28.71 69.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.571 -0.706 . . . . 0.0 109.713 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 34.99 15.86 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 18' ' ' PRO . 92.7 mt -81.95 -39.49 23.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.647 -0.914 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.52 30.1 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.548 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.71 152.62 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -143.99 149.33 36.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.623 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 m -99.48 119.01 37.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.448 ' CD1' HD12 ' A' ' 63' ' ' ILE . 68.4 m-85 -98.61 162.15 13.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.675 -0.641 . . . . 0.0 109.336 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 135.0 52.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.345 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.87 107.33 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.596 -0.69 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -122.3 -1.43 9.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.547 -0.721 . . . . 0.0 110.562 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.57 136.42 57.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.131 -0.98 . . . . 0.0 109.577 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.49 -38.97 92.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -72.48 -30.94 64.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.531 -0.731 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -151.59 20.04 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 55' ' ' ILE . 23.8 mm . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.946 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -60.51 -51.34 80.62 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.752 -1.217 . . . . 0.0 111.291 -178.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -73.08 -23.67 17.99 Favored 'Trans proline' 0 C--N 1.326 -0.637 0 C-N-CA 121.036 1.157 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -72.25 -27.76 62.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.352 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.438 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.2 m -81.83 -29.51 32.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.522 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.696 HG12 HG21 ' A' ' 80' ' ' THR . 29.9 t -71.76 -40.05 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.829 0.823 . . . . 0.0 108.858 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.491 ' C ' HD11 ' A' ' 44' ' ' LEU . 95.7 mt -71.43 -51.4 24.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.941 -0.474 . . . . 0.0 110.208 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.8 p -54.79 -27.65 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.38 -0.825 . . . . 0.0 110.037 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -74.12 -37.86 63.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.709 . . . . 0.0 109.959 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -72.8 -62.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -57.71 -20.71 36.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.13 -40.85 91.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -71.06 -22.57 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.624 -0.672 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.4 130.21 35.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 0.0 109.647 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -73.61 -25.96 60.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.676 -0.64 . . . . 0.0 109.754 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 145.26 44.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.448 -0.783 . . . . 0.0 109.639 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.63 97.09 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.608 -0.683 . . . . 0.0 109.602 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CB ' ' A' ' 65' ' ' ALA . 21.4 m -92.56 138.68 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -132.48 142.16 49.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.456 -0.778 . . . . 0.0 110.332 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 61' ' ' ILE . 8.8 tt -102.47 122.61 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.44 150.75 21.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.474 -0.766 . . . . 0.0 110.026 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 55' ' ' ILE . 26.9 t80 -160.38 115.27 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.733 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 64.04 27.1 14.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.673 -0.642 . . . . 0.0 110.285 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.7 -18.13 51.55 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.338 -0.934 . . . . 0.0 110.892 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 112.28 23.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.228 -1.16 . . . . 0.0 109.169 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 m -95.84 114.19 25.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.625 . . . . 0.0 109.842 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.95 147.68 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -70.27 136.39 49.82 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.877 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -55.03 -25.15 28.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.429 -0.795 . . . . 0.0 109.405 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.557 ' HA ' HG23 ' A' ' 23' ' ' VAL . 9.4 mttt -90.28 56.57 3.42 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -150.37 86.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.636 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 15.4 mt -61.28 -60.73 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.739 -0.601 . . . . 0.0 109.723 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 ttp -66.64 -27.2 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.7 74.87 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 46' ' ' SER . 45.8 t -87.93 -32.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -1.067 . . . . 0.0 109.529 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 47' ' ' ILE . 33.6 t -71.85 -23.8 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.471 -0.768 . . . . 0.0 109.861 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.3 p -59.24 -39.62 83.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 53' ' ' LEU . 4.0 mp -63.82 -34.02 76.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.211 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.07 4.74 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 14' ' ' ILE . 51.3 mt -75.41 153.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.963 . . . . 0.0 109.175 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.19 -179.0 6.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.701 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -62.47 136.08 57.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.756 -0.59 . . . . 0.0 109.652 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.77 56.86 1.69 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.37 -178.52 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.995 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -136.5 159.55 41.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.68 . . . . 0.0 109.277 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 35' ' ' LEU . 21.3 pt -150.22 138.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -115.63 105.66 13.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.695 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.448 HD12 ' CD1' ' A' ' 6' ' ' PHE . 88.8 mt -92.4 148.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 p -150.52 112.92 4.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.631 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.822 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -90.26 134.47 34.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.66 104.66 6.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.7 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.22 -145.21 8.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -59.55 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.92 . . . . 0.0 109.584 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -96.28 42.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.602 -0.686 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.15 -32.81 73.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.707 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -72.04 -50.0 32.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 109.461 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -61.9 -21.81 65.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 0.0 110.339 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.59 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -79.03 -51.8 9.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.363 -0.836 . . . . 0.0 111.557 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -56.34 -42.34 77.56 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.006 . . . . 0.0 110.809 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -72.14 -27.08 62.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.0 109.106 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -60.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.378 -0.826 . . . . 0.0 109.148 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.2 mp -60.56 -25.89 66.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 109.86 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.55 -54.45 45.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.961 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -61.79 -27.37 68.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.303 -0.873 . . . . 0.0 109.714 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.696 HG21 HG12 ' A' ' 21' ' ' VAL . 54.2 m -68.66 -34.51 75.82 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mmt -71.58 -31.87 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -91.52 -6.17 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.702 -0.624 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 p -78.09 -50.24 12.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -98.2 -59.52 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.553 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 139.55 69.22 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 86' ' ' LEU . 95.3 mt -109.39 -50.41 3.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.923 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.55 154.24 25.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.445 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 65' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -178.01 151.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.671 -0.643 . . . . 0.0 109.28 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -146.41 148.76 32.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.618 -0.676 . . . . 0.0 109.58 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -89.59 133.12 34.77 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.824 ' CE1' HD12 ' A' ' 63' ' ' ILE . 67.5 m-85 -117.57 148.58 41.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.954 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.72 115.75 29.6 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.849 HG22 HD11 ' A' ' 14' ' ' ILE . 8.9 t -68.86 109.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.687 -0.633 . . . . 0.0 109.402 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -117.03 -8.81 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 110.466 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.53 142.07 57.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.096 -1.003 . . . . 0.0 109.63 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.54 -40.75 97.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -74.83 -30.19 61.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.626 -0.671 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.71 -145.54 17.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.849 HD11 HG22 ' A' ' 8' ' ' VAL . 52.9 mt . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.632 -0.922 . . . . 0.0 109.292 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -50.34 -53.13 48.03 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 120.965 -1.084 . . . . 0.0 111.542 -178.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -73.38 -25.2 15.68 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.389 1.392 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.68 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.83 -18.6 60.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.526 -0.734 . . . . 0.0 109.615 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.428 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -87.03 -32.99 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 108.941 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.57 -35.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HB3' HD21 ' A' ' 44' ' ' LEU . 68.4 mt -76.38 -51.24 12.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.248 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 47' ' ' ILE . 11.4 p -54.8 -27.78 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.32 -0.862 . . . . 0.0 109.976 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -44.81 55.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -62.06 -62.23 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.546 -0.721 . . . . 0.0 109.845 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -55.22 -22.67 18.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.443 -0.786 . . . . 0.0 110.715 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -43.39 90.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.258 -0.901 . . . . 0.0 109.884 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -66.61 -29.32 69.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -90.05 126.9 35.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.487 -0.758 . . . . 0.0 109.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.84 -17.66 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.741 -0.599 . . . . 0.0 110.283 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.87 147.14 29.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.203 -0.936 . . . . 0.0 109.922 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.34 90.59 8.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.759 HG12 ' CB ' ' A' ' 65' ' ' ALA . 19.6 m -89.75 128.21 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.98 135.09 52.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.558 -0.714 . . . . 0.0 109.869 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.05 HD11 HD12 ' A' ' 61' ' ' ILE . 1.2 tt -89.72 155.07 19.45 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.12 142.55 51.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.867 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.542 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 59.3 t80 -160.37 128.09 4.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' ND2' ' CE2' ' A' ' 37' ' ' TYR . 9.0 m-80 60.68 36.66 19.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.477 -0.764 . . . . 0.0 110.012 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.62 22.9 78.05 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -116.2 169.28 9.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -1.059 . . . . 0.0 108.89 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 m -145.58 97.58 3.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.76 146.37 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -68.67 146.17 53.23 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 22' ' ' LEU . 6.8 tp -67.0 -10.71 52.59 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HA ' HG23 ' A' ' 23' ' ' VAL . 14.0 mttt -88.55 48.26 1.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.831 -1.168 . . . . 0.0 107.91 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.702 ' O ' HG23 ' A' ' 50' ' ' VAL . 45.2 t -149.54 85.08 1.43 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.847 . . . . 0.0 109.009 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.688 HD11 HG11 ' A' ' 23' ' ' VAL . 39.5 mt -69.06 -39.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.801 -0.562 . . . . 0.0 109.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ttt -73.53 -29.37 62.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.563 -0.71 . . . . 0.0 109.606 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.27 -38.07 81.39 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 46' ' ' SER . 44.0 t -60.67 -27.72 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.995 . . . . 0.0 109.691 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.4 t -83.91 -25.74 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.815 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -60.37 -38.92 85.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.443 -0.786 . . . . 0.0 109.799 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.42 -55.59 15.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.454 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.27 51.93 0.85 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 56' ' ' ALA . 42.9 mt -75.62 162.16 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.562 -0.964 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.9 -163.16 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -78.85 157.0 28.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.712 . . . . 0.0 109.557 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.97 61.03 6.82 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -138.39 173.21 11.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.931 . . . . 0.0 109.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -127.98 141.45 51.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.709 . . . . 0.0 109.208 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.05 HD12 HD11 ' A' ' 35' ' ' LEU . 20.2 pt -141.97 164.12 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.559 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -132.58 117.24 17.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.67 . . . . 0.0 109.836 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.824 HD12 ' CE1' ' A' ' 6' ' ' PHE . 89.6 mt -99.2 152.07 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -150.4 110.16 4.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.508 -0.745 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.759 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -91.35 130.09 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.99 103.19 4.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.453 -0.779 . . . . 0.0 109.98 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.27 -132.31 2.06 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.81 -67.18 0.85 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.963 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 46.53 1.19 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.548 -0.72 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 5.8 pt-20 -63.04 -37.25 86.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.49 -0.756 . . . . 0.0 110.21 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.25 -36.74 77.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -76.64 -20.59 56.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.457 -0.777 . . . . 0.0 110.284 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.776 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.16 -42.8 20.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.49 -41.64 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.438 -0.789 . . . . 0.0 110.047 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.715 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.9 p30 -79.27 -16.9 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.783 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.45 -52.37 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.776 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -65.28 -33.14 75.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.567 -0.708 . . . . 0.0 109.466 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.66 -52.81 63.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.551 -0.718 . . . . 0.0 109.987 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.12 -27.62 65.77 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.133 -0.98 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.2 m -69.86 -37.22 76.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mtt -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -76.15 -26.0 55.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 0.0 109.734 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -82.57 -67.03 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.729 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -66.71 -29.87 69.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.53 -0.731 . . . . 0.0 109.581 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.73 2.93 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.83 -30.37 20.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.654 -0.909 . . . . 0.0 109.743 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.7 146.94 5.91 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.479 -1.012 . . . . 0.0 109.469 -179.925 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -173.74 154.98 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.716 . . . . 0.0 109.543 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.52 139.92 19.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.561 -0.712 . . . . 0.0 109.651 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -89.96 143.15 27.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.205 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 63' ' ' ILE . 27.0 m-85 -125.92 169.76 12.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.7 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.76 135.82 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.582 -0.699 . . . . 0.0 109.332 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.674 HG22 HD11 ' A' ' 14' ' ' ILE . 12.1 t -81.43 112.08 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 109.319 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 m -114.12 -12.08 12.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 141.74 50.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -0.966 . . . . 0.0 109.985 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.71 -43.11 94.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.9 p -74.07 -32.78 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.53 -0.731 . . . . 0.0 109.366 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.54 -139.58 15.38 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.674 HD11 HG22 ' A' ' 8' ' ' VAL . 58.1 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.593 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -60.16 -61.31 8.18 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 120.943 -1.098 . . . . 0.0 110.589 -178.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HB3' HD22 ' A' ' 86' ' ' LEU . 31.9 Cg_endo -69.59 -12.36 33.07 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 121.283 1.322 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -81.88 -28.89 32.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.867 . . . . 0.0 109.008 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -78.89 -30.02 44.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 17' ' ' ARG . 11.5 t -68.78 -49.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.809 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.833 ' HB3' HD11 ' A' ' 44' ' ' LEU . 86.8 mt -63.91 -54.69 30.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.9 p -51.6 -28.58 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.307 -0.871 . . . . 0.0 110.506 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.01 -54.59 17.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.525 -0.735 . . . . 0.0 110.245 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 m -59.94 -53.35 58.87 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -0.813 . . . . 0.0 110.411 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.33 62.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.412 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.49 -37.74 79.04 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -71.57 -28.75 64.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.775 -0.578 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 81.7 m-85 -94.58 125.45 39.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.85 9.31 19.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.671 -0.643 . . . . 0.0 110.716 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.8 179.22 1.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.092 -1.005 . . . . 0.0 109.478 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -102.75 76.03 1.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.639 -0.663 . . . . 0.0 109.237 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.839 HG12 ' HB2' ' A' ' 65' ' ' ALA . 29.0 m -89.62 108.91 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -117.09 134.31 54.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.717 HD12 HG12 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -89.47 160.82 16.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -128.43 152.75 47.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.36 87.54 1.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.758 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 61.84 48.65 5.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.565 -0.709 . . . . 0.0 109.681 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.06 -7.47 74.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HB3' HD21 ' A' ' 53' ' ' LEU . 11.3 mmtm -91.09 101.32 14.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -1.204 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.35 98.03 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.558 -0.714 . . . . 0.0 109.746 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.77 148.1 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.7 140.95 56.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.3 tm? -57.22 -28.95 63.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 0.0 109.132 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.751 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.41 60.52 4.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.823 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -147.67 83.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.583 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 35.6 mt -66.21 -40.55 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.607 . . . . 0.0 109.657 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -77.6 -27.39 51.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.56 -0.713 . . . . 0.0 109.96 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.26 -29.72 63.87 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 46' ' ' SER . 42.9 t -73.52 -31.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -1.011 . . . . 0.0 109.579 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.28 -28.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.6 p -63.41 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 40' ' ' LYS . 24.2 mt -64.31 -72.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.563 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.4 48.93 0.3 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 56' ' ' ALA . 16.5 mt -75.97 162.05 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.981 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -150.06 -177.42 5.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 109.36 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 148.26 52.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.588 -0.695 . . . . 0.0 109.398 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.07 70.94 1.0 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -175.49 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.494 -1.004 . . . . 0.0 109.569 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -131.39 148.49 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 pt -149.8 153.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.621 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -127.75 127.07 42.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.713 . . . . 0.0 109.664 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.717 HG12 HD12 ' A' ' 35' ' ' LEU . 78.0 mt -112.31 148.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 p -150.77 112.11 4.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.839 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.93 134.41 35.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.83 103.3 3.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 0.0 109.661 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.73 -128.71 1.37 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.22 -59.47 2.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -104.44 52.65 0.75 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.533 -0.73 . . . . 0.0 109.637 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.468 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 10.0 pt-20 -65.5 -38.75 90.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.49 -0.756 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.98 -37.97 75.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 110.115 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 48.8 m-20 -76.71 -19.42 57.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.825 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -82.0 -43.9 17.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.16 -41.94 94.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.489 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 74' ' ' LEU . 42.1 p-10 -78.08 -20.33 52.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 109.727 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.26 -55.91 9.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.903 . . . . 0.0 108.593 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.825 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -68.87 -29.13 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.498 -0.751 . . . . 0.0 109.782 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -54.58 42.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.397 -0.815 . . . . 0.0 110.192 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.59 -33.54 71.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.807 . . . . 0.0 109.774 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -65.67 -34.06 77.33 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 mmm -71.94 -28.07 63.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.736 -0.603 . . . . 0.0 109.65 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -82.47 -23.8 34.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.591 -0.693 . . . . 0.0 110.177 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -85.85 -31.56 22.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 109.918 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -93.78 -21.8 19.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.725 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.06 33.3 29.75 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 18' ' ' PRO . 83.5 mt -81.94 -60.45 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.946 . . . . 0.0 109.615 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.31 156.04 26.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.423 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -117.14 150.79 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.414 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.936 ' HD2' HD13 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -142.74 142.09 31.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.754 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.5 m -96.51 143.56 27.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -127.21 174.04 9.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.547 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.86 124.39 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.596 -0.69 . . . . 0.0 109.416 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' CG2' HD11 ' A' ' 14' ' ' ILE . 11.1 t -88.32 123.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.382 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.84 10.95 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 110.258 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 147.13 35.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.429 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.19 -31.21 71.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.684 . . . . 0.0 109.584 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -80.68 -30.44 36.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 109.466 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.25 37.01 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.557 HD11 ' CG2' ' A' ' 8' ' ' VAL . 65.8 mt . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.558 -0.966 . . . . 0.0 109.5 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -51.48 -54.51 38.29 Favored Pre-proline 0 N--CA 1.508 2.462 0 O-C-N 120.801 -1.187 . . . . 0.0 111.55 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.2 Cg_endo -71.28 -23.2 24.49 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.122 1.214 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.645 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -74.94 -19.97 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.484 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.418 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -84.73 -32.66 23.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 108.815 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.58 -35.37 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.656 0.741 . . . . 0.0 109.039 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HB3' HD21 ' A' ' 44' ' ' LEU . 97.6 mt -76.57 -43.79 37.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.0 -0.437 . . . . 0.0 110.28 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.879 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.7 p -62.63 -28.31 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 109.458 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.77 -48.05 60.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.529 -0.732 . . . . 0.0 109.954 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -62.1 -57.35 11.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.903 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 44' ' ' LEU . . . -57.53 -23.18 48.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.542 -0.724 . . . . 0.0 110.372 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -59.75 -41.1 90.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.667 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -64.62 -32.04 73.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 54.4 m-85 -93.49 131.28 38.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.665 . . . . 0.0 109.397 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -94.29 12.56 26.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.557 -0.715 . . . . 0.0 110.345 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.12 169.43 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -91.03 76.99 6.13 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.929 HG12 ' HB2' ' A' ' 65' ' ' ALA . 19.4 m -89.63 89.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.596 -0.69 . . . . 0.0 109.527 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.87 123.84 42.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 109.7 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.514 HD23 ' C ' ' A' ' 35' ' ' LEU . 10.4 tt -89.51 108.3 19.58 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -89.13 123.72 33.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.703 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.16 72.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 t30 48.45 85.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.513 -0.742 . . . . 0.0 111.32 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 -38.69 3.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.36 159.47 17.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -1.119 . . . . 0.0 109.621 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.78 85.1 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -99.71 145.44 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -76.24 139.87 41.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD23 ' CB ' ' A' ' 26' ' ' ALA . 6.6 tp -58.99 -16.2 16.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.879 ' HA ' HG23 ' A' ' 23' ' ' VAL . 1.2 mptp? -86.92 49.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.774 -1.204 . . . . 0.0 108.197 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.745 ' O ' HG23 ' A' ' 50' ' ' VAL . 41.8 t -151.0 93.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 0.0 109.074 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.645 HG23 ' HB3' ' A' ' 19' ' ' ALA . 22.3 mt -71.11 -39.07 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.624 -0.672 . . . . 0.0 109.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -72.46 -28.52 62.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.585 -0.697 . . . . 0.0 109.614 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.72 -28.62 64.8 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 46' ' ' SER . 45.4 t -74.62 -26.25 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.475 -1.015 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -78.95 -26.98 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -0.791 . . . . 0.0 109.794 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p -68.42 -34.69 76.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 109.564 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 42' ' ' VAL . 16.3 mt -63.38 -45.92 88.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.461 -0.774 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.83 61.59 1.84 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.425 HD12 ' HB ' ' A' ' 14' ' ' ILE . 22.8 mt -88.96 149.17 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.562 -0.964 . . . . 0.0 109.142 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.98 -168.98 3.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.562 -0.711 . . . . 0.0 109.772 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -64.62 130.29 43.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.682 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.16 55.66 2.06 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.36 30.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.61 -0.935 . . . . 0.0 109.577 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -95.08 145.82 24.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.266 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -136.71 152.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 109.522 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 m -127.35 152.53 47.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.409 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.37 143.58 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.449 -0.782 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -147.85 107.84 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.971 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.929 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -90.53 130.97 36.52 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.31 97.1 3.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.88 -131.51 1.47 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.58 -71.23 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.933 . . . . 0.0 109.73 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -99.01 61.38 1.25 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.527 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.67 -27.55 66.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.537 -0.727 . . . . 0.0 109.995 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.94 -35.07 43.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.47 -0.769 . . . . 0.0 109.975 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 36.8 m-20 -73.73 -22.26 59.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.741 . . . . 0.0 110.344 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.814 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.6 -43.67 18.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.936 HD13 ' HD2' ' A' ' 4' ' ' LYS . 4.4 pp -68.7 -39.82 80.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.479 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.0 p30 -79.13 -20.48 48.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 109.795 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -72.73 -56.05 5.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.326 -0.859 . . . . 0.0 108.838 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.1 mt -66.65 -34.19 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.545 -0.722 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.63 -52.73 64.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.94 -26.74 68.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.373 -0.83 . . . . 0.0 109.709 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.5 m -70.22 -32.94 71.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.072 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.46 -27.12 63.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.725 -0.61 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -25.6 26.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 110.148 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 p -66.63 -54.33 24.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.535 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.49 -29.8 22.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.48 -0.763 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 48.99 4.53 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 86' ' ' LEU . 76.6 mt -82.43 -42.66 18.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.979 . . . . 0.0 109.511 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.38 142.87 8.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.497 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.89 153.79 19.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.728 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HD2' HD13 ' A' ' 74' ' ' LEU . 11.2 mtpp -141.8 133.79 27.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -89.98 130.37 36.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.287 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 63' ' ' ILE . 93.5 m-85 -116.02 154.2 30.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.604 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.37 127.82 54.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.635 -0.666 . . . . 0.0 109.235 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.73 114.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -121.12 -5.13 9.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.568 -0.707 . . . . 0.0 110.57 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.66 150.43 40.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.21 -57.46 11.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.467 -0.77 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -65.81 -33.4 75.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.59 -132.8 11.06 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.526 HG22 HG11 ' A' ' 50' ' ' VAL . 62.7 mt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.954 . . . . 0.0 109.387 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.4 ttt85 -53.75 -53.93 52.09 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.961 -1.087 . . . . 0.0 111.377 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.7 Cg_endo -73.87 -24.66 15.14 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.192 1.262 . . . . 0.0 110.523 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -71.99 -22.42 61.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.413 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.433 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -84.5 -31.95 24.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.007 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 17' ' ' ARG . 15.1 t -69.67 -39.38 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 44' ' ' LEU . 94.5 mt -74.84 -51.84 12.93 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.553 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.793 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -52.33 -28.44 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.252 -0.905 . . . . 0.0 110.149 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -74.84 -42.65 57.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -68.55 -65.62 0.68 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.775 . . . . 0.0 109.935 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.581 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -53.38 -24.64 12.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.473 -0.767 . . . . 0.0 110.581 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.22 -45.97 90.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 109.469 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -63.87 -25.52 68.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.645 -0.66 . . . . 0.0 109.822 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 91.2 m-85 -89.57 124.39 34.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.79 -21.24 65.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.072 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 147.88 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -89.88 88.96 7.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.608 -0.682 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.833 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.4 m -90.8 129.85 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -129.36 140.33 51.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.975 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 61' ' ' ILE . 6.4 tt -92.3 149.09 21.64 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -115.18 141.8 47.53 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.597 ' HD2' HD23 ' A' ' 53' ' ' LEU . 35.2 t80 -160.28 115.82 2.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.0 109.983 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 t30 63.9 23.47 13.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.557 -0.714 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.71 -18.21 51.25 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.788 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -88.97 118.55 28.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -1.172 . . . . 0.0 109.158 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -95.08 117.5 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.709 -0.619 . . . . 0.0 109.886 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.07 147.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 43' ' ' ASN . 1.4 t-20 -68.8 135.45 51.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -53.07 -29.12 28.37 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.369 -0.832 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.793 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -91.25 62.05 4.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -148.92 87.09 1.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 23' ' ' VAL . 39.3 mt -71.45 -38.76 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.733 -0.604 . . . . 0.0 109.873 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.1 ttp -77.7 -27.51 50.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.532 -0.73 . . . . 0.0 109.987 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.16 49.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 46' ' ' SER . 46.6 t -66.35 -33.36 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.471 -1.017 . . . . 0.0 109.759 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 t -75.59 -30.71 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 109.614 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.7 p -63.3 -28.02 69.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.692 . . . . 0.0 109.854 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HD2' ' A' ' 37' ' ' TYR . 5.7 mp -69.15 -76.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.761 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.02 51.79 0.23 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.0 mt -78.93 158.33 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.576 -0.955 . . . . 0.0 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -153.18 -168.15 2.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -73.9 146.44 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.757 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.63 57.32 3.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.14 170.64 15.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.946 . . . . 0.0 109.538 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -126.85 129.93 49.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.594 -0.692 . . . . 0.0 109.469 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 35' ' ' LEU . 24.4 pt -119.88 146.41 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.671 -0.643 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.06 107.33 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.747 . . . . 0.0 109.646 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.702 HD12 ' CE1' ' A' ' 6' ' ' PHE . 75.3 mt -92.54 154.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.282 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -150.12 105.95 3.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.833 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.78 124.34 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.36 107.4 7.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.463 -0.773 . . . . 0.0 109.79 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -138.84 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.25 -64.7 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.965 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.08 42.07 1.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.96 -28.6 67.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -0.75 . . . . 0.0 109.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.21 -35.49 63.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.26 -25.37 59.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.675 . . . . 0.0 110.03 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.789 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.6 -43.67 20.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.397 -0.814 . . . . 0.0 110.689 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.686 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -62.09 -41.62 98.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.327 -0.858 . . . . 0.0 110.69 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.686 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.8 p-10 -74.46 -27.07 60.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.246 -0.909 . . . . 0.0 109.764 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -64.24 -57.67 8.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.805 . . . . 0.0 109.266 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -63.59 -27.35 69.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.493 -0.755 . . . . 0.0 109.876 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.71 -58.01 9.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 109.682 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.85 -26.59 65.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.45 HG21 HG12 ' A' ' 21' ' ' VAL . 29.4 m -71.98 -34.02 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 0.0 109.015 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.6 -29.91 65.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -85.81 -21.19 28.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.69 . . . . 0.0 110.305 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -80.75 -55.07 5.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -73.45 -27.07 61.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.825 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.25 39.79 6.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 18' ' ' PRO . 80.7 mt -81.74 -52.76 6.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.687 -0.89 . . . . 0.0 109.651 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.24 145.8 12.59 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.593 -0.945 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.775 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.79 158.12 44.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.583 -0.698 . . . . 0.0 109.294 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -142.78 132.73 24.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 61' ' ' ILE . 32.2 m -95.07 139.05 31.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.543 -0.723 . . . . 0.0 109.297 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 63' ' ' ILE . 91.3 m-85 -122.69 162.76 21.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.524 -0.735 . . . . 0.0 109.709 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.76 125.23 50.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 14' ' ' ILE . 9.7 t -77.81 123.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.522 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 9' ' ' THR . 18.2 m -129.92 3.37 4.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.588 -0.695 . . . . 0.0 110.544 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.39 46.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.039 -1.038 . . . . 0.0 109.47 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.18 -37.71 88.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.693 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -80.01 -30.19 39.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.81 -148.6 18.88 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.824 HD11 HG22 ' A' ' 8' ' ' VAL . 58.8 mt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.945 . . . . 0.0 109.562 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -57.39 -60.66 9.07 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.856 -1.153 . . . . 0.0 110.598 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.8 -15.1 36.79 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.302 1.335 . . . . 0.0 110.787 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -79.71 -24.99 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.1 m -82.99 -29.59 28.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.187 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.36 -40.49 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.669 0.747 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HB3' HD21 ' A' ' 44' ' ' LEU . 95.4 mt -72.09 -46.35 57.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.967 -0.458 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.814 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.0 p -60.03 -29.01 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.791 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.61 -43.57 72.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.475 -0.766 . . . . 0.0 109.975 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -68.04 -60.83 2.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.049 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.607 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -57.2 -23.6 48.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.411 -0.806 . . . . 0.0 110.41 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -59.83 -41.3 91.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -26.39 67.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.743 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 90.8 m-85 -89.66 127.95 36.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.4 -0.813 . . . . 0.0 109.604 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -71.82 -21.62 61.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.806 -0.559 . . . . 0.0 110.075 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 149.1 23.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.67 92.46 9.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.63 -0.669 . . . . 0.0 109.449 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.859 HG12 ' CB ' ' A' ' 65' ' ' ALA . 35.9 m -92.8 102.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 109.195 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.72 137.68 41.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.777 . . . . 0.0 110.096 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.3 tt -90.77 150.56 21.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' N ' HD23 ' A' ' 35' ' ' LEU . 9.0 tt0 -120.72 135.43 55.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.481 -0.762 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.759 ' HB3' HD23 ' A' ' 53' ' ' LEU . 57.9 t80 -160.21 125.9 4.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 64.09 21.44 12.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.523 -0.735 . . . . 0.0 110.519 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.01 55.37 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.908 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -89.07 122.78 32.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -1.187 . . . . 0.0 109.307 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 m -105.22 103.65 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.768 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.7 146.97 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -67.04 143.19 56.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 26' ' ' ALA . 7.0 tp -63.37 -15.09 56.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.056 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.814 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.6 mttm -87.63 48.93 1.71 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.86 -1.15 . . . . 0.0 107.973 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 50' ' ' VAL . 15.0 t -150.61 84.09 1.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 108.992 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.67 HG23 ' HB3' ' A' ' 19' ' ' ALA . 27.7 mt -64.5 -37.89 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.7 ttm -74.39 -30.3 61.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.377 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.66 -35.93 92.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 46' ' ' SER . 42.4 t -68.38 -29.01 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.937 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 t -65.47 -34.48 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.488 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.9 p -63.17 -32.0 73.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' A' ' 37' ' ' TYR . 11.1 mp -70.54 -50.58 36.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.701 . . . . 0.0 109.393 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.84 59.46 3.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.554 HD12 ' HB ' ' A' ' 14' ' ' ILE . 49.0 mt -72.58 162.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -142.6 175.56 9.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.591 -0.693 . . . . 0.0 109.572 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -61.34 152.82 28.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.588 -0.695 . . . . 0.0 109.767 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.04 64.24 3.94 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.33 172.02 13.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.545 -0.973 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -124.76 129.8 51.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 5' ' ' THR . 23.6 pt -128.12 152.16 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.582 -0.699 . . . . 0.0 109.364 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.449 HG23 ' OG1' ' A' ' 5' ' ' THR . 1.3 m -131.67 109.43 10.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.432 HD12 ' CE1' ' A' ' 6' ' ' PHE . 88.1 mt -93.69 155.97 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.219 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -150.09 110.56 4.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.64 -0.662 . . . . 0.0 109.808 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.859 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.69 131.74 35.52 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.03 107.04 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.499 -0.751 . . . . 0.0 109.662 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.5 -133.41 2.4 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.15 -61.99 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.574 -0.957 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -98.39 44.44 1.03 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.686 -0.633 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.775 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 11.9 pt-20 -61.71 -31.29 71.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.707 . . . . 0.0 109.857 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.69 -36.47 70.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.565 -0.709 . . . . 0.0 109.616 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -78.44 -19.55 52.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.306 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.799 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.79 -44.85 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.165 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.79 -41.78 91.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.247 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.6 p30 -77.65 -19.89 54.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 0.0 109.501 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.18 -57.16 5.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.799 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.53 -30.11 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.575 -0.703 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -54.02 51.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.999 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.29 -26.69 66.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 109.888 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.8 m -70.18 -35.82 74.22 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.8 mmm -71.45 -30.48 66.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -83.91 -18.49 37.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.676 . . . . 0.0 110.318 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.2 p -74.81 -52.84 10.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.3 -27.49 24.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.756 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.93 48.71 4.04 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.78 -64.44 1.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.676 -0.896 . . . . 0.0 109.607 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.72 11.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.982 . . . . 0.0 109.518 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.94 153.4 33.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.43 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 7.6 tttp -135.55 140.52 44.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.702 -0.624 . . . . 0.0 109.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 m -96.63 130.49 43.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.591 -0.693 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CD2' HD12 ' A' ' 63' ' ' ILE . 97.2 m-85 -118.0 149.01 41.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.593 -0.692 . . . . 0.0 109.604 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.14 125.89 52.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 14' ' ' ILE . 15.9 t -81.4 119.6 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.598 -0.689 . . . . 0.0 109.593 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -140.49 22.27 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.571 -0.706 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.68 36.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.518 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.09 -41.18 97.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -78.72 -30.89 46.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.613 -0.679 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.18 -143.77 16.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 8' ' ' VAL . 57.0 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.7 mmt180 -62.68 -61.35 7.69 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.812 -1.18 . . . . 0.0 109.782 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.07 -13.71 36.92 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.198 1.265 . . . . 0.0 110.509 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -78.0 -30.3 50.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 108.784 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.3 m -79.5 -27.97 41.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.67 . . . . 0.0 109.572 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.79 -48.59 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.747 0.784 . . . . 0.0 109.084 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -65.77 -42.7 90.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 122.004 -0.435 . . . . 0.0 110.614 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.854 HG11 HD11 ' A' ' 47' ' ' ILE . 13.7 p -64.22 -30.46 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -70.92 -29.77 65.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.074 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.53 -58.5 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.508 -0.745 . . . . 0.0 110.434 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -61.6 -27.7 68.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.462 -0.774 . . . . 0.0 110.427 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 p -59.85 -32.77 70.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.354 -0.841 . . . . 0.0 109.708 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -73.39 -29.67 62.77 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.87 127.57 36.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.448 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.34 -2.99 44.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.684 -0.635 . . . . 0.0 110.681 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.14 167.6 3.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.67 82.18 3.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.606 -0.684 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.86 HG12 ' HB2' ' A' ' 65' ' ' ALA . 21.3 m -89.69 100.75 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.353 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -104.54 128.97 52.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.708 . . . . 0.0 109.921 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 35' ' ' LEU . 9.9 tt -89.46 142.95 27.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -117.01 143.03 46.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -139.87 71.19 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.566 -0.709 . . . . 0.0 109.772 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.45 62.69 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.564 -0.71 . . . . 0.0 110.852 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 -29.8 8.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -89.54 88.14 7.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -1.078 . . . . 0.0 109.402 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.2 m -93.04 94.7 9.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.695 -0.628 . . . . 0.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.07 145.83 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -70.08 146.83 50.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.7 tp -65.87 -12.01 51.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 23' ' ' VAL . 1.1 mptt -88.28 48.56 1.66 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.775 -1.203 . . . . 0.0 108.03 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 t -149.93 99.3 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.854 HD11 HG11 ' A' ' 23' ' ' VAL . 42.3 mm -70.47 -59.41 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.731 -0.606 . . . . 0.0 109.464 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.68 -22.19 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.711 -0.618 . . . . 0.0 110.163 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.87 63.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.8 t -68.78 -34.42 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.95 . . . . 0.0 109.616 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.3 t -71.83 -26.5 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.9 p -70.31 -33.93 72.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.473 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.1 -37.4 87.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.281 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.6 5.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 mt -78.44 152.36 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.992 . . . . 0.0 109.097 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.97 -168.58 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.547 -0.721 . . . . 0.0 109.8 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.49 131.93 50.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.672 -0.643 . . . . 0.0 109.704 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.93 55.58 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.41 172.96 12.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.548 -0.971 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -131.99 156.16 46.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.656 . . . . 0.0 109.296 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 pt -149.61 139.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.49 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 m -117.87 109.28 16.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.534 -0.729 . . . . 0.0 109.561 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.571 HD12 ' CD2' ' A' ' 6' ' ' PHE . 81.8 mt -96.85 150.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.589 -0.694 . . . . 0.0 109.401 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.24 109.88 4.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.653 -0.654 . . . . 0.0 109.609 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.86 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -89.73 131.49 35.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.11 101.72 4.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.802 . . . . 0.0 109.76 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.9 -123.67 0.85 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.95 -62.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.949 . . . . 0.0 109.314 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -96.64 51.51 1.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.293 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.413 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -67.91 -27.39 66.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -80.69 -33.15 35.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 41.0 m-20 -77.38 -21.61 52.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.73 . . . . 0.0 110.23 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.802 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.31 -43.21 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.342 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.55 -42.76 91.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.318 -0.864 . . . . 0.0 110.438 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 74' ' ' LEU . 33.3 p-10 -75.9 -21.95 56.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -0.873 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.81 -56.88 7.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -65.96 -30.58 71.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.682 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -53.28 60.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.14 -29.22 69.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -66.73 -35.31 79.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.6 mmm -71.59 -28.21 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -69.99 -47.49 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 109.908 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 p -66.91 -59.12 3.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -59.28 -23.44 62.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.505 -0.747 . . . . 0.0 110.154 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.89 34.97 88.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.92 -44.61 16.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.97 . . . . 0.0 109.616 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -176.19 28.67 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.494 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.731 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -51.46 152.53 2.58 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.378 -0.826 . . . . 0.0 110.501 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -140.91 167.93 21.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 109.517 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -112.4 150.75 30.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.341 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.57 148.58 41.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 121.47 45.4 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.573 ' CG2' HD11 ' A' ' 14' ' ' ILE . 21.4 t -87.02 125.56 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.564 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -143.93 22.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.712 . . . . 0.0 109.861 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 145.29 36.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.488 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.11 -43.18 95.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 0.0 109.674 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -77.44 -29.25 52.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.36 -155.83 24.53 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.757 ' HB ' HD12 ' A' ' 55' ' ' ILE . 61.4 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.537 -0.978 . . . . 0.0 109.415 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.11 -55.59 29.65 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.853 -1.154 . . . . 0.0 111.196 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.74 -23.32 22.81 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.233 1.288 . . . . 0.0 110.212 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.14 -22.33 61.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 0.0 109.309 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -84.33 -31.64 24.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.074 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.72 -40.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.614 0.721 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.768 ' HB3' HD11 ' A' ' 44' ' ' LEU . 92.3 mt -74.57 -51.77 13.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.008 -0.433 . . . . 0.0 110.357 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.824 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.4 p -51.83 -30.69 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.09 -39.76 63.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.605 -0.684 . . . . 0.0 109.75 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -66.53 -64.43 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.51 -0.743 . . . . 0.0 109.894 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -55.51 -24.28 30.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -61.37 -43.44 98.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.359 -0.838 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -62.96 -26.73 68.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 109.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CG ' ' HB2' ' A' ' 73' ' ' ALA . 93.2 m-85 -89.78 125.16 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.683 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -69.87 -22.97 63.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.81 25.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.373 -0.829 . . . . 0.0 109.858 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.06 95.83 10.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 109.759 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.765 HG12 ' CB ' ' A' ' 65' ' ' ALA . 21.6 m -97.04 120.41 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -116.88 123.92 48.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.554 -0.717 . . . . 0.0 110.326 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.116 HD11 HD12 ' A' ' 61' ' ' ILE . 7.2 tt -90.12 148.65 22.87 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -126.05 158.13 36.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.0 110.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.805 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 18.7 t80 -147.42 105.35 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -81.4 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.77 -0.581 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.87 26.56 1.46 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 114.88 19.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.468 -1.019 . . . . 0.0 109.175 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -89.79 90.07 8.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.586 -0.696 . . . . 0.0 110.025 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.83 148.04 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.43 139.75 36.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.4 tm? -53.54 -27.47 26.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.439 -0.788 . . . . 0.0 109.15 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.824 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.56 57.93 3.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.1 t -148.72 110.14 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 19' ' ' ALA . 24.9 mt -89.37 -42.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.251 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.445 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.2 ttt -79.15 -24.03 43.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.482 -0.761 . . . . 0.0 110.163 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.22 -29.5 53.35 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 46' ' ' SER . 39.5 t -84.3 -42.82 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -1.018 . . . . 0.0 109.742 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 48' ' ' MET . 12.1 p -61.94 -37.43 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -57.4 -29.48 64.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.699 -0.626 . . . . 0.0 110.107 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.41 -53.14 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 0.0 109.348 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.06 58.52 1.67 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.757 HD12 ' HB ' ' A' ' 14' ' ' ILE . 47.0 mt -78.12 162.91 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.647 -0.914 . . . . 0.0 109.211 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -144.95 -161.21 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.827 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 66.2 9.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.88 53.99 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -140.15 168.34 20.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.92 . . . . 0.0 109.554 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -126.14 133.26 51.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.116 HD12 HD11 ' A' ' 35' ' ' LEU . 26.8 pt -124.84 136.75 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.616 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -112.63 112.4 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.539 ' CG1' HD12 ' A' ' 35' ' ' LEU . 91.0 mt -93.71 155.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.644 -0.66 . . . . 0.0 109.343 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -149.45 104.68 3.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.717 -0.615 . . . . 0.0 109.349 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.765 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.56 135.04 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 106.94 4.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.44 -144.24 7.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.2 -73.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.958 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -95.32 45.47 1.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.308 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.42 -43.22 83.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.448 -0.782 . . . . 0.0 110.28 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.575 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.8 m120 -62.35 -37.15 84.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.881 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 7.5 m-20 -67.45 -33.26 74.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.694 -0.629 . . . . 0.0 110.984 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB2' ' CG ' ' A' ' 29' ' ' TYR . . . -73.44 -53.57 10.36 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.319 -0.863 . . . . 0.0 111.615 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -54.6 -45.64 73.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.241 -0.912 . . . . 0.0 111.297 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.74 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -67.1 -27.82 67.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 109.079 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.612 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -62.64 -52.36 63.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.072 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.37 -31.07 72.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 109.84 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.82 -52.2 66.09 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.87 . . . . 0.0 109.996 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.28 -27.62 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.6 m -70.62 -33.88 71.5 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmt -71.54 -31.13 66.69 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -86.24 -17.27 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -60.52 -49.93 75.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 109.81 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.42 -54.88 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.494 -0.754 . . . . 0.0 109.518 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.78 52.45 0.08 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.0 -63.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.562 -0.963 . . . . 0.0 109.566 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.49 134.89 4.7 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.534 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -60.92 153.66 24.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.425 -0.797 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -138.22 165.01 27.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m -115.83 138.21 51.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.693 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 63' ' ' ILE . 75.3 m-85 -125.02 144.85 50.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.718 . . . . 0.0 109.369 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.52 129.99 54.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.505 HG13 HD11 ' A' ' 14' ' ' ILE . 16.8 t -90.5 112.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.429 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -116.69 -14.31 10.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.686 -0.634 . . . . 0.0 110.292 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.94 140.33 56.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.877 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -68.56 -34.66 76.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.654 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -64.96 -28.72 69.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.763 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.15 -157.04 36.56 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.638 ' HB ' HD12 ' A' ' 55' ' ' ILE . 9.1 mm . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.974 . . . . 0.0 109.157 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.91 -54.98 37.83 Favored Pre-proline 0 N--CA 1.507 2.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.563 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 31.1 Cg_endo -70.11 -23.0 29.68 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.052 1.168 . . . . 0.0 110.283 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.9 -24.14 60.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.746 . . . . 0.0 109.134 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.51 HG23 ' CD1' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -82.45 -28.82 31.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.772 . . . . 0.0 109.158 179.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -70.26 -37.79 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.6 mt -74.97 -50.9 15.12 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.538 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.775 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.0 p -53.49 -28.91 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.5 -37.98 55.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.486 -0.759 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.1 m -71.95 -65.85 0.72 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.425 -0.797 . . . . 0.0 109.784 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -52.27 -27.33 14.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.674 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -61.71 -46.17 90.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -63.24 -21.87 66.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.685 . . . . 0.0 110.003 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 84.9 m-85 -89.53 127.1 35.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.16 -28.19 69.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.66 -0.65 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.39 53.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -89.93 94.38 9.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 0.0 109.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.75 HG12 ' CB ' ' A' ' 65' ' ' ALA . 28.2 m -89.89 135.06 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.64 -0.663 . . . . 0.0 109.248 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -132.08 138.25 48.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 0.0 110.171 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.576 HD11 HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -89.07 156.02 19.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.51 129.52 35.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.37 57.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 55.63 22.63 5.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.86 -41.16 0.61 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -89.96 87.79 7.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.523 -0.986 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 35' ' ' LEU . 25.7 m -91.74 112.6 24.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.05 148.24 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -64.92 138.96 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.0 tm? -54.54 -29.61 51.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.775 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.2 mttt -90.76 61.75 4.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -150.19 87.71 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.79 ' O ' HG23 ' A' ' 51' ' ' VAL . 34.6 mt -70.33 -39.79 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.668 -0.645 . . . . 0.0 109.68 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.78 -28.56 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.22 57.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 46' ' ' SER . 40.5 t -77.45 -33.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.485 -1.009 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 47' ' ' ILE . 40.2 t -69.36 -34.29 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 109.194 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.5 p -63.08 -34.65 78.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.607 -0.683 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 50' ' ' VAL . 12.0 mt -72.89 -38.96 66.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.423 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.47 73.35 0.58 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.638 HD12 ' HB ' ' A' ' 14' ' ' ILE . 23.9 mt -81.78 151.06 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.968 . . . . 0.0 109.161 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.4 172.14 13.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.642 -0.662 . . . . 0.0 109.839 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 159.27 1.43 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.56 40.79 99.08 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.63 121.14 34.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -84.8 132.69 34.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.608 -0.683 . . . . 0.0 109.354 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 35' ' ' LEU . 18.4 pt -127.22 163.44 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 109.383 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 m -140.14 111.4 7.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 64' ' ' SER . 93.2 mt -92.35 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.0 p -150.18 103.03 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.822 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.75 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 121.7 32.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.96 109.88 10.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 109.669 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.35 -150.21 10.8 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.51 -65.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.517 -0.99 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.73 47.5 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.637 -0.664 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -58.65 -41.46 86.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.727 . . . . 0.0 110.139 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -62.26 -30.13 70.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.91 -25.26 58.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.83 -39.97 25.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.816 . . . . 0.0 110.982 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.2 -42.46 93.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 0.0 110.459 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.709 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.7 p-10 -72.08 -28.44 63.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.0 109.187 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.673 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -61.0 -64.08 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.45 -0.781 . . . . 0.0 109.555 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -60.67 -25.54 66.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -0.828 . . . . 0.0 109.872 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -54.56 44.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.437 -0.789 . . . . 0.0 110.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 -28.26 69.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -66.22 -35.78 81.33 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -28.5 64.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.783 -0.573 . . . . 0.0 109.558 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -80.52 -25.19 38.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.782 . . . . 0.0 110.042 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 p -81.53 -63.14 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -0.766 . . . . 0.0 109.786 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.15 -29.11 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 109.731 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.2 6.24 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.77 -34.69 30.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.627 -0.925 . . . . 0.0 109.563 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.16 -179.42 41.83 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.56 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.58 150.58 31.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.045 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -134.64 163.03 30.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.708 -0.62 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 134.75 54.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.733 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -119.91 161.58 20.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.715 . . . . 0.0 109.547 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -120.2 123.68 43.85 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 14' ' ' ILE . 4.1 t -83.66 120.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -131.95 16.19 4.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.738 . . . . 0.0 110.183 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 144.86 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.46 -29.2 70.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -90.0 -30.87 17.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 109.496 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.56 -150.03 19.7 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 55' ' ' ILE . 59.8 mt . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.987 . . . . 0.0 109.424 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.096 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 9.2 ttp180 -54.17 -55.45 36.58 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.575 ' O ' HD12 ' A' ' 22' ' ' LEU . 31.0 Cg_endo -69.72 -22.17 32.64 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 120.922 1.081 . . . . 0.0 110.443 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -75.46 -21.66 57.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.259 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.3 m -82.12 -30.69 31.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.46 -0.775 . . . . 0.0 109.071 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 80' ' ' THR . 15.8 t -70.08 -34.49 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.783 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.2 mt -76.85 -49.1 16.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.02 -0.425 . . . . 0.0 110.5 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.5 p -56.54 -27.26 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -54.13 8.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.441 -0.787 . . . . 0.0 110.328 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -61.16 -60.55 3.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.524 -0.735 . . . . 0.0 110.419 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -55.49 -26.52 43.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.466 -0.771 . . . . 0.0 110.745 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.48 -42.12 99.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.408 -0.807 . . . . 0.0 109.474 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -64.25 -21.03 66.44 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.522 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 69.9 m-85 -89.4 133.88 34.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 0.0 109.696 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -77.32 -22.97 51.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.615 -0.678 . . . . 0.0 110.081 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.54 150.97 17.79 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.61 87.79 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.651 -0.656 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.5 m -90.02 118.16 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -120.25 124.9 46.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.75 142.55 27.64 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -129.98 155.76 45.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -145.8 105.27 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 -81.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.35 26.58 1.85 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -124.26 99.92 6.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.511 -0.994 . . . . 0.0 108.928 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -89.85 87.27 6.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.578 -0.702 . . . . 0.0 109.957 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.53 146.48 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -69.89 142.85 52.93 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.6 tm? -53.95 -28.88 40.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.403 -0.811 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.774 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -90.92 59.45 4.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.858 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.6 t -150.1 89.53 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 23' ' ' VAL . 34.2 mt -71.9 -51.8 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 109.519 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.0 tpt -61.49 -28.59 69.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.748 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.699 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -72.62 -40.53 53.38 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 46' ' ' SER . 41.0 t -64.56 -28.11 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.97 . . . . 0.0 109.601 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 47' ' ' ILE . 42.4 t -74.03 -31.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.8 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.6 p -64.3 -27.29 68.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 49' ' ' GLY . 3.3 mp -75.0 -46.76 32.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.798 . . . . 0.0 109.542 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.32 63.04 2.74 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.59 HD13 HD12 ' A' ' 14' ' ' ILE . 14.3 mt -74.21 162.58 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.922 . . . . 0.0 109.29 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -144.84 -164.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 109.759 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -72.98 135.23 44.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.778 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 45.16 7.43 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.03 161.72 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.598 -0.942 . . . . 0.0 109.408 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -124.5 118.59 26.96 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 151.99 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.744 . . . . 0.0 109.491 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.8 m -136.16 107.87 7.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.58 -0.7 . . . . 0.0 109.483 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 64' ' ' SER . 89.6 mt -92.25 159.28 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.614 -0.679 . . . . 0.0 109.275 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 63' ' ' ILE . 4.9 p -144.98 102.47 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.715 -0.616 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.72 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.88 121.48 32.04 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.75 105.33 6.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.354 -0.841 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.45 -140.68 4.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.67 -53.27 5.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.582 -0.952 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.3 45.59 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 109.418 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.56 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 7.6 pt-20 -66.16 -33.62 76.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 109.94 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.28 -35.29 61.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.448 -0.782 . . . . 0.0 109.839 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.75 -20.75 58.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.464 -0.773 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.821 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.41 -43.14 19.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.267 -0.895 . . . . 0.0 110.477 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.96 -41.7 95.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.324 -0.86 . . . . 0.0 110.694 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.726 ' N ' HD12 ' A' ' 74' ' ' LEU . 26.3 p-10 -74.84 -25.92 59.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -65.59 -60.47 2.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.35 -28.41 69.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 109.771 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.15 -54.95 39.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.12 -29.14 68.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.372 -0.83 . . . . 0.0 109.978 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 21' ' ' VAL . 39.8 m -69.03 -34.2 74.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.566 ' HE3' HD21 ' A' ' 22' ' ' LEU . 26.2 mmt -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.794 -0.567 . . . . 0.0 109.607 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -75.53 -28.6 59.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.783 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.3 p -66.23 -49.76 66.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.696 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -10.83 54.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.585 -0.697 . . . . 0.0 110.46 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.77 94.24 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.85 -62.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.583 -0.951 . . . . 0.0 109.648 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.67 120.76 1.38 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -49.94 155.2 0.94 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 110.771 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.37 162.64 38.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.318 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 6' ' ' PHE . 5.7 m -101.34 165.98 10.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.622 ' CD1' HD12 ' A' ' 63' ' ' ILE . 55.2 m-85 -149.52 145.55 26.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.691 . . . . 0.0 109.288 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -107.78 127.27 53.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.556 -0.715 . . . . 0.0 109.073 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 14' ' ' ILE . 19.5 t -90.72 120.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.753 -0.592 . . . . 0.0 109.634 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -134.12 23.5 3.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.702 -0.624 . . . . 0.0 109.929 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 144.12 37.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -56.6 -49.47 74.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.388 -0.82 . . . . 0.0 109.882 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -80.44 -29.5 37.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.371 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.63 -161.39 19.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 8' ' ' VAL . 74.4 mt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.613 -0.934 . . . . 0.0 109.187 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -50.68 -57.44 13.36 Favored Pre-proline 0 N--CA 1.507 2.405 0 O-C-N 120.829 -1.169 . . . . 0.0 111.184 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.5 Cg_endo -71.94 -18.31 27.97 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.333 1.355 . . . . 0.0 110.532 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -76.78 -21.69 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.787 . . . . 0.0 109.385 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -85.33 -33.87 21.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -72.5 -35.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.699 0.762 . . . . 0.0 109.068 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 44' ' ' LEU . 98.8 mt -77.17 -45.36 26.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.998 -0.439 . . . . 0.0 110.431 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.4 p -60.1 -27.47 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -73.44 -52.56 13.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.5 -0.75 . . . . 0.0 110.468 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.27 -54.39 46.33 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.422 -0.799 . . . . 0.0 110.344 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.68 -25.16 62.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.3 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.6 t -62.55 -38.6 90.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.348 -0.845 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.624 . . . . 0.0 109.931 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' CG ' ' HB2' ' A' ' 73' ' ' ALA . 88.3 m-85 -89.56 125.32 35.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 109.676 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -68.58 -24.73 64.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.874 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.62 144.63 42.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 109.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.67 96.14 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.773 HG12 ' CB ' ' A' ' 65' ' ' ALA . 19.8 m -89.96 131.39 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -122.08 130.61 53.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 110.379 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.718 HD11 ' HB ' ' A' ' 61' ' ' ILE . 19.1 tp -89.91 146.71 24.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.48 126.95 46.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.391 -0.818 . . . . 0.0 109.903 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.842 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 42.0 t80 -160.33 137.65 9.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.61 37.35 19.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.037 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.85 29.5 67.71 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -129.33 113.36 14.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.595 -0.944 . . . . 0.0 109.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.6 m -93.39 91.52 7.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.538 -0.726 . . . . 0.0 109.794 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.514 -0.741 . . . . 0.0 109.065 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -69.4 145.03 53.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 22' ' ' LEU . 7.0 tp -63.38 -13.25 37.49 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 5.3 mttt -87.17 50.51 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.77 -1.206 . . . . 0.0 108.113 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 50' ' ' VAL . 31.0 t -150.24 86.2 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 19' ' ' ALA . 27.7 mt -64.83 -41.36 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.768 -0.582 . . . . 0.0 109.658 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.6 tpt -72.74 -27.23 61.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.526 -0.734 . . . . 0.0 109.762 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -24.13 72.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 46' ' ' SER . 41.2 t -80.67 -31.36 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -1.058 . . . . 0.0 109.574 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 t -75.43 -28.54 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.839 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.2 p -62.08 -27.97 69.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.77 . . . . 0.0 109.776 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.53 -76.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.475 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.89 55.42 0.27 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 59' ' ' ALA . 17.9 mt -73.85 150.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.607 -0.937 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.03 -158.68 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.671 -0.643 . . . . 0.0 109.722 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -86.55 63.57 8.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.6 56.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.842 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -132.52 129.72 39.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.93 . . . . 0.0 109.488 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -84.65 129.45 34.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.718 ' HB ' HD11 ' A' ' 35' ' ' LEU . 23.7 pt -123.21 134.56 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.639 -0.663 . . . . 0.0 109.347 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -105.16 117.07 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 6' ' ' PHE . 86.8 mt -102.14 153.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -149.94 103.35 3.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.658 -0.651 . . . . 0.0 109.597 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.773 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.31 127.97 35.83 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.84 106.6 7.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.88 -145.67 7.17 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.09 -71.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.896 . . . . 0.0 109.594 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -98.91 52.73 0.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.535 -0.728 . . . . 0.0 109.416 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.92 -42.81 90.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.435 -0.79 . . . . 0.0 110.114 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.496 ' HA ' HD21 ' A' ' 74' ' ' LEU . 15.8 m-80 -62.0 -28.58 69.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 0.0 109.85 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -23.53 50.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.433 -0.792 . . . . 0.0 110.454 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.85 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.06 -47.11 14.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -62.26 -45.61 92.53 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.35 -0.844 . . . . 0.0 110.66 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.739 ' N ' HD12 ' A' ' 74' ' ' LEU . 36.4 p-10 -70.81 -25.26 62.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -62.1 -62.72 1.58 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.2 mp -62.76 -22.95 66.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.593 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.93 -52.39 65.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.49 -29.45 70.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -66.24 -33.85 76.68 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mmt -71.75 -28.24 63.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.749 -0.595 . . . . 0.0 109.665 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -86.89 -18.96 29.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 110.47 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -74.22 -67.59 0.6 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.34 -28.56 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.68 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.5 35.46 5.68 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 86' ' ' LEU . 95.6 mt -81.7 -49.7 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.748 -0.854 . . . . 0.0 109.696 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.1 -179.51 36.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.49 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -172.95 153.57 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.628 -0.67 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -144.58 148.16 34.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.679 -0.638 . . . . 0.0 109.632 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 6' ' ' PHE . 32.5 m -92.61 159.08 15.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.712 -0.617 . . . . 0.0 109.438 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.425 ' N ' HG22 ' A' ' 5' ' ' THR . 72.6 m-85 -143.08 172.68 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.171 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -136.68 122.74 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.745 HG22 HD11 ' A' ' 14' ' ' ILE . 19.6 t -75.11 111.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.638 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -16.67 13.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.728 -0.608 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.05 139.88 56.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.24 -0.912 . . . . 0.0 109.841 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.73 -42.71 90.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.1 p -63.09 -29.82 71.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.46 -157.07 24.46 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 8' ' ' VAL . 62.7 mt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.601 -0.941 . . . . 0.0 109.599 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.42 -60.7 7.67 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 120.852 -1.155 . . . . 0.0 111.001 -178.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.3 Cg_endo -69.7 -14.97 37.06 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.378 1.386 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -80.85 -23.96 38.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -0.831 . . . . 0.0 109.199 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -83.91 -30.04 26.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.192 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -74.31 -36.46 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.625 0.726 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.859 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.0 mt -78.13 -43.86 27.69 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.92 -0.488 . . . . 0.0 110.367 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.6 p -59.8 -29.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 0.0 109.804 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -74.27 -42.49 59.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -65.42 -61.39 2.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.499 -0.751 . . . . 0.0 110.158 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -58.94 -25.38 63.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 0.0 110.303 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.0 t -60.92 -39.02 87.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.279 -0.888 . . . . 0.0 109.155 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -66.95 -27.72 67.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.581 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 98.7 m-85 -89.72 119.53 30.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.723 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -65.61 -15.74 63.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.774 -0.579 . . . . 0.0 110.278 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.51 172.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.82 88.67 2.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.638 . . . . 0.0 109.441 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.922 HG12 ' HB2' ' A' ' 65' ' ' ALA . 28.8 m -89.72 111.19 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.392 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -110.43 133.43 53.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.458 -0.777 . . . . 0.0 109.876 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 61' ' ' ILE . 5.4 tt -90.22 148.63 22.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.68 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.39 107.55 12.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.51 -0.744 . . . . 0.0 109.445 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD1' HG12 ' A' ' 55' ' ' ILE . 15.2 t80 -92.88 71.69 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.441 -0.787 . . . . 0.0 110.003 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.66 85.57 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.656 -0.652 . . . . 0.0 111.592 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 -42.65 2.83 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -89.33 160.39 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.456 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -150.14 105.84 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.775 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.23 148.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 109.165 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.13 132.45 49.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 22' ' ' LEU . 2.0 tm? -50.24 -28.22 7.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.783 ' HA ' HG23 ' A' ' 23' ' ' VAL . 18.7 mttt -90.76 61.18 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.861 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.0 t -150.44 86.79 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.593 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 22.5 mt -63.93 -61.81 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.982 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 ttm -64.35 -21.66 66.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.465 -0.772 . . . . 0.0 110.167 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.57 60.29 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 46' ' ' SER . 46.7 t -82.18 -32.21 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.411 -1.053 . . . . 0.0 109.718 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 47' ' ' ILE . 27.3 t -64.33 -28.4 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.781 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -69.48 -25.65 64.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 0.0 110.022 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 53' ' ' LEU . 4.2 mm? -64.71 -37.12 86.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.486 -0.759 . . . . 0.0 109.592 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.88 38.02 28.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG12 ' CD1' ' A' ' 37' ' ' TYR . 28.3 mt -69.59 144.24 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.54 -0.976 . . . . 0.0 109.264 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.59 -165.76 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.49 42.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.61 72.93 0.58 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.82 170.1 16.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.977 . . . . 0.0 109.602 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.77 143.41 48.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.693 . . . . 0.0 109.236 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 35' ' ' LEU . 14.3 pt -145.79 126.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.539 -0.726 . . . . 0.0 109.524 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -101.64 118.39 36.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.406 HD12 ' CD1' ' A' ' 6' ' ' PHE . 91.0 mt -102.13 151.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -150.25 109.91 4.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.515 -0.74 . . . . 0.0 110.131 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.922 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -89.85 134.98 33.9 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.71 107.67 4.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.77 -127.32 1.36 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.2 -70.07 0.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.973 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -93.14 49.54 1.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.632 -0.668 . . . . 0.0 109.326 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -64.2 -40.9 97.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 0.0 110.039 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -68.48 -43.09 77.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.0 -23.9 65.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 0.0 110.314 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.22 -46.65 15.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.285 -0.885 . . . . 0.0 111.391 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -59.21 -41.74 89.31 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.697 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.88 -26.36 60.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.903 . . . . 0.0 109.221 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -60.27 -61.57 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.78 . . . . 0.0 109.24 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -60.64 -29.25 69.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.404 -0.81 . . . . 0.0 109.793 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.23 -37.73 86.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.487 -0.758 . . . . 0.0 109.919 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 80' ' ' THR . 1.3 pt-20 -72.75 -28.56 62.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.402 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 54.4 m -68.2 -37.6 81.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -27.89 63.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.777 -0.577 . . . . 0.0 109.567 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -86.87 -17.64 32.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 110.453 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -75.04 -52.12 11.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.886 . . . . 0.0 109.806 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.48 -35.1 14.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.653 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 44.81 1.52 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 86' ' ' LEU . 81.6 mt -81.71 -29.33 33.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -1.006 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.15 169.09 41.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.569 -179.859 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.87 153.96 36.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.558 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -142.9 144.64 32.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.678 -0.639 . . . . 0.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -90.15 146.3 24.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.675 -0.641 . . . . 0.0 109.402 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.585 ' CE1' HD12 ' A' ' 63' ' ' ILE . 36.0 m-85 -126.86 161.32 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.576 -0.703 . . . . 0.0 109.561 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.02 133.77 55.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 14' ' ' ILE . 21.1 t -87.25 106.5 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.371 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.463 ' O ' HG22 ' A' ' 9' ' ' THR . 8.2 m -124.48 14.78 8.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 110.177 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 148.67 34.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -54.49 17.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.354 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -66.09 -29.3 69.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.565 -0.709 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.77 -159.31 20.27 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.667 HD11 HG22 ' A' ' 8' ' ' VAL . 62.6 mt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.995 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -57.77 -60.34 10.24 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.952 -1.093 . . . . 0.0 110.845 -178.313 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -70.39 -13.54 33.18 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.341 1.36 . . . . 0.0 110.983 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -80.19 -28.65 38.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 108.914 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.604 HG23 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -80.84 -27.25 36.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 17' ' ' ARG . 37.4 t -71.57 -40.84 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 44' ' ' LEU . 55.8 mt -69.25 -53.98 17.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.161 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.2 p -53.14 -28.17 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -71.41 -43.12 67.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.935 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -69.18 -59.64 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.389 -0.819 . . . . 0.0 109.947 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 77' ' ' LEU . . . -57.0 -21.59 31.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.465 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.7 t -58.9 -41.84 88.15 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -65.94 -29.51 69.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.438 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 68.9 m-85 -93.67 128.52 39.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.26 8.94 21.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.87 -178.44 1.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.96 75.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.834 HG12 ' HB2' ' A' ' 65' ' ' ALA . 29.2 m -89.71 124.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 109.395 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -135.03 142.8 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.612 -0.68 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.6 tt -89.62 159.16 17.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.725 ' N ' HD23 ' A' ' 35' ' ' LEU . 7.6 tt0 -127.12 125.67 41.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 73.8 t80 -160.39 145.5 14.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.504 -0.748 . . . . 0.0 109.784 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 61.3 34.82 18.37 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.631 -0.668 . . . . 0.0 110.018 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 29.5 70.21 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -135.33 178.92 6.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.59 -0.947 . . . . 0.0 109.083 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 m -143.74 114.12 7.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.23 147.71 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -68.11 134.74 51.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.3 tm? -53.39 -26.95 21.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.456 -0.778 . . . . 0.0 109.293 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.679 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -90.63 57.07 3.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -146.38 88.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.768 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.6 mt -69.21 -39.23 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 0.0 109.993 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.5 ttm -82.59 -29.5 30.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.755 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.03 -43.15 96.22 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 46' ' ' SER . 40.8 t -67.76 -34.01 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.49 -1.006 . . . . 0.0 109.385 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -66.4 -28.65 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.707 . . . . 0.0 109.561 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -62.03 -34.14 75.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.505 -0.747 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mp -70.83 -46.84 62.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.583 -0.698 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.68 65.57 2.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.604 HD13 HD12 ' A' ' 14' ' ' ILE . 14.5 mt -77.09 162.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.603 -0.939 . . . . 0.0 109.269 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -134.5 -175.06 3.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.655 -0.653 . . . . 0.0 109.618 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 153.23 42.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.598 -0.689 . . . . 0.0 109.496 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.3 55.45 10.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.535 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -132.68 179.49 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.557 -0.967 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -132.82 140.86 48.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.538 HD12 HD11 ' A' ' 35' ' ' LEU . 26.9 pt -138.78 161.3 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.459 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.37 121.58 21.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 109.644 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.585 HD12 ' CE1' ' A' ' 6' ' ' PHE . 90.8 mt -105.01 149.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 p -150.3 112.83 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.834 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.79 134.59 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.01 102.87 3.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.394 -0.816 . . . . 0.0 109.821 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.88 -125.23 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.06 -72.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.956 . . . . 0.0 109.666 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.26 55.84 1.55 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.72 . . . . 0.0 109.385 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.18 -28.26 69.93 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -74.78 -44.4 49.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.44 -0.788 . . . . 0.0 109.946 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.8 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.5 -46.27 14.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.01 -1.056 . . . . 0.0 110.49 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.12 -42.42 96.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.348 -0.845 . . . . 0.0 110.669 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.713 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.7 p-10 -75.77 -22.41 56.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 109.391 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -66.86 -59.13 3.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.339 -0.851 . . . . 0.0 108.707 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -61.69 -28.39 69.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.527 -0.733 . . . . 0.0 109.848 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' OE2' ' CE2' ' A' ' 6' ' ' PHE . 4.8 tt0 -61.18 -56.28 22.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.477 -0.764 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.68 -30.67 70.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -68.56 -32.48 72.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -0.822 . . . . 0.0 108.915 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 30.6 mmm -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -76.0 -22.59 55.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.731 -0.605 . . . . 0.0 110.03 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 p -66.1 -50.04 65.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.399 -0.813 . . . . 0.0 109.675 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -97.84 10.1 41.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.565 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.5 89.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 86' ' ' LEU . 35.3 mt -132.46 -60.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.628 -0.924 . . . . 0.0 109.401 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.22 150.4 22.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -64.6 152.71 41.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -150.44 137.73 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.652 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.4 m -89.85 139.71 30.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.632 -0.667 . . . . 0.0 109.357 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.02 169.5 11.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 109.868 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 137.88 52.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.592 -0.693 . . . . 0.0 109.342 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.634 ' CG2' HG23 ' A' ' 61' ' ' ILE . 21.3 t -90.51 108.09 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.59 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -129.1 22.25 5.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.59 -0.694 . . . . 0.0 109.884 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.68 159.06 29.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.07 -61.75 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.562 -0.711 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -71.04 -29.36 65.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.718 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.18 -139.55 14.98 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.745 ' HB ' HD12 ' A' ' 55' ' ' ILE . 55.4 mt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.597 -0.943 . . . . 0.0 109.391 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.99 -54.07 51.15 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.906 -1.121 . . . . 0.0 111.092 -178.506 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -73.13 -21.44 20.44 Favored 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 121.115 1.21 . . . . 0.0 110.293 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -75.43 -21.43 58.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.33 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.52 -31.89 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.129 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.2 -45.21 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.3 mt -68.7 -49.57 57.88 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.8 p -55.93 -29.64 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.83 -36.16 70.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.913 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -72.43 -59.25 2.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.473 -0.767 . . . . 0.0 110.148 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.14 31.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.478 -0.764 . . . . 0.0 110.738 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.1 p -59.94 -42.61 94.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.289 -0.882 . . . . 0.0 109.645 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -28.02 69.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.609 -0.682 . . . . 0.0 109.622 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 78.5 m-85 -94.8 131.48 40.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.429 -0.794 . . . . 0.0 109.633 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.23 -11.46 57.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.668 -0.645 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.3 155.73 8.55 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.039 -1.038 . . . . 0.0 109.82 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.62 82.0 6.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.581 -0.699 . . . . 0.0 109.528 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.755 HG12 ' CB ' ' A' ' 65' ' ' ALA . 33.9 m -89.68 121.97 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -124.5 126.24 45.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 110.105 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.4 tt -89.97 155.45 19.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' N ' HD23 ' A' ' 35' ' ' LEU . 31.0 tt0 -122.16 158.53 29.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 110.053 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.808 ' CE1' HG23 ' A' ' 55' ' ' ILE . 34.3 t80 -145.48 98.46 3.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.04 -81.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.24 26.85 1.56 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -125.24 121.07 33.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.569 -0.96 . . . . 0.0 109.116 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.31 100.85 12.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.539 -0.726 . . . . 0.0 110.057 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.06 147.65 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -71.67 142.21 49.87 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 22' ' ' LEU . 1.6 tm? -58.02 -30.43 66.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.803 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.74 60.8 4.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -149.79 81.23 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.76 ' O ' HG23 ' A' ' 51' ' ' VAL . 37.6 mt -64.81 -38.66 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.697 -0.627 . . . . 0.0 109.662 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.81 -24.34 59.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.546 -0.721 . . . . 0.0 110.04 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 -31.24 46.08 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 46' ' ' SER . 45.7 t -79.92 -38.44 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -1.047 . . . . 0.0 109.485 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -62.9 -30.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.7 p -67.52 -32.64 73.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 50' ' ' VAL . 15.4 mt -74.0 -55.78 5.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.544 -0.722 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.43 63.77 1.69 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.808 HG23 ' CE1' ' A' ' 37' ' ' TYR . 61.8 mt -76.2 159.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.974 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.445 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -142.13 -175.04 4.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.707 -0.621 . . . . 0.0 109.558 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -70.46 146.96 49.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.628 -0.67 . . . . 0.0 109.603 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.42 61.88 2.39 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.33 -178.58 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.582 -0.952 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -128.49 148.48 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.634 HG23 ' CG2' ' A' ' 8' ' ' VAL . 19.3 pt -139.81 154.63 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.76 113.11 11.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.12 155.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.25 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 p -150.22 101.04 2.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.841 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.755 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.76 122.38 32.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.4 104.78 4.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 109.707 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.4 -125.2 0.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.58 -69.74 0.71 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.642 -0.917 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.67 49.17 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.78 -32.41 70.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.475 -0.766 . . . . 0.0 110.023 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.35 -33.18 72.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -77.47 -23.25 50.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 110.051 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.401 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -68.16 -42.12 80.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.698 ' N ' HD12 ' A' ' 74' ' ' LEU . 39.5 p30 -78.39 -18.86 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.31 -58.8 3.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.195 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -71.08 -24.96 62.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.82 -59.11 4.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.91 -28.55 67.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.355 -0.84 . . . . 0.0 109.771 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 40.6 m -67.25 -35.89 80.48 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.33 -28.4 64.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.699 -0.626 . . . . 0.0 109.422 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -83.0 -21.55 33.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.113 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 p -75.08 -53.61 8.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -80.17 -29.1 38.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 109.562 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.57 37.32 7.02 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.02 -37.38 26.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.691 -0.887 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.39 163.06 34.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.415 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.651 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.7 155.74 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.423 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.8 tttt -140.1 141.19 36.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.685 . . . . 0.0 109.645 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 m -99.13 158.99 15.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.2 m-85 -143.87 161.79 37.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -121.6 118.72 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.134 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.59 116.42 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.652 -0.655 . . . . 0.0 109.588 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -117.44 -16.03 10.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.726 -0.608 . . . . 0.0 110.357 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 151.97 36.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.68 -43.53 72.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -64.3 -32.5 74.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.589 -0.694 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.66 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.822 ' HB ' HD12 ' A' ' 55' ' ' ILE . 46.9 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.594 -0.944 . . . . 0.0 109.428 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.4 ttt180 -53.77 -52.98 62.66 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.046 -1.034 . . . . 0.0 111.109 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -74.27 -24.6 14.3 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.137 1.225 . . . . 0.0 110.332 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.36 -20.88 61.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.55 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.515 HG23 ' CD1' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -85.77 -34.16 21.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 108.979 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG12 HG21 ' A' ' 80' ' ' THR . 19.0 t -69.95 -34.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.9 mt -76.38 -51.5 11.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.397 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.8 p -54.17 -27.38 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.292 -0.88 . . . . 0.0 109.918 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.76 -45.63 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.676 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.401 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 21.4 m -61.05 -59.37 5.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 109.822 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.496 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -61.52 -26.43 67.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.041 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -59.86 -33.3 71.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -77.09 -26.32 53.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.619 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.528 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 96.3 m-85 -89.81 123.8 34.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.57 -24.21 67.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.692 -0.63 . . . . 0.0 109.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 141.76 53.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.401 -0.812 . . . . 0.0 109.789 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -89.51 98.56 11.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.587 -0.696 . . . . 0.0 109.235 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.777 HG12 ' CB ' ' A' ' 65' ' ' ALA . 32.1 m -89.96 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.575 -0.703 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -131.96 132.84 43.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -121.27 128.73 52.65 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.477 -0.764 . . . . 0.0 109.903 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.693 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 51.9 t80 -160.49 138.49 9.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.718 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.87 37.08 15.58 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.536 -0.727 . . . . 0.0 109.754 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.76 27.98 64.93 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -123.35 168.98 11.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.943 . . . . 0.0 109.026 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.8 m -142.22 103.52 4.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 109.95 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.83 146.2 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -69.19 142.79 54.2 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -64.05 -13.45 47.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.33 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.764 ' HA ' HG23 ' A' ' 23' ' ' VAL . 27.4 mttt -88.1 48.72 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.85 -1.157 . . . . 0.0 107.984 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 50' ' ' VAL . 21.9 t -150.54 82.36 1.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.0 109.049 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 51' ' ' VAL . 30.1 mt -63.63 -41.31 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.725 -0.61 . . . . 0.0 109.543 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.44 -29.98 66.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.29 -30.06 69.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 46' ' ' SER . 40.6 t -81.56 -31.13 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.97 . . . . 0.0 109.343 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.1 t -70.21 -31.68 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.616 -0.677 . . . . 0.0 109.397 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 p -63.89 -37.2 86.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.38 -46.62 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.605 -0.684 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.55 71.54 1.09 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.822 HD12 ' HB ' ' A' ' 14' ' ' ILE . 59.5 mt -84.36 162.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.624 -0.927 . . . . 0.0 109.389 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.486 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -149.11 -174.14 4.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.602 -0.686 . . . . 0.0 109.617 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.9 150.31 42.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.712 -0.617 . . . . 0.0 109.686 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 62.7 3.14 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -143.63 164.88 29.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.942 . . . . 0.0 109.62 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -126.2 123.04 37.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.601 HD13 HD11 ' A' ' 14' ' ' ILE . 21.9 pt -117.56 130.52 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.687 . . . . 0.0 109.293 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.07 115.27 29.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.52 -0.738 . . . . 0.0 109.804 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 ' CE1' ' A' ' 6' ' ' PHE . 81.6 mt -101.93 149.85 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.581 -0.699 . . . . 0.0 109.183 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 p -147.22 108.89 4.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.637 -0.664 . . . . 0.0 109.675 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.777 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.75 131.16 35.85 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.61 107.18 7.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -145.72 8.16 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -64.4 1.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.943 . . . . 0.0 109.65 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.14 44.34 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 14.3 pt-20 -62.03 -32.21 72.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.35 -33.29 69.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 109.578 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.19 -24.13 54.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.761 . . . . 0.0 110.07 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.795 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.78 -41.51 23.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 110.457 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.22 -41.84 96.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.294 -0.878 . . . . 0.0 110.4 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.713 ' N ' HD12 ' A' ' 74' ' ' LEU . 40.8 p30 -76.54 -21.04 56.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.25 -0.907 . . . . 0.0 109.763 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.444 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -67.78 -56.49 9.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.747 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.795 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.41 -28.24 69.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -54.31 47.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.462 -0.774 . . . . 0.0 109.66 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.68 -27.48 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.643 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.462 HG21 HG12 ' A' ' 21' ' ' VAL . 1.6 m -67.9 -33.89 75.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -28.74 64.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.68 -0.638 . . . . 0.0 109.293 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -81.51 -25.29 36.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.602 -0.686 . . . . 0.0 110.116 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 p -72.32 -58.89 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 109.69 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -75.17 -41.23 58.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 109.451 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.6 44.33 1.98 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.77 -38.57 25.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.578 -0.954 . . . . 0.0 109.463 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.57 150.38 14.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.454 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -160.24 155.57 25.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.69 -0.631 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.697 ' HG3' HD13 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -140.06 147.61 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.631 -0.668 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -99.38 146.53 26.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 80.4 m-85 -138.53 162.58 34.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -123.15 138.2 54.71 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.902 HG13 HD11 ' A' ' 14' ' ' ILE . 15.5 t -87.68 118.89 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.729 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -128.36 9.61 6.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 144.13 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.525 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.52 -34.41 74.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 p -71.14 -29.83 65.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.485 -0.759 . . . . 0.0 109.582 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.32 -150.62 19.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.902 HD11 HG13 ' A' ' 8' ' ' VAL . 15.6 mm . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.54 -0.977 . . . . 0.0 109.215 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.076 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -56.02 -52.59 71.39 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.954 -1.091 . . . . 0.0 111.112 -178.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.523 ' HB3' HD22 ' A' ' 86' ' ' LEU . 31.3 Cg_endo -71.84 -25.15 20.4 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.189 1.26 . . . . 0.0 110.497 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -71.09 -26.08 62.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 108.96 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 m -79.21 -30.2 43.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.477 -0.764 . . . . 0.0 109.27 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.67 -48.99 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.107 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB3' HD11 ' A' ' 44' ' ' LEU . 94.7 mt -65.8 -54.38 27.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.843 HG11 HD11 ' A' ' 47' ' ' ILE . 14.4 p -50.85 -30.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.388 -0.82 . . . . 0.0 110.739 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.33 -47.63 63.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.74 . . . . 0.0 110.339 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.525 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 2.8 m -65.96 -56.53 11.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -62.27 -17.78 59.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.442 -0.787 . . . . 0.0 110.437 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -64.66 -29.48 70.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.71 23.72 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.734 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.485 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 65.9 m-85 -131.79 120.14 22.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -22.19 66.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.655 -0.653 . . . . 0.0 109.958 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 147.52 34.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.0 109.818 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.75 89.74 7.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.616 -0.678 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.799 HG12 ' CB ' ' A' ' 65' ' ' ALA . 27.6 m -89.89 138.65 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -133.77 135.47 43.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.786 HD12 HG12 ' A' ' 63' ' ' ILE . 4.8 tp -95.78 131.29 42.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -108.73 119.4 39.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 110.449 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.615 ' CE1' HG23 ' A' ' 55' ' ' ILE . 28.7 t80 -103.82 97.52 7.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 72.37 -81.27 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.828 -0.545 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.04 26.76 2.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -124.52 116.06 21.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -1.014 . . . . 0.0 109.012 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -91.5 104.15 16.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.428 -0.795 . . . . 0.0 110.321 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.25 147.86 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -68.2 140.37 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.1 tm? -57.96 -27.32 63.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.429 -0.795 . . . . 0.0 109.035 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.649 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.8 mttm -90.02 51.5 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.805 . . . . 0.0 109.118 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.679 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.3 t -137.87 91.96 2.63 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.843 HD11 HG11 ' A' ' 23' ' ' VAL . 40.3 mm -68.11 -62.54 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.682 -0.636 . . . . 0.0 109.641 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -66.5 -25.76 66.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 109.91 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.6 -30.13 75.89 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 46' ' ' SER . 41.3 t -88.69 -30.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.513 -0.992 . . . . 0.0 109.442 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -69.05 -29.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.484 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -66.52 -30.41 70.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.717 . . . . 0.0 109.589 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 50' ' ' VAL . 27.1 mt -62.93 -66.43 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.723 . . . . 0.0 109.39 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.71 52.33 0.86 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.615 HG23 ' CE1' ' A' ' 37' ' ' TYR . 38.7 mt -78.5 150.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.548 -0.972 . . . . 0.0 109.041 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.96 -164.28 1.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.573 -0.705 . . . . 0.0 109.804 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -66.64 153.89 41.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 109.703 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.15 57.85 13.96 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -126.1 173.97 8.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.667 -0.902 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -128.37 141.13 51.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.653 ' HB ' HD11 ' A' ' 35' ' ' LEU . 13.1 pt -142.76 126.02 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.54 -0.725 . . . . 0.0 109.373 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 m -106.89 110.07 22.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.532 -0.73 . . . . 0.0 109.828 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.786 HG12 HD12 ' A' ' 35' ' ' LEU . 79.2 mt -94.19 150.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -150.1 109.75 4.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.67 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.799 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.82 132.52 35.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.38 102.67 4.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.362 -0.836 . . . . 0.0 109.748 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.45 -134.38 2.57 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.49 -58.82 2.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.95 . . . . 0.0 109.476 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.13 47.96 1.04 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.527 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 16.8 pt-20 -66.9 -40.35 87.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 110.114 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -70.31 -35.64 73.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.897 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.88 -24.18 59.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 110.105 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.815 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.65 -44.07 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.823 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -61.79 -42.8 99.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.293 -0.88 . . . . 0.0 110.635 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.715 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.0 p-10 -72.48 -27.51 62.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 0.0 109.151 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 25' ' ' THR . . . -61.19 -58.36 8.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 109.254 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -65.72 -22.66 66.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -62.71 1.46 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.34 -34.51 73.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.313 -0.867 . . . . 0.0 109.906 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.8 m -63.15 -32.87 74.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.408 -0.807 . . . . 0.0 108.971 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.33 -30.95 66.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -82.02 -19.18 40.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.655 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.7 p -80.66 -45.51 17.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 109.739 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -81.06 -28.74 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.729 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 32.26 8.02 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 18' ' ' PRO . 91.4 mt -81.72 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.665 -0.903 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.19 -173.08 13.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.665 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -107.32 150.12 27.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -142.18 150.78 41.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.7 -0.625 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 m -105.3 151.09 24.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 109.291 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.64 166.03 24.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.493 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -113.1 134.57 54.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.618 -0.676 . . . . 0.0 109.301 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.728 ' CG2' HG23 ' A' ' 61' ' ' ILE . 26.9 t -89.27 99.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 109.564 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -123.37 27.15 7.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 155.2 31.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -65.46 -43.71 89.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.265 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -101.15 21.77 13.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 109.851 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.34 -136.79 47.64 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.464 HG22 HG11 ' A' ' 50' ' ' VAL . 61.3 mt . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.573 -0.957 . . . . 0.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.1 -52.46 68.28 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 111.521 -178.398 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -72.89 -23.89 18.29 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.19 1.26 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -75.36 -22.26 57.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 109.526 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.41 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -83.72 -31.19 26.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.225 179.787 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG12 HG21 ' A' ' 80' ' ' THR . 17.6 t -71.53 -42.95 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.722 0.772 . . . . 0.0 108.998 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.78 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.2 mt -70.47 -50.31 39.4 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.463 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.6 p -55.3 -28.88 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -73.01 -36.83 67.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.485 -0.759 . . . . 0.0 109.861 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -73.94 -63.78 1.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.456 -0.777 . . . . 0.0 110.202 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -56.54 -25.08 50.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -61.3 -40.9 95.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -68.36 -26.47 65.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.442 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.1 m-85 -89.85 128.32 36.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.342 -0.849 . . . . 0.0 109.725 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.29 -23.44 62.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.666 -0.646 . . . . 0.0 110.291 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 146.06 26.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.305 -0.872 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 91.05 8.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.538 -0.726 . . . . 0.0 109.263 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.847 HG12 ' CB ' ' A' ' 65' ' ' ALA . 28.9 m -89.91 113.93 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.673 -0.642 . . . . 0.0 109.335 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -105.93 137.25 44.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 tt -100.72 116.27 32.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -89.61 143.21 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.843 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.561 ' CD2' HD23 ' A' ' 53' ' ' LEU . 15.1 t80 -132.38 68.9 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.7 . . . . 0.0 109.547 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.56 62.26 2.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.3 -38.85 2.95 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -89.15 90.88 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -1.031 . . . . 0.0 109.195 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.4 m -95.91 112.55 24.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 110.11 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.1 147.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -65.59 141.81 58.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.5 tm? -56.87 -29.58 63.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 109.139 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.764 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.97 61.02 4.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.854 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -148.78 88.74 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.597 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 34.1 mt -71.72 -40.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.618 -0.676 . . . . 0.0 109.937 -179.225 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -30.2 45.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 109.691 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.4 92.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 46' ' ' SER . 47.4 t -63.06 -28.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.54 -0.976 . . . . 0.0 109.52 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 47' ' ' ILE . 23.5 t -70.18 -31.3 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 109.401 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -62.89 -41.02 99.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.768 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.561 HD23 ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -63.11 -33.51 75.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 109.431 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.84 23.65 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 37' ' ' TYR . 54.6 mt -75.92 147.46 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.615 -0.933 . . . . 0.0 109.327 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.68 -167.52 1.84 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.52 150.34 32.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.577 -0.702 . . . . 0.0 109.538 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.84 3.7 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 179.97 6.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.941 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.16 136.19 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.728 HG23 ' CG2' ' A' ' 8' ' ' VAL . 31.6 pt -124.38 162.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.668 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 63' ' ' ILE . 21.0 m -136.34 161.26 36.3 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.402 ' N ' HG22 ' A' ' 62' ' ' THR . 30.2 mt -146.26 150.95 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.409 -0.807 . . . . 0.0 109.768 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -150.52 108.13 3.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.67 -0.643 . . . . 0.0 109.578 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.847 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.63 130.43 35.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 109.08 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 102.22 5.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.2 -142.24 5.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.16 -57.96 2.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.588 -0.948 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -96.72 48.3 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.688 . . . . 0.0 109.359 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.665 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 6.4 pt-20 -66.89 -29.08 68.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 109.744 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -77.74 -36.23 51.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.497 -0.752 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 29.9 m-20 -76.16 -20.72 57.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.117 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.769 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.36 -44.26 17.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.906 . . . . 0.0 110.296 -179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.83 -42.45 94.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.466 -0.771 . . . . 0.0 110.285 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.704 ' N ' HD12 ' A' ' 74' ' ' LEU . 23.8 p30 -78.55 -19.8 52.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.462 -0.774 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.76 -54.32 20.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -66.56 -30.9 71.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.665 -0.647 . . . . 0.0 109.6 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.18 -52.19 66.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.43 -0.794 . . . . 0.0 110.122 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.83 -29.44 70.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.58 HG21 HG12 ' A' ' 21' ' ' VAL . 88.2 m -67.67 -33.26 74.58 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.142 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.8 mtt -67.87 -29.29 68.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -84.64 -23.49 29.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.569 -0.707 . . . . 0.0 110.184 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -73.54 -55.33 6.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -85.06 -27.92 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.524 -0.735 . . . . 0.0 109.679 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.18 1.48 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 86' ' ' LEU . 98.0 mt -106.78 -37.8 6.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.957 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.84 158.34 30.83 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.245 0.545 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -99.91 157.06 16.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.782 . . . . 0.0 109.234 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -146.32 137.78 24.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 m -89.69 159.48 17.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.674 . . . . 0.0 109.244 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CD2' HD12 ' A' ' 63' ' ' ILE . 85.6 m-85 -145.4 143.31 30.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.6 -0.687 . . . . 0.0 109.69 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.57 127.92 46.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.214 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 59' ' ' ALA . 20.5 t -85.96 134.21 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 9' ' ' THR . 6.2 m -149.6 27.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.583 -0.698 . . . . 0.0 109.587 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.58 146.7 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -58.87 5.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.1 p -69.67 -31.31 69.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.687 . . . . 0.0 109.408 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.06 -154.22 16.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.434 ' CB ' HD12 ' A' ' 55' ' ' ILE . 38.7 mm . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.973 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.074 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.8 ttp85 -59.06 -55.17 49.1 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.77 -1.206 . . . . 0.0 111.094 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.0 Cg_endo -69.93 -21.51 32.59 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.04 1.16 . . . . 0.0 110.417 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.69 -22.53 50.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 109.272 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.461 ' HA ' HG12 ' A' ' 23' ' ' VAL . 6.5 m -81.13 -29.38 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.81 . . . . 0.0 109.152 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.24 -41.1 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -69.52 -51.78 32.53 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.297 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -57.55 -28.26 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.389 -0.819 . . . . 0.0 109.816 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -69.96 -36.64 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -60.22 2.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.627 -0.67 . . . . 0.0 110.13 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -58.83 -24.83 62.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.473 -0.767 . . . . 0.0 110.359 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 t -60.84 -39.23 88.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -23.21 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.671 -0.643 . . . . 0.0 109.885 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.658 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m-85 -89.46 127.72 35.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -0.865 . . . . 0.0 109.632 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.87 -22.8 62.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.72 -0.612 . . . . 0.0 109.905 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.17 45.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 109.715 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.67 93.9 9.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.56 -0.713 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.733 HG12 ' CB ' ' A' ' 65' ' ' ALA . 18.2 m -89.84 127.72 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -118.91 126.68 52.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 110.486 -178.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.562 HD21 ' HB ' ' A' ' 61' ' ' ILE . 2.3 tt -89.79 133.73 34.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -113.35 130.16 56.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.448 -0.782 . . . . 0.0 110.167 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE2' HG12 ' A' ' 55' ' ' ILE . 35.7 t80 -160.46 136.95 8.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.55 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.28 37.44 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.581 -0.7 . . . . 0.0 109.748 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.96 28.76 66.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -127.17 111.37 13.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.599 -0.942 . . . . 0.0 109.158 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -89.79 87.78 7.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.866 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -97.33 146.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.147 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -73.64 152.44 40.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.5 tp -69.61 -9.04 52.49 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.288 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 11.1 mttt -88.7 48.79 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.764 -1.21 . . . . 0.0 107.991 178.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.665 ' O ' HG23 ' A' ' 50' ' ' VAL . 13.8 t -150.41 95.43 2.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.381 -0.825 . . . . 0.0 109.298 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.665 HG23 ' HB3' ' A' ' 19' ' ' ALA . 29.7 mt -76.97 -38.81 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.677 -0.639 . . . . 0.0 109.557 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpt -74.65 -34.03 62.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.59 99.24 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 46' ' ' SER . 42.7 t -62.11 -28.31 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.98 . . . . 0.0 109.424 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -63.2 -35.06 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 p -63.5 -34.58 78.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.643 -0.66 . . . . 0.0 109.365 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 42' ' ' VAL . 32.9 mt -66.01 -59.02 4.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 109.333 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.2 67.32 1.54 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 56' ' ' ALA . 50.2 mt -81.22 162.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.557 -0.967 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.98 178.57 9.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.572 -0.705 . . . . 0.0 109.463 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -62.02 137.97 58.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.48 39.96 9.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -120.47 179.59 4.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.604 -0.939 . . . . 0.0 109.468 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -137.95 153.2 49.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.678 -0.639 . . . . 0.0 109.365 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.562 ' HB ' HD21 ' A' ' 35' ' ' LEU . 20.7 pt -150.19 132.47 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.88 107.51 18.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.558 -0.714 . . . . 0.0 109.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.499 HD12 ' CD2' ' A' ' 6' ' ' PHE . 82.0 mt -94.11 153.81 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -148.04 107.96 4.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.67 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.733 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 125.92 35.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.526 -0.734 . . . . 0.0 109.06 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.85 107.12 8.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.32 8.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.61 -58.02 3.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 0.0 109.536 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.63 42.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.671 . . . . 0.0 109.361 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.01 -29.24 70.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.588 -0.695 . . . . 0.0 109.798 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -78.15 -33.46 50.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -76.42 -22.15 55.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.721 . . . . 0.0 110.125 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.804 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.54 -42.52 20.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.696 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.08 -42.35 94.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.693 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.696 ' N ' HD12 ' A' ' 74' ' ' LEU . 19.6 p30 -75.06 -22.53 58.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 109.622 -179.682 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.658 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -67.33 -59.5 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 108.745 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -62.83 -28.88 70.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.52 -0.737 . . . . 0.0 109.781 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.33 -55.9 26.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.459 -0.776 . . . . 0.0 109.938 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -58.73 -27.24 64.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 110.038 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -70.91 -36.86 72.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 mmt -71.0 -29.85 65.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.754 -0.591 . . . . 0.0 109.459 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -83.5 -21.75 32.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.575 -0.703 . . . . 0.0 110.229 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -75.2 -70.22 0.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 109.781 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -62.2 -28.22 69.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.713 . . . . 0.0 109.753 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.79 39.91 5.41 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 86' ' ' LEU . 93.7 mt -81.81 -56.12 4.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.552 -0.97 . . . . 0.0 109.373 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.78 176.54 27.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.57 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.29 153.15 20.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.599 -0.688 . . . . 0.0 109.441 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 7.3 tttp -141.71 149.47 40.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 109.374 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -89.92 153.02 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.534 -0.729 . . . . 0.0 109.476 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.563 ' CD1' HD12 ' A' ' 63' ' ' ILE . 76.7 m-85 -142.27 145.49 34.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.624 -0.672 . . . . 0.0 109.398 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.97 126.93 52.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 14' ' ' ILE . 31.2 t -81.61 116.1 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.589 -0.694 . . . . 0.0 109.552 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -134.34 26.37 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 86' ' ' LEU . . . -77.46 164.55 25.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 109.466 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.55 -34.22 73.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.572 -0.705 . . . . 0.0 109.316 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -114.48 24.25 12.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.73 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.65 -139.07 46.77 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.688 HD11 HG22 ' A' ' 8' ' ' VAL . 48.8 mt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.906 . . . . 0.0 109.307 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.63 -53.72 59.48 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.961 -1.087 . . . . 0.0 110.829 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -73.88 -21.67 18.34 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.113 1.208 . . . . 0.0 110.456 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.25 -24.03 60.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.258 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.468 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -84.55 -31.12 24.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 109.16 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 17' ' ' ARG . 23.3 t -73.03 -35.48 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.721 0.772 . . . . 0.0 109.047 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' C ' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -77.87 -43.35 30.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.996 -0.44 . . . . 0.0 110.554 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 47' ' ' ILE . 10.7 p -61.72 -27.94 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 109.681 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -72.43 -50.35 26.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.528 -0.733 . . . . 0.0 110.025 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -61.57 -59.07 5.77 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.51 -0.743 . . . . 0.0 109.991 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -58.78 -23.51 60.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -38.98 83.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -29.06 69.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.483 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.638 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 96.5 m-85 -89.65 118.37 29.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.46 -15.68 62.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.657 -0.652 . . . . 0.0 110.243 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.35 29.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.7 86.95 6.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.391 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.712 HG12 ' CB ' ' A' ' 65' ' ' ALA . 16.7 m -89.73 119.98 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -112.12 132.82 54.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.732 . . . . 0.0 109.994 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 36' ' ' GLU . 5.0 tt -89.93 135.12 33.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.661 ' N ' HD23 ' A' ' 35' ' ' LEU . 34.2 tt0 -105.93 140.36 39.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.737 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.626 ' CE1' HG23 ' A' ' 55' ' ' ILE . 27.5 t80 -140.82 84.54 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.667 -0.646 . . . . 0.0 109.532 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.42 52.06 6.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.614 -0.679 . . . . 0.0 110.089 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.86 -12.96 64.17 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.412 -0.899 . . . . 0.0 110.874 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -89.48 86.91 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -1.175 . . . . 0.0 109.348 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 m -91.63 92.97 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.879 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.94 147.5 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.01 142.55 57.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD23 ' HB3' ' A' ' 26' ' ' ALA . 7.2 tp -64.14 -13.75 50.27 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.618 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.22 48.36 1.63 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.186 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 50' ' ' VAL . 16.8 t -150.27 84.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.818 . . . . 0.0 109.139 -179.542 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.667 HD11 HG11 ' A' ' 23' ' ' VAL . 33.1 mt -67.45 -46.31 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 0.0 109.255 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 ttm -64.35 -29.74 70.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.634 -0.667 . . . . 0.0 109.36 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.07 91.88 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 46' ' ' SER . 21.8 t -70.49 -39.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.972 . . . . 0.0 109.286 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 47' ' ' ILE . 33.7 t -64.11 -30.63 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -68.14 -31.6 71.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.637 -0.664 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.91 -67.58 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.79 47.8 1.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 37' ' ' TYR . 15.5 mt -63.73 157.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.953 . . . . 0.0 109.122 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -136.01 -170.49 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -84.13 150.66 25.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 109.474 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.02 46.95 14.53 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.33 178.46 6.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.481 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.78 147.75 49.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.679 . . . . 0.0 109.466 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.418 ' HB ' HD21 ' A' ' 35' ' ' LEU . 28.4 pt -142.5 157.36 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -131.37 109.63 10.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 109.639 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.563 HD12 ' CD1' ' A' ' 6' ' ' PHE . 90.0 mt -92.32 152.41 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.729 . . . . 0.0 109.145 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -150.2 109.54 3.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.78 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.712 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 126.64 35.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 103.86 5.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.475 -0.766 . . . . 0.0 109.618 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.54 -130.85 1.8 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.86 -74.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.629 -0.924 . . . . 0.0 109.59 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -90.34 53.0 2.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 16.4 pt-20 -67.8 -30.45 69.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.869 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.27 -37.81 60.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.712 . . . . 0.0 109.797 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.83 -24.88 58.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 110.19 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.784 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.9 -43.18 20.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.832 . . . . 0.0 110.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -62.51 -42.01 99.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.9 p-10 -74.13 -26.93 60.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 -60.77 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.805 . . . . 0.0 109.28 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -61.95 -28.07 69.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 109.969 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -56.61 19.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.919 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.79 -28.28 69.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -67.8 -32.59 73.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -30.78 66.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -81.17 -24.17 37.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.635 -0.666 . . . . 0.0 109.989 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -73.98 -69.33 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.61 -28.79 70.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.45 44.73 5.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 93.3 mt -81.87 -33.82 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.612 -0.934 . . . . 0.0 109.572 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.03 153.45 10.85 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.387 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -91.56 153.48 19.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 10.3 tttm -143.28 150.31 39.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.659 . . . . 0.0 109.631 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -97.16 152.42 18.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 63' ' ' ILE . 96.5 m-85 -142.08 148.2 38.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.627 -0.671 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -110.11 117.61 34.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.712 . . . . 0.0 109.145 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.727 HG22 HD11 ' A' ' 14' ' ' ILE . 15.5 t -74.15 112.97 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.736 -0.602 . . . . 0.0 109.503 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.6 17.62 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.701 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.25 38.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 109.373 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.12 91.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.552 -0.717 . . . . 0.0 109.716 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -75.17 -29.61 60.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.438 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 -166.38 24.87 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 8' ' ' VAL . 62.8 mt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.567 -0.96 . . . . 0.0 109.435 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -57.88 -60.96 8.36 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.875 -1.141 . . . . 0.0 110.575 -178.594 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.59 -13.67 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.265 1.31 . . . . 0.0 110.786 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -79.91 -26.12 40.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 108.974 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.403 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -82.09 -29.78 31.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -0.755 . . . . 0.0 109.056 179.389 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.38 -43.93 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.1 mt -69.11 -51.6 36.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.465 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.9 p -53.44 -29.54 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -70.75 -40.68 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.411 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 22.7 m -69.52 -63.95 0.97 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.926 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -54.92 -24.91 25.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.468 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 t -60.06 -44.86 94.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 109.328 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -65.45 -28.85 69.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.623 -0.673 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -89.65 129.91 36.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 109.269 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.23 -7.98 58.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.618 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.4 168.93 1.87 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.98 . . . . 0.0 109.707 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.99 87.09 4.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.429 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.926 HG12 ' HB2' ' A' ' 65' ' ' ALA . 19.0 m -95.84 98.64 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -107.11 131.89 53.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 0.0 109.761 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.821 HD11 HD12 ' A' ' 61' ' ' ILE . 8.5 tt -89.99 153.19 20.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.328 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' N ' HD23 ' A' ' 35' ' ' LEU . 9.1 tp10 -126.07 145.25 50.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.759 . . . . 0.0 109.447 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.617 ' HB3' HD23 ' A' ' 53' ' ' LEU . 29.9 t80 -160.29 108.48 1.66 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.531 -0.731 . . . . 0.0 109.835 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.82 50.52 8.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 109.93 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.49 27.98 71.71 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.41 97.92 5.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 109.133 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -91.79 102.02 14.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.557 -0.714 . . . . 0.0 110.062 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.95 147.46 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.87 135.37 52.4 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -53.99 -25.62 21.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.373 -0.829 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.7 mttt -90.61 54.58 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.86 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -145.64 85.22 1.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 19' ' ' ALA . 30.7 mt -67.42 -40.32 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.708 -0.62 . . . . 0.0 110.118 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.4 ttt -74.45 -27.68 60.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.48 -0.762 . . . . 0.0 109.835 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.89 59.14 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 46' ' ' SER . 37.4 t -67.39 -38.58 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -1.017 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -29.17 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.47 -0.768 . . . . 0.0 109.626 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.9 p -65.77 -29.62 70.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 37' ' ' TYR . 9.5 mp -62.49 -56.09 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.561 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.18 43.65 3.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.625 HD13 HD12 ' A' ' 14' ' ' ILE . 42.2 mt -70.88 158.0 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -1.003 . . . . 0.0 109.3 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.94 -164.47 1.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.551 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -66.94 130.14 42.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.586 -0.696 . . . . 0.0 109.568 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.65 79.7 0.94 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -147.97 167.35 25.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.611 -0.934 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.51 119.85 23.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 109.27 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 35' ' ' LEU . 26.5 pt -120.33 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.717 . . . . 0.0 109.556 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -112.25 111.84 23.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.603 -0.685 . . . . 0.0 109.738 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.548 HD12 ' CE2' ' A' ' 6' ' ' PHE . 90.1 mt -92.41 158.75 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 63' ' ' ILE . 5.5 p -150.31 103.13 3.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.926 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.96 123.66 36.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.49 105.77 4.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.56 -124.89 0.93 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.02 -65.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.962 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -97.97 53.83 1.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.18 -29.76 68.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.531 -0.73 . . . . 0.0 109.816 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -76.43 -36.16 58.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.769 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.84 -23.9 58.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.703 . . . . 0.0 110.111 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.85 -43.6 19.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.825 . . . . 0.0 110.722 -179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -63.87 -41.53 97.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.23 -0.919 . . . . 0.0 110.542 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.718 ' N ' HD12 ' A' ' 74' ' ' LEU . 24.5 p-10 -76.81 -22.49 53.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 -179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB1' ' CG2' ' A' ' 25' ' ' THR . . . -68.98 -53.96 17.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.258 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -73.22 -26.34 61.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.513 -0.742 . . . . 0.0 109.995 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -58.47 6.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.416 -0.802 . . . . 0.0 109.76 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -29.11 68.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.449 -0.782 . . . . 0.0 109.702 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.0 m -68.49 -34.22 75.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmm -71.49 -32.25 68.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.636 -0.665 . . . . 0.0 109.455 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -77.28 -27.38 53.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.66 -0.65 . . . . 0.0 109.951 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 p -71.46 -70.66 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.485 -0.759 . . . . 0.0 109.637 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -64.43 -28.29 69.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.691 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.57 45.35 6.49 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 86' ' ' LEU . 96.2 mt -83.33 -37.9 22.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.579 -0.953 . . . . 0.0 109.845 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.67 114.4 0.5 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.994 . . . . 0.0 109.613 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.642 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 154.34 1.66 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.361 -0.837 . . . . 0.0 110.563 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -139.66 165.78 26.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.682 -0.636 . . . . 0.0 109.48 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -118.18 126.78 52.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' A' ' 63' ' ' ILE . 73.7 m-85 -109.44 150.15 28.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.584 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.86 117.11 33.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.415 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.624 HG13 HD11 ' A' ' 14' ' ' ILE . 26.6 t -76.22 124.19 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.648 -0.657 . . . . 0.0 109.661 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 9' ' ' THR . 9.2 m -142.5 21.57 2.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.899 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 143.39 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.1 -43.56 70.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.533 -0.73 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -69.04 -35.59 76.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 0.0 109.462 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.73 -164.15 12.97 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' A' ' 55' ' ' ILE . 27.2 mm . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.978 . . . . 0.0 109.307 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.9 mmm180 -59.58 -61.27 8.2 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.958 -1.088 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.9 Cg_endo -69.49 -17.48 38.78 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.296 1.33 . . . . 0.0 110.669 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.1 -25.95 52.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.483 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.7 m -82.98 -29.92 28.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.25 -41.85 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.669 0.747 . . . . 0.0 109.162 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' A' ' 44' ' ' LEU . 97.2 mt -71.97 -47.02 55.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.978 -0.451 . . . . 0.0 110.587 -179.131 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.2 p -59.07 -28.92 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -44.22 70.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.648 -0.657 . . . . 0.0 110.011 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -66.67 -59.68 3.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.484 -0.76 . . . . 0.0 110.013 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -57.61 -22.14 43.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 110.499 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.2 t -59.13 -40.91 86.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.277 -0.89 . . . . 0.0 109.719 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -69.05 -26.62 65.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.73 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.684 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 94.1 m-85 -89.82 121.6 32.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.64 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.36 -18.84 63.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.691 -0.631 . . . . 0.0 110.089 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.8 148.46 25.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.212 -0.93 . . . . 0.0 109.848 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -89.78 92.05 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.728 HG12 ' CB ' ' A' ' 65' ' ' ALA . 17.0 m -91.69 120.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -117.7 134.22 55.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.972 HD11 HD12 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -89.5 145.59 25.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.05 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.38 129.11 55.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.397 -0.815 . . . . 0.0 110.084 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.487 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 54.1 t80 -160.33 141.42 12.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.533 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.487 ' ND2' ' CE2' ' A' ' 37' ' ' TYR . 4.0 m-80 61.79 33.78 17.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.722 . . . . 0.0 109.741 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.76 30.16 74.19 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -125.32 175.29 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.626 -0.926 . . . . 0.0 108.989 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.5 m -148.65 101.2 3.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.11 146.49 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.644 -0.66 . . . . 0.0 109.227 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -70.22 140.82 52.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -62.85 -15.51 54.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.203 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -88.26 49.68 1.84 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.986 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 50' ' ' VAL . 7.0 t -150.07 90.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.696 HG23 ' HB3' ' A' ' 19' ' ' ALA . 32.1 mt -71.43 -45.48 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.824 -0.548 . . . . 0.0 109.773 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ttt -66.17 -27.22 67.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.771 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.91 -37.15 51.04 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 46' ' ' SER . 41.5 t -65.56 -35.8 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.516 -0.991 . . . . 0.0 109.45 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.72 -29.3 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.493 -0.754 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.0 p -62.76 -33.09 74.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.566 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mp -74.55 -55.01 6.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.489 -0.757 . . . . 0.0 109.277 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.03 64.99 2.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.628 HD12 ' HB ' ' A' ' 14' ' ' ILE . 15.2 mt -74.5 162.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.97 . . . . 0.0 109.165 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -136.33 -172.04 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.579 -0.7 . . . . 0.0 109.746 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 142.92 38.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.58 8.03 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.94 166.91 17.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.961 . . . . 0.0 109.434 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.25 123.03 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.677 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.972 HD12 HD11 ' A' ' 35' ' ' LEU . 29.9 pt -113.87 138.68 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.551 -0.718 . . . . 0.0 109.366 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.09 108.73 19.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.762 . . . . 0.0 109.692 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.716 HG12 HD12 ' A' ' 35' ' ' LEU . 86.7 mt -93.27 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -150.08 106.45 3.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.638 -0.664 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.728 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.99 124.99 35.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 108.93 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.439 -0.788 . . . . 0.0 109.831 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -142.44 6.37 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.53 -63.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.991 . . . . 0.0 109.381 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -97.63 41.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.662 -0.648 . . . . 0.0 109.334 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -49.15 78.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.659 -0.65 . . . . 0.0 110.794 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.519 ' HA ' HD21 ' A' ' 74' ' ' LEU . 19.2 m-20 -60.89 -36.4 79.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.156 -0.965 . . . . 0.0 109.983 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.3 -22.88 60.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.587 -0.696 . . . . 0.0 110.651 -179.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.748 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.04 -48.04 13.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.925 . . . . 0.0 110.852 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.742 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -60.65 -45.05 95.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.304 -0.872 . . . . 0.0 110.857 -178.529 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.742 ' N ' HD12 ' A' ' 74' ' ' LEU . 21.1 p-10 -68.87 -27.34 65.72 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.684 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -63.75 -54.7 31.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 108.758 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.05 -28.72 70.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.643 -0.661 . . . . 0.0 109.783 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -62.31 -53.99 47.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -60.31 -27.9 67.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.813 . . . . 0.0 109.922 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -71.54 -33.79 69.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.4 mmm -71.66 -31.82 67.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -82.12 -21.37 36.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 110.155 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.0 p -59.54 -40.28 86.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.972 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -111.76 -50.74 2.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.575 -0.703 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.03 54.29 0.19 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 86' ' ' LEU . 84.6 mt -85.56 -63.6 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.595 -0.944 . . . . 0.0 109.608 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 118.82 1.14 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -178.97 153.52 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -151.88 139.39 19.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.615 -0.678 . . . . 0.0 109.848 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 m -89.92 121.15 31.77 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.72 ' CD1' HD12 ' A' ' 63' ' ' ILE . 71.6 m-85 -103.71 152.29 21.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.65 . . . . 0.0 109.694 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -100.71 131.25 46.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 55' ' ' ILE . 17.2 t -90.04 114.49 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.74 . . . . 0.0 109.632 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -135.42 21.18 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.595 -0.691 . . . . 0.0 109.857 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.22 32.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.545 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -69.8 -50.53 42.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -73.45 -30.31 63.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -152.62 18.86 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.764 ' HB ' HD12 ' A' ' 55' ' ' ILE . 17.7 mm -109.52 58.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.98 . . . . 0.0 109.143 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.418 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.62 76.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.873 -1.142 . . . . 0.0 112.563 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.18 -54.18 44.26 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 120.919 -1.113 . . . . 0.0 111.347 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.0 Cg_endo -72.56 -25.61 17.52 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 121.36 1.373 . . . . 0.0 110.313 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -71.45 -21.39 61.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.558 -0.714 . . . . 0.0 109.332 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -85.02 -31.23 23.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 17' ' ' ARG . 17.1 t -71.29 -37.64 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.664 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.0 mt -75.01 -50.4 16.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.009 -0.432 . . . . 0.0 110.299 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.768 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.7 p -53.91 -29.12 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.241 -0.912 . . . . 0.0 109.95 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -73.6 -39.85 64.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.704 . . . . 0.0 109.472 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -68.49 -66.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -54.71 -23.25 16.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.52 -0.737 . . . . 0.0 110.47 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -45.0 92.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.809 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -62.7 -28.62 70.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.661 . . . . 0.0 109.479 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.95 129.17 36.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 -16.93 59.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.703 -0.623 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 150.96 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.21 -0.931 . . . . 0.0 109.91 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.01 83.38 6.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.696 -0.628 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.758 HG12 ' CB ' ' A' ' 65' ' ' ALA . 22.1 m -89.67 123.53 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.41 146.22 48.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 110.036 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.73 HD11 HD12 ' A' ' 61' ' ' ILE . 2.9 tt -96.31 157.09 16.06 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.519 ' N ' HD23 ' A' ' 35' ' ' LEU . 2.6 tt0 -124.09 134.21 53.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.615 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 67.2 t80 -160.17 129.33 5.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.0 109.785 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.34 30.89 20.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.631 -0.668 . . . . 0.0 109.975 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.26 30.46 71.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.38 116.46 17.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.954 . . . . 0.0 109.296 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -96.13 107.86 20.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.612 -0.68 . . . . 0.0 109.96 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.7 148.06 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -65.23 132.75 49.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.861 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.3 tm? -52.05 -26.78 11.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.768 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.92 53.83 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -143.47 84.78 1.82 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.686 HD11 HG11 ' A' ' 23' ' ' VAL . 26.8 mt -67.88 -40.11 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 tpt -76.52 -26.12 54.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.568 -0.708 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.03 -31.98 57.12 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 46' ' ' SER . 39.4 t -73.52 -27.8 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.97 . . . . 0.0 109.638 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 47' ' ' ILE . 25.2 t -62.01 -33.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.376 -0.828 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.0 p -63.26 -31.89 73.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.66 -45.51 61.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.86 62.31 5.61 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.764 HD12 ' HB ' ' A' ' 14' ' ' ILE . 54.4 mt -75.74 153.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.985 . . . . 0.0 109.34 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.43 -166.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.0 109.702 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 142.07 34.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.649 -0.657 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 43.61 6.25 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.615 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -137.5 178.98 6.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.961 . . . . 0.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -132.77 153.5 51.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.488 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 35' ' ' LEU . 27.1 pt -141.21 144.33 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.606 -0.684 . . . . 0.0 109.286 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.02 116.71 27.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' CD1' ' A' ' 6' ' ' PHE . 85.8 mt -102.84 151.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 p -150.4 113.34 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.529 -0.732 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.758 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.81 130.48 36.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.4 99.88 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.81 -138.36 3.77 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.96 -74.14 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.975 . . . . 0.0 109.388 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.78 50.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.4 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.31 -31.44 70.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -73.95 -35.93 64.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.39 -0.819 . . . . 0.0 109.835 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 -26.38 63.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.428 -0.795 . . . . 0.0 110.31 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -78.93 -45.03 21.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 111.259 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -60.62 -41.8 95.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.935 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.694 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.97 -25.7 60.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 29' ' ' TYR . . . -64.0 -57.04 10.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.04 -28.44 70.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 109.842 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.24 -55.05 36.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.62 -26.64 65.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.4 m -72.07 -34.9 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -28.51 63.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.744 -0.597 . . . . 0.0 109.474 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -85.21 -23.32 28.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.709 . . . . 0.0 110.107 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -67.3 -50.64 59.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.396 -0.815 . . . . 0.0 109.657 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.49 -42.55 9.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 43.41 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 86' ' ' LEU . 92.4 mt -81.84 -31.33 31.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.981 . . . . 0.0 109.463 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.16 168.88 42.01 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.654 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.05 153.37 48.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 129.09 26.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 109.657 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.869 ' OG1' HG23 ' A' ' 62' ' ' THR . 45.9 m -99.13 136.55 38.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.611 -0.681 . . . . 0.0 109.374 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 63' ' ' ILE . 76.7 m-85 -119.54 174.49 6.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.564 -0.71 . . . . 0.0 109.718 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.6 129.72 54.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.612 -0.68 . . . . 0.0 109.217 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HD11 ' A' ' 14' ' ' ILE . 21.5 t -89.74 113.34 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.577 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 16.31 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.704 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.14 34.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.289 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -62.1 -49.92 73.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -69.12 -28.81 66.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.576 -0.702 . . . . 0.0 109.554 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.35 -152.01 23.11 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 8' ' ' VAL . 61.8 mt -113.76 77.81 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.979 . . . . 0.0 109.394 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.409 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.07 80.5 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.822 -1.174 . . . . 0.0 112.256 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -54.58 -54.96 43.02 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.929 -1.107 . . . . 0.0 111.285 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.64 -22.74 23.82 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.114 1.21 . . . . 0.0 110.347 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.493 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.86 -22.63 59.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.423 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -83.13 -29.75 28.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.256 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.17 -40.16 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 109.178 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 44' ' ' LEU . 96.1 mt -73.25 -43.81 60.48 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.954 -0.467 . . . . 0.0 110.394 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.3 p -61.52 -29.83 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.873 . . . . 0.0 109.479 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -45.42 74.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.556 -0.715 . . . . 0.0 109.753 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -64.3 -60.48 3.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.465 -0.772 . . . . 0.0 109.758 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 45' ' ' LYS . . . -57.8 -20.92 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.608 -0.683 . . . . 0.0 110.624 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -60.45 -40.6 91.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -66.58 -32.11 73.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 109.374 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 71.9 m-85 -90.96 130.34 36.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.2 14.13 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 177.65 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.71 78.21 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.772 HG12 ' HB2' ' A' ' 65' ' ' ALA . 17.5 m -89.39 85.86 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.677 -0.639 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.0 123.71 34.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.738 -0.602 . . . . 0.0 109.956 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 63' ' ' ILE . 42.0 tp -91.51 133.57 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -119.42 129.53 54.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.627 -0.671 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.755 ' HB3' HD22 ' A' ' 53' ' ' LEU . 16.2 t80 -116.4 74.16 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 109.834 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 48.3 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.574 -0.704 . . . . 0.0 111.409 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.95 -37.72 3.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB3' HD21 ' A' ' 53' ' ' LEU . 12.5 mmtt -89.64 161.56 16.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -1.061 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 m -150.1 75.93 1.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.613 -0.679 . . . . 0.0 109.708 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.764 ' CG2' HD11 ' A' ' 53' ' ' LEU . 3.6 m -92.52 145.14 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -71.87 141.79 49.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 22' ' ' LEU . 1.6 tm? -54.9 -27.62 44.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.408 -0.808 . . . . 0.0 109.168 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.71 56.1 3.17 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -150.21 89.87 1.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 19' ' ' ALA . 21.0 mt -66.43 -37.15 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.796 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 ttm -75.28 -24.93 57.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.69 -0.631 . . . . 0.0 109.906 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.12 44.68 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 46' ' ' SER . 53.1 t -68.33 -43.94 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.997 . . . . 0.0 109.209 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.59 -29.33 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 p -70.96 -26.27 63.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.802 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.764 HD11 ' CG2' ' A' ' 42' ' ' VAL . 61.5 mt -59.67 -33.88 72.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.466 -0.771 . . . . 0.0 109.958 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.03 38.41 35.45 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 56' ' ' ALA . 34.6 mt -75.45 163.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.968 . . . . 0.0 109.123 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.478 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -148.56 -162.38 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.99 68.83 10.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.63 63.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.474 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -141.88 -175.72 4.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.884 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -132.32 132.52 43.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.583 ' HB ' HD11 ' A' ' 35' ' ' LEU . 22.9 pt -122.53 151.1 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.545 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.869 HG23 ' OG1' ' A' ' 5' ' ' THR . 7.3 m -139.95 108.43 5.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.8 mp -91.43 161.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.582 -0.699 . . . . 0.0 109.85 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 63' ' ' ILE . 9.7 p -150.62 105.95 3.36 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.772 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -90.88 135.14 33.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.96 92.42 1.72 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -0.778 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.27 129.14 1.15 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 55.88 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.677 -0.896 . . . . 0.0 111.031 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -122.81 64.13 0.97 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 110.003 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.654 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 14.5 pt-20 -57.84 -35.24 70.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 110.342 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 -32.94 73.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.73 -25.31 53.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.453 -0.779 . . . . 0.0 110.457 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.792 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.93 -40.8 23.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.814 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -66.35 -42.21 88.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 0.0 110.451 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.709 ' N ' HD12 ' A' ' 74' ' ' LEU . 22.2 p-10 -75.09 -22.99 57.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.385 -0.822 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -65.81 -58.68 5.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.091 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.792 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -69.74 -25.15 63.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -0.772 . . . . 0.0 110.064 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HA ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -62.81 -59.57 4.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.311 -0.868 . . . . 0.0 109.965 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -60.17 -28.97 68.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 109.774 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -66.46 -35.58 80.63 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.713 -0.617 . . . . 0.0 109.641 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -85.33 -21.59 28.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 110.283 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.8 p -70.66 -52.59 20.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.79 -29.07 22.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.726 . . . . 0.0 109.549 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.18 5.56 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 86' ' ' LEU . 74.0 mt -81.58 -44.72 16.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.644 -0.915 . . . . 0.0 109.53 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.47 141.92 7.19 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.399 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.17 153.57 25.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -140.09 164.91 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.569 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -112.12 128.78 56.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.608 -0.682 . . . . 0.0 109.329 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 63' ' ' ILE . 78.0 m-85 -117.53 150.19 39.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.418 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.72 129.49 51.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 59' ' ' ALA . 21.5 t -90.78 118.46 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.731 -0.606 . . . . 0.0 109.554 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 9' ' ' THR . 19.5 m -140.24 24.81 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 109.755 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.28 34.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.457 -0.777 . . . . 0.0 109.47 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.16 -45.53 69.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.605 -0.685 . . . . 0.0 109.499 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -76.02 -31.66 59.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.618 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.25 -148.17 17.96 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.563 HD12 HG21 ' A' ' 55' ' ' ILE . 59.9 mt -113.66 79.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.989 . . . . 0.0 109.498 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.717 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.717 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -57.29 -42.58 81.99 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.161 -0.962 . . . . 0.0 112.943 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIP . 1.9 ttt85 -56.52 -57.16 25.13 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.744 -1.223 . . . . 0.0 111.082 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -70.11 -17.81 35.74 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.076 1.184 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.646 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -80.65 -21.98 40.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.539 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 2.6 m -83.41 -31.32 26.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.58 -39.23 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.799 0.809 . . . . 0.0 108.933 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.5 mt -72.95 -49.78 27.33 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.539 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.3 p -57.74 -29.44 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.87 -43.09 72.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.465 -0.772 . . . . 0.0 109.835 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -66.48 -59.84 3.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.934 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -59.62 -23.62 63.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.542 -0.724 . . . . 0.0 110.373 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 t -61.73 -37.53 84.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.372 -0.83 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.34 -20.67 60.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.719 -0.613 . . . . 0.0 110.169 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.54 128.02 35.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.27 -0.893 . . . . 0.0 109.597 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -70.13 -24.93 63.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.646 . . . . 0.0 109.711 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.8 39.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.803 . . . . 0.0 109.852 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.72 95.57 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.672 -0.642 . . . . 0.0 109.565 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.628 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.8 m -89.85 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -132.6 130.59 40.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.29 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 36' ' ' GLU . 2.5 tt -89.83 139.11 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.709 ' N ' HD23 ' A' ' 35' ' ' LEU . 7.0 tt0 -113.96 113.97 25.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 109.842 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.702 ' CE1' HG23 ' A' ' 55' ' ' ILE . 13.6 t80 -95.47 68.02 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.511 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m120 48.13 85.07 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.551 -0.718 . . . . 0.0 111.178 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.12 -39.82 2.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -89.53 159.01 17.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.398 -1.06 . . . . 0.0 109.37 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -150.18 91.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.585 -0.697 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -65.48 146.08 55.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.618 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -65.54 -12.06 49.44 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.823 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -88.47 48.73 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 50' ' ' VAL . 46.7 t -150.14 95.54 2.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.828 . . . . 0.0 109.164 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 19' ' ' ALA . 28.8 mt -77.12 -40.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 109.589 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.65 -29.1 63.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.52 -29.43 67.96 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 46' ' ' SER . 43.8 t -73.65 -43.47 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -1.046 . . . . 0.0 109.452 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.42 -29.81 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.618 -0.676 . . . . 0.0 109.588 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.8 p -66.57 -30.65 71.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.67 -51.32 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.37 50.33 2.41 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.702 HG23 ' CE1' ' A' ' 37' ' ' TYR . 55.2 mt -77.0 159.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.59 -0.947 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -147.82 179.38 7.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.852 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -61.84 147.17 47.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.529 -0.732 . . . . 0.0 109.78 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 64.07 2.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -150.37 125.11 9.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.991 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.04 124.58 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.709 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' HB ' HD21 ' A' ' 35' ' ' LEU . 32.3 pt -112.48 160.85 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.249 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 m -136.0 111.5 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.645 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 6' ' ' PHE . 90.2 mt -91.9 160.28 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 63' ' ' ILE . 9.6 p -149.91 101.21 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.104 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.628 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.97 126.87 35.9 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.88 111.4 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 -135.1 2.91 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -57.08 3.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.583 -0.951 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -104.83 45.86 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.571 -0.706 . . . . 0.0 109.302 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.44 -37.01 79.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.571 -0.705 . . . . 0.0 110.191 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 74.7 m-80 -67.77 -37.77 82.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 109.985 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.66 -25.28 62.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 110.138 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -79.87 -42.1 24.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 111.21 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -62.02 -41.59 98.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.68 ' N ' HD12 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -76.17 -23.58 54.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.333 -0.854 . . . . 0.0 109.788 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -63.89 -60.09 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.306 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.91 -28.82 69.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.007 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.31 -52.64 64.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 109.841 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.3 -27.53 69.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -68.89 -31.59 70.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.7 mmt -71.35 -30.8 66.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -86.22 -17.43 34.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 110.316 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 p -73.11 -52.95 12.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -100.9 10.71 40.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.45 99.01 0.01 OUTLIER Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 mt -140.5 -50.71 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.519 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.04 139.36 6.42 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.996 . . . . 0.0 109.522 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.72 152.34 26.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.655 -0.653 . . . . 0.0 109.589 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -142.69 142.7 32.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.566 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 m -95.14 128.58 42.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.687 -0.633 . . . . 0.0 109.373 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.546 ' CD1' HD12 ' A' ' 63' ' ' ILE . 85.4 m-85 -112.88 152.62 29.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.619 -0.676 . . . . 0.0 109.583 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -116.06 116.34 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.623 -0.673 . . . . 0.0 109.203 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.715 HG22 HD11 ' A' ' 14' ' ' ILE . 11.4 t -75.5 118.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -116.63 -15.26 10.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.618 -0.676 . . . . 0.0 110.333 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.18 146.3 39.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.149 -0.97 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -49.76 71.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.657 . . . . 0.0 109.574 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -63.26 -30.96 72.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.86 -138.39 14.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 8' ' ' VAL . 57.1 mt -122.48 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.937 . . . . 0.0 109.541 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.628 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -58.69 -35.64 72.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.153 -0.967 . . . . 0.0 112.264 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HB2' ' NE2' ' A' ' 15' ' ' HIP . 9.8 mtm180 -58.24 -60.13 11.17 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.879 -1.138 . . . . 0.0 110.527 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.669 ' HB3' HD13 ' A' ' 86' ' ' LEU . 32.4 Cg_endo -70.7 -15.94 33.59 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.318 1.345 . . . . 0.0 110.681 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.568 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.56 -25.92 50.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.212 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.417 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -83.54 -30.47 27.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.22 -36.79 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.672 0.748 . . . . 0.0 109.044 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB3' HD21 ' A' ' 44' ' ' LEU . 72.2 mt -75.26 -44.81 43.87 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.999 -0.438 . . . . 0.0 110.366 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.843 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.7 p -60.7 -29.07 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.31 -36.91 63.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -67.33 -60.07 2.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.48 -0.762 . . . . 0.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -59.1 -21.79 59.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.446 -0.784 . . . . 0.0 110.107 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.8 t -57.2 -38.9 74.38 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.285 -0.884 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.98 -30.01 66.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.585 -0.697 . . . . 0.0 109.42 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 77.4 m-85 -92.65 124.97 37.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -82.24 2.8 30.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 110.625 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.2 -179.78 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.544 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.34 80.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 0.0 109.41 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 65' ' ' ALA . 34.8 m -89.61 111.84 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.671 . . . . 0.0 109.248 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -120.64 134.12 55.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.551 -0.718 . . . . 0.0 110.028 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.3 tt -92.35 154.95 18.24 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.647 ' N ' HD23 ' A' ' 35' ' ' LEU . 23.1 tt0 -134.4 129.93 36.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.459 -0.776 . . . . 0.0 109.865 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.435 ' CD2' HG12 ' A' ' 55' ' ' ILE . 39.3 t80 -160.31 132.47 6.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 109.687 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.16 40.71 17.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.737 . . . . 0.0 109.978 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.78 28.09 65.16 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.24 102.79 7.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.582 -0.952 . . . . 0.0 109.129 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 m -93.5 99.85 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.593 -0.692 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.65 146.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -67.79 143.02 56.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 22' ' ' LEU . 7.4 tp -62.99 -14.98 54.54 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.164 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.843 ' HA ' HG23 ' A' ' 23' ' ' VAL . 2.4 mptt -87.67 49.98 1.91 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 50' ' ' VAL . 23.3 t -150.24 99.23 2.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.0 mt -79.39 -39.94 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 109.858 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 ttt -75.75 -17.72 59.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.426 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -90.03 -44.55 4.73 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 46' ' ' SER . 45.0 t -61.32 -29.44 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.444 -1.033 . . . . 0.0 109.788 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' ILE . 40.6 t -75.93 -30.68 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.48 -0.763 . . . . 0.0 109.285 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -62.23 -26.66 68.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 49' ' ' GLY . 1.7 mp -62.06 -52.73 62.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.87 54.74 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.525 HD12 ' HB ' ' A' ' 14' ' ' ILE . 46.7 mt -77.44 157.67 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.539 -0.977 . . . . 0.0 109.337 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.41 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.2 -171.22 3.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.567 -0.708 . . . . 0.0 109.421 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -68.19 144.75 54.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.641 -0.662 . . . . 0.0 109.625 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.79 54.76 7.0 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.14 155.89 48.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.956 . . . . 0.0 109.472 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.37 122.06 43.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.565 -0.71 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.612 HD12 HD11 ' A' ' 35' ' ' LEU . 22.6 pt -118.23 133.23 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -104.65 120.34 41.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.528 -0.732 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.546 HD12 ' CD1' ' A' ' 6' ' ' PHE . 82.3 mt -110.5 148.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.46 112.55 4.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 0.0 110.194 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.877 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -91.14 130.07 37.07 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.89 105.29 5.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.854 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.92 -136.05 3.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.9 -73.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.988 . . . . 0.0 109.659 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -90.31 51.9 2.12 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.682 -0.636 . . . . 0.0 109.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.579 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 10.4 pt-20 -67.66 -28.33 67.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.5 -0.75 . . . . 0.0 109.81 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -77.57 -35.22 53.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 109.561 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 38.6 m-20 -76.8 -20.47 56.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.0 110.107 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.804 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.65 -43.65 18.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.49 -42.91 91.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.349 -0.845 . . . . 0.0 110.547 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.71 ' N ' HD12 ' A' ' 74' ' ' LEU . 44.7 p-10 -75.87 -22.11 56.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -67.25 -57.58 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -64.34 -31.18 72.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.569 -0.707 . . . . 0.0 109.648 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.55 -52.62 64.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.174 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.22 -27.58 69.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 m -69.11 -32.76 72.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -70.83 -31.5 68.24 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -77.89 -27.85 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.727 -0.608 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -77.41 -66.33 0.85 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.75 . . . . 0.0 109.651 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.87 -28.71 69.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.571 -0.706 . . . . 0.0 109.713 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 34.99 15.86 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 18' ' ' PRO . 92.7 mt -81.95 -39.49 23.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.647 -0.914 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.52 30.1 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.548 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.71 152.62 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -143.99 149.33 36.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.623 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 m -99.48 119.01 37.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.448 ' CD1' HD12 ' A' ' 63' ' ' ILE . 68.4 m-85 -98.61 162.15 13.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.675 -0.641 . . . . 0.0 109.336 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 135.0 52.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.345 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.87 107.33 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.596 -0.69 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -122.3 -1.43 9.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.547 -0.721 . . . . 0.0 110.562 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.57 136.42 57.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.131 -0.98 . . . . 0.0 109.577 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.49 -38.97 92.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -72.48 -30.94 64.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.531 -0.731 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -151.59 20.04 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 55' ' ' ILE . 23.8 mm -109.27 82.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.946 . . . . 0.0 109.335 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.54 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -71.69 -32.11 67.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.91 -1.119 . . . . 0.0 112.423 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -60.51 -51.34 80.62 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.752 -1.217 . . . . 0.0 111.291 -178.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -73.08 -23.67 17.99 Favored 'Trans proline' 0 C--N 1.326 -0.637 0 C-N-CA 121.036 1.157 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -72.25 -27.76 62.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.352 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.438 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.2 m -81.83 -29.51 32.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.522 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.696 HG12 HG21 ' A' ' 80' ' ' THR . 29.9 t -71.76 -40.05 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.829 0.823 . . . . 0.0 108.858 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' C ' HD11 ' A' ' 44' ' ' LEU . 95.7 mt -71.43 -51.4 24.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.941 -0.474 . . . . 0.0 110.208 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.8 p -54.79 -27.65 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.38 -0.825 . . . . 0.0 110.037 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -74.12 -37.86 63.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.709 . . . . 0.0 109.959 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -72.8 -62.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -57.71 -20.71 36.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.13 -40.85 91.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -71.06 -22.57 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.624 -0.672 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.4 130.21 35.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 0.0 109.647 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -73.61 -25.96 60.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.676 -0.64 . . . . 0.0 109.754 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 145.26 44.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.448 -0.783 . . . . 0.0 109.639 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.63 97.09 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.608 -0.683 . . . . 0.0 109.602 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CB ' ' A' ' 65' ' ' ALA . 21.4 m -92.56 138.68 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -132.48 142.16 49.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.456 -0.778 . . . . 0.0 110.332 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 61' ' ' ILE . 8.8 tt -102.47 122.61 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.44 150.75 21.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.474 -0.766 . . . . 0.0 110.026 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 55' ' ' ILE . 26.9 t80 -160.38 115.27 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.733 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 64.04 27.1 14.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.673 -0.642 . . . . 0.0 110.285 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.7 -18.13 51.55 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.338 -0.934 . . . . 0.0 110.892 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 112.28 23.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.228 -1.16 . . . . 0.0 109.169 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 m -95.84 114.19 25.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.625 . . . . 0.0 109.842 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.95 147.68 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -70.27 136.39 49.82 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.877 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -55.03 -25.15 28.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.429 -0.795 . . . . 0.0 109.405 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.557 ' HA ' HG23 ' A' ' 23' ' ' VAL . 9.4 mttt -90.28 56.57 3.42 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -150.37 86.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.636 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 15.4 mt -61.28 -60.73 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.739 -0.601 . . . . 0.0 109.723 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 ttp -66.64 -27.2 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.7 74.87 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 46' ' ' SER . 45.8 t -87.93 -32.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -1.067 . . . . 0.0 109.529 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' C ' ' A' ' 15' ' ' HIP . 33.6 t -71.85 -23.8 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.471 -0.768 . . . . 0.0 109.861 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.3 p -59.24 -39.62 83.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 53' ' ' LEU . 4.0 mp -63.82 -34.02 76.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.211 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.07 4.74 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 14' ' ' ILE . 51.3 mt -75.41 153.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.963 . . . . 0.0 109.175 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.19 -179.0 6.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.701 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -62.47 136.08 57.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.756 -0.59 . . . . 0.0 109.652 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.77 56.86 1.69 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.37 -178.52 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.995 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -136.5 159.55 41.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.68 . . . . 0.0 109.277 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 35' ' ' LEU . 21.3 pt -150.22 138.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -115.63 105.66 13.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.695 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.448 HD12 ' CD1' ' A' ' 6' ' ' PHE . 88.8 mt -92.4 148.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 p -150.52 112.92 4.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.631 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.822 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -90.26 134.47 34.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.66 104.66 6.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.7 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.22 -145.21 8.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -59.55 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.92 . . . . 0.0 109.584 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -96.28 42.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.602 -0.686 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.15 -32.81 73.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.707 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -72.04 -50.0 32.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 109.461 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -61.9 -21.81 65.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 0.0 110.339 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -79.03 -51.8 9.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.363 -0.836 . . . . 0.0 111.557 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -56.34 -42.34 77.56 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.006 . . . . 0.0 110.809 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -72.14 -27.08 62.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.0 109.106 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -60.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.378 -0.826 . . . . 0.0 109.148 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.2 mp -60.56 -25.89 66.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 109.86 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.55 -54.45 45.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.961 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -61.79 -27.37 68.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.303 -0.873 . . . . 0.0 109.714 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.696 HG21 HG12 ' A' ' 21' ' ' VAL . 54.2 m -68.66 -34.51 75.82 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mmt -71.58 -31.87 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -91.52 -6.17 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.702 -0.624 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 p -78.09 -50.24 12.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -98.2 -59.52 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.553 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 139.55 69.22 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 86' ' ' LEU . 95.3 mt -109.39 -50.41 3.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.923 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.55 154.24 25.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.445 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 65' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -178.01 151.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.671 -0.643 . . . . 0.0 109.28 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -146.41 148.76 32.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.618 -0.676 . . . . 0.0 109.58 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -89.59 133.12 34.77 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.824 ' CE1' HD12 ' A' ' 63' ' ' ILE . 67.5 m-85 -117.57 148.58 41.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.954 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.72 115.75 29.6 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.849 HG22 HD11 ' A' ' 14' ' ' ILE . 8.9 t -68.86 109.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.687 -0.633 . . . . 0.0 109.402 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -117.03 -8.81 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 110.466 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.53 142.07 57.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.096 -1.003 . . . . 0.0 109.63 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.54 -40.75 97.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -74.83 -30.19 61.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.626 -0.671 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.71 -145.54 17.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.849 HD11 HG22 ' A' ' 8' ' ' VAL . 52.9 mt -114.69 59.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.632 -0.922 . . . . 0.0 109.292 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.424 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.25 -46.0 57.84 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.757 -1.215 . . . . 0.0 112.191 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -50.34 -53.13 48.03 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 120.965 -1.084 . . . . 0.0 111.542 -178.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -73.38 -25.2 15.68 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.389 1.392 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.68 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.83 -18.6 60.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.526 -0.734 . . . . 0.0 109.615 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.428 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -87.03 -32.99 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 108.941 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.57 -35.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HB3' HD21 ' A' ' 44' ' ' LEU . 68.4 mt -76.38 -51.24 12.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.248 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 47' ' ' ILE . 11.4 p -54.8 -27.78 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.32 -0.862 . . . . 0.0 109.976 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -44.81 55.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -62.06 -62.23 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.546 -0.721 . . . . 0.0 109.845 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -55.22 -22.67 18.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.443 -0.786 . . . . 0.0 110.715 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -43.39 90.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.258 -0.901 . . . . 0.0 109.884 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -66.61 -29.32 69.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -90.05 126.9 35.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.487 -0.758 . . . . 0.0 109.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.84 -17.66 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.741 -0.599 . . . . 0.0 110.283 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.87 147.14 29.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.203 -0.936 . . . . 0.0 109.922 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.34 90.59 8.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG12 ' CB ' ' A' ' 65' ' ' ALA . 19.6 m -89.75 128.21 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.98 135.09 52.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.558 -0.714 . . . . 0.0 109.869 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.05 HD11 HD12 ' A' ' 61' ' ' ILE . 1.2 tt -89.72 155.07 19.45 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.12 142.55 51.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.867 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.542 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 59.3 t80 -160.37 128.09 4.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' ND2' ' CE2' ' A' ' 37' ' ' TYR . 9.0 m-80 60.68 36.66 19.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.477 -0.764 . . . . 0.0 110.012 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.62 22.9 78.05 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -116.2 169.28 9.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -1.059 . . . . 0.0 108.89 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 m -145.58 97.58 3.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.76 146.37 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -68.67 146.17 53.23 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 22' ' ' LEU . 6.8 tp -67.0 -10.71 52.59 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HA ' HG23 ' A' ' 23' ' ' VAL . 14.0 mttt -88.55 48.26 1.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.831 -1.168 . . . . 0.0 107.91 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.702 ' O ' HG23 ' A' ' 50' ' ' VAL . 45.2 t -149.54 85.08 1.43 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.847 . . . . 0.0 109.009 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.688 HD11 HG11 ' A' ' 23' ' ' VAL . 39.5 mt -69.06 -39.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.801 -0.562 . . . . 0.0 109.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ttt -73.53 -29.37 62.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.563 -0.71 . . . . 0.0 109.606 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.27 -38.07 81.39 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 46' ' ' SER . 44.0 t -60.67 -27.72 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.995 . . . . 0.0 109.691 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.4 t -83.91 -25.74 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.815 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -60.37 -38.92 85.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.443 -0.786 . . . . 0.0 109.799 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.42 -55.59 15.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.454 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.27 51.93 0.85 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 56' ' ' ALA . 42.9 mt -75.62 162.16 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.562 -0.964 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.9 -163.16 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -78.85 157.0 28.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.712 . . . . 0.0 109.557 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.97 61.03 6.82 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -138.39 173.21 11.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.931 . . . . 0.0 109.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -127.98 141.45 51.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.709 . . . . 0.0 109.208 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.05 HD12 HD11 ' A' ' 35' ' ' LEU . 20.2 pt -141.97 164.12 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.559 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -132.58 117.24 17.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.67 . . . . 0.0 109.836 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.824 HD12 ' CE1' ' A' ' 6' ' ' PHE . 89.6 mt -99.2 152.07 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -150.4 110.16 4.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.508 -0.745 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.759 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -91.35 130.09 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.99 103.19 4.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.453 -0.779 . . . . 0.0 109.98 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.27 -132.31 2.06 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.81 -67.18 0.85 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.963 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 46.53 1.19 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.548 -0.72 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 5.8 pt-20 -63.04 -37.25 86.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.49 -0.756 . . . . 0.0 110.21 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.25 -36.74 77.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -76.64 -20.59 56.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.457 -0.777 . . . . 0.0 110.284 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.776 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.16 -42.8 20.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.49 -41.64 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.438 -0.789 . . . . 0.0 110.047 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.715 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.9 p30 -79.27 -16.9 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.783 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.45 -52.37 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.776 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -65.28 -33.14 75.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.567 -0.708 . . . . 0.0 109.466 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.66 -52.81 63.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.551 -0.718 . . . . 0.0 109.987 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.12 -27.62 65.77 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.133 -0.98 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.2 m -69.86 -37.22 76.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mtt -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -76.15 -26.0 55.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 0.0 109.734 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -82.57 -67.03 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.729 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -66.71 -29.87 69.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.53 -0.731 . . . . 0.0 109.581 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.73 2.93 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.83 -30.37 20.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.654 -0.909 . . . . 0.0 109.743 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.7 146.94 5.91 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.479 -1.012 . . . . 0.0 109.469 -179.925 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -173.74 154.98 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.716 . . . . 0.0 109.543 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.52 139.92 19.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.561 -0.712 . . . . 0.0 109.651 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -89.96 143.15 27.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.205 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 63' ' ' ILE . 27.0 m-85 -125.92 169.76 12.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.7 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.76 135.82 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.582 -0.699 . . . . 0.0 109.332 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.674 HG22 HD11 ' A' ' 14' ' ' ILE . 12.1 t -81.43 112.08 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 109.319 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 m -114.12 -12.08 12.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 141.74 50.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -0.966 . . . . 0.0 109.985 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.71 -43.11 94.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.9 p -74.07 -32.78 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.53 -0.731 . . . . 0.0 109.366 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.54 -139.58 15.38 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.674 HD11 HG22 ' A' ' 8' ' ' VAL . 58.1 mt -122.96 82.33 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.66 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.66 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -54.18 -36.3 63.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.34 -0.85 . . . . 0.0 112.305 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -60.16 -61.31 8.18 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 120.943 -1.098 . . . . 0.0 110.589 -178.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HB3' HD22 ' A' ' 86' ' ' LEU . 31.9 Cg_endo -69.59 -12.36 33.07 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 121.283 1.322 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -81.88 -28.89 32.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.867 . . . . 0.0 109.008 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -78.89 -30.02 44.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 17' ' ' ARG . 11.5 t -68.78 -49.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.809 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.833 ' HB3' HD11 ' A' ' 44' ' ' LEU . 86.8 mt -63.91 -54.69 30.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.9 p -51.6 -28.58 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.307 -0.871 . . . . 0.0 110.506 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.01 -54.59 17.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.525 -0.735 . . . . 0.0 110.245 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 m -59.94 -53.35 58.87 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -0.813 . . . . 0.0 110.411 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.33 62.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.412 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.49 -37.74 79.04 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -71.57 -28.75 64.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.775 -0.578 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 81.7 m-85 -94.58 125.45 39.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.85 9.31 19.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.671 -0.643 . . . . 0.0 110.716 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.8 179.22 1.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.092 -1.005 . . . . 0.0 109.478 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -102.75 76.03 1.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.639 -0.663 . . . . 0.0 109.237 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.839 HG12 ' HB2' ' A' ' 65' ' ' ALA . 29.0 m -89.62 108.91 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -117.09 134.31 54.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.717 HD12 HG12 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -89.47 160.82 16.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -128.43 152.75 47.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.36 87.54 1.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.758 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 61.84 48.65 5.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.565 -0.709 . . . . 0.0 109.681 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.06 -7.47 74.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HB3' HD21 ' A' ' 53' ' ' LEU . 11.3 mmtm -91.09 101.32 14.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -1.204 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.35 98.03 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.558 -0.714 . . . . 0.0 109.746 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.77 148.1 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.7 140.95 56.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.837 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.3 tm? -57.22 -28.95 63.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 0.0 109.132 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.751 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.41 60.52 4.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.823 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -147.67 83.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.583 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 35.6 mt -66.21 -40.55 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.607 . . . . 0.0 109.657 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -77.6 -27.39 51.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.56 -0.713 . . . . 0.0 109.96 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.26 -29.72 63.87 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 46' ' ' SER . 42.9 t -73.52 -31.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -1.011 . . . . 0.0 109.579 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.28 -28.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.6 p -63.41 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 40' ' ' LYS . 24.2 mt -64.31 -72.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.563 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.4 48.93 0.3 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 56' ' ' ALA . 16.5 mt -75.97 162.05 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.981 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -150.06 -177.42 5.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 109.36 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 148.26 52.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.588 -0.695 . . . . 0.0 109.398 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.07 70.94 1.0 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -175.49 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.494 -1.004 . . . . 0.0 109.569 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -131.39 148.49 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 pt -149.8 153.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.621 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -127.75 127.07 42.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.713 . . . . 0.0 109.664 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.717 HG12 HD12 ' A' ' 35' ' ' LEU . 78.0 mt -112.31 148.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 p -150.77 112.11 4.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.839 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.93 134.41 35.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.83 103.3 3.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 0.0 109.661 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.73 -128.71 1.37 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.22 -59.47 2.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -104.44 52.65 0.75 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.533 -0.73 . . . . 0.0 109.637 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 10.0 pt-20 -65.5 -38.75 90.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.49 -0.756 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.98 -37.97 75.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 110.115 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 48.8 m-20 -76.71 -19.42 57.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.825 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -82.0 -43.9 17.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.16 -41.94 94.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.489 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 74' ' ' LEU . 42.1 p-10 -78.08 -20.33 52.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 109.727 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.26 -55.91 9.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.903 . . . . 0.0 108.593 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.825 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -68.87 -29.13 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.498 -0.751 . . . . 0.0 109.782 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -54.58 42.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.397 -0.815 . . . . 0.0 110.192 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.59 -33.54 71.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.807 . . . . 0.0 109.774 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -65.67 -34.06 77.33 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 mmm -71.94 -28.07 63.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.736 -0.603 . . . . 0.0 109.65 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -82.47 -23.8 34.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.591 -0.693 . . . . 0.0 110.177 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -85.85 -31.56 22.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 109.918 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -93.78 -21.8 19.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.725 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.06 33.3 29.75 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 18' ' ' PRO . 83.5 mt -81.94 -60.45 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.946 . . . . 0.0 109.615 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.31 156.04 26.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.423 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -117.14 150.79 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.414 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.936 ' HD2' HD13 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -142.74 142.09 31.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.754 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.5 m -96.51 143.56 27.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -127.21 174.04 9.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.547 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.86 124.39 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.596 -0.69 . . . . 0.0 109.416 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' CG2' HD11 ' A' ' 14' ' ' ILE . 11.1 t -88.32 123.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.382 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.84 10.95 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 110.258 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 147.13 35.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.429 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.19 -31.21 71.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.684 . . . . 0.0 109.584 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -80.68 -30.44 36.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 109.466 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.25 37.01 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.557 HD11 ' CG2' ' A' ' 8' ' ' VAL . 65.8 mt -106.76 80.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.558 -0.966 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.521 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -62.61 -48.21 80.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.175 -0.953 . . . . 0.0 112.734 -177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.439 ' HB2' ' CE1' ' A' ' 15' ' ' HIP . 0.3 OUTLIER -51.48 -54.51 38.29 Favored Pre-proline 0 N--CA 1.508 2.462 0 O-C-N 120.801 -1.187 . . . . 0.0 111.55 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.2 Cg_endo -71.28 -23.2 24.49 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.122 1.214 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.645 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -74.94 -19.97 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.484 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.418 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -84.73 -32.66 23.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 108.815 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.58 -35.37 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.656 0.741 . . . . 0.0 109.039 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HB3' HD21 ' A' ' 44' ' ' LEU . 97.6 mt -76.57 -43.79 37.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.0 -0.437 . . . . 0.0 110.28 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.879 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.7 p -62.63 -28.31 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 109.458 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.77 -48.05 60.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.529 -0.732 . . . . 0.0 109.954 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -62.1 -57.35 11.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.903 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 44' ' ' LEU . . . -57.53 -23.18 48.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.542 -0.724 . . . . 0.0 110.372 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -59.75 -41.1 90.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.667 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -64.62 -32.04 73.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 54.4 m-85 -93.49 131.28 38.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.665 . . . . 0.0 109.397 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -94.29 12.56 26.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.557 -0.715 . . . . 0.0 110.345 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.12 169.43 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -91.03 76.99 6.13 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.929 HG12 ' HB2' ' A' ' 65' ' ' ALA . 19.4 m -89.63 89.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.596 -0.69 . . . . 0.0 109.527 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.87 123.84 42.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 109.7 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.514 HD23 ' C ' ' A' ' 35' ' ' LEU . 10.4 tt -89.51 108.3 19.58 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -89.13 123.72 33.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.703 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.16 72.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 t30 48.45 85.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.513 -0.742 . . . . 0.0 111.32 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 -38.69 3.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.36 159.47 17.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -1.119 . . . . 0.0 109.621 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.78 85.1 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -99.71 145.44 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -76.24 139.87 41.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD23 ' CB ' ' A' ' 26' ' ' ALA . 6.6 tp -58.99 -16.2 16.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.879 ' HA ' HG23 ' A' ' 23' ' ' VAL . 1.2 mptp? -86.92 49.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.774 -1.204 . . . . 0.0 108.197 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.745 ' O ' HG23 ' A' ' 50' ' ' VAL . 41.8 t -151.0 93.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 0.0 109.074 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.645 HG23 ' HB3' ' A' ' 19' ' ' ALA . 22.3 mt -71.11 -39.07 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.624 -0.672 . . . . 0.0 109.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -72.46 -28.52 62.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.585 -0.697 . . . . 0.0 109.614 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.72 -28.62 64.8 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 46' ' ' SER . 45.4 t -74.62 -26.25 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.475 -1.015 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -78.95 -26.98 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -0.791 . . . . 0.0 109.794 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p -68.42 -34.69 76.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 109.564 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 42' ' ' VAL . 16.3 mt -63.38 -45.92 88.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.461 -0.774 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.83 61.59 1.84 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.425 HD12 ' HB ' ' A' ' 14' ' ' ILE . 22.8 mt -88.96 149.17 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.562 -0.964 . . . . 0.0 109.142 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.98 -168.98 3.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.562 -0.711 . . . . 0.0 109.772 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -64.62 130.29 43.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.682 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.16 55.66 2.06 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.36 30.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.61 -0.935 . . . . 0.0 109.577 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -95.08 145.82 24.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.266 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -136.71 152.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 109.522 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 m -127.35 152.53 47.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.409 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.37 143.58 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.449 -0.782 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -147.85 107.84 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.971 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.929 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -90.53 130.97 36.52 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.31 97.1 3.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.88 -131.51 1.47 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.58 -71.23 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.933 . . . . 0.0 109.73 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -99.01 61.38 1.25 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.527 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.67 -27.55 66.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.537 -0.727 . . . . 0.0 109.995 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.94 -35.07 43.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.47 -0.769 . . . . 0.0 109.975 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 36.8 m-20 -73.73 -22.26 59.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.741 . . . . 0.0 110.344 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.814 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.6 -43.67 18.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.936 HD13 ' HD2' ' A' ' 4' ' ' LYS . 4.4 pp -68.7 -39.82 80.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.479 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.0 p30 -79.13 -20.48 48.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 109.795 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -72.73 -56.05 5.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.326 -0.859 . . . . 0.0 108.838 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.1 mt -66.65 -34.19 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.545 -0.722 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.63 -52.73 64.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.94 -26.74 68.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.373 -0.83 . . . . 0.0 109.709 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.5 m -70.22 -32.94 71.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.072 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.46 -27.12 63.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.725 -0.61 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -25.6 26.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 110.148 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 p -66.63 -54.33 24.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.535 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.49 -29.8 22.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.48 -0.763 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 48.99 4.53 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 86' ' ' LEU . 76.6 mt -82.43 -42.66 18.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.979 . . . . 0.0 109.511 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.38 142.87 8.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.497 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.89 153.79 19.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.728 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HD2' HD13 ' A' ' 74' ' ' LEU . 11.2 mtpp -141.8 133.79 27.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -89.98 130.37 36.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.287 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 63' ' ' ILE . 93.5 m-85 -116.02 154.2 30.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.604 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.37 127.82 54.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.635 -0.666 . . . . 0.0 109.235 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.73 114.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -121.12 -5.13 9.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.568 -0.707 . . . . 0.0 110.57 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.66 150.43 40.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.21 -57.46 11.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.467 -0.77 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -65.81 -33.4 75.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.59 -132.8 11.06 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.526 HG22 HG11 ' A' ' 50' ' ' VAL . 62.7 mt -116.24 83.58 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.954 . . . . 0.0 109.387 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.423 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.36 67.18 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.634 -1.291 . . . . 0.0 112.153 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.4 ttt85 -53.75 -53.93 52.09 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.961 -1.087 . . . . 0.0 111.377 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.7 Cg_endo -73.87 -24.66 15.14 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.192 1.262 . . . . 0.0 110.523 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -71.99 -22.42 61.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.413 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.433 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -84.5 -31.95 24.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.007 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 17' ' ' ARG . 15.1 t -69.67 -39.38 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 44' ' ' LEU . 94.5 mt -74.84 -51.84 12.93 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.553 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.793 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -52.33 -28.44 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.252 -0.905 . . . . 0.0 110.149 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -74.84 -42.65 57.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -68.55 -65.62 0.68 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.775 . . . . 0.0 109.935 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.581 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -53.38 -24.64 12.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.473 -0.767 . . . . 0.0 110.581 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.22 -45.97 90.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 109.469 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -63.87 -25.52 68.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.645 -0.66 . . . . 0.0 109.822 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 91.2 m-85 -89.57 124.39 34.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.79 -21.24 65.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.072 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 147.88 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -89.88 88.96 7.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.608 -0.682 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.833 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.4 m -90.8 129.85 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -129.36 140.33 51.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.975 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 61' ' ' ILE . 6.4 tt -92.3 149.09 21.64 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -115.18 141.8 47.53 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.597 ' HD2' HD23 ' A' ' 53' ' ' LEU . 35.2 t80 -160.28 115.82 2.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.0 109.983 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 t30 63.9 23.47 13.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.557 -0.714 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.71 -18.21 51.25 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.788 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -88.97 118.55 28.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -1.172 . . . . 0.0 109.158 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -95.08 117.5 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.709 -0.619 . . . . 0.0 109.886 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.07 147.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 43' ' ' ASN . 1.4 t-20 -68.8 135.45 51.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -53.07 -29.12 28.37 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.369 -0.832 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.793 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -91.25 62.05 4.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -148.92 87.09 1.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 23' ' ' VAL . 39.3 mt -71.45 -38.76 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.733 -0.604 . . . . 0.0 109.873 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.1 ttp -77.7 -27.51 50.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.532 -0.73 . . . . 0.0 109.987 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.16 49.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 46' ' ' SER . 46.6 t -66.35 -33.36 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.471 -1.017 . . . . 0.0 109.759 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 t -75.59 -30.71 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 109.614 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.7 p -63.3 -28.02 69.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.692 . . . . 0.0 109.854 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HD2' ' A' ' 37' ' ' TYR . 5.7 mp -69.15 -76.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.761 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.02 51.79 0.23 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.0 mt -78.93 158.33 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.576 -0.955 . . . . 0.0 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -153.18 -168.15 2.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -73.9 146.44 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.757 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.63 57.32 3.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.14 170.64 15.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.946 . . . . 0.0 109.538 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -126.85 129.93 49.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.594 -0.692 . . . . 0.0 109.469 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 35' ' ' LEU . 24.4 pt -119.88 146.41 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.671 -0.643 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.06 107.33 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.747 . . . . 0.0 109.646 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.702 HD12 ' CE1' ' A' ' 6' ' ' PHE . 75.3 mt -92.54 154.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.282 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -150.12 105.95 3.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.833 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.78 124.34 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.36 107.4 7.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.463 -0.773 . . . . 0.0 109.79 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -138.84 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.25 -64.7 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.965 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.08 42.07 1.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.96 -28.6 67.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -0.75 . . . . 0.0 109.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.21 -35.49 63.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.26 -25.37 59.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.675 . . . . 0.0 110.03 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.789 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.6 -43.67 20.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.397 -0.814 . . . . 0.0 110.689 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.686 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -62.09 -41.62 98.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.327 -0.858 . . . . 0.0 110.69 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.686 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.8 p-10 -74.46 -27.07 60.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.246 -0.909 . . . . 0.0 109.764 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -64.24 -57.67 8.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.805 . . . . 0.0 109.266 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -63.59 -27.35 69.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.493 -0.755 . . . . 0.0 109.876 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.71 -58.01 9.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 109.682 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.85 -26.59 65.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.45 HG21 HG12 ' A' ' 21' ' ' VAL . 29.4 m -71.98 -34.02 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 0.0 109.015 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.6 -29.91 65.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -85.81 -21.19 28.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.69 . . . . 0.0 110.305 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -80.75 -55.07 5.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -73.45 -27.07 61.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.825 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.25 39.79 6.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 18' ' ' PRO . 80.7 mt -81.74 -52.76 6.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.687 -0.89 . . . . 0.0 109.651 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.24 145.8 12.59 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.593 -0.945 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.775 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.79 158.12 44.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.583 -0.698 . . . . 0.0 109.294 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -142.78 132.73 24.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 61' ' ' ILE . 32.2 m -95.07 139.05 31.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.543 -0.723 . . . . 0.0 109.297 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 63' ' ' ILE . 91.3 m-85 -122.69 162.76 21.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.524 -0.735 . . . . 0.0 109.709 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.76 125.23 50.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 14' ' ' ILE . 9.7 t -77.81 123.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.522 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 9' ' ' THR . 18.2 m -129.92 3.37 4.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.588 -0.695 . . . . 0.0 110.544 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.39 46.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.039 -1.038 . . . . 0.0 109.47 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.18 -37.71 88.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.693 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -80.01 -30.19 39.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.81 -148.6 18.88 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.824 HD11 HG22 ' A' ' 8' ' ' VAL . 58.8 mt -114.42 86.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.945 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.451 ' O1P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' HB3' ' O1P' ' A' ' 15' ' ' HIP . . . -56.57 -37.54 70.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.181 -0.949 . . . . 0.0 112.241 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HB2' ' NE2' ' A' ' 15' ' ' HIP . 0.0 OUTLIER -57.39 -60.66 9.07 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.856 -1.153 . . . . 0.0 110.598 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.8 -15.1 36.79 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.302 1.335 . . . . 0.0 110.787 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -79.71 -24.99 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.1 m -82.99 -29.59 28.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.187 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.36 -40.49 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.669 0.747 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HB3' HD21 ' A' ' 44' ' ' LEU . 95.4 mt -72.09 -46.35 57.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.967 -0.458 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.814 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.0 p -60.03 -29.01 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.791 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.61 -43.57 72.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.475 -0.766 . . . . 0.0 109.975 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -68.04 -60.83 2.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.049 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.607 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -57.2 -23.6 48.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.411 -0.806 . . . . 0.0 110.41 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -59.83 -41.3 91.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -26.39 67.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.743 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 90.8 m-85 -89.66 127.95 36.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.4 -0.813 . . . . 0.0 109.604 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -71.82 -21.62 61.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.806 -0.559 . . . . 0.0 110.075 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 149.1 23.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.67 92.46 9.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.63 -0.669 . . . . 0.0 109.449 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.859 HG12 ' CB ' ' A' ' 65' ' ' ALA . 35.9 m -92.8 102.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 109.195 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.72 137.68 41.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.777 . . . . 0.0 110.096 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.3 tt -90.77 150.56 21.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' N ' HD23 ' A' ' 35' ' ' LEU . 9.0 tt0 -120.72 135.43 55.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.481 -0.762 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.759 ' HB3' HD23 ' A' ' 53' ' ' LEU . 57.9 t80 -160.21 125.9 4.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 64.09 21.44 12.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.523 -0.735 . . . . 0.0 110.519 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.01 55.37 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.908 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -89.07 122.78 32.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -1.187 . . . . 0.0 109.307 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 m -105.22 103.65 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.768 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.7 146.97 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -67.04 143.19 56.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 26' ' ' ALA . 7.0 tp -63.37 -15.09 56.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.056 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.814 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.6 mttm -87.63 48.93 1.71 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.86 -1.15 . . . . 0.0 107.973 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 50' ' ' VAL . 15.0 t -150.61 84.09 1.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 108.992 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.67 HG23 ' HB3' ' A' ' 19' ' ' ALA . 27.7 mt -64.5 -37.89 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.7 ttm -74.39 -30.3 61.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.377 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.66 -35.93 92.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 46' ' ' SER . 42.4 t -68.38 -29.01 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.937 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 t -65.47 -34.48 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.488 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.9 p -63.17 -32.0 73.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' A' ' 37' ' ' TYR . 11.1 mp -70.54 -50.58 36.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.701 . . . . 0.0 109.393 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.84 59.46 3.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.554 HD12 ' HB ' ' A' ' 14' ' ' ILE . 49.0 mt -72.58 162.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -142.6 175.56 9.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.591 -0.693 . . . . 0.0 109.572 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -61.34 152.82 28.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.588 -0.695 . . . . 0.0 109.767 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.04 64.24 3.94 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.33 172.02 13.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.545 -0.973 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -124.76 129.8 51.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 5' ' ' THR . 23.6 pt -128.12 152.16 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.582 -0.699 . . . . 0.0 109.364 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.449 HG23 ' OG1' ' A' ' 5' ' ' THR . 1.3 m -131.67 109.43 10.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.432 HD12 ' CE1' ' A' ' 6' ' ' PHE . 88.1 mt -93.69 155.97 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.219 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -150.09 110.56 4.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.64 -0.662 . . . . 0.0 109.808 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.859 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.69 131.74 35.52 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.03 107.04 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.499 -0.751 . . . . 0.0 109.662 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.5 -133.41 2.4 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.15 -61.99 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.574 -0.957 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -98.39 44.44 1.03 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.686 -0.633 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.775 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 11.9 pt-20 -61.71 -31.29 71.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.707 . . . . 0.0 109.857 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.69 -36.47 70.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.565 -0.709 . . . . 0.0 109.616 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -78.44 -19.55 52.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.306 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.799 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.79 -44.85 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.165 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.79 -41.78 91.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.247 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.6 p30 -77.65 -19.89 54.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 0.0 109.501 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.18 -57.16 5.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.799 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.53 -30.11 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.575 -0.703 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -54.02 51.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.999 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.29 -26.69 66.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 109.888 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.8 m -70.18 -35.82 74.22 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.8 mmm -71.45 -30.48 66.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -83.91 -18.49 37.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.676 . . . . 0.0 110.318 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.2 p -74.81 -52.84 10.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.3 -27.49 24.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.756 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.93 48.71 4.04 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.78 -64.44 1.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.676 -0.896 . . . . 0.0 109.607 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.72 11.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.982 . . . . 0.0 109.518 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.94 153.4 33.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.43 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 7.6 tttp -135.55 140.52 44.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.702 -0.624 . . . . 0.0 109.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 m -96.63 130.49 43.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.591 -0.693 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CD2' HD12 ' A' ' 63' ' ' ILE . 97.2 m-85 -118.0 149.01 41.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.593 -0.692 . . . . 0.0 109.604 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.14 125.89 52.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 14' ' ' ILE . 15.9 t -81.4 119.6 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.598 -0.689 . . . . 0.0 109.593 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -140.49 22.27 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.571 -0.706 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.68 36.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.518 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.09 -41.18 97.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -78.72 -30.89 46.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.613 -0.679 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.18 -143.77 16.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 8' ' ' VAL . 57.0 mt -126.18 82.16 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.703 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.703 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -57.51 -28.44 63.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.253 -0.904 . . . . 0.0 111.974 -177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.7 mmt180 -62.68 -61.35 7.69 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.812 -1.18 . . . . 0.0 109.782 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.07 -13.71 36.92 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.198 1.265 . . . . 0.0 110.509 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -78.0 -30.3 50.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 108.784 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.3 m -79.5 -27.97 41.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.67 . . . . 0.0 109.572 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.79 -48.59 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.747 0.784 . . . . 0.0 109.084 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -65.77 -42.7 90.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 122.004 -0.435 . . . . 0.0 110.614 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.854 HG11 HD11 ' A' ' 47' ' ' ILE . 13.7 p -64.22 -30.46 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -70.92 -29.77 65.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.074 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.53 -58.5 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.508 -0.745 . . . . 0.0 110.434 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -61.6 -27.7 68.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.462 -0.774 . . . . 0.0 110.427 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 p -59.85 -32.77 70.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.354 -0.841 . . . . 0.0 109.708 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -73.39 -29.67 62.77 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.87 127.57 36.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.448 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.34 -2.99 44.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.684 -0.635 . . . . 0.0 110.681 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.14 167.6 3.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.67 82.18 3.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.606 -0.684 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.86 HG12 ' HB2' ' A' ' 65' ' ' ALA . 21.3 m -89.69 100.75 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.353 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -104.54 128.97 52.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.708 . . . . 0.0 109.921 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 35' ' ' LEU . 9.9 tt -89.46 142.95 27.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -117.01 143.03 46.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -139.87 71.19 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.566 -0.709 . . . . 0.0 109.772 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.45 62.69 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.564 -0.71 . . . . 0.0 110.852 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 -29.8 8.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -89.54 88.14 7.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -1.078 . . . . 0.0 109.402 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.2 m -93.04 94.7 9.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.695 -0.628 . . . . 0.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.07 145.83 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -70.08 146.83 50.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.7 tp -65.87 -12.01 51.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 23' ' ' VAL . 1.1 mptt -88.28 48.56 1.66 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.775 -1.203 . . . . 0.0 108.03 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 t -149.93 99.3 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.854 HD11 HG11 ' A' ' 23' ' ' VAL . 42.3 mm -70.47 -59.41 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.731 -0.606 . . . . 0.0 109.464 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.68 -22.19 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.711 -0.618 . . . . 0.0 110.163 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.87 63.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.8 t -68.78 -34.42 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.95 . . . . 0.0 109.616 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.3 t -71.83 -26.5 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.9 p -70.31 -33.93 72.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.473 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.1 -37.4 87.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.281 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.6 5.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 mt -78.44 152.36 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.992 . . . . 0.0 109.097 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.97 -168.58 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.547 -0.721 . . . . 0.0 109.8 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.49 131.93 50.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.672 -0.643 . . . . 0.0 109.704 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.93 55.58 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.41 172.96 12.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.548 -0.971 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -131.99 156.16 46.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.656 . . . . 0.0 109.296 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 pt -149.61 139.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.49 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 m -117.87 109.28 16.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.534 -0.729 . . . . 0.0 109.561 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.571 HD12 ' CD2' ' A' ' 6' ' ' PHE . 81.8 mt -96.85 150.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.589 -0.694 . . . . 0.0 109.401 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.24 109.88 4.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.653 -0.654 . . . . 0.0 109.609 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.86 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -89.73 131.49 35.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.11 101.72 4.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.802 . . . . 0.0 109.76 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.9 -123.67 0.85 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.95 -62.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.949 . . . . 0.0 109.314 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -96.64 51.51 1.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.293 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.413 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -67.91 -27.39 66.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -80.69 -33.15 35.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 41.0 m-20 -77.38 -21.61 52.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.73 . . . . 0.0 110.23 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.802 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.31 -43.21 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.342 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.55 -42.76 91.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.318 -0.864 . . . . 0.0 110.438 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 74' ' ' LEU . 33.3 p-10 -75.9 -21.95 56.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -0.873 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.81 -56.88 7.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -65.96 -30.58 71.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.682 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -53.28 60.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.14 -29.22 69.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -66.73 -35.31 79.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.6 mmm -71.59 -28.21 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -69.99 -47.49 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 109.908 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 p -66.91 -59.12 3.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -59.28 -23.44 62.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.505 -0.747 . . . . 0.0 110.154 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.89 34.97 88.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.92 -44.61 16.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.97 . . . . 0.0 109.616 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -176.19 28.67 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.494 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.731 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -51.46 152.53 2.58 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.378 -0.826 . . . . 0.0 110.501 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -140.91 167.93 21.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 109.517 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -112.4 150.75 30.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.341 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.57 148.58 41.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 121.47 45.4 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.573 ' CG2' HD11 ' A' ' 14' ' ' ILE . 21.4 t -87.02 125.56 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.564 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -143.93 22.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.712 . . . . 0.0 109.861 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 145.29 36.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.488 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.11 -43.18 95.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 0.0 109.674 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -77.44 -29.25 52.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.36 -155.83 24.53 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.757 ' HB ' HD12 ' A' ' 55' ' ' ILE . 61.4 mt -109.02 66.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.537 -0.978 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.409 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.22 84.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.949 -1.095 . . . . 0.0 112.359 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.11 -55.59 29.65 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.853 -1.154 . . . . 0.0 111.196 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.74 -23.32 22.81 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.233 1.288 . . . . 0.0 110.212 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.14 -22.33 61.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 0.0 109.309 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -84.33 -31.64 24.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.074 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.72 -40.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.614 0.721 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.768 ' HB3' HD11 ' A' ' 44' ' ' LEU . 92.3 mt -74.57 -51.77 13.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.008 -0.433 . . . . 0.0 110.357 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.824 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.4 p -51.83 -30.69 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.09 -39.76 63.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.605 -0.684 . . . . 0.0 109.75 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -66.53 -64.43 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.51 -0.743 . . . . 0.0 109.894 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -55.51 -24.28 30.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -61.37 -43.44 98.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.359 -0.838 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -62.96 -26.73 68.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 109.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CG ' ' HB2' ' A' ' 73' ' ' ALA . 93.2 m-85 -89.78 125.16 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.683 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -69.87 -22.97 63.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.81 25.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.373 -0.829 . . . . 0.0 109.858 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.06 95.83 10.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 109.759 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.765 HG12 ' CB ' ' A' ' 65' ' ' ALA . 21.6 m -97.04 120.41 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -116.88 123.92 48.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.554 -0.717 . . . . 0.0 110.326 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.116 HD11 HD12 ' A' ' 61' ' ' ILE . 7.2 tt -90.12 148.65 22.87 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -126.05 158.13 36.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.0 110.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.805 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 18.7 t80 -147.42 105.35 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -81.4 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.77 -0.581 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.87 26.56 1.46 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 114.88 19.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.468 -1.019 . . . . 0.0 109.175 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -89.79 90.07 8.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.586 -0.696 . . . . 0.0 110.025 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.83 148.04 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.43 139.75 36.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.4 tm? -53.54 -27.47 26.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.439 -0.788 . . . . 0.0 109.15 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.824 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.56 57.93 3.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.1 t -148.72 110.14 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 19' ' ' ALA . 24.9 mt -89.37 -42.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.251 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.445 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.2 ttt -79.15 -24.03 43.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.482 -0.761 . . . . 0.0 110.163 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.22 -29.5 53.35 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 46' ' ' SER . 39.5 t -84.3 -42.82 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -1.018 . . . . 0.0 109.742 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 48' ' ' MET . 12.1 p -61.94 -37.43 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -57.4 -29.48 64.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.699 -0.626 . . . . 0.0 110.107 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.41 -53.14 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 0.0 109.348 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.06 58.52 1.67 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.757 HD12 ' HB ' ' A' ' 14' ' ' ILE . 47.0 mt -78.12 162.91 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.647 -0.914 . . . . 0.0 109.211 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -144.95 -161.21 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.827 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 66.2 9.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.88 53.99 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -140.15 168.34 20.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.92 . . . . 0.0 109.554 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -126.14 133.26 51.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.116 HD12 HD11 ' A' ' 35' ' ' LEU . 26.8 pt -124.84 136.75 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.616 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -112.63 112.4 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.539 ' CG1' HD12 ' A' ' 35' ' ' LEU . 91.0 mt -93.71 155.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.644 -0.66 . . . . 0.0 109.343 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -149.45 104.68 3.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.717 -0.615 . . . . 0.0 109.349 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.765 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.56 135.04 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 106.94 4.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.44 -144.24 7.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.2 -73.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.958 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -95.32 45.47 1.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.308 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.42 -43.22 83.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.448 -0.782 . . . . 0.0 110.28 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.575 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.8 m120 -62.35 -37.15 84.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.881 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 7.5 m-20 -67.45 -33.26 74.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.694 -0.629 . . . . 0.0 110.984 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB2' ' CG ' ' A' ' 29' ' ' TYR . . . -73.44 -53.57 10.36 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.319 -0.863 . . . . 0.0 111.615 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -54.6 -45.64 73.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.241 -0.912 . . . . 0.0 111.297 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.74 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -67.1 -27.82 67.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 109.079 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.612 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -62.64 -52.36 63.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.072 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.37 -31.07 72.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 109.84 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.82 -52.2 66.09 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.87 . . . . 0.0 109.996 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.28 -27.62 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.6 m -70.62 -33.88 71.5 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmt -71.54 -31.13 66.69 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -86.24 -17.27 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -60.52 -49.93 75.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 109.81 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.42 -54.88 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.494 -0.754 . . . . 0.0 109.518 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.78 52.45 0.08 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.0 -63.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.562 -0.963 . . . . 0.0 109.566 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.49 134.89 4.7 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.534 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -60.92 153.66 24.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.425 -0.797 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -138.22 165.01 27.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m -115.83 138.21 51.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.693 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 63' ' ' ILE . 75.3 m-85 -125.02 144.85 50.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.718 . . . . 0.0 109.369 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.52 129.99 54.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.505 HG13 HD11 ' A' ' 14' ' ' ILE . 16.8 t -90.5 112.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.429 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -116.69 -14.31 10.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.686 -0.634 . . . . 0.0 110.292 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.94 140.33 56.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.877 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -68.56 -34.66 76.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.654 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -64.96 -28.72 69.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.763 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.15 -157.04 36.56 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.638 ' HB ' HD12 ' A' ' 55' ' ' ILE . 9.1 mm -110.81 89.66 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.974 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.713 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.713 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -59.61 -46.35 89.24 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.305 -0.872 . . . . 0.0 112.912 -177.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.91 -54.98 37.83 Favored Pre-proline 0 N--CA 1.507 2.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.563 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 31.1 Cg_endo -70.11 -23.0 29.68 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.052 1.168 . . . . 0.0 110.283 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.9 -24.14 60.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.746 . . . . 0.0 109.134 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.51 HG23 ' CD1' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -82.45 -28.82 31.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.772 . . . . 0.0 109.158 179.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -70.26 -37.79 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.6 mt -74.97 -50.9 15.12 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.538 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.775 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.0 p -53.49 -28.91 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.5 -37.98 55.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.486 -0.759 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.1 m -71.95 -65.85 0.72 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.425 -0.797 . . . . 0.0 109.784 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -52.27 -27.33 14.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.674 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -61.71 -46.17 90.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -63.24 -21.87 66.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.685 . . . . 0.0 110.003 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 84.9 m-85 -89.53 127.1 35.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.16 -28.19 69.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.66 -0.65 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.39 53.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -89.93 94.38 9.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 0.0 109.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.75 HG12 ' CB ' ' A' ' 65' ' ' ALA . 28.2 m -89.89 135.06 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.64 -0.663 . . . . 0.0 109.248 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -132.08 138.25 48.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 0.0 110.171 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.576 HD11 HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -89.07 156.02 19.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.51 129.52 35.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.37 57.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 55.63 22.63 5.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.86 -41.16 0.61 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -89.96 87.79 7.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.523 -0.986 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 35' ' ' LEU . 25.7 m -91.74 112.6 24.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.05 148.24 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -64.92 138.96 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.0 tm? -54.54 -29.61 51.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.775 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.2 mttt -90.76 61.75 4.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -150.19 87.71 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.79 ' O ' HG23 ' A' ' 51' ' ' VAL . 34.6 mt -70.33 -39.79 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.668 -0.645 . . . . 0.0 109.68 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.78 -28.56 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.22 57.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 46' ' ' SER . 40.5 t -77.45 -33.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.485 -1.009 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 47' ' ' ILE . 40.2 t -69.36 -34.29 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 109.194 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.5 p -63.08 -34.65 78.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.607 -0.683 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 50' ' ' VAL . 12.0 mt -72.89 -38.96 66.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.423 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.47 73.35 0.58 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.638 HD12 ' HB ' ' A' ' 14' ' ' ILE . 23.9 mt -81.78 151.06 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.968 . . . . 0.0 109.161 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.4 172.14 13.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.642 -0.662 . . . . 0.0 109.839 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 159.27 1.43 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.56 40.79 99.08 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.63 121.14 34.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -84.8 132.69 34.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.608 -0.683 . . . . 0.0 109.354 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 35' ' ' LEU . 18.4 pt -127.22 163.44 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 109.383 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 m -140.14 111.4 7.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 64' ' ' SER . 93.2 mt -92.35 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.0 p -150.18 103.03 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.822 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.75 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 121.7 32.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.96 109.88 10.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 109.669 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.35 -150.21 10.8 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.51 -65.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.517 -0.99 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.73 47.5 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.637 -0.664 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -58.65 -41.46 86.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.727 . . . . 0.0 110.139 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -62.26 -30.13 70.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.91 -25.26 58.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.83 -39.97 25.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.816 . . . . 0.0 110.982 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.2 -42.46 93.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 0.0 110.459 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.709 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.7 p-10 -72.08 -28.44 63.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.0 109.187 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.673 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -61.0 -64.08 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.45 -0.781 . . . . 0.0 109.555 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -60.67 -25.54 66.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -0.828 . . . . 0.0 109.872 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -54.56 44.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.437 -0.789 . . . . 0.0 110.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 -28.26 69.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -66.22 -35.78 81.33 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -28.5 64.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.783 -0.573 . . . . 0.0 109.558 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -80.52 -25.19 38.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.782 . . . . 0.0 110.042 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 p -81.53 -63.14 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -0.766 . . . . 0.0 109.786 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.15 -29.11 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 109.731 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.2 6.24 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.77 -34.69 30.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.627 -0.925 . . . . 0.0 109.563 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.16 -179.42 41.83 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.56 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.58 150.58 31.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.045 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -134.64 163.03 30.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.708 -0.62 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 134.75 54.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.733 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -119.91 161.58 20.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.715 . . . . 0.0 109.547 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -120.2 123.68 43.85 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 14' ' ' ILE . 4.1 t -83.66 120.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -131.95 16.19 4.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.738 . . . . 0.0 110.183 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 144.86 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.46 -29.2 70.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -90.0 -30.87 17.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 109.496 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.56 -150.03 19.7 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 55' ' ' ILE . 59.8 mt -112.29 91.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.987 . . . . 0.0 109.424 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.707 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -58.94 -45.12 91.21 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.214 -0.929 . . . . 0.0 112.972 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 9.2 ttp180 -54.17 -55.45 36.58 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.575 ' O ' HD12 ' A' ' 22' ' ' LEU . 31.0 Cg_endo -69.72 -22.17 32.64 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 120.922 1.081 . . . . 0.0 110.443 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -75.46 -21.66 57.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.259 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.3 m -82.12 -30.69 31.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.46 -0.775 . . . . 0.0 109.071 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 80' ' ' THR . 15.8 t -70.08 -34.49 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.783 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.2 mt -76.85 -49.1 16.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.02 -0.425 . . . . 0.0 110.5 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.5 p -56.54 -27.26 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -54.13 8.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.441 -0.787 . . . . 0.0 110.328 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -61.16 -60.55 3.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.524 -0.735 . . . . 0.0 110.419 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -55.49 -26.52 43.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.466 -0.771 . . . . 0.0 110.745 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.48 -42.12 99.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.408 -0.807 . . . . 0.0 109.474 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -64.25 -21.03 66.44 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.522 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 69.9 m-85 -89.4 133.88 34.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 0.0 109.696 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -77.32 -22.97 51.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.615 -0.678 . . . . 0.0 110.081 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.54 150.97 17.79 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.61 87.79 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.651 -0.656 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.5 m -90.02 118.16 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -120.25 124.9 46.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.75 142.55 27.64 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -129.98 155.76 45.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -145.8 105.27 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 -81.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.35 26.58 1.85 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -124.26 99.92 6.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.511 -0.994 . . . . 0.0 108.928 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -89.85 87.27 6.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.578 -0.702 . . . . 0.0 109.957 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.53 146.48 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -69.89 142.85 52.93 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.6 tm? -53.95 -28.88 40.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.403 -0.811 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.774 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -90.92 59.45 4.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.858 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.6 t -150.1 89.53 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 23' ' ' VAL . 34.2 mt -71.9 -51.8 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 109.519 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.0 tpt -61.49 -28.59 69.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.748 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.699 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -72.62 -40.53 53.38 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 46' ' ' SER . 41.0 t -64.56 -28.11 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.97 . . . . 0.0 109.601 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 47' ' ' ILE . 42.4 t -74.03 -31.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.8 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.6 p -64.3 -27.29 68.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 49' ' ' GLY . 3.3 mp -75.0 -46.76 32.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.798 . . . . 0.0 109.542 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.32 63.04 2.74 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.59 HD13 HD12 ' A' ' 14' ' ' ILE . 14.3 mt -74.21 162.58 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.922 . . . . 0.0 109.29 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -144.84 -164.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 109.759 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -72.98 135.23 44.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.778 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 45.16 7.43 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.03 161.72 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.598 -0.942 . . . . 0.0 109.408 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -124.5 118.59 26.96 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 151.99 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.744 . . . . 0.0 109.491 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.8 m -136.16 107.87 7.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.58 -0.7 . . . . 0.0 109.483 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 64' ' ' SER . 89.6 mt -92.25 159.28 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.614 -0.679 . . . . 0.0 109.275 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 63' ' ' ILE . 4.9 p -144.98 102.47 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.715 -0.616 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.72 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.88 121.48 32.04 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.75 105.33 6.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.354 -0.841 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.45 -140.68 4.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.67 -53.27 5.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.582 -0.952 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.3 45.59 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 109.418 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.56 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 7.6 pt-20 -66.16 -33.62 76.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 109.94 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.28 -35.29 61.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.448 -0.782 . . . . 0.0 109.839 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.75 -20.75 58.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.464 -0.773 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.821 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.41 -43.14 19.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.267 -0.895 . . . . 0.0 110.477 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.96 -41.7 95.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.324 -0.86 . . . . 0.0 110.694 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.726 ' N ' HD12 ' A' ' 74' ' ' LEU . 26.3 p-10 -74.84 -25.92 59.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -65.59 -60.47 2.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.35 -28.41 69.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 109.771 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.15 -54.95 39.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.12 -29.14 68.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.372 -0.83 . . . . 0.0 109.978 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 21' ' ' VAL . 39.8 m -69.03 -34.2 74.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.566 ' HE3' HD21 ' A' ' 22' ' ' LEU . 26.2 mmt -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.794 -0.567 . . . . 0.0 109.607 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -75.53 -28.6 59.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.783 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.3 p -66.23 -49.76 66.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.696 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -10.83 54.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.585 -0.697 . . . . 0.0 110.46 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.77 94.24 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.85 -62.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.583 -0.951 . . . . 0.0 109.648 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.67 120.76 1.38 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -49.94 155.2 0.94 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 110.771 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.37 162.64 38.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.318 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 6' ' ' PHE . 5.7 m -101.34 165.98 10.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' CD1' HD12 ' A' ' 63' ' ' ILE . 55.2 m-85 -149.52 145.55 26.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.691 . . . . 0.0 109.288 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -107.78 127.27 53.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.556 -0.715 . . . . 0.0 109.073 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 14' ' ' ILE . 19.5 t -90.72 120.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.753 -0.592 . . . . 0.0 109.634 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -134.12 23.5 3.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.702 -0.624 . . . . 0.0 109.929 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 144.12 37.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -56.6 -49.47 74.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.388 -0.82 . . . . 0.0 109.882 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -80.44 -29.5 37.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.371 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.63 -161.39 19.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 8' ' ' VAL . 74.4 mt -99.46 63.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.613 -0.934 . . . . 0.0 109.187 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.421 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.71 -47.8 84.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.052 -1.03 . . . . 0.0 112.608 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HB2' ' NE2' ' A' ' 15' ' ' HIP . 0.0 OUTLIER -50.68 -57.44 13.36 Favored Pre-proline 0 N--CA 1.507 2.405 0 O-C-N 120.829 -1.169 . . . . 0.0 111.184 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.5 Cg_endo -71.94 -18.31 27.97 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.333 1.355 . . . . 0.0 110.532 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -76.78 -21.69 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.787 . . . . 0.0 109.385 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -85.33 -33.87 21.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -72.5 -35.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.699 0.762 . . . . 0.0 109.068 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 44' ' ' LEU . 98.8 mt -77.17 -45.36 26.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.998 -0.439 . . . . 0.0 110.431 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.4 p -60.1 -27.47 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -73.44 -52.56 13.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.5 -0.75 . . . . 0.0 110.468 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.27 -54.39 46.33 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.422 -0.799 . . . . 0.0 110.344 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.68 -25.16 62.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.3 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.6 t -62.55 -38.6 90.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.348 -0.845 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.624 . . . . 0.0 109.931 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' CG ' ' HB2' ' A' ' 73' ' ' ALA . 88.3 m-85 -89.56 125.32 35.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 109.676 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -68.58 -24.73 64.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.874 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.62 144.63 42.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 109.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.67 96.14 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.773 HG12 ' CB ' ' A' ' 65' ' ' ALA . 19.8 m -89.96 131.39 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -122.08 130.61 53.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 110.379 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.718 HD11 ' HB ' ' A' ' 61' ' ' ILE . 19.1 tp -89.91 146.71 24.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.48 126.95 46.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.391 -0.818 . . . . 0.0 109.903 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.842 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 42.0 t80 -160.33 137.65 9.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.61 37.35 19.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.037 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.85 29.5 67.71 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -129.33 113.36 14.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.595 -0.944 . . . . 0.0 109.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.6 m -93.39 91.52 7.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.538 -0.726 . . . . 0.0 109.794 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.514 -0.741 . . . . 0.0 109.065 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -69.4 145.03 53.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 22' ' ' LEU . 7.0 tp -63.38 -13.25 37.49 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 5.3 mttt -87.17 50.51 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.77 -1.206 . . . . 0.0 108.113 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 50' ' ' VAL . 31.0 t -150.24 86.2 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 19' ' ' ALA . 27.7 mt -64.83 -41.36 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.768 -0.582 . . . . 0.0 109.658 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.6 tpt -72.74 -27.23 61.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.526 -0.734 . . . . 0.0 109.762 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -24.13 72.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 46' ' ' SER . 41.2 t -80.67 -31.36 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -1.058 . . . . 0.0 109.574 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 t -75.43 -28.54 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.839 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.2 p -62.08 -27.97 69.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.77 . . . . 0.0 109.776 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.53 -76.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.475 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.89 55.42 0.27 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 59' ' ' ALA . 17.9 mt -73.85 150.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.607 -0.937 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.03 -158.68 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.671 -0.643 . . . . 0.0 109.722 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -86.55 63.57 8.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.6 56.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.842 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -132.52 129.72 39.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.93 . . . . 0.0 109.488 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -84.65 129.45 34.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.718 ' HB ' HD11 ' A' ' 35' ' ' LEU . 23.7 pt -123.21 134.56 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.639 -0.663 . . . . 0.0 109.347 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -105.16 117.07 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 6' ' ' PHE . 86.8 mt -102.14 153.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -149.94 103.35 3.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.658 -0.651 . . . . 0.0 109.597 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.773 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.31 127.97 35.83 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.84 106.6 7.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.88 -145.67 7.17 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.09 -71.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.896 . . . . 0.0 109.594 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -98.91 52.73 0.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.535 -0.728 . . . . 0.0 109.416 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.92 -42.81 90.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.435 -0.79 . . . . 0.0 110.114 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.496 ' HA ' HD21 ' A' ' 74' ' ' LEU . 15.8 m-80 -62.0 -28.58 69.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 0.0 109.85 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -23.53 50.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.433 -0.792 . . . . 0.0 110.454 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.85 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.06 -47.11 14.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -62.26 -45.61 92.53 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.35 -0.844 . . . . 0.0 110.66 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.739 ' N ' HD12 ' A' ' 74' ' ' LEU . 36.4 p-10 -70.81 -25.26 62.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -62.1 -62.72 1.58 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.2 mp -62.76 -22.95 66.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.593 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.93 -52.39 65.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.49 -29.45 70.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -66.24 -33.85 76.68 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mmt -71.75 -28.24 63.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.749 -0.595 . . . . 0.0 109.665 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -86.89 -18.96 29.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 110.47 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -74.22 -67.59 0.6 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.34 -28.56 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.68 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.5 35.46 5.68 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 86' ' ' LEU . 95.6 mt -81.7 -49.7 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.748 -0.854 . . . . 0.0 109.696 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.1 -179.51 36.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.49 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -172.95 153.57 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.628 -0.67 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -144.58 148.16 34.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.679 -0.638 . . . . 0.0 109.632 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 6' ' ' PHE . 32.5 m -92.61 159.08 15.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.712 -0.617 . . . . 0.0 109.438 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.425 ' N ' HG22 ' A' ' 5' ' ' THR . 72.6 m-85 -143.08 172.68 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.171 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -136.68 122.74 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.745 HG22 HD11 ' A' ' 14' ' ' ILE . 19.6 t -75.11 111.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.638 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -16.67 13.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.728 -0.608 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.05 139.88 56.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.24 -0.912 . . . . 0.0 109.841 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.73 -42.71 90.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.1 p -63.09 -29.82 71.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.46 -157.07 24.46 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 8' ' ' VAL . 62.7 mt -107.44 78.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.601 -0.941 . . . . 0.0 109.599 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.619 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -54.24 -41.66 69.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.269 -0.894 . . . . 0.0 112.336 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.42 -60.7 7.67 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 120.852 -1.155 . . . . 0.0 111.001 -178.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.3 Cg_endo -69.7 -14.97 37.06 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.378 1.386 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -80.85 -23.96 38.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -0.831 . . . . 0.0 109.199 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -83.91 -30.04 26.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.192 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -74.31 -36.46 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.625 0.726 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.859 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.0 mt -78.13 -43.86 27.69 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.92 -0.488 . . . . 0.0 110.367 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.6 p -59.8 -29.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 0.0 109.804 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -74.27 -42.49 59.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -65.42 -61.39 2.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.499 -0.751 . . . . 0.0 110.158 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -58.94 -25.38 63.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 0.0 110.303 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.0 t -60.92 -39.02 87.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.279 -0.888 . . . . 0.0 109.155 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -66.95 -27.72 67.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.581 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 98.7 m-85 -89.72 119.53 30.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.723 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -65.61 -15.74 63.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.774 -0.579 . . . . 0.0 110.278 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.51 172.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.82 88.67 2.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.638 . . . . 0.0 109.441 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.922 HG12 ' HB2' ' A' ' 65' ' ' ALA . 28.8 m -89.72 111.19 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.392 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -110.43 133.43 53.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.458 -0.777 . . . . 0.0 109.876 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 61' ' ' ILE . 5.4 tt -90.22 148.63 22.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.68 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.39 107.55 12.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.51 -0.744 . . . . 0.0 109.445 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD1' HG12 ' A' ' 55' ' ' ILE . 15.2 t80 -92.88 71.69 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.441 -0.787 . . . . 0.0 110.003 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.66 85.57 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.656 -0.652 . . . . 0.0 111.592 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 -42.65 2.83 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -89.33 160.39 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.456 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -150.14 105.84 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.775 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.23 148.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 109.165 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.13 132.45 49.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 22' ' ' LEU . 2.0 tm? -50.24 -28.22 7.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.783 ' HA ' HG23 ' A' ' 23' ' ' VAL . 18.7 mttt -90.76 61.18 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.861 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.0 t -150.44 86.79 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.593 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 22.5 mt -63.93 -61.81 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.982 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 ttm -64.35 -21.66 66.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.465 -0.772 . . . . 0.0 110.167 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.57 60.29 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 46' ' ' SER . 46.7 t -82.18 -32.21 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.411 -1.053 . . . . 0.0 109.718 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 47' ' ' ILE . 27.3 t -64.33 -28.4 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.781 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -69.48 -25.65 64.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 0.0 110.022 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 53' ' ' LEU . 4.2 mm? -64.71 -37.12 86.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.486 -0.759 . . . . 0.0 109.592 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.88 38.02 28.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG12 ' CD1' ' A' ' 37' ' ' TYR . 28.3 mt -69.59 144.24 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.54 -0.976 . . . . 0.0 109.264 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.59 -165.76 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.49 42.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.61 72.93 0.58 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.82 170.1 16.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.977 . . . . 0.0 109.602 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.77 143.41 48.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.693 . . . . 0.0 109.236 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 35' ' ' LEU . 14.3 pt -145.79 126.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.539 -0.726 . . . . 0.0 109.524 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -101.64 118.39 36.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.406 HD12 ' CD1' ' A' ' 6' ' ' PHE . 91.0 mt -102.13 151.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -150.25 109.91 4.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.515 -0.74 . . . . 0.0 110.131 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.922 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -89.85 134.98 33.9 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.71 107.67 4.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.77 -127.32 1.36 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.2 -70.07 0.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.973 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -93.14 49.54 1.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.632 -0.668 . . . . 0.0 109.326 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -64.2 -40.9 97.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 0.0 110.039 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -68.48 -43.09 77.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.0 -23.9 65.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 0.0 110.314 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.22 -46.65 15.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.285 -0.885 . . . . 0.0 111.391 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -59.21 -41.74 89.31 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.697 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.88 -26.36 60.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.903 . . . . 0.0 109.221 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -60.27 -61.57 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.78 . . . . 0.0 109.24 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -60.64 -29.25 69.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.404 -0.81 . . . . 0.0 109.793 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.23 -37.73 86.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.487 -0.758 . . . . 0.0 109.919 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 80' ' ' THR . 1.3 pt-20 -72.75 -28.56 62.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.402 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 54.4 m -68.2 -37.6 81.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -27.89 63.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.777 -0.577 . . . . 0.0 109.567 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -86.87 -17.64 32.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 110.453 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -75.04 -52.12 11.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.886 . . . . 0.0 109.806 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.48 -35.1 14.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.653 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 44.81 1.52 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 86' ' ' LEU . 81.6 mt -81.71 -29.33 33.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -1.006 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.15 169.09 41.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.569 -179.859 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.87 153.96 36.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.558 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -142.9 144.64 32.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.678 -0.639 . . . . 0.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -90.15 146.3 24.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.675 -0.641 . . . . 0.0 109.402 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.585 ' CE1' HD12 ' A' ' 63' ' ' ILE . 36.0 m-85 -126.86 161.32 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.576 -0.703 . . . . 0.0 109.561 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.02 133.77 55.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 14' ' ' ILE . 21.1 t -87.25 106.5 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.371 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.463 ' O ' HG22 ' A' ' 9' ' ' THR . 8.2 m -124.48 14.78 8.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 110.177 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 148.67 34.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -54.49 17.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.354 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -66.09 -29.3 69.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.565 -0.709 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.77 -159.31 20.27 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.667 HD11 HG22 ' A' ' 8' ' ' VAL . 62.6 mt -106.74 78.23 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.995 . . . . 0.0 109.362 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.476 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.279 -0.888 . . . . 0.0 112.603 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HB2' ' NE2' ' A' ' 15' ' ' HIP . 0.0 OUTLIER -57.77 -60.34 10.24 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.952 -1.093 . . . . 0.0 110.845 -178.313 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -70.39 -13.54 33.18 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.341 1.36 . . . . 0.0 110.983 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -80.19 -28.65 38.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 108.914 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.604 HG23 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -80.84 -27.25 36.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 17' ' ' ARG . 37.4 t -71.57 -40.84 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 44' ' ' LEU . 55.8 mt -69.25 -53.98 17.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.161 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.2 p -53.14 -28.17 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -71.41 -43.12 67.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.935 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -69.18 -59.64 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.389 -0.819 . . . . 0.0 109.947 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 77' ' ' LEU . . . -57.0 -21.59 31.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.465 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.7 t -58.9 -41.84 88.15 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -65.94 -29.51 69.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.438 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 68.9 m-85 -93.67 128.52 39.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.26 8.94 21.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.87 -178.44 1.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.96 75.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.834 HG12 ' HB2' ' A' ' 65' ' ' ALA . 29.2 m -89.71 124.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 109.395 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -135.03 142.8 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.612 -0.68 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.6 tt -89.62 159.16 17.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.725 ' N ' HD23 ' A' ' 35' ' ' LEU . 7.6 tt0 -127.12 125.67 41.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 73.8 t80 -160.39 145.5 14.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.504 -0.748 . . . . 0.0 109.784 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 61.3 34.82 18.37 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.631 -0.668 . . . . 0.0 110.018 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 29.5 70.21 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -135.33 178.92 6.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.59 -0.947 . . . . 0.0 109.083 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 m -143.74 114.12 7.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.23 147.71 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -68.11 134.74 51.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.3 tm? -53.39 -26.95 21.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.456 -0.778 . . . . 0.0 109.293 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.679 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -90.63 57.07 3.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -146.38 88.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.768 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.6 mt -69.21 -39.23 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 0.0 109.993 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.5 ttm -82.59 -29.5 30.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.755 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.03 -43.15 96.22 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 46' ' ' SER . 40.8 t -67.76 -34.01 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.49 -1.006 . . . . 0.0 109.385 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -66.4 -28.65 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.707 . . . . 0.0 109.561 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -62.03 -34.14 75.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.505 -0.747 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mp -70.83 -46.84 62.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.583 -0.698 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.68 65.57 2.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.604 HD13 HD12 ' A' ' 14' ' ' ILE . 14.5 mt -77.09 162.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.603 -0.939 . . . . 0.0 109.269 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -134.5 -175.06 3.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.655 -0.653 . . . . 0.0 109.618 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 153.23 42.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.598 -0.689 . . . . 0.0 109.496 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.3 55.45 10.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.535 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -132.68 179.49 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.557 -0.967 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -132.82 140.86 48.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.538 HD12 HD11 ' A' ' 35' ' ' LEU . 26.9 pt -138.78 161.3 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.459 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.37 121.58 21.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 109.644 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.585 HD12 ' CE1' ' A' ' 6' ' ' PHE . 90.8 mt -105.01 149.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 p -150.3 112.83 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.834 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.79 134.59 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.01 102.87 3.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.394 -0.816 . . . . 0.0 109.821 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.88 -125.23 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.06 -72.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.956 . . . . 0.0 109.666 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.26 55.84 1.55 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.72 . . . . 0.0 109.385 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.18 -28.26 69.93 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -74.78 -44.4 49.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.44 -0.788 . . . . 0.0 109.946 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.8 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.5 -46.27 14.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.01 -1.056 . . . . 0.0 110.49 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.12 -42.42 96.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.348 -0.845 . . . . 0.0 110.669 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.713 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.7 p-10 -75.77 -22.41 56.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 109.391 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -66.86 -59.13 3.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.339 -0.851 . . . . 0.0 108.707 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -61.69 -28.39 69.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.527 -0.733 . . . . 0.0 109.848 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' OE2' ' CE2' ' A' ' 6' ' ' PHE . 4.8 tt0 -61.18 -56.28 22.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.477 -0.764 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.68 -30.67 70.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -68.56 -32.48 72.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -0.822 . . . . 0.0 108.915 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 30.6 mmm -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -76.0 -22.59 55.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.731 -0.605 . . . . 0.0 110.03 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 p -66.1 -50.04 65.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.399 -0.813 . . . . 0.0 109.675 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -97.84 10.1 41.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.565 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.5 89.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 86' ' ' LEU . 35.3 mt -132.46 -60.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.628 -0.924 . . . . 0.0 109.401 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.22 150.4 22.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -64.6 152.71 41.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -150.44 137.73 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.652 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.4 m -89.85 139.71 30.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.632 -0.667 . . . . 0.0 109.357 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.02 169.5 11.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 109.868 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 137.88 52.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.592 -0.693 . . . . 0.0 109.342 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.634 ' CG2' HG23 ' A' ' 61' ' ' ILE . 21.3 t -90.51 108.09 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.59 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -129.1 22.25 5.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.59 -0.694 . . . . 0.0 109.884 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.68 159.06 29.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.07 -61.75 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.562 -0.711 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -71.04 -29.36 65.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.718 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.18 -139.55 14.98 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.745 ' HB ' HD12 ' A' ' 55' ' ' ILE . 55.4 mt -122.15 73.15 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.597 -0.943 . . . . 0.0 109.391 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.432 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.7 69.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.712 -1.243 . . . . 0.0 112.247 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.99 -54.07 51.15 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.906 -1.121 . . . . 0.0 111.092 -178.506 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -73.13 -21.44 20.44 Favored 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 121.115 1.21 . . . . 0.0 110.293 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -75.43 -21.43 58.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.33 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.52 -31.89 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.129 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.2 -45.21 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.3 mt -68.7 -49.57 57.88 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.8 p -55.93 -29.64 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.83 -36.16 70.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.913 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -72.43 -59.25 2.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.473 -0.767 . . . . 0.0 110.148 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.14 31.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.478 -0.764 . . . . 0.0 110.738 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.1 p -59.94 -42.61 94.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.289 -0.882 . . . . 0.0 109.645 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -28.02 69.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.609 -0.682 . . . . 0.0 109.622 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 78.5 m-85 -94.8 131.48 40.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.429 -0.794 . . . . 0.0 109.633 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.23 -11.46 57.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.668 -0.645 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.3 155.73 8.55 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.039 -1.038 . . . . 0.0 109.82 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.62 82.0 6.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.581 -0.699 . . . . 0.0 109.528 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.755 HG12 ' CB ' ' A' ' 65' ' ' ALA . 33.9 m -89.68 121.97 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -124.5 126.24 45.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 110.105 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.4 tt -89.97 155.45 19.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' N ' HD23 ' A' ' 35' ' ' LEU . 31.0 tt0 -122.16 158.53 29.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 110.053 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.808 ' CE1' HG23 ' A' ' 55' ' ' ILE . 34.3 t80 -145.48 98.46 3.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.04 -81.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.24 26.85 1.56 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -125.24 121.07 33.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.569 -0.96 . . . . 0.0 109.116 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.31 100.85 12.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.539 -0.726 . . . . 0.0 110.057 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.06 147.65 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -71.67 142.21 49.87 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 22' ' ' LEU . 1.6 tm? -58.02 -30.43 66.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.803 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.74 60.8 4.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -149.79 81.23 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.76 ' O ' HG23 ' A' ' 51' ' ' VAL . 37.6 mt -64.81 -38.66 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.697 -0.627 . . . . 0.0 109.662 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.81 -24.34 59.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.546 -0.721 . . . . 0.0 110.04 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 -31.24 46.08 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 46' ' ' SER . 45.7 t -79.92 -38.44 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -1.047 . . . . 0.0 109.485 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -62.9 -30.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.7 p -67.52 -32.64 73.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 50' ' ' VAL . 15.4 mt -74.0 -55.78 5.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.544 -0.722 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.43 63.77 1.69 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.808 HG23 ' CE1' ' A' ' 37' ' ' TYR . 61.8 mt -76.2 159.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.974 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.445 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -142.13 -175.04 4.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.707 -0.621 . . . . 0.0 109.558 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -70.46 146.96 49.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.628 -0.67 . . . . 0.0 109.603 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.42 61.88 2.39 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.33 -178.58 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.582 -0.952 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -128.49 148.48 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.634 HG23 ' CG2' ' A' ' 8' ' ' VAL . 19.3 pt -139.81 154.63 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.76 113.11 11.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.12 155.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.25 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 p -150.22 101.04 2.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.841 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.755 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.76 122.38 32.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.4 104.78 4.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 109.707 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.4 -125.2 0.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.58 -69.74 0.71 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.642 -0.917 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.67 49.17 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.78 -32.41 70.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.475 -0.766 . . . . 0.0 110.023 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.35 -33.18 72.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -77.47 -23.25 50.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 110.051 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.401 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -68.16 -42.12 80.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.698 ' N ' HD12 ' A' ' 74' ' ' LEU . 39.5 p30 -78.39 -18.86 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.31 -58.8 3.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.195 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -71.08 -24.96 62.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.82 -59.11 4.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.91 -28.55 67.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.355 -0.84 . . . . 0.0 109.771 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 40.6 m -67.25 -35.89 80.48 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.33 -28.4 64.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.699 -0.626 . . . . 0.0 109.422 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -83.0 -21.55 33.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.113 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 p -75.08 -53.61 8.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -80.17 -29.1 38.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 109.562 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.57 37.32 7.02 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.02 -37.38 26.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.691 -0.887 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.39 163.06 34.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.415 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.651 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.7 155.74 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.423 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.8 tttt -140.1 141.19 36.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.685 . . . . 0.0 109.645 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 m -99.13 158.99 15.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.2 m-85 -143.87 161.79 37.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -121.6 118.72 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.134 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.59 116.42 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.652 -0.655 . . . . 0.0 109.588 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -117.44 -16.03 10.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.726 -0.608 . . . . 0.0 110.357 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 151.97 36.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.68 -43.53 72.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -64.3 -32.5 74.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.589 -0.694 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.66 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.822 ' HB ' HD12 ' A' ' 55' ' ' ILE . 46.9 mt -132.04 87.72 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.594 -0.944 . . . . 0.0 109.428 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.421 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.65 60.54 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.743 -1.223 . . . . 0.0 111.968 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.4 ttt180 -53.77 -52.98 62.66 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.046 -1.034 . . . . 0.0 111.109 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -74.27 -24.6 14.3 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.137 1.225 . . . . 0.0 110.332 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.36 -20.88 61.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.55 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.515 HG23 ' CD1' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -85.77 -34.16 21.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 108.979 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG12 HG21 ' A' ' 80' ' ' THR . 19.0 t -69.95 -34.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.9 mt -76.38 -51.5 11.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.397 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.8 p -54.17 -27.38 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.292 -0.88 . . . . 0.0 109.918 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.76 -45.63 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.676 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.401 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 21.4 m -61.05 -59.37 5.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 109.822 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.496 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -61.52 -26.43 67.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.041 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -59.86 -33.3 71.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -77.09 -26.32 53.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.619 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.528 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 96.3 m-85 -89.81 123.8 34.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.57 -24.21 67.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.692 -0.63 . . . . 0.0 109.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 141.76 53.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.401 -0.812 . . . . 0.0 109.789 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -89.51 98.56 11.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.587 -0.696 . . . . 0.0 109.235 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.777 HG12 ' CB ' ' A' ' 65' ' ' ALA . 32.1 m -89.96 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.575 -0.703 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -131.96 132.84 43.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -121.27 128.73 52.65 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.477 -0.764 . . . . 0.0 109.903 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.693 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 51.9 t80 -160.49 138.49 9.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.718 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.87 37.08 15.58 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.536 -0.727 . . . . 0.0 109.754 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.76 27.98 64.93 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -123.35 168.98 11.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.943 . . . . 0.0 109.026 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.8 m -142.22 103.52 4.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 109.95 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.83 146.2 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -69.19 142.79 54.2 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -64.05 -13.45 47.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.33 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.764 ' HA ' HG23 ' A' ' 23' ' ' VAL . 27.4 mttt -88.1 48.72 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.85 -1.157 . . . . 0.0 107.984 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 50' ' ' VAL . 21.9 t -150.54 82.36 1.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.0 109.049 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 51' ' ' VAL . 30.1 mt -63.63 -41.31 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.725 -0.61 . . . . 0.0 109.543 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.44 -29.98 66.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.29 -30.06 69.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 46' ' ' SER . 40.6 t -81.56 -31.13 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.97 . . . . 0.0 109.343 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.1 t -70.21 -31.68 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.616 -0.677 . . . . 0.0 109.397 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 p -63.89 -37.2 86.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.38 -46.62 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.605 -0.684 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.55 71.54 1.09 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.822 HD12 ' HB ' ' A' ' 14' ' ' ILE . 59.5 mt -84.36 162.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.624 -0.927 . . . . 0.0 109.389 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.486 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -149.11 -174.14 4.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.602 -0.686 . . . . 0.0 109.617 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.9 150.31 42.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.712 -0.617 . . . . 0.0 109.686 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 62.7 3.14 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -143.63 164.88 29.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.942 . . . . 0.0 109.62 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -126.2 123.04 37.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.601 HD13 HD11 ' A' ' 14' ' ' ILE . 21.9 pt -117.56 130.52 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.687 . . . . 0.0 109.293 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.07 115.27 29.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.52 -0.738 . . . . 0.0 109.804 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 ' CE1' ' A' ' 6' ' ' PHE . 81.6 mt -101.93 149.85 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.581 -0.699 . . . . 0.0 109.183 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 p -147.22 108.89 4.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.637 -0.664 . . . . 0.0 109.675 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.777 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.75 131.16 35.85 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.61 107.18 7.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -145.72 8.16 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -64.4 1.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.943 . . . . 0.0 109.65 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.14 44.34 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 14.3 pt-20 -62.03 -32.21 72.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.35 -33.29 69.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 109.578 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.19 -24.13 54.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.761 . . . . 0.0 110.07 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.795 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.78 -41.51 23.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 110.457 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.22 -41.84 96.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.294 -0.878 . . . . 0.0 110.4 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.713 ' N ' HD12 ' A' ' 74' ' ' LEU . 40.8 p30 -76.54 -21.04 56.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.25 -0.907 . . . . 0.0 109.763 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.444 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -67.78 -56.49 9.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.747 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.795 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.41 -28.24 69.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -54.31 47.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.462 -0.774 . . . . 0.0 109.66 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.68 -27.48 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.643 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.462 HG21 HG12 ' A' ' 21' ' ' VAL . 1.6 m -67.9 -33.89 75.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -28.74 64.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.68 -0.638 . . . . 0.0 109.293 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -81.51 -25.29 36.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.602 -0.686 . . . . 0.0 110.116 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 p -72.32 -58.89 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 109.69 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -75.17 -41.23 58.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 109.451 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.6 44.33 1.98 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.77 -38.57 25.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.578 -0.954 . . . . 0.0 109.463 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.57 150.38 14.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.454 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -160.24 155.57 25.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.69 -0.631 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.697 ' HG3' HD13 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -140.06 147.61 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.631 -0.668 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -99.38 146.53 26.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 80.4 m-85 -138.53 162.58 34.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -123.15 138.2 54.71 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.902 HG13 HD11 ' A' ' 14' ' ' ILE . 15.5 t -87.68 118.89 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.729 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -128.36 9.61 6.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 144.13 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.525 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.52 -34.41 74.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 p -71.14 -29.83 65.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.485 -0.759 . . . . 0.0 109.582 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.32 -150.62 19.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.902 HD11 HG13 ' A' ' 8' ' ' VAL . 15.6 mm -114.15 56.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.54 -0.977 . . . . 0.0 109.215 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.42 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.38 65.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.73 -1.231 . . . . 0.0 112.404 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -56.02 -52.59 71.39 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.954 -1.091 . . . . 0.0 111.112 -178.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' HB3' HD22 ' A' ' 86' ' ' LEU . 31.3 Cg_endo -71.84 -25.15 20.4 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.189 1.26 . . . . 0.0 110.497 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -71.09 -26.08 62.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 108.96 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 m -79.21 -30.2 43.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.477 -0.764 . . . . 0.0 109.27 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.67 -48.99 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.107 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB3' HD11 ' A' ' 44' ' ' LEU . 94.7 mt -65.8 -54.38 27.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.843 HG11 HD11 ' A' ' 47' ' ' ILE . 14.4 p -50.85 -30.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.388 -0.82 . . . . 0.0 110.739 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.33 -47.63 63.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.74 . . . . 0.0 110.339 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.525 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 2.8 m -65.96 -56.53 11.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -62.27 -17.78 59.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.442 -0.787 . . . . 0.0 110.437 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -64.66 -29.48 70.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.71 23.72 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.734 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.485 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 65.9 m-85 -131.79 120.14 22.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -22.19 66.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.655 -0.653 . . . . 0.0 109.958 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 147.52 34.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.0 109.818 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.75 89.74 7.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.616 -0.678 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.799 HG12 ' CB ' ' A' ' 65' ' ' ALA . 27.6 m -89.89 138.65 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -133.77 135.47 43.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.786 HD12 HG12 ' A' ' 63' ' ' ILE . 4.8 tp -95.78 131.29 42.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -108.73 119.4 39.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 110.449 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.615 ' CE1' HG23 ' A' ' 55' ' ' ILE . 28.7 t80 -103.82 97.52 7.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 72.37 -81.27 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.828 -0.545 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.04 26.76 2.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -124.52 116.06 21.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -1.014 . . . . 0.0 109.012 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -91.5 104.15 16.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.428 -0.795 . . . . 0.0 110.321 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.25 147.86 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -68.2 140.37 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.1 tm? -57.96 -27.32 63.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.429 -0.795 . . . . 0.0 109.035 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.649 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.8 mttm -90.02 51.5 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.805 . . . . 0.0 109.118 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.679 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.3 t -137.87 91.96 2.63 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.843 HD11 HG11 ' A' ' 23' ' ' VAL . 40.3 mm -68.11 -62.54 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.682 -0.636 . . . . 0.0 109.641 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -66.5 -25.76 66.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 109.91 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.6 -30.13 75.89 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 46' ' ' SER . 41.3 t -88.69 -30.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.513 -0.992 . . . . 0.0 109.442 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -69.05 -29.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.484 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -66.52 -30.41 70.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.717 . . . . 0.0 109.589 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 50' ' ' VAL . 27.1 mt -62.93 -66.43 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.723 . . . . 0.0 109.39 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.71 52.33 0.86 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.615 HG23 ' CE1' ' A' ' 37' ' ' TYR . 38.7 mt -78.5 150.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.548 -0.972 . . . . 0.0 109.041 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.96 -164.28 1.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.573 -0.705 . . . . 0.0 109.804 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -66.64 153.89 41.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 109.703 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.15 57.85 13.96 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -126.1 173.97 8.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.667 -0.902 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -128.37 141.13 51.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.653 ' HB ' HD11 ' A' ' 35' ' ' LEU . 13.1 pt -142.76 126.02 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.54 -0.725 . . . . 0.0 109.373 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 m -106.89 110.07 22.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.532 -0.73 . . . . 0.0 109.828 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.786 HG12 HD12 ' A' ' 35' ' ' LEU . 79.2 mt -94.19 150.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -150.1 109.75 4.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.67 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.799 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.82 132.52 35.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.38 102.67 4.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.362 -0.836 . . . . 0.0 109.748 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.45 -134.38 2.57 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.49 -58.82 2.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.95 . . . . 0.0 109.476 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.13 47.96 1.04 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 16.8 pt-20 -66.9 -40.35 87.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 110.114 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -70.31 -35.64 73.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.897 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.88 -24.18 59.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 110.105 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.815 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.65 -44.07 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.823 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -61.79 -42.8 99.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.293 -0.88 . . . . 0.0 110.635 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.715 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.0 p-10 -72.48 -27.51 62.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 0.0 109.151 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 25' ' ' THR . . . -61.19 -58.36 8.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 109.254 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -65.72 -22.66 66.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -62.71 1.46 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.34 -34.51 73.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.313 -0.867 . . . . 0.0 109.906 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.8 m -63.15 -32.87 74.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.408 -0.807 . . . . 0.0 108.971 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.33 -30.95 66.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -82.02 -19.18 40.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.655 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.7 p -80.66 -45.51 17.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 109.739 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -81.06 -28.74 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.729 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 32.26 8.02 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 18' ' ' PRO . 91.4 mt -81.72 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.665 -0.903 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.19 -173.08 13.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.665 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -107.32 150.12 27.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -142.18 150.78 41.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.7 -0.625 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 m -105.3 151.09 24.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 109.291 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.64 166.03 24.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.493 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -113.1 134.57 54.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.618 -0.676 . . . . 0.0 109.301 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.728 ' CG2' HG23 ' A' ' 61' ' ' ILE . 26.9 t -89.27 99.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 109.564 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -123.37 27.15 7.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 155.2 31.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -65.46 -43.71 89.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.265 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -101.15 21.77 13.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 109.851 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.34 -136.79 47.64 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.464 HG22 HG11 ' A' ' 50' ' ' VAL . 61.3 mt -119.44 88.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.573 -0.957 . . . . 0.0 109.426 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.416 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.65 63.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.75 -1.219 . . . . 0.0 112.044 -178.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.1 -52.46 68.28 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 111.521 -178.398 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -72.89 -23.89 18.29 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.19 1.26 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -75.36 -22.26 57.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 109.526 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.41 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -83.72 -31.19 26.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.225 179.787 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG12 HG21 ' A' ' 80' ' ' THR . 17.6 t -71.53 -42.95 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.722 0.772 . . . . 0.0 108.998 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.78 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.2 mt -70.47 -50.31 39.4 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.463 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.6 p -55.3 -28.88 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -73.01 -36.83 67.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.485 -0.759 . . . . 0.0 109.861 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -73.94 -63.78 1.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.456 -0.777 . . . . 0.0 110.202 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -56.54 -25.08 50.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -61.3 -40.9 95.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -68.36 -26.47 65.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.442 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.1 m-85 -89.85 128.32 36.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.342 -0.849 . . . . 0.0 109.725 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.29 -23.44 62.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.666 -0.646 . . . . 0.0 110.291 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 146.06 26.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.305 -0.872 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 91.05 8.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.538 -0.726 . . . . 0.0 109.263 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.847 HG12 ' CB ' ' A' ' 65' ' ' ALA . 28.9 m -89.91 113.93 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.673 -0.642 . . . . 0.0 109.335 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -105.93 137.25 44.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 tt -100.72 116.27 32.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -89.61 143.21 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.843 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.561 ' CD2' HD23 ' A' ' 53' ' ' LEU . 15.1 t80 -132.38 68.9 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.7 . . . . 0.0 109.547 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.56 62.26 2.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.3 -38.85 2.95 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -89.15 90.88 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -1.031 . . . . 0.0 109.195 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.4 m -95.91 112.55 24.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 110.11 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.1 147.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -65.59 141.81 58.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.5 tm? -56.87 -29.58 63.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 109.139 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.764 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.97 61.02 4.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.854 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -148.78 88.74 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.597 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 34.1 mt -71.72 -40.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.618 -0.676 . . . . 0.0 109.937 -179.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -30.2 45.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 109.691 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.4 92.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 46' ' ' SER . 47.4 t -63.06 -28.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.54 -0.976 . . . . 0.0 109.52 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 47' ' ' ILE . 23.5 t -70.18 -31.3 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 109.401 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -62.89 -41.02 99.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.768 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.561 HD23 ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -63.11 -33.51 75.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 109.431 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.84 23.65 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 37' ' ' TYR . 54.6 mt -75.92 147.46 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.615 -0.933 . . . . 0.0 109.327 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.68 -167.52 1.84 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.52 150.34 32.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.577 -0.702 . . . . 0.0 109.538 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.84 3.7 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 179.97 6.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.941 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.16 136.19 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.728 HG23 ' CG2' ' A' ' 8' ' ' VAL . 31.6 pt -124.38 162.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.668 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 63' ' ' ILE . 21.0 m -136.34 161.26 36.3 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.402 ' N ' HG22 ' A' ' 62' ' ' THR . 30.2 mt -146.26 150.95 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.409 -0.807 . . . . 0.0 109.768 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -150.52 108.13 3.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.67 -0.643 . . . . 0.0 109.578 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.847 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.63 130.43 35.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 109.08 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 102.22 5.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.2 -142.24 5.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.16 -57.96 2.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.588 -0.948 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -96.72 48.3 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.688 . . . . 0.0 109.359 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.665 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 6.4 pt-20 -66.89 -29.08 68.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 109.744 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -77.74 -36.23 51.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.497 -0.752 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 29.9 m-20 -76.16 -20.72 57.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.117 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.769 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.36 -44.26 17.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.906 . . . . 0.0 110.296 -179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.83 -42.45 94.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.466 -0.771 . . . . 0.0 110.285 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.704 ' N ' HD12 ' A' ' 74' ' ' LEU . 23.8 p30 -78.55 -19.8 52.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.462 -0.774 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.76 -54.32 20.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -66.56 -30.9 71.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.665 -0.647 . . . . 0.0 109.6 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.18 -52.19 66.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.43 -0.794 . . . . 0.0 110.122 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.83 -29.44 70.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.58 HG21 HG12 ' A' ' 21' ' ' VAL . 88.2 m -67.67 -33.26 74.58 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.142 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.8 mtt -67.87 -29.29 68.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -84.64 -23.49 29.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.569 -0.707 . . . . 0.0 110.184 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -73.54 -55.33 6.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -85.06 -27.92 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.524 -0.735 . . . . 0.0 109.679 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.18 1.48 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 86' ' ' LEU . 98.0 mt -106.78 -37.8 6.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.957 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.84 158.34 30.83 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.245 0.545 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -99.91 157.06 16.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.782 . . . . 0.0 109.234 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -146.32 137.78 24.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 m -89.69 159.48 17.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.674 . . . . 0.0 109.244 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CD2' HD12 ' A' ' 63' ' ' ILE . 85.6 m-85 -145.4 143.31 30.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.6 -0.687 . . . . 0.0 109.69 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.57 127.92 46.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.214 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 59' ' ' ALA . 20.5 t -85.96 134.21 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 9' ' ' THR . 6.2 m -149.6 27.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.583 -0.698 . . . . 0.0 109.587 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.58 146.7 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -58.87 5.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.1 p -69.67 -31.31 69.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.687 . . . . 0.0 109.408 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.06 -154.22 16.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.434 ' CB ' HD12 ' A' ' 55' ' ' ILE . 38.7 mm -104.7 85.3 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.973 . . . . 0.0 109.364 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.606 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.606 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -60.77 -40.04 91.03 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.18 -0.95 . . . . 0.0 112.978 -177.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' CE1' ' A' ' 15' ' ' HIP . 1.8 ttp85 -59.06 -55.17 49.1 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.77 -1.206 . . . . 0.0 111.094 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.0 Cg_endo -69.93 -21.51 32.59 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.04 1.16 . . . . 0.0 110.417 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.69 -22.53 50.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 109.272 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.461 ' HA ' HG12 ' A' ' 23' ' ' VAL . 6.5 m -81.13 -29.38 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.81 . . . . 0.0 109.152 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.24 -41.1 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -69.52 -51.78 32.53 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.297 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -57.55 -28.26 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.389 -0.819 . . . . 0.0 109.816 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -69.96 -36.64 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -60.22 2.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.627 -0.67 . . . . 0.0 110.13 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -58.83 -24.83 62.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.473 -0.767 . . . . 0.0 110.359 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 t -60.84 -39.23 88.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -23.21 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.671 -0.643 . . . . 0.0 109.885 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.658 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m-85 -89.46 127.72 35.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -0.865 . . . . 0.0 109.632 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.87 -22.8 62.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.72 -0.612 . . . . 0.0 109.905 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.17 45.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 109.715 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.67 93.9 9.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.56 -0.713 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.733 HG12 ' CB ' ' A' ' 65' ' ' ALA . 18.2 m -89.84 127.72 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -118.91 126.68 52.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 110.486 -178.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.562 HD21 ' HB ' ' A' ' 61' ' ' ILE . 2.3 tt -89.79 133.73 34.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -113.35 130.16 56.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.448 -0.782 . . . . 0.0 110.167 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE2' HG12 ' A' ' 55' ' ' ILE . 35.7 t80 -160.46 136.95 8.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.55 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.28 37.44 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.581 -0.7 . . . . 0.0 109.748 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.96 28.76 66.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -127.17 111.37 13.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.599 -0.942 . . . . 0.0 109.158 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -89.79 87.78 7.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.866 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -97.33 146.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.147 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -73.64 152.44 40.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.5 tp -69.61 -9.04 52.49 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.288 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 11.1 mttt -88.7 48.79 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.764 -1.21 . . . . 0.0 107.991 178.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.665 ' O ' HG23 ' A' ' 50' ' ' VAL . 13.8 t -150.41 95.43 2.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.381 -0.825 . . . . 0.0 109.298 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.665 HG23 ' HB3' ' A' ' 19' ' ' ALA . 29.7 mt -76.97 -38.81 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.677 -0.639 . . . . 0.0 109.557 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpt -74.65 -34.03 62.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.59 99.24 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 46' ' ' SER . 42.7 t -62.11 -28.31 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.98 . . . . 0.0 109.424 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -63.2 -35.06 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 p -63.5 -34.58 78.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.643 -0.66 . . . . 0.0 109.365 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 42' ' ' VAL . 32.9 mt -66.01 -59.02 4.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 109.333 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.2 67.32 1.54 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 56' ' ' ALA . 50.2 mt -81.22 162.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.557 -0.967 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.98 178.57 9.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.572 -0.705 . . . . 0.0 109.463 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -62.02 137.97 58.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.48 39.96 9.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -120.47 179.59 4.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.604 -0.939 . . . . 0.0 109.468 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -137.95 153.2 49.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.678 -0.639 . . . . 0.0 109.365 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.562 ' HB ' HD21 ' A' ' 35' ' ' LEU . 20.7 pt -150.19 132.47 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.88 107.51 18.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.558 -0.714 . . . . 0.0 109.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.499 HD12 ' CD2' ' A' ' 6' ' ' PHE . 82.0 mt -94.11 153.81 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -148.04 107.96 4.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.67 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.733 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 125.92 35.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.526 -0.734 . . . . 0.0 109.06 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.85 107.12 8.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.32 8.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.61 -58.02 3.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 0.0 109.536 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.63 42.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.671 . . . . 0.0 109.361 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.01 -29.24 70.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.588 -0.695 . . . . 0.0 109.798 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -78.15 -33.46 50.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -76.42 -22.15 55.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.721 . . . . 0.0 110.125 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.804 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.54 -42.52 20.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.696 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.08 -42.35 94.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.693 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.696 ' N ' HD12 ' A' ' 74' ' ' LEU . 19.6 p30 -75.06 -22.53 58.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 109.622 -179.682 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.658 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -67.33 -59.5 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 108.745 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -62.83 -28.88 70.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.52 -0.737 . . . . 0.0 109.781 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.33 -55.9 26.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.459 -0.776 . . . . 0.0 109.938 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -58.73 -27.24 64.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 110.038 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -70.91 -36.86 72.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 mmt -71.0 -29.85 65.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.754 -0.591 . . . . 0.0 109.459 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -83.5 -21.75 32.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.575 -0.703 . . . . 0.0 110.229 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -75.2 -70.22 0.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 109.781 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -62.2 -28.22 69.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.713 . . . . 0.0 109.753 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.79 39.91 5.41 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 86' ' ' LEU . 93.7 mt -81.81 -56.12 4.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.552 -0.97 . . . . 0.0 109.373 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.78 176.54 27.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.57 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.29 153.15 20.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.599 -0.688 . . . . 0.0 109.441 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 7.3 tttp -141.71 149.47 40.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 109.374 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -89.92 153.02 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.534 -0.729 . . . . 0.0 109.476 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.563 ' CD1' HD12 ' A' ' 63' ' ' ILE . 76.7 m-85 -142.27 145.49 34.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.624 -0.672 . . . . 0.0 109.398 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.97 126.93 52.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 14' ' ' ILE . 31.2 t -81.61 116.1 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.589 -0.694 . . . . 0.0 109.552 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -134.34 26.37 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 86' ' ' LEU . . . -77.46 164.55 25.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 109.466 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.55 -34.22 73.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.572 -0.705 . . . . 0.0 109.316 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -114.48 24.25 12.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.73 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.65 -139.07 46.77 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.688 HD11 HG22 ' A' ' 8' ' ' VAL . 48.8 mt -121.69 87.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.906 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.426 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.83 65.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.758 -1.214 . . . . 0.0 112.021 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.63 -53.72 59.48 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.961 -1.087 . . . . 0.0 110.829 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -73.88 -21.67 18.34 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.113 1.208 . . . . 0.0 110.456 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.25 -24.03 60.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.258 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.468 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -84.55 -31.12 24.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 109.16 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 17' ' ' ARG . 23.3 t -73.03 -35.48 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.721 0.772 . . . . 0.0 109.047 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' C ' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -77.87 -43.35 30.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.996 -0.44 . . . . 0.0 110.554 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 47' ' ' ILE . 10.7 p -61.72 -27.94 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 109.681 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -72.43 -50.35 26.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.528 -0.733 . . . . 0.0 110.025 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -61.57 -59.07 5.77 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.51 -0.743 . . . . 0.0 109.991 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -58.78 -23.51 60.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -38.98 83.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -29.06 69.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.483 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.638 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 96.5 m-85 -89.65 118.37 29.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.46 -15.68 62.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.657 -0.652 . . . . 0.0 110.243 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.35 29.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.7 86.95 6.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.391 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.712 HG12 ' CB ' ' A' ' 65' ' ' ALA . 16.7 m -89.73 119.98 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -112.12 132.82 54.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.732 . . . . 0.0 109.994 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 36' ' ' GLU . 5.0 tt -89.93 135.12 33.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.661 ' N ' HD23 ' A' ' 35' ' ' LEU . 34.2 tt0 -105.93 140.36 39.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.737 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.626 ' CE1' HG23 ' A' ' 55' ' ' ILE . 27.5 t80 -140.82 84.54 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.667 -0.646 . . . . 0.0 109.532 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.42 52.06 6.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.614 -0.679 . . . . 0.0 110.089 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.86 -12.96 64.17 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.412 -0.899 . . . . 0.0 110.874 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -89.48 86.91 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -1.175 . . . . 0.0 109.348 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 m -91.63 92.97 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.879 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.94 147.5 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.01 142.55 57.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD23 ' HB3' ' A' ' 26' ' ' ALA . 7.2 tp -64.14 -13.75 50.27 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.618 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.22 48.36 1.63 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.186 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 50' ' ' VAL . 16.8 t -150.27 84.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.818 . . . . 0.0 109.139 -179.542 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.667 HD11 HG11 ' A' ' 23' ' ' VAL . 33.1 mt -67.45 -46.31 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 0.0 109.255 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 ttm -64.35 -29.74 70.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.634 -0.667 . . . . 0.0 109.36 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.07 91.88 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 46' ' ' SER . 21.8 t -70.49 -39.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.972 . . . . 0.0 109.286 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 47' ' ' ILE . 33.7 t -64.11 -30.63 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -68.14 -31.6 71.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.637 -0.664 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.91 -67.58 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.79 47.8 1.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 37' ' ' TYR . 15.5 mt -63.73 157.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.953 . . . . 0.0 109.122 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -136.01 -170.49 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -84.13 150.66 25.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 109.474 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.02 46.95 14.53 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.33 178.46 6.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.481 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.78 147.75 49.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.679 . . . . 0.0 109.466 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.418 ' HB ' HD21 ' A' ' 35' ' ' LEU . 28.4 pt -142.5 157.36 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -131.37 109.63 10.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 109.639 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.563 HD12 ' CD1' ' A' ' 6' ' ' PHE . 90.0 mt -92.32 152.41 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.729 . . . . 0.0 109.145 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -150.2 109.54 3.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.78 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.712 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 126.64 35.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 103.86 5.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.475 -0.766 . . . . 0.0 109.618 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.54 -130.85 1.8 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.86 -74.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.629 -0.924 . . . . 0.0 109.59 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -90.34 53.0 2.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 16.4 pt-20 -67.8 -30.45 69.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.869 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.27 -37.81 60.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.712 . . . . 0.0 109.797 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.83 -24.88 58.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 110.19 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.784 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.9 -43.18 20.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.832 . . . . 0.0 110.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -62.51 -42.01 99.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.9 p-10 -74.13 -26.93 60.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 -60.77 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.805 . . . . 0.0 109.28 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -61.95 -28.07 69.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 109.969 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -56.61 19.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.919 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.79 -28.28 69.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -67.8 -32.59 73.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -30.78 66.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -81.17 -24.17 37.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.635 -0.666 . . . . 0.0 109.989 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -73.98 -69.33 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.61 -28.79 70.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.45 44.73 5.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 93.3 mt -81.87 -33.82 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.612 -0.934 . . . . 0.0 109.572 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.03 153.45 10.85 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.387 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -91.56 153.48 19.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 10.3 tttm -143.28 150.31 39.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.659 . . . . 0.0 109.631 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -97.16 152.42 18.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 63' ' ' ILE . 96.5 m-85 -142.08 148.2 38.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.627 -0.671 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -110.11 117.61 34.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.712 . . . . 0.0 109.145 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.727 HG22 HD11 ' A' ' 14' ' ' ILE . 15.5 t -74.15 112.97 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.736 -0.602 . . . . 0.0 109.503 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.6 17.62 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.701 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.25 38.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 109.373 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.12 91.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.552 -0.717 . . . . 0.0 109.716 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -75.17 -29.61 60.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.438 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 -166.38 24.87 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 8' ' ' VAL . 62.8 mt -100.59 82.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.567 -0.96 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.656 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.656 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -55.04 -37.74 67.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.235 -0.916 . . . . 0.0 112.285 -177.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -57.88 -60.96 8.36 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.875 -1.141 . . . . 0.0 110.575 -178.594 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.59 -13.67 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.265 1.31 . . . . 0.0 110.786 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -79.91 -26.12 40.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 108.974 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.403 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -82.09 -29.78 31.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -0.755 . . . . 0.0 109.056 179.389 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.38 -43.93 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.1 mt -69.11 -51.6 36.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.465 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.9 p -53.44 -29.54 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -70.75 -40.68 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.411 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 22.7 m -69.52 -63.95 0.97 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.926 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -54.92 -24.91 25.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.468 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 t -60.06 -44.86 94.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 109.328 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -65.45 -28.85 69.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.623 -0.673 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -89.65 129.91 36.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 109.269 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.23 -7.98 58.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.618 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.4 168.93 1.87 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.98 . . . . 0.0 109.707 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.99 87.09 4.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.429 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.926 HG12 ' HB2' ' A' ' 65' ' ' ALA . 19.0 m -95.84 98.64 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -107.11 131.89 53.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 0.0 109.761 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.821 HD11 HD12 ' A' ' 61' ' ' ILE . 8.5 tt -89.99 153.19 20.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.328 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' N ' HD23 ' A' ' 35' ' ' LEU . 9.1 tp10 -126.07 145.25 50.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.759 . . . . 0.0 109.447 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.617 ' HB3' HD23 ' A' ' 53' ' ' LEU . 29.9 t80 -160.29 108.48 1.66 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.531 -0.731 . . . . 0.0 109.835 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.82 50.52 8.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 109.93 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.49 27.98 71.71 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.41 97.92 5.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 109.133 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -91.79 102.02 14.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.557 -0.714 . . . . 0.0 110.062 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.95 147.46 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.87 135.37 52.4 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -53.99 -25.62 21.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.373 -0.829 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.7 mttt -90.61 54.58 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.86 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -145.64 85.22 1.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 19' ' ' ALA . 30.7 mt -67.42 -40.32 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.708 -0.62 . . . . 0.0 110.118 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.4 ttt -74.45 -27.68 60.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.48 -0.762 . . . . 0.0 109.835 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.89 59.14 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 46' ' ' SER . 37.4 t -67.39 -38.58 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -1.017 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -29.17 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.47 -0.768 . . . . 0.0 109.626 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.9 p -65.77 -29.62 70.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 37' ' ' TYR . 9.5 mp -62.49 -56.09 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.561 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.18 43.65 3.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.625 HD13 HD12 ' A' ' 14' ' ' ILE . 42.2 mt -70.88 158.0 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -1.003 . . . . 0.0 109.3 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.94 -164.47 1.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.551 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -66.94 130.14 42.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.586 -0.696 . . . . 0.0 109.568 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.65 79.7 0.94 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -147.97 167.35 25.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.611 -0.934 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.51 119.85 23.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 109.27 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 35' ' ' LEU . 26.5 pt -120.33 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.717 . . . . 0.0 109.556 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -112.25 111.84 23.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.603 -0.685 . . . . 0.0 109.738 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.548 HD12 ' CE2' ' A' ' 6' ' ' PHE . 90.1 mt -92.41 158.75 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 63' ' ' ILE . 5.5 p -150.31 103.13 3.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.926 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.96 123.66 36.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.49 105.77 4.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.56 -124.89 0.93 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.02 -65.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.962 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -97.97 53.83 1.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.18 -29.76 68.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.531 -0.73 . . . . 0.0 109.816 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -76.43 -36.16 58.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.769 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.84 -23.9 58.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.703 . . . . 0.0 110.111 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.85 -43.6 19.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.825 . . . . 0.0 110.722 -179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -63.87 -41.53 97.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.23 -0.919 . . . . 0.0 110.542 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.718 ' N ' HD12 ' A' ' 74' ' ' LEU . 24.5 p-10 -76.81 -22.49 53.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 -179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB1' ' CG2' ' A' ' 25' ' ' THR . . . -68.98 -53.96 17.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.258 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -73.22 -26.34 61.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.513 -0.742 . . . . 0.0 109.995 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -58.47 6.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.416 -0.802 . . . . 0.0 109.76 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -29.11 68.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.449 -0.782 . . . . 0.0 109.702 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.0 m -68.49 -34.22 75.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmm -71.49 -32.25 68.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.636 -0.665 . . . . 0.0 109.455 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -77.28 -27.38 53.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.66 -0.65 . . . . 0.0 109.951 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 p -71.46 -70.66 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.485 -0.759 . . . . 0.0 109.637 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -64.43 -28.29 69.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.691 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.57 45.35 6.49 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 86' ' ' LEU . 96.2 mt -83.33 -37.9 22.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.579 -0.953 . . . . 0.0 109.845 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.67 114.4 0.5 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.994 . . . . 0.0 109.613 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.642 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 154.34 1.66 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.361 -0.837 . . . . 0.0 110.563 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -139.66 165.78 26.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.682 -0.636 . . . . 0.0 109.48 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -118.18 126.78 52.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' A' ' 63' ' ' ILE . 73.7 m-85 -109.44 150.15 28.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.584 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.86 117.11 33.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.415 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.624 HG13 HD11 ' A' ' 14' ' ' ILE . 26.6 t -76.22 124.19 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.648 -0.657 . . . . 0.0 109.661 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 9' ' ' THR . 9.2 m -142.5 21.57 2.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.899 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 143.39 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.1 -43.56 70.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.533 -0.73 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -69.04 -35.59 76.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 0.0 109.462 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.73 -164.15 12.97 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' A' ' 55' ' ' ILE . 27.2 mm -106.94 78.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.978 . . . . 0.0 109.307 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.687 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.687 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -58.95 -30.85 68.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 111.864 -177.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.9 mmm180 -59.58 -61.27 8.2 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.958 -1.088 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.9 Cg_endo -69.49 -17.48 38.78 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.296 1.33 . . . . 0.0 110.669 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.1 -25.95 52.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.483 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.7 m -82.98 -29.92 28.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.25 -41.85 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.669 0.747 . . . . 0.0 109.162 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' A' ' 44' ' ' LEU . 97.2 mt -71.97 -47.02 55.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.978 -0.451 . . . . 0.0 110.587 -179.131 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.2 p -59.07 -28.92 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -44.22 70.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.648 -0.657 . . . . 0.0 110.011 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -66.67 -59.68 3.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.484 -0.76 . . . . 0.0 110.013 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -57.61 -22.14 43.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 110.499 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.2 t -59.13 -40.91 86.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.277 -0.89 . . . . 0.0 109.719 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -69.05 -26.62 65.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.73 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.684 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 94.1 m-85 -89.82 121.6 32.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.64 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.36 -18.84 63.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.691 -0.631 . . . . 0.0 110.089 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.8 148.46 25.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.212 -0.93 . . . . 0.0 109.848 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -89.78 92.05 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.728 HG12 ' CB ' ' A' ' 65' ' ' ALA . 17.0 m -91.69 120.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -117.7 134.22 55.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.972 HD11 HD12 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -89.5 145.59 25.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.05 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.38 129.11 55.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.397 -0.815 . . . . 0.0 110.084 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.487 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 54.1 t80 -160.33 141.42 12.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.533 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.487 ' ND2' ' CE2' ' A' ' 37' ' ' TYR . 4.0 m-80 61.79 33.78 17.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.722 . . . . 0.0 109.741 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.76 30.16 74.19 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -125.32 175.29 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.626 -0.926 . . . . 0.0 108.989 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.5 m -148.65 101.2 3.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.11 146.49 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.644 -0.66 . . . . 0.0 109.227 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -70.22 140.82 52.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -62.85 -15.51 54.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.203 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -88.26 49.68 1.84 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.986 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 50' ' ' VAL . 7.0 t -150.07 90.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.696 HG23 ' HB3' ' A' ' 19' ' ' ALA . 32.1 mt -71.43 -45.48 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.824 -0.548 . . . . 0.0 109.773 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ttt -66.17 -27.22 67.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.771 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.91 -37.15 51.04 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 46' ' ' SER . 41.5 t -65.56 -35.8 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.516 -0.991 . . . . 0.0 109.45 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.72 -29.3 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.493 -0.754 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.0 p -62.76 -33.09 74.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.566 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mp -74.55 -55.01 6.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.489 -0.757 . . . . 0.0 109.277 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.03 64.99 2.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.628 HD12 ' HB ' ' A' ' 14' ' ' ILE . 15.2 mt -74.5 162.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.97 . . . . 0.0 109.165 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -136.33 -172.04 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.579 -0.7 . . . . 0.0 109.746 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 142.92 38.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.58 8.03 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.94 166.91 17.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.961 . . . . 0.0 109.434 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.25 123.03 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.677 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.972 HD12 HD11 ' A' ' 35' ' ' LEU . 29.9 pt -113.87 138.68 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.551 -0.718 . . . . 0.0 109.366 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.09 108.73 19.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.762 . . . . 0.0 109.692 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.716 HG12 HD12 ' A' ' 35' ' ' LEU . 86.7 mt -93.27 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -150.08 106.45 3.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.638 -0.664 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.728 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.99 124.99 35.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 108.93 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.439 -0.788 . . . . 0.0 109.831 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -142.44 6.37 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.53 -63.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.991 . . . . 0.0 109.381 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -97.63 41.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.662 -0.648 . . . . 0.0 109.334 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -49.15 78.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.659 -0.65 . . . . 0.0 110.794 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.519 ' HA ' HD21 ' A' ' 74' ' ' LEU . 19.2 m-20 -60.89 -36.4 79.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.156 -0.965 . . . . 0.0 109.983 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.3 -22.88 60.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.587 -0.696 . . . . 0.0 110.651 -179.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.748 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.04 -48.04 13.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.925 . . . . 0.0 110.852 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.742 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -60.65 -45.05 95.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.304 -0.872 . . . . 0.0 110.857 -178.529 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.742 ' N ' HD12 ' A' ' 74' ' ' LEU . 21.1 p-10 -68.87 -27.34 65.72 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.684 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -63.75 -54.7 31.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 108.758 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.05 -28.72 70.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.643 -0.661 . . . . 0.0 109.783 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -62.31 -53.99 47.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -60.31 -27.9 67.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.813 . . . . 0.0 109.922 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -71.54 -33.79 69.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.4 mmm -71.66 -31.82 67.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -82.12 -21.37 36.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 110.155 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.0 p -59.54 -40.28 86.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.972 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -111.76 -50.74 2.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.575 -0.703 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.03 54.29 0.19 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 86' ' ' LEU . 84.6 mt -85.56 -63.6 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.595 -0.944 . . . . 0.0 109.608 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 118.82 1.14 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.478 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -178.97 153.52 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -151.88 139.39 19.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.615 -0.678 . . . . 0.0 109.848 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 m -89.92 121.15 31.77 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.72 ' CD1' HD12 ' A' ' 63' ' ' ILE . 71.6 m-85 -103.71 152.29 21.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.65 . . . . 0.0 109.694 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -100.71 131.25 46.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 55' ' ' ILE . 17.2 t -90.04 114.49 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.74 . . . . 0.0 109.632 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -135.42 21.18 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.595 -0.691 . . . . 0.0 109.857 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.22 32.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.545 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -69.8 -50.53 42.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -73.45 -30.31 63.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -152.62 18.86 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.764 ' HB ' HD12 ' A' ' 55' ' ' ILE . 17.7 mm . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.98 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.18 -54.18 44.26 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 120.919 -1.113 . . . . 0.0 111.347 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.0 Cg_endo -72.56 -25.61 17.52 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 121.36 1.373 . . . . 0.0 110.313 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -71.45 -21.39 61.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.558 -0.714 . . . . 0.0 109.332 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -85.02 -31.23 23.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 17' ' ' ARG . 17.1 t -71.29 -37.64 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.664 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.0 mt -75.01 -50.4 16.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.009 -0.432 . . . . 0.0 110.299 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.768 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.7 p -53.91 -29.12 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.241 -0.912 . . . . 0.0 109.95 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -73.6 -39.85 64.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.704 . . . . 0.0 109.472 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -68.49 -66.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -54.71 -23.25 16.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.52 -0.737 . . . . 0.0 110.47 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -45.0 92.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.809 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -62.7 -28.62 70.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.661 . . . . 0.0 109.479 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.95 129.17 36.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 -16.93 59.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.703 -0.623 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 150.96 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.21 -0.931 . . . . 0.0 109.91 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.01 83.38 6.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.696 -0.628 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.758 HG12 ' CB ' ' A' ' 65' ' ' ALA . 22.1 m -89.67 123.53 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.41 146.22 48.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 110.036 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.73 HD11 HD12 ' A' ' 61' ' ' ILE . 2.9 tt -96.31 157.09 16.06 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.519 ' N ' HD23 ' A' ' 35' ' ' LEU . 2.6 tt0 -124.09 134.21 53.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.615 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 67.2 t80 -160.17 129.33 5.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.0 109.785 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.34 30.89 20.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.631 -0.668 . . . . 0.0 109.975 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.26 30.46 71.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.38 116.46 17.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.954 . . . . 0.0 109.296 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -96.13 107.86 20.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.612 -0.68 . . . . 0.0 109.96 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.7 148.06 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -65.23 132.75 49.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.861 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.3 tm? -52.05 -26.78 11.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.768 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.92 53.83 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -143.47 84.78 1.82 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.686 HD11 HG11 ' A' ' 23' ' ' VAL . 26.8 mt -67.88 -40.11 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 tpt -76.52 -26.12 54.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.568 -0.708 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.03 -31.98 57.12 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 46' ' ' SER . 39.4 t -73.52 -27.8 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.97 . . . . 0.0 109.638 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 47' ' ' ILE . 25.2 t -62.01 -33.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.376 -0.828 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.0 p -63.26 -31.89 73.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.66 -45.51 61.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.86 62.31 5.61 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.764 HD12 ' HB ' ' A' ' 14' ' ' ILE . 54.4 mt -75.74 153.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.985 . . . . 0.0 109.34 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.43 -166.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.0 109.702 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 142.07 34.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.649 -0.657 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 43.61 6.25 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.615 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -137.5 178.98 6.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.961 . . . . 0.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -132.77 153.5 51.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.488 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 35' ' ' LEU . 27.1 pt -141.21 144.33 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.606 -0.684 . . . . 0.0 109.286 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.02 116.71 27.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' CD1' ' A' ' 6' ' ' PHE . 85.8 mt -102.84 151.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 p -150.4 113.34 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.529 -0.732 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.758 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.81 130.48 36.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.4 99.88 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.81 -138.36 3.77 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.96 -74.14 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.975 . . . . 0.0 109.388 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.78 50.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.4 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.31 -31.44 70.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 2' ' ' ALA . 1.0 OUTLIER -73.95 -35.93 64.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.39 -0.819 . . . . 0.0 109.835 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 -26.38 63.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.428 -0.795 . . . . 0.0 110.31 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -78.93 -45.03 21.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 111.259 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -60.62 -41.8 95.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.935 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.694 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.97 -25.7 60.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 29' ' ' TYR . . . -64.0 -57.04 10.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.04 -28.44 70.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 109.842 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.24 -55.05 36.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.62 -26.64 65.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.4 m -72.07 -34.9 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -28.51 63.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.744 -0.597 . . . . 0.0 109.474 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -85.21 -23.32 28.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.709 . . . . 0.0 110.107 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -67.3 -50.64 59.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.396 -0.815 . . . . 0.0 109.657 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.49 -42.55 9.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 43.41 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 86' ' ' LEU . 92.4 mt -81.84 -31.33 31.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.981 . . . . 0.0 109.463 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.16 168.88 42.01 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.654 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.05 153.37 48.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 129.09 26.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 109.657 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.869 ' OG1' HG23 ' A' ' 62' ' ' THR . 45.9 m -99.13 136.55 38.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.611 -0.681 . . . . 0.0 109.374 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 63' ' ' ILE . 76.7 m-85 -119.54 174.49 6.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.564 -0.71 . . . . 0.0 109.718 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.6 129.72 54.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.612 -0.68 . . . . 0.0 109.217 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HD11 ' A' ' 14' ' ' ILE . 21.5 t -89.74 113.34 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.577 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 16.31 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.704 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.14 34.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.289 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -62.1 -49.92 73.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -69.12 -28.81 66.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.576 -0.702 . . . . 0.0 109.554 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.35 -152.01 23.11 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 8' ' ' VAL . 61.8 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.979 . . . . 0.0 109.394 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -54.58 -54.96 43.02 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.929 -1.107 . . . . 0.0 111.285 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.64 -22.74 23.82 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.114 1.21 . . . . 0.0 110.347 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.493 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.86 -22.63 59.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.423 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -83.13 -29.75 28.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.256 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.17 -40.16 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 109.178 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 44' ' ' LEU . 96.1 mt -73.25 -43.81 60.48 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.954 -0.467 . . . . 0.0 110.394 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.3 p -61.52 -29.83 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.873 . . . . 0.0 109.479 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -45.42 74.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.556 -0.715 . . . . 0.0 109.753 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -64.3 -60.48 3.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.465 -0.772 . . . . 0.0 109.758 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 45' ' ' LYS . . . -57.8 -20.92 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.608 -0.683 . . . . 0.0 110.624 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -60.45 -40.6 91.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -66.58 -32.11 73.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 109.374 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 71.9 m-85 -90.96 130.34 36.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.2 14.13 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 177.65 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.71 78.21 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.772 HG12 ' HB2' ' A' ' 65' ' ' ALA . 17.5 m -89.39 85.86 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.677 -0.639 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.0 123.71 34.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.738 -0.602 . . . . 0.0 109.956 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 63' ' ' ILE . 42.0 tp -91.51 133.57 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -119.42 129.53 54.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.627 -0.671 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.755 ' HB3' HD22 ' A' ' 53' ' ' LEU . 16.2 t80 -116.4 74.16 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 109.834 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 48.3 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.574 -0.704 . . . . 0.0 111.409 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.95 -37.72 3.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB3' HD21 ' A' ' 53' ' ' LEU . 12.5 mmtt -89.64 161.56 16.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -1.061 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 m -150.1 75.93 1.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.613 -0.679 . . . . 0.0 109.708 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.764 ' CG2' HD11 ' A' ' 53' ' ' LEU . 3.6 m -92.52 145.14 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -71.87 141.79 49.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 22' ' ' LEU . 1.6 tm? -54.9 -27.62 44.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.408 -0.808 . . . . 0.0 109.168 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.71 56.1 3.17 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -150.21 89.87 1.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 19' ' ' ALA . 21.0 mt -66.43 -37.15 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.796 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 ttm -75.28 -24.93 57.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.69 -0.631 . . . . 0.0 109.906 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.12 44.68 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 46' ' ' SER . 53.1 t -68.33 -43.94 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.997 . . . . 0.0 109.209 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.59 -29.33 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 p -70.96 -26.27 63.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.802 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.764 HD11 ' CG2' ' A' ' 42' ' ' VAL . 61.5 mt -59.67 -33.88 72.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.466 -0.771 . . . . 0.0 109.958 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.03 38.41 35.45 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 56' ' ' ALA . 34.6 mt -75.45 163.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.968 . . . . 0.0 109.123 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.478 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -148.56 -162.38 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.99 68.83 10.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.63 63.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.474 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -141.88 -175.72 4.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.884 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -132.32 132.52 43.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.583 ' HB ' HD11 ' A' ' 35' ' ' LEU . 22.9 pt -122.53 151.1 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.545 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.869 HG23 ' OG1' ' A' ' 5' ' ' THR . 7.3 m -139.95 108.43 5.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.8 mp -91.43 161.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.582 -0.699 . . . . 0.0 109.85 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 63' ' ' ILE . 9.7 p -150.62 105.95 3.36 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.772 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -90.88 135.14 33.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.96 92.42 1.72 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -0.778 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.27 129.14 1.15 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 55.88 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.677 -0.896 . . . . 0.0 111.031 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -122.81 64.13 0.97 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 110.003 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.654 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 14.5 pt-20 -57.84 -35.24 70.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 110.342 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 -32.94 73.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.73 -25.31 53.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.453 -0.779 . . . . 0.0 110.457 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.792 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.93 -40.8 23.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.814 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -66.35 -42.21 88.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 0.0 110.451 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.709 ' N ' HD12 ' A' ' 74' ' ' LEU . 22.2 p-10 -75.09 -22.99 57.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.385 -0.822 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -65.81 -58.68 5.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.091 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.792 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -69.74 -25.15 63.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -0.772 . . . . 0.0 110.064 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HA ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -62.81 -59.57 4.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.311 -0.868 . . . . 0.0 109.965 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -60.17 -28.97 68.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 109.774 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -66.46 -35.58 80.63 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.713 -0.617 . . . . 0.0 109.641 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -85.33 -21.59 28.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 110.283 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.8 p -70.66 -52.59 20.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.79 -29.07 22.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.726 . . . . 0.0 109.549 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.18 5.56 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 86' ' ' LEU . 74.0 mt -81.58 -44.72 16.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.644 -0.915 . . . . 0.0 109.53 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.47 141.92 7.19 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.399 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.17 153.57 25.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -140.09 164.91 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.569 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -112.12 128.78 56.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.608 -0.682 . . . . 0.0 109.329 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 63' ' ' ILE . 78.0 m-85 -117.53 150.19 39.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.418 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.72 129.49 51.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 59' ' ' ALA . 21.5 t -90.78 118.46 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.731 -0.606 . . . . 0.0 109.554 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 9' ' ' THR . 19.5 m -140.24 24.81 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 109.755 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.28 34.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.457 -0.777 . . . . 0.0 109.47 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.16 -45.53 69.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.605 -0.685 . . . . 0.0 109.499 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -76.02 -31.66 59.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.618 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.25 -148.17 17.96 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.563 HD12 HG21 ' A' ' 55' ' ' ILE . 59.9 mt . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.989 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.038 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.9 ttt85 -56.52 -57.16 25.13 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.744 -1.223 . . . . 0.0 111.082 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -70.11 -17.81 35.74 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.076 1.184 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.646 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -80.65 -21.98 40.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.539 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 2.6 m -83.41 -31.32 26.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.58 -39.23 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.799 0.809 . . . . 0.0 108.933 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.5 mt -72.95 -49.78 27.33 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.539 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.3 p -57.74 -29.44 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.87 -43.09 72.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.465 -0.772 . . . . 0.0 109.835 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -66.48 -59.84 3.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.934 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -59.62 -23.62 63.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.542 -0.724 . . . . 0.0 110.373 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 t -61.73 -37.53 84.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.372 -0.83 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.34 -20.67 60.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.719 -0.613 . . . . 0.0 110.169 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.54 128.02 35.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.27 -0.893 . . . . 0.0 109.597 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -70.13 -24.93 63.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.646 . . . . 0.0 109.711 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.8 39.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.803 . . . . 0.0 109.852 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.72 95.57 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.672 -0.642 . . . . 0.0 109.565 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.628 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.8 m -89.85 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -132.6 130.59 40.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.29 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 36' ' ' GLU . 2.5 tt -89.83 139.11 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.709 ' N ' HD23 ' A' ' 35' ' ' LEU . 7.0 tt0 -113.96 113.97 25.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 109.842 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.702 ' CE1' HG23 ' A' ' 55' ' ' ILE . 13.6 t80 -95.47 68.02 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.511 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m120 48.13 85.07 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.551 -0.718 . . . . 0.0 111.178 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.12 -39.82 2.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -89.53 159.01 17.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.398 -1.06 . . . . 0.0 109.37 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -150.18 91.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.585 -0.697 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -65.48 146.08 55.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.618 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -65.54 -12.06 49.44 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.823 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -88.47 48.73 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 50' ' ' VAL . 46.7 t -150.14 95.54 2.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.828 . . . . 0.0 109.164 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 19' ' ' ALA . 28.8 mt -77.12 -40.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 109.589 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.65 -29.1 63.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.52 -29.43 67.96 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 46' ' ' SER . 43.8 t -73.65 -43.47 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -1.046 . . . . 0.0 109.452 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.42 -29.81 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.618 -0.676 . . . . 0.0 109.588 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.8 p -66.57 -30.65 71.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.67 -51.32 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.37 50.33 2.41 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.702 HG23 ' CE1' ' A' ' 37' ' ' TYR . 55.2 mt -77.0 159.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.59 -0.947 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -147.82 179.38 7.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.852 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -61.84 147.17 47.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.529 -0.732 . . . . 0.0 109.78 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 64.07 2.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -150.37 125.11 9.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.991 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.04 124.58 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.709 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' HB ' HD21 ' A' ' 35' ' ' LEU . 32.3 pt -112.48 160.85 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.249 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 m -136.0 111.5 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.645 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 6' ' ' PHE . 90.2 mt -91.9 160.28 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 63' ' ' ILE . 9.6 p -149.91 101.21 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.104 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.628 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.97 126.87 35.9 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.88 111.4 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 -135.1 2.91 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -57.08 3.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.583 -0.951 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -104.83 45.86 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.571 -0.706 . . . . 0.0 109.302 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.44 -37.01 79.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.571 -0.705 . . . . 0.0 110.191 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 74.7 m-80 -67.77 -37.77 82.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 109.985 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.66 -25.28 62.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 110.138 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -79.87 -42.1 24.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 111.21 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -62.02 -41.59 98.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.68 ' N ' HD12 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -76.17 -23.58 54.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.333 -0.854 . . . . 0.0 109.788 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -63.89 -60.09 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.306 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.91 -28.82 69.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.007 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.31 -52.64 64.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 109.841 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.3 -27.53 69.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -68.89 -31.59 70.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.7 mmt -71.35 -30.8 66.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -86.22 -17.43 34.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 110.316 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 p -73.11 -52.95 12.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -100.9 10.71 40.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.45 99.01 0.01 OUTLIER Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 mt -140.5 -50.71 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.519 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.04 139.36 6.42 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.996 . . . . 0.0 109.522 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.72 152.34 26.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.655 -0.653 . . . . 0.0 109.589 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -142.69 142.7 32.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.566 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 m -95.14 128.58 42.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.687 -0.633 . . . . 0.0 109.373 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.546 ' CD1' HD12 ' A' ' 63' ' ' ILE . 85.4 m-85 -112.88 152.62 29.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.619 -0.676 . . . . 0.0 109.583 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -116.06 116.34 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.623 -0.673 . . . . 0.0 109.203 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.715 HG22 HD11 ' A' ' 14' ' ' ILE . 11.4 t -75.5 118.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -116.63 -15.26 10.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.618 -0.676 . . . . 0.0 110.333 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.18 146.3 39.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.149 -0.97 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -49.76 71.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.657 . . . . 0.0 109.574 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -63.26 -30.96 72.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.86 -138.39 14.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 8' ' ' VAL . 57.1 mt . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.937 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 9.8 mtm180 -58.24 -60.13 11.17 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.879 -1.138 . . . . 0.0 110.527 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.669 ' HB3' HD13 ' A' ' 86' ' ' LEU . 32.4 Cg_endo -70.7 -15.94 33.59 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.318 1.345 . . . . 0.0 110.681 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.568 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.56 -25.92 50.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.212 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.417 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -83.54 -30.47 27.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.22 -36.79 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.672 0.748 . . . . 0.0 109.044 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB3' HD21 ' A' ' 44' ' ' LEU . 72.2 mt -75.26 -44.81 43.87 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.999 -0.438 . . . . 0.0 110.366 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.843 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.7 p -60.7 -29.07 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.31 -36.91 63.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -67.33 -60.07 2.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.48 -0.762 . . . . 0.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -59.1 -21.79 59.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.446 -0.784 . . . . 0.0 110.107 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.8 t -57.2 -38.9 74.38 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.285 -0.884 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.98 -30.01 66.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.585 -0.697 . . . . 0.0 109.42 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 77.4 m-85 -92.65 124.97 37.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -82.24 2.8 30.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 110.625 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.2 -179.78 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.544 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.34 80.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 0.0 109.41 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 65' ' ' ALA . 34.8 m -89.61 111.84 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.671 . . . . 0.0 109.248 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -120.64 134.12 55.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.551 -0.718 . . . . 0.0 110.028 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.3 tt -92.35 154.95 18.24 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.647 ' N ' HD23 ' A' ' 35' ' ' LEU . 23.1 tt0 -134.4 129.93 36.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.459 -0.776 . . . . 0.0 109.865 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.435 ' CD2' HG12 ' A' ' 55' ' ' ILE . 39.3 t80 -160.31 132.47 6.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 109.687 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.16 40.71 17.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.737 . . . . 0.0 109.978 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.78 28.09 65.16 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.24 102.79 7.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.582 -0.952 . . . . 0.0 109.129 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 m -93.5 99.85 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.593 -0.692 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.65 146.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -67.79 143.02 56.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 22' ' ' LEU . 7.4 tp -62.99 -14.98 54.54 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.164 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.843 ' HA ' HG23 ' A' ' 23' ' ' VAL . 2.4 mptt -87.67 49.98 1.91 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 50' ' ' VAL . 23.3 t -150.24 99.23 2.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.0 mt -79.39 -39.94 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 109.858 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 ttt -75.75 -17.72 59.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.426 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -90.03 -44.55 4.73 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 46' ' ' SER . 45.0 t -61.32 -29.44 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.444 -1.033 . . . . 0.0 109.788 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' ILE . 40.6 t -75.93 -30.68 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.48 -0.763 . . . . 0.0 109.285 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -62.23 -26.66 68.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 49' ' ' GLY . 1.7 mp -62.06 -52.73 62.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.87 54.74 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.525 HD12 ' HB ' ' A' ' 14' ' ' ILE . 46.7 mt -77.44 157.67 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.539 -0.977 . . . . 0.0 109.337 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.41 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.2 -171.22 3.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.567 -0.708 . . . . 0.0 109.421 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -68.19 144.75 54.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.641 -0.662 . . . . 0.0 109.625 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.79 54.76 7.0 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.14 155.89 48.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.956 . . . . 0.0 109.472 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.37 122.06 43.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.565 -0.71 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.612 HD12 HD11 ' A' ' 35' ' ' LEU . 22.6 pt -118.23 133.23 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -104.65 120.34 41.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.528 -0.732 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.546 HD12 ' CD1' ' A' ' 6' ' ' PHE . 82.3 mt -110.5 148.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.46 112.55 4.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 0.0 110.194 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.877 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -91.14 130.07 37.07 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.89 105.29 5.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.854 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.92 -136.05 3.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.9 -73.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.988 . . . . 0.0 109.659 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -90.31 51.9 2.12 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.682 -0.636 . . . . 0.0 109.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.579 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 10.4 pt-20 -67.66 -28.33 67.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.5 -0.75 . . . . 0.0 109.81 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -77.57 -35.22 53.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 109.561 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 38.6 m-20 -76.8 -20.47 56.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.0 110.107 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.804 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.65 -43.65 18.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.49 -42.91 91.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.349 -0.845 . . . . 0.0 110.547 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.71 ' N ' HD12 ' A' ' 74' ' ' LEU . 44.7 p-10 -75.87 -22.11 56.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.25 -57.58 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -64.34 -31.18 72.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.569 -0.707 . . . . 0.0 109.648 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.55 -52.62 64.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.174 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.22 -27.58 69.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 m -69.11 -32.76 72.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -70.83 -31.5 68.24 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -77.89 -27.85 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.727 -0.608 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -77.41 -66.33 0.85 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.75 . . . . 0.0 109.651 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.87 -28.71 69.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.571 -0.706 . . . . 0.0 109.713 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 34.99 15.86 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 18' ' ' PRO . 92.7 mt -81.95 -39.49 23.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.647 -0.914 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.52 30.1 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.548 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.71 152.62 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -143.99 149.33 36.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.623 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 m -99.48 119.01 37.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.448 ' CD1' HD12 ' A' ' 63' ' ' ILE . 68.4 m-85 -98.61 162.15 13.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.675 -0.641 . . . . 0.0 109.336 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 135.0 52.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.345 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.87 107.33 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.596 -0.69 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -122.3 -1.43 9.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.547 -0.721 . . . . 0.0 110.562 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.57 136.42 57.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.131 -0.98 . . . . 0.0 109.577 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.49 -38.97 92.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -72.48 -30.94 64.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.531 -0.731 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -151.59 20.04 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 55' ' ' ILE . 23.8 mm . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.946 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -60.51 -51.34 80.62 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.752 -1.217 . . . . 0.0 111.291 -178.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -73.08 -23.67 17.99 Favored 'Trans proline' 0 C--N 1.326 -0.637 0 C-N-CA 121.036 1.157 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -72.25 -27.76 62.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.352 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.438 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.2 m -81.83 -29.51 32.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.522 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.696 HG12 HG21 ' A' ' 80' ' ' THR . 29.9 t -71.76 -40.05 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.829 0.823 . . . . 0.0 108.858 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.491 ' C ' HD11 ' A' ' 44' ' ' LEU . 95.7 mt -71.43 -51.4 24.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.941 -0.474 . . . . 0.0 110.208 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.8 p -54.79 -27.65 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.38 -0.825 . . . . 0.0 110.037 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -74.12 -37.86 63.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.709 . . . . 0.0 109.959 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -72.8 -62.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -57.71 -20.71 36.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.13 -40.85 91.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -71.06 -22.57 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.624 -0.672 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.4 130.21 35.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 0.0 109.647 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -73.61 -25.96 60.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.676 -0.64 . . . . 0.0 109.754 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 145.26 44.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.448 -0.783 . . . . 0.0 109.639 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.63 97.09 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.608 -0.683 . . . . 0.0 109.602 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CB ' ' A' ' 65' ' ' ALA . 21.4 m -92.56 138.68 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -132.48 142.16 49.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.456 -0.778 . . . . 0.0 110.332 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 61' ' ' ILE . 8.8 tt -102.47 122.61 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.44 150.75 21.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.474 -0.766 . . . . 0.0 110.026 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 55' ' ' ILE . 26.9 t80 -160.38 115.27 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.733 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 64.04 27.1 14.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.673 -0.642 . . . . 0.0 110.285 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.7 -18.13 51.55 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.338 -0.934 . . . . 0.0 110.892 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 112.28 23.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.228 -1.16 . . . . 0.0 109.169 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 m -95.84 114.19 25.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.625 . . . . 0.0 109.842 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.95 147.68 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -70.27 136.39 49.82 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.877 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.2 tm? -55.03 -25.15 28.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.429 -0.795 . . . . 0.0 109.405 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.557 ' HA ' HG23 ' A' ' 23' ' ' VAL . 9.4 mttt -90.28 56.57 3.42 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -150.37 86.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.636 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 15.4 mt -61.28 -60.73 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.739 -0.601 . . . . 0.0 109.723 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 ttp -66.64 -27.2 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.7 74.87 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 46' ' ' SER . 45.8 t -87.93 -32.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -1.067 . . . . 0.0 109.529 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 47' ' ' ILE . 33.6 t -71.85 -23.8 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.471 -0.768 . . . . 0.0 109.861 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.3 p -59.24 -39.62 83.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 53' ' ' LEU . 4.0 mp -63.82 -34.02 76.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.211 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.07 4.74 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 14' ' ' ILE . 51.3 mt -75.41 153.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.963 . . . . 0.0 109.175 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.19 -179.0 6.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.701 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -62.47 136.08 57.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.756 -0.59 . . . . 0.0 109.652 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.77 56.86 1.69 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.37 -178.52 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.995 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -136.5 159.55 41.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.68 . . . . 0.0 109.277 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 35' ' ' LEU . 21.3 pt -150.22 138.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -115.63 105.66 13.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.695 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.448 HD12 ' CD1' ' A' ' 6' ' ' PHE . 88.8 mt -92.4 148.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 p -150.52 112.92 4.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.631 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.822 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -90.26 134.47 34.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.66 104.66 6.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.7 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.22 -145.21 8.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -59.55 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.92 . . . . 0.0 109.584 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -96.28 42.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.602 -0.686 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.15 -32.81 73.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.707 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -72.04 -50.0 32.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 109.461 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -61.9 -21.81 65.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 0.0 110.339 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.59 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -79.03 -51.8 9.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.363 -0.836 . . . . 0.0 111.557 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -56.34 -42.34 77.56 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.006 . . . . 0.0 110.809 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -72.14 -27.08 62.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.0 109.106 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -60.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.378 -0.826 . . . . 0.0 109.148 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.2 mp -60.56 -25.89 66.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 109.86 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.55 -54.45 45.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.961 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -61.79 -27.37 68.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.303 -0.873 . . . . 0.0 109.714 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.696 HG21 HG12 ' A' ' 21' ' ' VAL . 54.2 m -68.66 -34.51 75.82 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mmt -71.58 -31.87 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -91.52 -6.17 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.702 -0.624 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 p -78.09 -50.24 12.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -98.2 -59.52 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.553 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 139.55 69.22 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 86' ' ' LEU . 95.3 mt -109.39 -50.41 3.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.923 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.55 154.24 25.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.445 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 65' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -178.01 151.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.671 -0.643 . . . . 0.0 109.28 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -146.41 148.76 32.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.618 -0.676 . . . . 0.0 109.58 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -89.59 133.12 34.77 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.824 ' CE1' HD12 ' A' ' 63' ' ' ILE . 67.5 m-85 -117.57 148.58 41.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.954 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.72 115.75 29.6 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.849 HG22 HD11 ' A' ' 14' ' ' ILE . 8.9 t -68.86 109.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.687 -0.633 . . . . 0.0 109.402 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -117.03 -8.81 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 110.466 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.53 142.07 57.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.096 -1.003 . . . . 0.0 109.63 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.54 -40.75 97.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -74.83 -30.19 61.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.626 -0.671 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.71 -145.54 17.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.849 HD11 HG22 ' A' ' 8' ' ' VAL . 52.9 mt . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.632 -0.922 . . . . 0.0 109.292 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -50.34 -53.13 48.03 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 120.965 -1.084 . . . . 0.0 111.542 -178.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -73.38 -25.2 15.68 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.389 1.392 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.68 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.83 -18.6 60.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.526 -0.734 . . . . 0.0 109.615 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.428 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -87.03 -32.99 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 108.941 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.57 -35.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HB3' HD21 ' A' ' 44' ' ' LEU . 68.4 mt -76.38 -51.24 12.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.248 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 47' ' ' ILE . 11.4 p -54.8 -27.78 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.32 -0.862 . . . . 0.0 109.976 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -44.81 55.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -62.06 -62.23 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.546 -0.721 . . . . 0.0 109.845 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -55.22 -22.67 18.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.443 -0.786 . . . . 0.0 110.715 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -43.39 90.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.258 -0.901 . . . . 0.0 109.884 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -66.61 -29.32 69.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -90.05 126.9 35.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.487 -0.758 . . . . 0.0 109.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.84 -17.66 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.741 -0.599 . . . . 0.0 110.283 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.87 147.14 29.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.203 -0.936 . . . . 0.0 109.922 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.34 90.59 8.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.759 HG12 ' CB ' ' A' ' 65' ' ' ALA . 19.6 m -89.75 128.21 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.98 135.09 52.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.558 -0.714 . . . . 0.0 109.869 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.05 HD11 HD12 ' A' ' 61' ' ' ILE . 1.2 tt -89.72 155.07 19.45 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.12 142.55 51.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.867 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.542 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 59.3 t80 -160.37 128.09 4.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.68 36.66 19.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.477 -0.764 . . . . 0.0 110.012 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.62 22.9 78.05 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -116.2 169.28 9.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -1.059 . . . . 0.0 108.89 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 m -145.58 97.58 3.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.76 146.37 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -68.67 146.17 53.23 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 22' ' ' LEU . 6.8 tp -67.0 -10.71 52.59 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HA ' HG23 ' A' ' 23' ' ' VAL . 14.0 mttt -88.55 48.26 1.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.831 -1.168 . . . . 0.0 107.91 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.702 ' O ' HG23 ' A' ' 50' ' ' VAL . 45.2 t -149.54 85.08 1.43 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.847 . . . . 0.0 109.009 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.688 HD11 HG11 ' A' ' 23' ' ' VAL . 39.5 mt -69.06 -39.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.801 -0.562 . . . . 0.0 109.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ttt -73.53 -29.37 62.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.563 -0.71 . . . . 0.0 109.606 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.27 -38.07 81.39 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 46' ' ' SER . 44.0 t -60.67 -27.72 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.995 . . . . 0.0 109.691 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.4 t -83.91 -25.74 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.815 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -60.37 -38.92 85.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.443 -0.786 . . . . 0.0 109.799 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.42 -55.59 15.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.454 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.27 51.93 0.85 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 56' ' ' ALA . 42.9 mt -75.62 162.16 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.562 -0.964 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.9 -163.16 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -78.85 157.0 28.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.712 . . . . 0.0 109.557 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.97 61.03 6.82 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -138.39 173.21 11.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.931 . . . . 0.0 109.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -127.98 141.45 51.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.709 . . . . 0.0 109.208 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.05 HD12 HD11 ' A' ' 35' ' ' LEU . 20.2 pt -141.97 164.12 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.559 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -132.58 117.24 17.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.67 . . . . 0.0 109.836 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.824 HD12 ' CE1' ' A' ' 6' ' ' PHE . 89.6 mt -99.2 152.07 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -150.4 110.16 4.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.508 -0.745 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.759 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -91.35 130.09 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.99 103.19 4.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.453 -0.779 . . . . 0.0 109.98 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.27 -132.31 2.06 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.81 -67.18 0.85 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.963 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 46.53 1.19 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.548 -0.72 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 5.8 pt-20 -63.04 -37.25 86.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.49 -0.756 . . . . 0.0 110.21 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.25 -36.74 77.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -76.64 -20.59 56.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.457 -0.777 . . . . 0.0 110.284 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.776 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.16 -42.8 20.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.49 -41.64 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.438 -0.789 . . . . 0.0 110.047 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.715 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.9 p30 -79.27 -16.9 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.783 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.45 -52.37 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.776 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -65.28 -33.14 75.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.567 -0.708 . . . . 0.0 109.466 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.66 -52.81 63.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.551 -0.718 . . . . 0.0 109.987 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.12 -27.62 65.77 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.133 -0.98 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.2 m -69.86 -37.22 76.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mtt -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -76.15 -26.0 55.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 0.0 109.734 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -82.57 -67.03 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.729 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -66.71 -29.87 69.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.53 -0.731 . . . . 0.0 109.581 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.73 2.93 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.83 -30.37 20.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.654 -0.909 . . . . 0.0 109.743 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.7 146.94 5.91 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.479 -1.012 . . . . 0.0 109.469 -179.925 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -173.74 154.98 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.716 . . . . 0.0 109.543 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.52 139.92 19.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.561 -0.712 . . . . 0.0 109.651 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -89.96 143.15 27.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.205 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 63' ' ' ILE . 27.0 m-85 -125.92 169.76 12.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.7 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.76 135.82 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.582 -0.699 . . . . 0.0 109.332 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.674 HG22 HD11 ' A' ' 14' ' ' ILE . 12.1 t -81.43 112.08 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 109.319 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 m -114.12 -12.08 12.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 141.74 50.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -0.966 . . . . 0.0 109.985 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.71 -43.11 94.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.9 p -74.07 -32.78 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.53 -0.731 . . . . 0.0 109.366 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.54 -139.58 15.38 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.674 HD11 HG22 ' A' ' 8' ' ' VAL . 58.1 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.593 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -60.16 -61.31 8.18 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 120.943 -1.098 . . . . 0.0 110.589 -178.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HB3' HD22 ' A' ' 86' ' ' LEU . 31.9 Cg_endo -69.59 -12.36 33.07 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 121.283 1.322 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -81.88 -28.89 32.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.867 . . . . 0.0 109.008 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -78.89 -30.02 44.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 17' ' ' ARG . 11.5 t -68.78 -49.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.809 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.833 ' HB3' HD11 ' A' ' 44' ' ' LEU . 86.8 mt -63.91 -54.69 30.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.9 p -51.6 -28.58 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.307 -0.871 . . . . 0.0 110.506 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.01 -54.59 17.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.525 -0.735 . . . . 0.0 110.245 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 m -59.94 -53.35 58.87 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -0.813 . . . . 0.0 110.411 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.33 62.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.412 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.49 -37.74 79.04 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -71.57 -28.75 64.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.775 -0.578 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 81.7 m-85 -94.58 125.45 39.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.85 9.31 19.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.671 -0.643 . . . . 0.0 110.716 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.8 179.22 1.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.092 -1.005 . . . . 0.0 109.478 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -102.75 76.03 1.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.639 -0.663 . . . . 0.0 109.237 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.839 HG12 ' HB2' ' A' ' 65' ' ' ALA . 29.0 m -89.62 108.91 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -117.09 134.31 54.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.717 HD12 HG12 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -89.47 160.82 16.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -128.43 152.75 47.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.36 87.54 1.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.758 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 61.84 48.65 5.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.565 -0.709 . . . . 0.0 109.681 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.06 -7.47 74.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HB3' HD21 ' A' ' 53' ' ' LEU . 11.3 mmtm -91.09 101.32 14.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -1.204 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.35 98.03 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.558 -0.714 . . . . 0.0 109.746 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.77 148.1 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.7 140.95 56.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.837 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.3 tm? -57.22 -28.95 63.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 0.0 109.132 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.751 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.41 60.52 4.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.823 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -147.67 83.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.583 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 35.6 mt -66.21 -40.55 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.607 . . . . 0.0 109.657 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -77.6 -27.39 51.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.56 -0.713 . . . . 0.0 109.96 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.26 -29.72 63.87 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 46' ' ' SER . 42.9 t -73.52 -31.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -1.011 . . . . 0.0 109.579 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.28 -28.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.6 p -63.41 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 40' ' ' LYS . 24.2 mt -64.31 -72.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.563 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.4 48.93 0.3 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 56' ' ' ALA . 16.5 mt -75.97 162.05 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.981 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -150.06 -177.42 5.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 109.36 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 148.26 52.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.588 -0.695 . . . . 0.0 109.398 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.07 70.94 1.0 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -175.49 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.494 -1.004 . . . . 0.0 109.569 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -131.39 148.49 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 pt -149.8 153.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.621 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -127.75 127.07 42.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.713 . . . . 0.0 109.664 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.717 HG12 HD12 ' A' ' 35' ' ' LEU . 78.0 mt -112.31 148.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 p -150.77 112.11 4.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.839 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.93 134.41 35.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.83 103.3 3.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 0.0 109.661 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.73 -128.71 1.37 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.22 -59.47 2.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -104.44 52.65 0.75 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.533 -0.73 . . . . 0.0 109.637 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.468 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 10.0 pt-20 -65.5 -38.75 90.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.49 -0.756 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.98 -37.97 75.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 110.115 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 48.8 m-20 -76.71 -19.42 57.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.825 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -82.0 -43.9 17.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.16 -41.94 94.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.489 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 74' ' ' LEU . 42.1 p-10 -78.08 -20.33 52.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 109.727 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.26 -55.91 9.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.903 . . . . 0.0 108.593 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.825 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -68.87 -29.13 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.498 -0.751 . . . . 0.0 109.782 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -54.58 42.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.397 -0.815 . . . . 0.0 110.192 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.59 -33.54 71.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.807 . . . . 0.0 109.774 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -65.67 -34.06 77.33 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 mmm -71.94 -28.07 63.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.736 -0.603 . . . . 0.0 109.65 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -82.47 -23.8 34.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.591 -0.693 . . . . 0.0 110.177 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -85.85 -31.56 22.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 109.918 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -93.78 -21.8 19.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.725 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.06 33.3 29.75 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 18' ' ' PRO . 83.5 mt -81.94 -60.45 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.946 . . . . 0.0 109.615 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.31 156.04 26.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.423 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -117.14 150.79 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.414 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.936 ' HD2' HD13 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -142.74 142.09 31.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.754 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.5 m -96.51 143.56 27.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -127.21 174.04 9.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.547 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.86 124.39 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.596 -0.69 . . . . 0.0 109.416 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' CG2' HD11 ' A' ' 14' ' ' ILE . 11.1 t -88.32 123.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.382 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.84 10.95 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 110.258 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 147.13 35.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.429 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.19 -31.21 71.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.684 . . . . 0.0 109.584 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -80.68 -30.44 36.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 109.466 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.25 37.01 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.557 HD11 ' CG2' ' A' ' 8' ' ' VAL . 65.8 mt . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.558 -0.966 . . . . 0.0 109.5 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -51.48 -54.51 38.29 Favored Pre-proline 0 N--CA 1.508 2.462 0 O-C-N 120.801 -1.187 . . . . 0.0 111.55 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.2 Cg_endo -71.28 -23.2 24.49 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.122 1.214 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.645 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -74.94 -19.97 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.484 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.418 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -84.73 -32.66 23.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 108.815 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.58 -35.37 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.656 0.741 . . . . 0.0 109.039 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HB3' HD21 ' A' ' 44' ' ' LEU . 97.6 mt -76.57 -43.79 37.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.0 -0.437 . . . . 0.0 110.28 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.879 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.7 p -62.63 -28.31 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 109.458 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.77 -48.05 60.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.529 -0.732 . . . . 0.0 109.954 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -62.1 -57.35 11.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.903 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 44' ' ' LEU . . . -57.53 -23.18 48.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.542 -0.724 . . . . 0.0 110.372 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -59.75 -41.1 90.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.667 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -64.62 -32.04 73.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 54.4 m-85 -93.49 131.28 38.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.665 . . . . 0.0 109.397 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -94.29 12.56 26.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.557 -0.715 . . . . 0.0 110.345 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.12 169.43 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -91.03 76.99 6.13 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.929 HG12 ' HB2' ' A' ' 65' ' ' ALA . 19.4 m -89.63 89.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.596 -0.69 . . . . 0.0 109.527 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.87 123.84 42.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 109.7 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.514 ' C ' HD23 ' A' ' 35' ' ' LEU . 10.4 tt -89.51 108.3 19.58 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -89.13 123.72 33.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.703 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.16 72.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 t30 48.45 85.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.513 -0.742 . . . . 0.0 111.32 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 -38.69 3.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.36 159.47 17.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -1.119 . . . . 0.0 109.621 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.78 85.1 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -99.71 145.44 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 139.87 41.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD23 ' CB ' ' A' ' 26' ' ' ALA . 6.6 tp -58.99 -16.2 16.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.879 ' HA ' HG23 ' A' ' 23' ' ' VAL . 1.2 mptp? -86.92 49.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.774 -1.204 . . . . 0.0 108.197 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.745 ' O ' HG23 ' A' ' 50' ' ' VAL . 41.8 t -151.0 93.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 0.0 109.074 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.645 HG23 ' HB3' ' A' ' 19' ' ' ALA . 22.3 mt -71.11 -39.07 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.624 -0.672 . . . . 0.0 109.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -72.46 -28.52 62.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.585 -0.697 . . . . 0.0 109.614 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.72 -28.62 64.8 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 46' ' ' SER . 45.4 t -74.62 -26.25 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.475 -1.015 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -78.95 -26.98 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -0.791 . . . . 0.0 109.794 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p -68.42 -34.69 76.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 109.564 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 42' ' ' VAL . 16.3 mt -63.38 -45.92 88.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.461 -0.774 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.83 61.59 1.84 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.425 HD12 ' HB ' ' A' ' 14' ' ' ILE . 22.8 mt -88.96 149.17 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.562 -0.964 . . . . 0.0 109.142 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.98 -168.98 3.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.562 -0.711 . . . . 0.0 109.772 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -64.62 130.29 43.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.682 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.16 55.66 2.06 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.36 30.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.61 -0.935 . . . . 0.0 109.577 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -95.08 145.82 24.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.266 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -136.71 152.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 109.522 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 m -127.35 152.53 47.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.409 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.37 143.58 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.449 -0.782 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -147.85 107.84 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.971 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.929 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -90.53 130.97 36.52 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.31 97.1 3.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.88 -131.51 1.47 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.58 -71.23 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.933 . . . . 0.0 109.73 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -99.01 61.38 1.25 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.527 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.67 -27.55 66.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.537 -0.727 . . . . 0.0 109.995 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.94 -35.07 43.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.47 -0.769 . . . . 0.0 109.975 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 36.8 m-20 -73.73 -22.26 59.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.741 . . . . 0.0 110.344 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.814 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.6 -43.67 18.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.936 HD13 ' HD2' ' A' ' 4' ' ' LYS . 4.4 pp -68.7 -39.82 80.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.479 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.0 p30 -79.13 -20.48 48.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 109.795 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -72.73 -56.05 5.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.326 -0.859 . . . . 0.0 108.838 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.1 mt -66.65 -34.19 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.545 -0.722 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.63 -52.73 64.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.94 -26.74 68.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.373 -0.83 . . . . 0.0 109.709 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.5 m -70.22 -32.94 71.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.072 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.46 -27.12 63.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.725 -0.61 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -25.6 26.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 110.148 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 p -66.63 -54.33 24.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.535 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.49 -29.8 22.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.48 -0.763 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 48.99 4.53 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 86' ' ' LEU . 76.6 mt -82.43 -42.66 18.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.979 . . . . 0.0 109.511 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.38 142.87 8.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.497 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.89 153.79 19.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.728 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HD2' HD13 ' A' ' 74' ' ' LEU . 11.2 mtpp -141.8 133.79 27.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -89.98 130.37 36.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.287 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 63' ' ' ILE . 93.5 m-85 -116.02 154.2 30.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.604 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.37 127.82 54.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.635 -0.666 . . . . 0.0 109.235 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.73 114.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -121.12 -5.13 9.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.568 -0.707 . . . . 0.0 110.57 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.66 150.43 40.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.21 -57.46 11.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.467 -0.77 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -65.81 -33.4 75.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.59 -132.8 11.06 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.526 HG22 HG11 ' A' ' 50' ' ' VAL . 62.7 mt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.954 . . . . 0.0 109.387 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.4 ttt85 -53.75 -53.93 52.09 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.961 -1.087 . . . . 0.0 111.377 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.7 Cg_endo -73.87 -24.66 15.14 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.192 1.262 . . . . 0.0 110.523 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -71.99 -22.42 61.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.413 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.433 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -84.5 -31.95 24.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.007 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 17' ' ' ARG . 15.1 t -69.67 -39.38 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 44' ' ' LEU . 94.5 mt -74.84 -51.84 12.93 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.553 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.793 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -52.33 -28.44 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.252 -0.905 . . . . 0.0 110.149 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -74.84 -42.65 57.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -68.55 -65.62 0.68 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.775 . . . . 0.0 109.935 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.581 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -53.38 -24.64 12.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.473 -0.767 . . . . 0.0 110.581 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.22 -45.97 90.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 109.469 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -63.87 -25.52 68.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.645 -0.66 . . . . 0.0 109.822 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 91.2 m-85 -89.57 124.39 34.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.79 -21.24 65.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.072 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 147.88 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -89.88 88.96 7.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.608 -0.682 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.833 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.4 m -90.8 129.85 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -129.36 140.33 51.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.975 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 61' ' ' ILE . 6.4 tt -92.3 149.09 21.64 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -115.18 141.8 47.53 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.597 ' HD2' HD23 ' A' ' 53' ' ' LEU . 35.2 t80 -160.28 115.82 2.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.0 109.983 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 t30 63.9 23.47 13.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.557 -0.714 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.71 -18.21 51.25 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.788 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -88.97 118.55 28.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -1.172 . . . . 0.0 109.158 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -95.08 117.5 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.709 -0.619 . . . . 0.0 109.886 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.07 147.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.8 135.45 51.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.828 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.7 tm? -53.07 -29.12 28.37 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.369 -0.832 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.793 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -91.25 62.05 4.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -148.92 87.09 1.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 23' ' ' VAL . 39.3 mt -71.45 -38.76 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.733 -0.604 . . . . 0.0 109.873 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.1 ttp -77.7 -27.51 50.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.532 -0.73 . . . . 0.0 109.987 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.16 49.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 46' ' ' SER . 46.6 t -66.35 -33.36 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.471 -1.017 . . . . 0.0 109.759 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 t -75.59 -30.71 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 109.614 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.7 p -63.3 -28.02 69.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.692 . . . . 0.0 109.854 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HD2' ' A' ' 37' ' ' TYR . 5.7 mp -69.15 -76.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.761 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.02 51.79 0.23 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.0 mt -78.93 158.33 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.576 -0.955 . . . . 0.0 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -153.18 -168.15 2.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -73.9 146.44 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.757 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.63 57.32 3.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.14 170.64 15.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.946 . . . . 0.0 109.538 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -126.85 129.93 49.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.594 -0.692 . . . . 0.0 109.469 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 35' ' ' LEU . 24.4 pt -119.88 146.41 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.671 -0.643 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.06 107.33 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.747 . . . . 0.0 109.646 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.702 HD12 ' CE1' ' A' ' 6' ' ' PHE . 75.3 mt -92.54 154.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.282 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -150.12 105.95 3.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.833 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.78 124.34 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.36 107.4 7.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.463 -0.773 . . . . 0.0 109.79 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -138.84 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.25 -64.7 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.965 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.08 42.07 1.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.96 -28.6 67.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -0.75 . . . . 0.0 109.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.21 -35.49 63.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.26 -25.37 59.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.675 . . . . 0.0 110.03 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.789 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.6 -43.67 20.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.397 -0.814 . . . . 0.0 110.689 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.686 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -62.09 -41.62 98.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.327 -0.858 . . . . 0.0 110.69 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.686 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.8 p-10 -74.46 -27.07 60.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.246 -0.909 . . . . 0.0 109.764 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -64.24 -57.67 8.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.805 . . . . 0.0 109.266 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -63.59 -27.35 69.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.493 -0.755 . . . . 0.0 109.876 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.71 -58.01 9.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 109.682 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.85 -26.59 65.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.45 HG21 HG12 ' A' ' 21' ' ' VAL . 29.4 m -71.98 -34.02 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 0.0 109.015 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.6 -29.91 65.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -85.81 -21.19 28.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.69 . . . . 0.0 110.305 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -80.75 -55.07 5.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -73.45 -27.07 61.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.825 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.25 39.79 6.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 18' ' ' PRO . 80.7 mt -81.74 -52.76 6.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.687 -0.89 . . . . 0.0 109.651 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.24 145.8 12.59 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.593 -0.945 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.775 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.79 158.12 44.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.583 -0.698 . . . . 0.0 109.294 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -142.78 132.73 24.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 61' ' ' ILE . 32.2 m -95.07 139.05 31.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.543 -0.723 . . . . 0.0 109.297 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 63' ' ' ILE . 91.3 m-85 -122.69 162.76 21.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.524 -0.735 . . . . 0.0 109.709 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.76 125.23 50.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 14' ' ' ILE . 9.7 t -77.81 123.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.522 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 9' ' ' THR . 18.2 m -129.92 3.37 4.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.588 -0.695 . . . . 0.0 110.544 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.39 46.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.039 -1.038 . . . . 0.0 109.47 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.18 -37.71 88.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.693 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -80.01 -30.19 39.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.81 -148.6 18.88 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.824 HD11 HG22 ' A' ' 8' ' ' VAL . 58.8 mt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.945 . . . . 0.0 109.562 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -57.39 -60.66 9.07 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.856 -1.153 . . . . 0.0 110.598 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.8 -15.1 36.79 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.302 1.335 . . . . 0.0 110.787 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -79.71 -24.99 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.1 m -82.99 -29.59 28.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.187 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.36 -40.49 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.669 0.747 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HB3' HD21 ' A' ' 44' ' ' LEU . 95.4 mt -72.09 -46.35 57.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.967 -0.458 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.814 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.0 p -60.03 -29.01 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.791 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.61 -43.57 72.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.475 -0.766 . . . . 0.0 109.975 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -68.04 -60.83 2.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.049 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.607 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -57.2 -23.6 48.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.411 -0.806 . . . . 0.0 110.41 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -59.83 -41.3 91.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -26.39 67.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.743 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 90.8 m-85 -89.66 127.95 36.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.4 -0.813 . . . . 0.0 109.604 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -71.82 -21.62 61.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.806 -0.559 . . . . 0.0 110.075 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 149.1 23.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.67 92.46 9.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.63 -0.669 . . . . 0.0 109.449 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.859 HG12 ' CB ' ' A' ' 65' ' ' ALA . 35.9 m -92.8 102.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 109.195 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.72 137.68 41.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.777 . . . . 0.0 110.096 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.3 tt -90.77 150.56 21.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' N ' HD23 ' A' ' 35' ' ' LEU . 9.0 tt0 -120.72 135.43 55.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.481 -0.762 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.759 ' HB3' HD23 ' A' ' 53' ' ' LEU . 57.9 t80 -160.21 125.9 4.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 64.09 21.44 12.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.523 -0.735 . . . . 0.0 110.519 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.01 55.37 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.908 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -89.07 122.78 32.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -1.187 . . . . 0.0 109.307 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 m -105.22 103.65 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.768 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.7 146.97 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -67.04 143.19 56.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 26' ' ' ALA . 7.0 tp -63.37 -15.09 56.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.056 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.814 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.6 mttm -87.63 48.93 1.71 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.86 -1.15 . . . . 0.0 107.973 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 50' ' ' VAL . 15.0 t -150.61 84.09 1.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 108.992 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.67 HG23 ' HB3' ' A' ' 19' ' ' ALA . 27.7 mt -64.5 -37.89 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.7 ttm -74.39 -30.3 61.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.377 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.66 -35.93 92.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 46' ' ' SER . 42.4 t -68.38 -29.01 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.937 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 t -65.47 -34.48 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.488 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.9 p -63.17 -32.0 73.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' A' ' 37' ' ' TYR . 11.1 mp -70.54 -50.58 36.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.701 . . . . 0.0 109.393 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.84 59.46 3.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.554 HD12 ' HB ' ' A' ' 14' ' ' ILE . 49.0 mt -72.58 162.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -142.6 175.56 9.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.591 -0.693 . . . . 0.0 109.572 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -61.34 152.82 28.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.588 -0.695 . . . . 0.0 109.767 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.04 64.24 3.94 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.33 172.02 13.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.545 -0.973 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -124.76 129.8 51.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 5' ' ' THR . 23.6 pt -128.12 152.16 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.582 -0.699 . . . . 0.0 109.364 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.449 HG23 ' OG1' ' A' ' 5' ' ' THR . 1.3 m -131.67 109.43 10.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.432 HD12 ' CE1' ' A' ' 6' ' ' PHE . 88.1 mt -93.69 155.97 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.219 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -150.09 110.56 4.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.64 -0.662 . . . . 0.0 109.808 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.859 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.69 131.74 35.52 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.03 107.04 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.499 -0.751 . . . . 0.0 109.662 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.5 -133.41 2.4 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.15 -61.99 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.574 -0.957 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -98.39 44.44 1.03 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.686 -0.633 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.775 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 11.9 pt-20 -61.71 -31.29 71.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.707 . . . . 0.0 109.857 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.69 -36.47 70.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.565 -0.709 . . . . 0.0 109.616 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -78.44 -19.55 52.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.306 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.799 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.79 -44.85 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.165 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.79 -41.78 91.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.247 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.6 p30 -77.65 -19.89 54.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 0.0 109.501 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.18 -57.16 5.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.799 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.53 -30.11 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.575 -0.703 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -54.02 51.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.999 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.29 -26.69 66.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 109.888 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.8 m -70.18 -35.82 74.22 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.8 mmm -71.45 -30.48 66.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -83.91 -18.49 37.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.676 . . . . 0.0 110.318 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.2 p -74.81 -52.84 10.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.3 -27.49 24.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.756 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.93 48.71 4.04 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.78 -64.44 1.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.676 -0.896 . . . . 0.0 109.607 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.72 11.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.982 . . . . 0.0 109.518 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.94 153.4 33.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.43 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 7.6 tttp -135.55 140.52 44.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.702 -0.624 . . . . 0.0 109.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 m -96.63 130.49 43.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.591 -0.693 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CD2' HD12 ' A' ' 63' ' ' ILE . 97.2 m-85 -118.0 149.01 41.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.593 -0.692 . . . . 0.0 109.604 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.14 125.89 52.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 14' ' ' ILE . 15.9 t -81.4 119.6 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.598 -0.689 . . . . 0.0 109.593 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -140.49 22.27 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.571 -0.706 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.68 36.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.518 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.09 -41.18 97.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -78.72 -30.89 46.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.613 -0.679 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.18 -143.77 16.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 8' ' ' VAL . 57.0 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.7 mmt180 -62.68 -61.35 7.69 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.812 -1.18 . . . . 0.0 109.782 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.07 -13.71 36.92 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.198 1.265 . . . . 0.0 110.509 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -78.0 -30.3 50.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 108.784 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.3 m -79.5 -27.97 41.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.67 . . . . 0.0 109.572 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.79 -48.59 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.747 0.784 . . . . 0.0 109.084 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -65.77 -42.7 90.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 122.004 -0.435 . . . . 0.0 110.614 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.854 HG11 HD11 ' A' ' 47' ' ' ILE . 13.7 p -64.22 -30.46 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -70.92 -29.77 65.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.074 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.53 -58.5 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.508 -0.745 . . . . 0.0 110.434 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -61.6 -27.7 68.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.462 -0.774 . . . . 0.0 110.427 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 p -59.85 -32.77 70.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.354 -0.841 . . . . 0.0 109.708 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -73.39 -29.67 62.77 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.87 127.57 36.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.448 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.34 -2.99 44.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.684 -0.635 . . . . 0.0 110.681 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.14 167.6 3.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.67 82.18 3.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.606 -0.684 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.86 HG12 ' HB2' ' A' ' 65' ' ' ALA . 21.3 m -89.69 100.75 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.353 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -104.54 128.97 52.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.708 . . . . 0.0 109.921 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 35' ' ' LEU . 9.9 tt -89.46 142.95 27.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -117.01 143.03 46.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -139.87 71.19 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.566 -0.709 . . . . 0.0 109.772 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.45 62.69 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.564 -0.71 . . . . 0.0 110.852 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 -29.8 8.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -89.54 88.14 7.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -1.078 . . . . 0.0 109.402 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.2 m -93.04 94.7 9.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.695 -0.628 . . . . 0.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.07 145.83 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -70.08 146.83 50.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.7 tp -65.87 -12.01 51.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 23' ' ' VAL . 1.1 mptt -88.28 48.56 1.66 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.775 -1.203 . . . . 0.0 108.03 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 t -149.93 99.3 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.854 HD11 HG11 ' A' ' 23' ' ' VAL . 42.3 mm -70.47 -59.41 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.731 -0.606 . . . . 0.0 109.464 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.68 -22.19 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.711 -0.618 . . . . 0.0 110.163 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.87 63.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.8 t -68.78 -34.42 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.95 . . . . 0.0 109.616 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.3 t -71.83 -26.5 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.9 p -70.31 -33.93 72.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.473 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.1 -37.4 87.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.281 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.6 5.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 mt -78.44 152.36 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.992 . . . . 0.0 109.097 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.97 -168.58 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.547 -0.721 . . . . 0.0 109.8 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.49 131.93 50.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.672 -0.643 . . . . 0.0 109.704 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.93 55.58 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.41 172.96 12.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.548 -0.971 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -131.99 156.16 46.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.656 . . . . 0.0 109.296 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 pt -149.61 139.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.49 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 m -117.87 109.28 16.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.534 -0.729 . . . . 0.0 109.561 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.571 HD12 ' CD2' ' A' ' 6' ' ' PHE . 81.8 mt -96.85 150.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.589 -0.694 . . . . 0.0 109.401 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.24 109.88 4.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.653 -0.654 . . . . 0.0 109.609 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.86 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -89.73 131.49 35.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.11 101.72 4.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.802 . . . . 0.0 109.76 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.9 -123.67 0.85 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.95 -62.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.949 . . . . 0.0 109.314 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -96.64 51.51 1.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.293 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.413 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -67.91 -27.39 66.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -80.69 -33.15 35.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 41.0 m-20 -77.38 -21.61 52.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.73 . . . . 0.0 110.23 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.802 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.31 -43.21 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.342 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.55 -42.76 91.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.318 -0.864 . . . . 0.0 110.438 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 74' ' ' LEU . 33.3 p-10 -75.9 -21.95 56.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -0.873 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.81 -56.88 7.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -65.96 -30.58 71.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.682 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -53.28 60.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.14 -29.22 69.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -66.73 -35.31 79.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.6 mmm -71.59 -28.21 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -69.99 -47.49 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 109.908 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 p -66.91 -59.12 3.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -59.28 -23.44 62.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.505 -0.747 . . . . 0.0 110.154 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.89 34.97 88.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.92 -44.61 16.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.97 . . . . 0.0 109.616 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -176.19 28.67 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.494 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.731 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -51.46 152.53 2.58 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.378 -0.826 . . . . 0.0 110.501 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -140.91 167.93 21.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 109.517 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -112.4 150.75 30.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.341 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.57 148.58 41.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 121.47 45.4 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.573 ' CG2' HD11 ' A' ' 14' ' ' ILE . 21.4 t -87.02 125.56 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.564 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -143.93 22.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.712 . . . . 0.0 109.861 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 145.29 36.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.488 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.11 -43.18 95.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 0.0 109.674 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -77.44 -29.25 52.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.36 -155.83 24.53 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.757 ' HB ' HD12 ' A' ' 55' ' ' ILE . 61.4 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.537 -0.978 . . . . 0.0 109.415 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.11 -55.59 29.65 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.853 -1.154 . . . . 0.0 111.196 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.74 -23.32 22.81 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.233 1.288 . . . . 0.0 110.212 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.14 -22.33 61.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 0.0 109.309 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -84.33 -31.64 24.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.074 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.72 -40.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.614 0.721 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.768 ' HB3' HD11 ' A' ' 44' ' ' LEU . 92.3 mt -74.57 -51.77 13.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.008 -0.433 . . . . 0.0 110.357 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.824 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.4 p -51.83 -30.69 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.09 -39.76 63.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.605 -0.684 . . . . 0.0 109.75 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -66.53 -64.43 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.51 -0.743 . . . . 0.0 109.894 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -55.51 -24.28 30.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -61.37 -43.44 98.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.359 -0.838 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -62.96 -26.73 68.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 109.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CG ' ' HB2' ' A' ' 73' ' ' ALA . 93.2 m-85 -89.78 125.16 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.683 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -69.87 -22.97 63.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.81 25.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.373 -0.829 . . . . 0.0 109.858 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.06 95.83 10.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 109.759 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.765 HG12 ' CB ' ' A' ' 65' ' ' ALA . 21.6 m -97.04 120.41 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -116.88 123.92 48.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.554 -0.717 . . . . 0.0 110.326 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.116 HD11 HD12 ' A' ' 61' ' ' ILE . 7.2 tt -90.12 148.65 22.87 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -126.05 158.13 36.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.0 110.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.805 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 18.7 t80 -147.42 105.35 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -81.4 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.77 -0.581 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.87 26.56 1.46 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 114.88 19.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.468 -1.019 . . . . 0.0 109.175 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -89.79 90.07 8.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.586 -0.696 . . . . 0.0 110.025 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.83 148.04 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.43 139.75 36.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.843 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.4 tm? -53.54 -27.47 26.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.439 -0.788 . . . . 0.0 109.15 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.824 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.56 57.93 3.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.1 t -148.72 110.14 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 19' ' ' ALA . 24.9 mt -89.37 -42.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.251 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.445 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.2 ttt -79.15 -24.03 43.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.482 -0.761 . . . . 0.0 110.163 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.22 -29.5 53.35 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 46' ' ' SER . 39.5 t -84.3 -42.82 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -1.018 . . . . 0.0 109.742 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 48' ' ' MET . 12.1 p -61.94 -37.43 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -57.4 -29.48 64.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.699 -0.626 . . . . 0.0 110.107 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.41 -53.14 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 0.0 109.348 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.06 58.52 1.67 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.757 HD12 ' HB ' ' A' ' 14' ' ' ILE . 47.0 mt -78.12 162.91 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.647 -0.914 . . . . 0.0 109.211 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -144.95 -161.21 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.827 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 66.2 9.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.88 53.99 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -140.15 168.34 20.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.92 . . . . 0.0 109.554 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -126.14 133.26 51.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.116 HD12 HD11 ' A' ' 35' ' ' LEU . 26.8 pt -124.84 136.75 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.616 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -112.63 112.4 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.539 ' CG1' HD12 ' A' ' 35' ' ' LEU . 91.0 mt -93.71 155.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.644 -0.66 . . . . 0.0 109.343 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -149.45 104.68 3.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.717 -0.615 . . . . 0.0 109.349 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.765 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.56 135.04 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 106.94 4.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.44 -144.24 7.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.2 -73.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.958 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -95.32 45.47 1.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.308 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.42 -43.22 83.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.448 -0.782 . . . . 0.0 110.28 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.575 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.8 m120 -62.35 -37.15 84.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.881 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 7.5 m-20 -67.45 -33.26 74.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.694 -0.629 . . . . 0.0 110.984 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB2' ' CG ' ' A' ' 29' ' ' TYR . . . -73.44 -53.57 10.36 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.319 -0.863 . . . . 0.0 111.615 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -54.6 -45.64 73.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.241 -0.912 . . . . 0.0 111.297 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.74 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -67.1 -27.82 67.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 109.079 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.612 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -62.64 -52.36 63.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.072 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.37 -31.07 72.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 109.84 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.82 -52.2 66.09 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.87 . . . . 0.0 109.996 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.28 -27.62 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.6 m -70.62 -33.88 71.5 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmt -71.54 -31.13 66.69 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -86.24 -17.27 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -60.52 -49.93 75.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 109.81 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.42 -54.88 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.494 -0.754 . . . . 0.0 109.518 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.78 52.45 0.08 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.0 -63.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.562 -0.963 . . . . 0.0 109.566 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.49 134.89 4.7 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.534 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -60.92 153.66 24.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.425 -0.797 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -138.22 165.01 27.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m -115.83 138.21 51.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.693 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 63' ' ' ILE . 75.3 m-85 -125.02 144.85 50.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.718 . . . . 0.0 109.369 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.52 129.99 54.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.505 HG13 HD11 ' A' ' 14' ' ' ILE . 16.8 t -90.5 112.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.429 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -116.69 -14.31 10.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.686 -0.634 . . . . 0.0 110.292 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.94 140.33 56.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.877 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -68.56 -34.66 76.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.654 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -64.96 -28.72 69.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.763 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.15 -157.04 36.56 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.638 ' HB ' HD12 ' A' ' 55' ' ' ILE . 9.1 mm . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.974 . . . . 0.0 109.157 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.91 -54.98 37.83 Favored Pre-proline 0 N--CA 1.507 2.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.563 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 31.1 Cg_endo -70.11 -23.0 29.68 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.052 1.168 . . . . 0.0 110.283 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.9 -24.14 60.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.746 . . . . 0.0 109.134 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.51 HG23 ' CD1' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -82.45 -28.82 31.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.772 . . . . 0.0 109.158 179.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -70.26 -37.79 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.6 mt -74.97 -50.9 15.12 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.538 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.775 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.0 p -53.49 -28.91 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.5 -37.98 55.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.486 -0.759 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.1 m -71.95 -65.85 0.72 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.425 -0.797 . . . . 0.0 109.784 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -52.27 -27.33 14.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.674 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -61.71 -46.17 90.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -63.24 -21.87 66.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.685 . . . . 0.0 110.003 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 84.9 m-85 -89.53 127.1 35.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.16 -28.19 69.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.66 -0.65 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.39 53.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -89.93 94.38 9.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 0.0 109.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.75 HG12 ' CB ' ' A' ' 65' ' ' ALA . 28.2 m -89.89 135.06 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.64 -0.663 . . . . 0.0 109.248 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -132.08 138.25 48.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 0.0 110.171 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.576 HD11 HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -89.07 156.02 19.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.51 129.52 35.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.37 57.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 55.63 22.63 5.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.86 -41.16 0.61 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -89.96 87.79 7.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.523 -0.986 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 35' ' ' LEU . 25.7 m -91.74 112.6 24.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.05 148.24 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -64.92 138.96 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.846 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.0 tm? -54.54 -29.61 51.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.775 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.2 mttt -90.76 61.75 4.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -150.19 87.71 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.79 ' O ' HG23 ' A' ' 51' ' ' VAL . 34.6 mt -70.33 -39.79 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.668 -0.645 . . . . 0.0 109.68 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.78 -28.56 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.22 57.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 46' ' ' SER . 40.5 t -77.45 -33.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.485 -1.009 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 47' ' ' ILE . 40.2 t -69.36 -34.29 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 109.194 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.5 p -63.08 -34.65 78.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.607 -0.683 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 50' ' ' VAL . 12.0 mt -72.89 -38.96 66.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.423 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.47 73.35 0.58 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.638 HD12 ' HB ' ' A' ' 14' ' ' ILE . 23.9 mt -81.78 151.06 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.968 . . . . 0.0 109.161 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.4 172.14 13.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.642 -0.662 . . . . 0.0 109.839 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 159.27 1.43 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.56 40.79 99.08 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.63 121.14 34.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -84.8 132.69 34.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.608 -0.683 . . . . 0.0 109.354 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 35' ' ' LEU . 18.4 pt -127.22 163.44 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 109.383 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 m -140.14 111.4 7.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 64' ' ' SER . 93.2 mt -92.35 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.0 p -150.18 103.03 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.822 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.75 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 121.7 32.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.96 109.88 10.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 109.669 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.35 -150.21 10.8 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.51 -65.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.517 -0.99 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.73 47.5 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.637 -0.664 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -58.65 -41.46 86.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.727 . . . . 0.0 110.139 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -62.26 -30.13 70.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.91 -25.26 58.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.83 -39.97 25.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.816 . . . . 0.0 110.982 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.2 -42.46 93.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 0.0 110.459 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.709 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.7 p-10 -72.08 -28.44 63.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.0 109.187 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.673 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -61.0 -64.08 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.45 -0.781 . . . . 0.0 109.555 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -60.67 -25.54 66.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -0.828 . . . . 0.0 109.872 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -54.56 44.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.437 -0.789 . . . . 0.0 110.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 -28.26 69.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -66.22 -35.78 81.33 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -28.5 64.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.783 -0.573 . . . . 0.0 109.558 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -80.52 -25.19 38.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.782 . . . . 0.0 110.042 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 p -81.53 -63.14 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -0.766 . . . . 0.0 109.786 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.15 -29.11 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 109.731 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.2 6.24 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.77 -34.69 30.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.627 -0.925 . . . . 0.0 109.563 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.16 -179.42 41.83 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.56 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.58 150.58 31.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.045 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -134.64 163.03 30.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.708 -0.62 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 134.75 54.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.733 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -119.91 161.58 20.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.715 . . . . 0.0 109.547 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -120.2 123.68 43.85 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 14' ' ' ILE . 4.1 t -83.66 120.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -131.95 16.19 4.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.738 . . . . 0.0 110.183 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 144.86 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.46 -29.2 70.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -90.0 -30.87 17.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 109.496 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.56 -150.03 19.7 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 55' ' ' ILE . 59.8 mt . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.987 . . . . 0.0 109.424 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.096 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 9.2 ttp180 -54.17 -55.45 36.58 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.575 ' O ' HD12 ' A' ' 22' ' ' LEU . 31.0 Cg_endo -69.72 -22.17 32.64 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 120.922 1.081 . . . . 0.0 110.443 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -75.46 -21.66 57.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.259 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.3 m -82.12 -30.69 31.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.46 -0.775 . . . . 0.0 109.071 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 80' ' ' THR . 15.8 t -70.08 -34.49 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.783 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.2 mt -76.85 -49.1 16.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.02 -0.425 . . . . 0.0 110.5 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.5 p -56.54 -27.26 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -54.13 8.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.441 -0.787 . . . . 0.0 110.328 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -61.16 -60.55 3.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.524 -0.735 . . . . 0.0 110.419 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -55.49 -26.52 43.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.466 -0.771 . . . . 0.0 110.745 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.48 -42.12 99.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.408 -0.807 . . . . 0.0 109.474 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -64.25 -21.03 66.44 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.522 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 69.9 m-85 -89.4 133.88 34.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 0.0 109.696 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -77.32 -22.97 51.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.615 -0.678 . . . . 0.0 110.081 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.54 150.97 17.79 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.61 87.79 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.651 -0.656 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.5 m -90.02 118.16 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -120.25 124.9 46.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.75 142.55 27.64 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -129.98 155.76 45.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -145.8 105.27 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 -81.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.35 26.58 1.85 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -124.26 99.92 6.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.511 -0.994 . . . . 0.0 108.928 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -89.85 87.27 6.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.578 -0.702 . . . . 0.0 109.957 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.53 146.48 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -69.89 142.85 52.93 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.845 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.6 tm? -53.95 -28.88 40.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.403 -0.811 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.774 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -90.92 59.45 4.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.858 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.6 t -150.1 89.53 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 23' ' ' VAL . 34.2 mt -71.9 -51.8 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 109.519 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.0 tpt -61.49 -28.59 69.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.748 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.699 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -72.62 -40.53 53.38 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 46' ' ' SER . 41.0 t -64.56 -28.11 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.97 . . . . 0.0 109.601 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 47' ' ' ILE . 42.4 t -74.03 -31.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.8 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.6 p -64.3 -27.29 68.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 49' ' ' GLY . 3.3 mp -75.0 -46.76 32.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.798 . . . . 0.0 109.542 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.32 63.04 2.74 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.59 HD13 HD12 ' A' ' 14' ' ' ILE . 14.3 mt -74.21 162.58 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.922 . . . . 0.0 109.29 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -144.84 -164.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 109.759 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -72.98 135.23 44.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.778 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 45.16 7.43 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.03 161.72 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.598 -0.942 . . . . 0.0 109.408 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -124.5 118.59 26.96 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 151.99 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.744 . . . . 0.0 109.491 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.8 m -136.16 107.87 7.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.58 -0.7 . . . . 0.0 109.483 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 64' ' ' SER . 89.6 mt -92.25 159.28 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.614 -0.679 . . . . 0.0 109.275 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 63' ' ' ILE . 4.9 p -144.98 102.47 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.715 -0.616 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.72 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.88 121.48 32.04 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.75 105.33 6.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.354 -0.841 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.45 -140.68 4.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.67 -53.27 5.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.582 -0.952 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.3 45.59 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 109.418 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.56 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 7.6 pt-20 -66.16 -33.62 76.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 109.94 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.28 -35.29 61.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.448 -0.782 . . . . 0.0 109.839 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.75 -20.75 58.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.464 -0.773 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.821 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.41 -43.14 19.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.267 -0.895 . . . . 0.0 110.477 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.96 -41.7 95.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.324 -0.86 . . . . 0.0 110.694 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.726 ' N ' HD12 ' A' ' 74' ' ' LEU . 26.3 p-10 -74.84 -25.92 59.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -65.59 -60.47 2.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.35 -28.41 69.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 109.771 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.15 -54.95 39.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.12 -29.14 68.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.372 -0.83 . . . . 0.0 109.978 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 21' ' ' VAL . 39.8 m -69.03 -34.2 74.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.566 ' HE3' HD21 ' A' ' 22' ' ' LEU . 26.2 mmt -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.794 -0.567 . . . . 0.0 109.607 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -75.53 -28.6 59.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.783 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.3 p -66.23 -49.76 66.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.696 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -10.83 54.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.585 -0.697 . . . . 0.0 110.46 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.77 94.24 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.85 -62.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.583 -0.951 . . . . 0.0 109.648 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.67 120.76 1.38 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -49.94 155.2 0.94 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 110.771 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.37 162.64 38.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.318 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 6' ' ' PHE . 5.7 m -101.34 165.98 10.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.622 ' CD1' HD12 ' A' ' 63' ' ' ILE . 55.2 m-85 -149.52 145.55 26.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.691 . . . . 0.0 109.288 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -107.78 127.27 53.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.556 -0.715 . . . . 0.0 109.073 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 14' ' ' ILE . 19.5 t -90.72 120.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.753 -0.592 . . . . 0.0 109.634 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -134.12 23.5 3.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.702 -0.624 . . . . 0.0 109.929 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 144.12 37.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -56.6 -49.47 74.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.388 -0.82 . . . . 0.0 109.882 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -80.44 -29.5 37.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.371 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.63 -161.39 19.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 8' ' ' VAL . 74.4 mt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.613 -0.934 . . . . 0.0 109.187 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -50.68 -57.44 13.36 Favored Pre-proline 0 N--CA 1.507 2.405 0 O-C-N 120.829 -1.169 . . . . 0.0 111.184 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.5 Cg_endo -71.94 -18.31 27.97 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.333 1.355 . . . . 0.0 110.532 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -76.78 -21.69 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.787 . . . . 0.0 109.385 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -85.33 -33.87 21.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -72.5 -35.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.699 0.762 . . . . 0.0 109.068 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 44' ' ' LEU . 98.8 mt -77.17 -45.36 26.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.998 -0.439 . . . . 0.0 110.431 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.4 p -60.1 -27.47 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -73.44 -52.56 13.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.5 -0.75 . . . . 0.0 110.468 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.27 -54.39 46.33 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.422 -0.799 . . . . 0.0 110.344 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.68 -25.16 62.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.3 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.6 t -62.55 -38.6 90.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.348 -0.845 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.624 . . . . 0.0 109.931 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' CG ' ' HB2' ' A' ' 73' ' ' ALA . 88.3 m-85 -89.56 125.32 35.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 109.676 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -68.58 -24.73 64.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.874 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.62 144.63 42.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 109.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.67 96.14 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.773 HG12 ' CB ' ' A' ' 65' ' ' ALA . 19.8 m -89.96 131.39 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -122.08 130.61 53.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 110.379 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.718 HD11 ' HB ' ' A' ' 61' ' ' ILE . 19.1 tp -89.91 146.71 24.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.48 126.95 46.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.391 -0.818 . . . . 0.0 109.903 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.842 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 42.0 t80 -160.33 137.65 9.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.61 37.35 19.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.037 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.85 29.5 67.71 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -129.33 113.36 14.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.595 -0.944 . . . . 0.0 109.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.6 m -93.39 91.52 7.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.538 -0.726 . . . . 0.0 109.794 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.514 -0.741 . . . . 0.0 109.065 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -69.4 145.03 53.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 22' ' ' LEU . 7.0 tp -63.38 -13.25 37.49 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 5.3 mttt -87.17 50.51 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.77 -1.206 . . . . 0.0 108.113 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 50' ' ' VAL . 31.0 t -150.24 86.2 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 19' ' ' ALA . 27.7 mt -64.83 -41.36 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.768 -0.582 . . . . 0.0 109.658 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.6 tpt -72.74 -27.23 61.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.526 -0.734 . . . . 0.0 109.762 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -24.13 72.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 46' ' ' SER . 41.2 t -80.67 -31.36 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -1.058 . . . . 0.0 109.574 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 t -75.43 -28.54 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.839 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.2 p -62.08 -27.97 69.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.77 . . . . 0.0 109.776 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.53 -76.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.475 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.89 55.42 0.27 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 59' ' ' ALA . 17.9 mt -73.85 150.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.607 -0.937 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.03 -158.68 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.671 -0.643 . . . . 0.0 109.722 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -86.55 63.57 8.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.6 56.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.842 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -132.52 129.72 39.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.93 . . . . 0.0 109.488 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -84.65 129.45 34.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.718 ' HB ' HD11 ' A' ' 35' ' ' LEU . 23.7 pt -123.21 134.56 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.639 -0.663 . . . . 0.0 109.347 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -105.16 117.07 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 6' ' ' PHE . 86.8 mt -102.14 153.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -149.94 103.35 3.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.658 -0.651 . . . . 0.0 109.597 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.773 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.31 127.97 35.83 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.84 106.6 7.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.88 -145.67 7.17 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.09 -71.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.896 . . . . 0.0 109.594 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -98.91 52.73 0.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.535 -0.728 . . . . 0.0 109.416 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.92 -42.81 90.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.435 -0.79 . . . . 0.0 110.114 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.496 ' HA ' HD21 ' A' ' 74' ' ' LEU . 15.8 m-80 -62.0 -28.58 69.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 0.0 109.85 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -23.53 50.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.433 -0.792 . . . . 0.0 110.454 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.85 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.06 -47.11 14.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -62.26 -45.61 92.53 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.35 -0.844 . . . . 0.0 110.66 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.739 ' N ' HD12 ' A' ' 74' ' ' LEU . 36.4 p-10 -70.81 -25.26 62.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -62.1 -62.72 1.58 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.2 mp -62.76 -22.95 66.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.593 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.93 -52.39 65.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.49 -29.45 70.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -66.24 -33.85 76.68 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mmt -71.75 -28.24 63.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.749 -0.595 . . . . 0.0 109.665 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -86.89 -18.96 29.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 110.47 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -74.22 -67.59 0.6 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.34 -28.56 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.68 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.5 35.46 5.68 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 86' ' ' LEU . 95.6 mt -81.7 -49.7 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.748 -0.854 . . . . 0.0 109.696 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.1 -179.51 36.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.49 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -172.95 153.57 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.628 -0.67 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -144.58 148.16 34.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.679 -0.638 . . . . 0.0 109.632 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 6' ' ' PHE . 32.5 m -92.61 159.08 15.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.712 -0.617 . . . . 0.0 109.438 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.425 ' N ' HG22 ' A' ' 5' ' ' THR . 72.6 m-85 -143.08 172.68 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.171 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -136.68 122.74 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.745 HG22 HD11 ' A' ' 14' ' ' ILE . 19.6 t -75.11 111.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.638 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -16.67 13.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.728 -0.608 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.05 139.88 56.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.24 -0.912 . . . . 0.0 109.841 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.73 -42.71 90.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.1 p -63.09 -29.82 71.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.46 -157.07 24.46 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 8' ' ' VAL . 62.7 mt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.601 -0.941 . . . . 0.0 109.599 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.42 -60.7 7.67 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 120.852 -1.155 . . . . 0.0 111.001 -178.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.3 Cg_endo -69.7 -14.97 37.06 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.378 1.386 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -80.85 -23.96 38.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -0.831 . . . . 0.0 109.199 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -83.91 -30.04 26.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.192 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -74.31 -36.46 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.625 0.726 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.859 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.0 mt -78.13 -43.86 27.69 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.92 -0.488 . . . . 0.0 110.367 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.6 p -59.8 -29.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 0.0 109.804 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -74.27 -42.49 59.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -65.42 -61.39 2.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.499 -0.751 . . . . 0.0 110.158 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -58.94 -25.38 63.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 0.0 110.303 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.0 t -60.92 -39.02 87.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.279 -0.888 . . . . 0.0 109.155 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -66.95 -27.72 67.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.581 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 98.7 m-85 -89.72 119.53 30.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.723 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -65.61 -15.74 63.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.774 -0.579 . . . . 0.0 110.278 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.51 172.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.82 88.67 2.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.638 . . . . 0.0 109.441 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.922 HG12 ' HB2' ' A' ' 65' ' ' ALA . 28.8 m -89.72 111.19 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.392 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -110.43 133.43 53.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.458 -0.777 . . . . 0.0 109.876 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 61' ' ' ILE . 5.4 tt -90.22 148.63 22.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.68 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.39 107.55 12.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.51 -0.744 . . . . 0.0 109.445 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD1' HG12 ' A' ' 55' ' ' ILE . 15.2 t80 -92.88 71.69 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.441 -0.787 . . . . 0.0 110.003 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.66 85.57 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.656 -0.652 . . . . 0.0 111.592 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 -42.65 2.83 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -89.33 160.39 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.456 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -150.14 105.84 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.775 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.23 148.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 109.165 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.13 132.45 49.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.859 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.0 tm? -50.24 -28.22 7.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.783 ' HA ' HG23 ' A' ' 23' ' ' VAL . 18.7 mttt -90.76 61.18 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.861 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.0 t -150.44 86.79 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.593 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 22.5 mt -63.93 -61.81 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.982 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 ttm -64.35 -21.66 66.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.465 -0.772 . . . . 0.0 110.167 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.57 60.29 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 46' ' ' SER . 46.7 t -82.18 -32.21 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.411 -1.053 . . . . 0.0 109.718 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 47' ' ' ILE . 27.3 t -64.33 -28.4 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.781 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -69.48 -25.65 64.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 0.0 110.022 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 53' ' ' LEU . 4.2 mm? -64.71 -37.12 86.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.486 -0.759 . . . . 0.0 109.592 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.88 38.02 28.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG12 ' CD1' ' A' ' 37' ' ' TYR . 28.3 mt -69.59 144.24 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.54 -0.976 . . . . 0.0 109.264 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.59 -165.76 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.49 42.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.61 72.93 0.58 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.82 170.1 16.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.977 . . . . 0.0 109.602 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.77 143.41 48.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.693 . . . . 0.0 109.236 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 35' ' ' LEU . 14.3 pt -145.79 126.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.539 -0.726 . . . . 0.0 109.524 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -101.64 118.39 36.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.406 HD12 ' CD1' ' A' ' 6' ' ' PHE . 91.0 mt -102.13 151.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -150.25 109.91 4.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.515 -0.74 . . . . 0.0 110.131 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.922 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -89.85 134.98 33.9 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.71 107.67 4.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.77 -127.32 1.36 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.2 -70.07 0.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.973 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -93.14 49.54 1.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.632 -0.668 . . . . 0.0 109.326 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -64.2 -40.9 97.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 0.0 110.039 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -68.48 -43.09 77.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.0 -23.9 65.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 0.0 110.314 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.22 -46.65 15.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.285 -0.885 . . . . 0.0 111.391 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -59.21 -41.74 89.31 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.697 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.88 -26.36 60.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.903 . . . . 0.0 109.221 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -60.27 -61.57 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.78 . . . . 0.0 109.24 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -60.64 -29.25 69.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.404 -0.81 . . . . 0.0 109.793 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.23 -37.73 86.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.487 -0.758 . . . . 0.0 109.919 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 80' ' ' THR . 1.3 pt-20 -72.75 -28.56 62.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.402 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 54.4 m -68.2 -37.6 81.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -27.89 63.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.777 -0.577 . . . . 0.0 109.567 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -86.87 -17.64 32.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 110.453 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -75.04 -52.12 11.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.886 . . . . 0.0 109.806 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.48 -35.1 14.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.653 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 44.81 1.52 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 86' ' ' LEU . 81.6 mt -81.71 -29.33 33.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -1.006 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.15 169.09 41.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.569 -179.859 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.87 153.96 36.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.558 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -142.9 144.64 32.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.678 -0.639 . . . . 0.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -90.15 146.3 24.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.675 -0.641 . . . . 0.0 109.402 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.585 ' CE1' HD12 ' A' ' 63' ' ' ILE . 36.0 m-85 -126.86 161.32 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.576 -0.703 . . . . 0.0 109.561 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.02 133.77 55.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 14' ' ' ILE . 21.1 t -87.25 106.5 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.371 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 9' ' ' THR . 8.2 m -124.48 14.78 8.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 110.177 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 148.67 34.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -54.49 17.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.354 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -66.09 -29.3 69.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.565 -0.709 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.77 -159.31 20.27 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.667 HD11 HG22 ' A' ' 8' ' ' VAL . 62.6 mt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.995 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -57.77 -60.34 10.24 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.952 -1.093 . . . . 0.0 110.845 -178.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -70.39 -13.54 33.18 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.341 1.36 . . . . 0.0 110.983 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -80.19 -28.65 38.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 108.914 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.604 HG23 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -80.84 -27.25 36.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 17' ' ' ARG . 37.4 t -71.57 -40.84 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 44' ' ' LEU . 55.8 mt -69.25 -53.98 17.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.161 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.2 p -53.14 -28.17 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -71.41 -43.12 67.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.935 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -69.18 -59.64 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.389 -0.819 . . . . 0.0 109.947 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 77' ' ' LEU . . . -57.0 -21.59 31.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.465 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.7 t -58.9 -41.84 88.15 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -65.94 -29.51 69.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.438 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 68.9 m-85 -93.67 128.52 39.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.26 8.94 21.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.87 -178.44 1.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.96 75.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.834 HG12 ' HB2' ' A' ' 65' ' ' ALA . 29.2 m -89.71 124.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 109.395 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -135.03 142.8 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.612 -0.68 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.6 tt -89.62 159.16 17.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.725 ' N ' HD23 ' A' ' 35' ' ' LEU . 7.6 tt0 -127.12 125.67 41.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 73.8 t80 -160.39 145.5 14.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.504 -0.748 . . . . 0.0 109.784 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 61.3 34.82 18.37 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.631 -0.668 . . . . 0.0 110.018 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 29.5 70.21 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -135.33 178.92 6.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.59 -0.947 . . . . 0.0 109.083 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 m -143.74 114.12 7.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.23 147.71 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -68.11 134.74 51.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.846 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.3 tm? -53.39 -26.95 21.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.456 -0.778 . . . . 0.0 109.293 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.679 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -90.63 57.07 3.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -146.38 88.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.768 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.6 mt -69.21 -39.23 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 0.0 109.993 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.5 ttm -82.59 -29.5 30.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.755 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.03 -43.15 96.22 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 46' ' ' SER . 40.8 t -67.76 -34.01 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.49 -1.006 . . . . 0.0 109.385 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -66.4 -28.65 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.707 . . . . 0.0 109.561 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -62.03 -34.14 75.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.505 -0.747 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mp -70.83 -46.84 62.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.583 -0.698 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.68 65.57 2.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.604 HD13 HD12 ' A' ' 14' ' ' ILE . 14.5 mt -77.09 162.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.603 -0.939 . . . . 0.0 109.269 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -134.5 -175.06 3.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.655 -0.653 . . . . 0.0 109.618 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 153.23 42.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.598 -0.689 . . . . 0.0 109.496 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.3 55.45 10.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.535 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -132.68 179.49 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.557 -0.967 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -132.82 140.86 48.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.538 HD12 HD11 ' A' ' 35' ' ' LEU . 26.9 pt -138.78 161.3 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.459 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.37 121.58 21.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 109.644 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.585 HD12 ' CE1' ' A' ' 6' ' ' PHE . 90.8 mt -105.01 149.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 p -150.3 112.83 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.834 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.79 134.59 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.01 102.87 3.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.394 -0.816 . . . . 0.0 109.821 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.88 -125.23 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.06 -72.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.956 . . . . 0.0 109.666 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.26 55.84 1.55 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.72 . . . . 0.0 109.385 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.18 -28.26 69.93 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -74.78 -44.4 49.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.44 -0.788 . . . . 0.0 109.946 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.8 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.5 -46.27 14.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.01 -1.056 . . . . 0.0 110.49 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.12 -42.42 96.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.348 -0.845 . . . . 0.0 110.669 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.713 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.7 p-10 -75.77 -22.41 56.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 109.391 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -66.86 -59.13 3.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.339 -0.851 . . . . 0.0 108.707 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -61.69 -28.39 69.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.527 -0.733 . . . . 0.0 109.848 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' OE2' ' CE2' ' A' ' 6' ' ' PHE . 4.8 tt0 -61.18 -56.28 22.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.477 -0.764 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.68 -30.67 70.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -68.56 -32.48 72.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -0.822 . . . . 0.0 108.915 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 30.6 mmm -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -76.0 -22.59 55.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.731 -0.605 . . . . 0.0 110.03 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 p -66.1 -50.04 65.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.399 -0.813 . . . . 0.0 109.675 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -97.84 10.1 41.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.565 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.5 89.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 86' ' ' LEU . 35.3 mt -132.46 -60.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.628 -0.924 . . . . 0.0 109.401 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.22 150.4 22.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -64.6 152.71 41.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -150.44 137.73 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.652 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.4 m -89.85 139.71 30.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.632 -0.667 . . . . 0.0 109.357 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.02 169.5 11.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 109.868 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 137.88 52.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.592 -0.693 . . . . 0.0 109.342 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.634 ' CG2' HG23 ' A' ' 61' ' ' ILE . 21.3 t -90.51 108.09 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.59 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -129.1 22.25 5.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.59 -0.694 . . . . 0.0 109.884 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.68 159.06 29.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.07 -61.75 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.562 -0.711 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -71.04 -29.36 65.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.718 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.18 -139.55 14.98 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.745 ' HB ' HD12 ' A' ' 55' ' ' ILE . 55.4 mt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.597 -0.943 . . . . 0.0 109.391 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.99 -54.07 51.15 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.906 -1.121 . . . . 0.0 111.092 -178.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -73.13 -21.44 20.44 Favored 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 121.115 1.21 . . . . 0.0 110.293 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -75.43 -21.43 58.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.33 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.52 -31.89 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.129 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.2 -45.21 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.3 mt -68.7 -49.57 57.88 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.8 p -55.93 -29.64 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.83 -36.16 70.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.913 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -72.43 -59.25 2.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.473 -0.767 . . . . 0.0 110.148 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.14 31.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.478 -0.764 . . . . 0.0 110.738 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.1 p -59.94 -42.61 94.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.289 -0.882 . . . . 0.0 109.645 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -28.02 69.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.609 -0.682 . . . . 0.0 109.622 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 78.5 m-85 -94.8 131.48 40.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.429 -0.794 . . . . 0.0 109.633 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.23 -11.46 57.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.668 -0.645 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.3 155.73 8.55 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.039 -1.038 . . . . 0.0 109.82 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.62 82.0 6.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.581 -0.699 . . . . 0.0 109.528 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.755 HG12 ' CB ' ' A' ' 65' ' ' ALA . 33.9 m -89.68 121.97 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -124.5 126.24 45.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 110.105 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.4 tt -89.97 155.45 19.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' N ' HD23 ' A' ' 35' ' ' LEU . 31.0 tt0 -122.16 158.53 29.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 110.053 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.808 ' CE1' HG23 ' A' ' 55' ' ' ILE . 34.3 t80 -145.48 98.46 3.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.04 -81.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.24 26.85 1.56 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -125.24 121.07 33.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.569 -0.96 . . . . 0.0 109.116 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.31 100.85 12.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.539 -0.726 . . . . 0.0 110.057 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.06 147.65 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -71.67 142.21 49.87 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 22' ' ' LEU . 1.6 tm? -58.02 -30.43 66.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.803 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.74 60.8 4.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -149.79 81.23 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.76 ' O ' HG23 ' A' ' 51' ' ' VAL . 37.6 mt -64.81 -38.66 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.697 -0.627 . . . . 0.0 109.662 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.81 -24.34 59.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.546 -0.721 . . . . 0.0 110.04 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 -31.24 46.08 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 46' ' ' SER . 45.7 t -79.92 -38.44 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -1.047 . . . . 0.0 109.485 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -62.9 -30.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.7 p -67.52 -32.64 73.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 50' ' ' VAL . 15.4 mt -74.0 -55.78 5.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.544 -0.722 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.43 63.77 1.69 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.808 HG23 ' CE1' ' A' ' 37' ' ' TYR . 61.8 mt -76.2 159.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.974 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.445 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -142.13 -175.04 4.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.707 -0.621 . . . . 0.0 109.558 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -70.46 146.96 49.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.628 -0.67 . . . . 0.0 109.603 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.42 61.88 2.39 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.33 -178.58 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.582 -0.952 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -128.49 148.48 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.634 HG23 ' CG2' ' A' ' 8' ' ' VAL . 19.3 pt -139.81 154.63 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.76 113.11 11.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.12 155.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.25 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 p -150.22 101.04 2.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.841 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.755 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.76 122.38 32.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.4 104.78 4.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 109.707 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.4 -125.2 0.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.58 -69.74 0.71 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.642 -0.917 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.67 49.17 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.78 -32.41 70.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.475 -0.766 . . . . 0.0 110.023 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.35 -33.18 72.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -77.47 -23.25 50.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 110.051 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.401 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -68.16 -42.12 80.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.698 ' N ' HD12 ' A' ' 74' ' ' LEU . 39.5 p30 -78.39 -18.86 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.31 -58.8 3.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.195 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -71.08 -24.96 62.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.82 -59.11 4.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.91 -28.55 67.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.355 -0.84 . . . . 0.0 109.771 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 40.6 m -67.25 -35.89 80.48 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.33 -28.4 64.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.699 -0.626 . . . . 0.0 109.422 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -83.0 -21.55 33.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.113 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 p -75.08 -53.61 8.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -80.17 -29.1 38.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 109.562 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.57 37.32 7.02 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.02 -37.38 26.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.691 -0.887 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.39 163.06 34.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.415 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.651 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.7 155.74 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.423 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.8 tttt -140.1 141.19 36.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.685 . . . . 0.0 109.645 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 m -99.13 158.99 15.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.2 m-85 -143.87 161.79 37.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -121.6 118.72 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.134 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.59 116.42 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.652 -0.655 . . . . 0.0 109.588 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -117.44 -16.03 10.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.726 -0.608 . . . . 0.0 110.357 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 151.97 36.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.68 -43.53 72.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -64.3 -32.5 74.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.589 -0.694 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.66 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.822 ' HB ' HD12 ' A' ' 55' ' ' ILE . 46.9 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.594 -0.944 . . . . 0.0 109.428 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.4 ttt180 -53.77 -52.98 62.66 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.046 -1.034 . . . . 0.0 111.109 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -74.27 -24.6 14.3 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.137 1.225 . . . . 0.0 110.332 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.36 -20.88 61.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.55 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.515 HG23 ' CD1' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -85.77 -34.16 21.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 108.979 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG12 HG21 ' A' ' 80' ' ' THR . 19.0 t -69.95 -34.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.9 mt -76.38 -51.5 11.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.397 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.8 p -54.17 -27.38 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.292 -0.88 . . . . 0.0 109.918 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.76 -45.63 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.676 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.401 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 21.4 m -61.05 -59.37 5.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 109.822 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.496 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -61.52 -26.43 67.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.041 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -59.86 -33.3 71.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -77.09 -26.32 53.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.619 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.528 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 96.3 m-85 -89.81 123.8 34.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.57 -24.21 67.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.692 -0.63 . . . . 0.0 109.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 141.76 53.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.401 -0.812 . . . . 0.0 109.789 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -89.51 98.56 11.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.587 -0.696 . . . . 0.0 109.235 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.777 HG12 ' CB ' ' A' ' 65' ' ' ALA . 32.1 m -89.96 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.575 -0.703 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -131.96 132.84 43.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -121.27 128.73 52.65 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.477 -0.764 . . . . 0.0 109.903 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.693 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 51.9 t80 -160.49 138.49 9.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.718 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.87 37.08 15.58 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.536 -0.727 . . . . 0.0 109.754 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.76 27.98 64.93 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -123.35 168.98 11.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.943 . . . . 0.0 109.026 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.8 m -142.22 103.52 4.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 109.95 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.83 146.2 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -69.19 142.79 54.2 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -64.05 -13.45 47.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.33 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.764 ' HA ' HG23 ' A' ' 23' ' ' VAL . 27.4 mttt -88.1 48.72 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.85 -1.157 . . . . 0.0 107.984 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 50' ' ' VAL . 21.9 t -150.54 82.36 1.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.0 109.049 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 51' ' ' VAL . 30.1 mt -63.63 -41.31 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.725 -0.61 . . . . 0.0 109.543 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.44 -29.98 66.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.29 -30.06 69.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 46' ' ' SER . 40.6 t -81.56 -31.13 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.97 . . . . 0.0 109.343 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.1 t -70.21 -31.68 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.616 -0.677 . . . . 0.0 109.397 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 p -63.89 -37.2 86.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.38 -46.62 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.605 -0.684 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.55 71.54 1.09 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.822 HD12 ' HB ' ' A' ' 14' ' ' ILE . 59.5 mt -84.36 162.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.624 -0.927 . . . . 0.0 109.389 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.486 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -149.11 -174.14 4.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.602 -0.686 . . . . 0.0 109.617 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.9 150.31 42.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.712 -0.617 . . . . 0.0 109.686 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 62.7 3.14 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -143.63 164.88 29.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.942 . . . . 0.0 109.62 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -126.2 123.04 37.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.601 HD13 HD11 ' A' ' 14' ' ' ILE . 21.9 pt -117.56 130.52 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.687 . . . . 0.0 109.293 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.07 115.27 29.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.52 -0.738 . . . . 0.0 109.804 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 ' CE1' ' A' ' 6' ' ' PHE . 81.6 mt -101.93 149.85 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.581 -0.699 . . . . 0.0 109.183 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 p -147.22 108.89 4.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.637 -0.664 . . . . 0.0 109.675 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.777 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.75 131.16 35.85 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.61 107.18 7.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -145.72 8.16 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -64.4 1.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.943 . . . . 0.0 109.65 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.14 44.34 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 14.3 pt-20 -62.03 -32.21 72.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.35 -33.29 69.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 109.578 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.19 -24.13 54.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.761 . . . . 0.0 110.07 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.795 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.78 -41.51 23.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 110.457 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.22 -41.84 96.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.294 -0.878 . . . . 0.0 110.4 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.713 ' N ' HD12 ' A' ' 74' ' ' LEU . 40.8 p30 -76.54 -21.04 56.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.25 -0.907 . . . . 0.0 109.763 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.444 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -67.78 -56.49 9.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.747 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.795 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.41 -28.24 69.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -54.31 47.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.462 -0.774 . . . . 0.0 109.66 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.68 -27.48 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.643 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.462 HG21 HG12 ' A' ' 21' ' ' VAL . 1.6 m -67.9 -33.89 75.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -28.74 64.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.68 -0.638 . . . . 0.0 109.293 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -81.51 -25.29 36.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.602 -0.686 . . . . 0.0 110.116 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 p -72.32 -58.89 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 109.69 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -75.17 -41.23 58.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 109.451 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.6 44.33 1.98 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.77 -38.57 25.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.578 -0.954 . . . . 0.0 109.463 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.57 150.38 14.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.454 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -160.24 155.57 25.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.69 -0.631 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.697 ' HG3' HD13 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -140.06 147.61 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.631 -0.668 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -99.38 146.53 26.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 80.4 m-85 -138.53 162.58 34.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -123.15 138.2 54.71 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.902 HG13 HD11 ' A' ' 14' ' ' ILE . 15.5 t -87.68 118.89 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.729 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -128.36 9.61 6.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 144.13 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.525 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.52 -34.41 74.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 p -71.14 -29.83 65.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.485 -0.759 . . . . 0.0 109.582 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.32 -150.62 19.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.902 HD11 HG13 ' A' ' 8' ' ' VAL . 15.6 mm . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.54 -0.977 . . . . 0.0 109.215 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.076 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -56.02 -52.59 71.39 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.954 -1.091 . . . . 0.0 111.112 -178.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.523 ' HB3' HD22 ' A' ' 86' ' ' LEU . 31.3 Cg_endo -71.84 -25.15 20.4 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.189 1.26 . . . . 0.0 110.497 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -71.09 -26.08 62.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 108.96 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 m -79.21 -30.2 43.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.477 -0.764 . . . . 0.0 109.27 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.67 -48.99 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.107 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB3' HD11 ' A' ' 44' ' ' LEU . 94.7 mt -65.8 -54.38 27.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.843 HG11 HD11 ' A' ' 47' ' ' ILE . 14.4 p -50.85 -30.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.388 -0.82 . . . . 0.0 110.739 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.33 -47.63 63.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.74 . . . . 0.0 110.339 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.525 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 2.8 m -65.96 -56.53 11.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -62.27 -17.78 59.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.442 -0.787 . . . . 0.0 110.437 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -64.66 -29.48 70.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.71 23.72 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.734 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.485 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 65.9 m-85 -131.79 120.14 22.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -22.19 66.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.655 -0.653 . . . . 0.0 109.958 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 147.52 34.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.0 109.818 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.75 89.74 7.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.616 -0.678 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.799 HG12 ' CB ' ' A' ' 65' ' ' ALA . 27.6 m -89.89 138.65 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -133.77 135.47 43.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.786 HD12 HG12 ' A' ' 63' ' ' ILE . 4.8 tp -95.78 131.29 42.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -108.73 119.4 39.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 110.449 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.615 ' CE1' HG23 ' A' ' 55' ' ' ILE . 28.7 t80 -103.82 97.52 7.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 72.37 -81.27 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.828 -0.545 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.04 26.76 2.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -124.52 116.06 21.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -1.014 . . . . 0.0 109.012 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -91.5 104.15 16.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.428 -0.795 . . . . 0.0 110.321 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.25 147.86 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -68.2 140.37 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.853 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.1 tm? -57.96 -27.32 63.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.429 -0.795 . . . . 0.0 109.035 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.649 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.8 mttm -90.02 51.5 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.805 . . . . 0.0 109.118 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.679 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.3 t -137.87 91.96 2.63 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.843 HD11 HG11 ' A' ' 23' ' ' VAL . 40.3 mm -68.11 -62.54 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.682 -0.636 . . . . 0.0 109.641 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -66.5 -25.76 66.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 109.91 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.6 -30.13 75.89 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 46' ' ' SER . 41.3 t -88.69 -30.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.513 -0.992 . . . . 0.0 109.442 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -69.05 -29.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.484 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -66.52 -30.41 70.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.717 . . . . 0.0 109.589 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 50' ' ' VAL . 27.1 mt -62.93 -66.43 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.723 . . . . 0.0 109.39 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.71 52.33 0.86 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.615 HG23 ' CE1' ' A' ' 37' ' ' TYR . 38.7 mt -78.5 150.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.548 -0.972 . . . . 0.0 109.041 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.96 -164.28 1.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.573 -0.705 . . . . 0.0 109.804 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -66.64 153.89 41.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 109.703 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.15 57.85 13.96 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -126.1 173.97 8.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.667 -0.902 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -128.37 141.13 51.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.653 ' HB ' HD11 ' A' ' 35' ' ' LEU . 13.1 pt -142.76 126.02 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.54 -0.725 . . . . 0.0 109.373 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 m -106.89 110.07 22.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.532 -0.73 . . . . 0.0 109.828 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.786 HG12 HD12 ' A' ' 35' ' ' LEU . 79.2 mt -94.19 150.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -150.1 109.75 4.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.67 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.799 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.82 132.52 35.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.38 102.67 4.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.362 -0.836 . . . . 0.0 109.748 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.45 -134.38 2.57 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.49 -58.82 2.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.95 . . . . 0.0 109.476 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.13 47.96 1.04 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.527 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 16.8 pt-20 -66.9 -40.35 87.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 110.114 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -70.31 -35.64 73.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.897 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.88 -24.18 59.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 110.105 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.815 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.65 -44.07 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.823 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -61.79 -42.8 99.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.293 -0.88 . . . . 0.0 110.635 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.715 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.0 p-10 -72.48 -27.51 62.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 0.0 109.151 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 25' ' ' THR . . . -61.19 -58.36 8.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 109.254 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -65.72 -22.66 66.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -62.71 1.46 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.34 -34.51 73.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.313 -0.867 . . . . 0.0 109.906 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.8 m -63.15 -32.87 74.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.408 -0.807 . . . . 0.0 108.971 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.33 -30.95 66.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -82.02 -19.18 40.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.655 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.7 p -80.66 -45.51 17.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 109.739 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -81.06 -28.74 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.729 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 32.26 8.02 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 18' ' ' PRO . 91.4 mt -81.72 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.665 -0.903 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.19 -173.08 13.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.665 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -107.32 150.12 27.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -142.18 150.78 41.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.7 -0.625 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 m -105.3 151.09 24.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 109.291 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.64 166.03 24.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.493 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -113.1 134.57 54.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.618 -0.676 . . . . 0.0 109.301 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.728 ' CG2' HG23 ' A' ' 61' ' ' ILE . 26.9 t -89.27 99.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 109.564 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -123.37 27.15 7.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 155.2 31.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -65.46 -43.71 89.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.265 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -101.15 21.77 13.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 109.851 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.34 -136.79 47.64 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.464 HG22 HG11 ' A' ' 50' ' ' VAL . 61.3 mt . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.573 -0.957 . . . . 0.0 109.426 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.1 -52.46 68.28 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 111.521 -178.398 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -72.89 -23.89 18.29 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.19 1.26 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -75.36 -22.26 57.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 109.526 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.41 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -83.72 -31.19 26.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.225 179.787 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG12 HG21 ' A' ' 80' ' ' THR . 17.6 t -71.53 -42.95 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.722 0.772 . . . . 0.0 108.998 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.78 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.2 mt -70.47 -50.31 39.4 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.463 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.6 p -55.3 -28.88 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -73.01 -36.83 67.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.485 -0.759 . . . . 0.0 109.861 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -73.94 -63.78 1.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.456 -0.777 . . . . 0.0 110.202 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -56.54 -25.08 50.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -61.3 -40.9 95.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -68.36 -26.47 65.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.442 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.1 m-85 -89.85 128.32 36.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.342 -0.849 . . . . 0.0 109.725 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.29 -23.44 62.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.666 -0.646 . . . . 0.0 110.291 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 146.06 26.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.305 -0.872 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 91.05 8.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.538 -0.726 . . . . 0.0 109.263 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.847 HG12 ' CB ' ' A' ' 65' ' ' ALA . 28.9 m -89.91 113.93 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.673 -0.642 . . . . 0.0 109.335 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -105.93 137.25 44.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 tt -100.72 116.27 32.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -89.61 143.21 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.843 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.561 ' CD2' HD23 ' A' ' 53' ' ' LEU . 15.1 t80 -132.38 68.9 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.7 . . . . 0.0 109.547 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.56 62.26 2.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.3 -38.85 2.95 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -89.15 90.88 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -1.031 . . . . 0.0 109.195 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.4 m -95.91 112.55 24.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 110.11 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.1 147.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -65.59 141.81 58.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.833 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.5 tm? -56.87 -29.58 63.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 109.139 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.764 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.97 61.02 4.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -148.78 88.74 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.597 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 34.1 mt -71.72 -40.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.618 -0.676 . . . . 0.0 109.937 -179.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -30.2 45.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 109.691 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.4 92.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 46' ' ' SER . 47.4 t -63.06 -28.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.54 -0.976 . . . . 0.0 109.52 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 47' ' ' ILE . 23.5 t -70.18 -31.3 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 109.401 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -62.89 -41.02 99.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.768 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.561 HD23 ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -63.11 -33.51 75.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 109.431 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.84 23.65 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 37' ' ' TYR . 54.6 mt -75.92 147.46 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.615 -0.933 . . . . 0.0 109.327 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.68 -167.52 1.84 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.52 150.34 32.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.577 -0.702 . . . . 0.0 109.538 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.84 3.7 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 179.97 6.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.941 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.16 136.19 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.728 HG23 ' CG2' ' A' ' 8' ' ' VAL . 31.6 pt -124.38 162.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.668 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 63' ' ' ILE . 21.0 m -136.34 161.26 36.3 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.402 ' N ' HG22 ' A' ' 62' ' ' THR . 30.2 mt -146.26 150.95 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.409 -0.807 . . . . 0.0 109.768 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -150.52 108.13 3.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.67 -0.643 . . . . 0.0 109.578 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.847 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.63 130.43 35.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 109.08 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 102.22 5.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.2 -142.24 5.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.16 -57.96 2.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.588 -0.948 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -96.72 48.3 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.688 . . . . 0.0 109.359 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.665 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 6.4 pt-20 -66.89 -29.08 68.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 109.744 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -77.74 -36.23 51.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.497 -0.752 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 29.9 m-20 -76.16 -20.72 57.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.117 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.769 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.36 -44.26 17.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.906 . . . . 0.0 110.296 -179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.83 -42.45 94.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.466 -0.771 . . . . 0.0 110.285 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.704 ' N ' HD12 ' A' ' 74' ' ' LEU . 23.8 p30 -78.55 -19.8 52.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.462 -0.774 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.76 -54.32 20.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -66.56 -30.9 71.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.665 -0.647 . . . . 0.0 109.6 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.18 -52.19 66.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.43 -0.794 . . . . 0.0 110.122 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.83 -29.44 70.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.58 HG21 HG12 ' A' ' 21' ' ' VAL . 88.2 m -67.67 -33.26 74.58 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.8 mtt -67.87 -29.29 68.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -84.64 -23.49 29.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.569 -0.707 . . . . 0.0 110.184 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -73.54 -55.33 6.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -85.06 -27.92 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.524 -0.735 . . . . 0.0 109.679 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.18 1.48 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 86' ' ' LEU . 98.0 mt -106.78 -37.8 6.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.957 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.84 158.34 30.83 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.245 0.545 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -99.91 157.06 16.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.782 . . . . 0.0 109.234 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -146.32 137.78 24.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 m -89.69 159.48 17.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.674 . . . . 0.0 109.244 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CD2' HD12 ' A' ' 63' ' ' ILE . 85.6 m-85 -145.4 143.31 30.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.6 -0.687 . . . . 0.0 109.69 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.57 127.92 46.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.214 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 59' ' ' ALA . 20.5 t -85.96 134.21 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 9' ' ' THR . 6.2 m -149.6 27.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.583 -0.698 . . . . 0.0 109.587 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.58 146.7 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -58.87 5.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.1 p -69.67 -31.31 69.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.687 . . . . 0.0 109.408 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.06 -154.22 16.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.434 ' CB ' HD12 ' A' ' 55' ' ' ILE . 38.7 mm . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.973 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.074 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.8 ttp85 -59.06 -55.17 49.1 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.77 -1.206 . . . . 0.0 111.094 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.0 Cg_endo -69.93 -21.51 32.59 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.04 1.16 . . . . 0.0 110.417 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.69 -22.53 50.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 109.272 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.461 ' HA ' HG12 ' A' ' 23' ' ' VAL . 6.5 m -81.13 -29.38 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.81 . . . . 0.0 109.152 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.24 -41.1 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -69.52 -51.78 32.53 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.297 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -57.55 -28.26 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.389 -0.819 . . . . 0.0 109.816 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -69.96 -36.64 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -60.22 2.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.627 -0.67 . . . . 0.0 110.13 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -58.83 -24.83 62.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.473 -0.767 . . . . 0.0 110.359 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 t -60.84 -39.23 88.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -23.21 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.671 -0.643 . . . . 0.0 109.885 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.658 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m-85 -89.46 127.72 35.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -0.865 . . . . 0.0 109.632 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.87 -22.8 62.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.72 -0.612 . . . . 0.0 109.905 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.17 45.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 109.715 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.67 93.9 9.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.56 -0.713 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.733 HG12 ' CB ' ' A' ' 65' ' ' ALA . 18.2 m -89.84 127.72 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -118.91 126.68 52.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 110.486 -178.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.562 HD21 ' HB ' ' A' ' 61' ' ' ILE . 2.3 tt -89.79 133.73 34.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -113.35 130.16 56.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.448 -0.782 . . . . 0.0 110.167 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE2' HG12 ' A' ' 55' ' ' ILE . 35.7 t80 -160.46 136.95 8.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.55 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.28 37.44 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.581 -0.7 . . . . 0.0 109.748 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.96 28.76 66.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -127.17 111.37 13.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.599 -0.942 . . . . 0.0 109.158 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -89.79 87.78 7.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.866 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -97.33 146.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.147 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -73.64 152.44 40.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.5 tp -69.61 -9.04 52.49 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.288 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 11.1 mttt -88.7 48.79 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.764 -1.21 . . . . 0.0 107.991 178.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.665 ' O ' HG23 ' A' ' 50' ' ' VAL . 13.8 t -150.41 95.43 2.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.381 -0.825 . . . . 0.0 109.298 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.665 HG23 ' HB3' ' A' ' 19' ' ' ALA . 29.7 mt -76.97 -38.81 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.677 -0.639 . . . . 0.0 109.557 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpt -74.65 -34.03 62.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.59 99.24 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 46' ' ' SER . 42.7 t -62.11 -28.31 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.98 . . . . 0.0 109.424 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -63.2 -35.06 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 p -63.5 -34.58 78.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.643 -0.66 . . . . 0.0 109.365 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 42' ' ' VAL . 32.9 mt -66.01 -59.02 4.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 109.333 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.2 67.32 1.54 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 56' ' ' ALA . 50.2 mt -81.22 162.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.557 -0.967 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.98 178.57 9.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.572 -0.705 . . . . 0.0 109.463 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -62.02 137.97 58.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.48 39.96 9.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -120.47 179.59 4.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.604 -0.939 . . . . 0.0 109.468 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -137.95 153.2 49.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.678 -0.639 . . . . 0.0 109.365 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.562 ' HB ' HD21 ' A' ' 35' ' ' LEU . 20.7 pt -150.19 132.47 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.88 107.51 18.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.558 -0.714 . . . . 0.0 109.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.499 HD12 ' CD2' ' A' ' 6' ' ' PHE . 82.0 mt -94.11 153.81 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -148.04 107.96 4.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.67 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.733 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 125.92 35.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.526 -0.734 . . . . 0.0 109.06 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.85 107.12 8.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.32 8.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.61 -58.02 3.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 0.0 109.536 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.63 42.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.671 . . . . 0.0 109.361 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.01 -29.24 70.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.588 -0.695 . . . . 0.0 109.798 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -78.15 -33.46 50.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -76.42 -22.15 55.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.721 . . . . 0.0 110.125 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.804 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.54 -42.52 20.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.696 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.08 -42.35 94.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.693 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.696 ' N ' HD12 ' A' ' 74' ' ' LEU . 19.6 p30 -75.06 -22.53 58.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 109.622 -179.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.658 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -67.33 -59.5 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 108.745 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -62.83 -28.88 70.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.52 -0.737 . . . . 0.0 109.781 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.33 -55.9 26.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.459 -0.776 . . . . 0.0 109.938 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -58.73 -27.24 64.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 110.038 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -70.91 -36.86 72.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 mmt -71.0 -29.85 65.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.754 -0.591 . . . . 0.0 109.459 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -83.5 -21.75 32.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.575 -0.703 . . . . 0.0 110.229 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -75.2 -70.22 0.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 109.781 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -62.2 -28.22 69.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.713 . . . . 0.0 109.753 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.79 39.91 5.41 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 86' ' ' LEU . 93.7 mt -81.81 -56.12 4.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.552 -0.97 . . . . 0.0 109.373 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.78 176.54 27.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.57 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.29 153.15 20.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.599 -0.688 . . . . 0.0 109.441 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 7.3 tttp -141.71 149.47 40.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 109.374 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -89.92 153.02 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.534 -0.729 . . . . 0.0 109.476 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.563 ' CD1' HD12 ' A' ' 63' ' ' ILE . 76.7 m-85 -142.27 145.49 34.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.624 -0.672 . . . . 0.0 109.398 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.97 126.93 52.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 14' ' ' ILE . 31.2 t -81.61 116.1 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.589 -0.694 . . . . 0.0 109.552 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -134.34 26.37 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 86' ' ' LEU . . . -77.46 164.55 25.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 109.466 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.55 -34.22 73.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.572 -0.705 . . . . 0.0 109.316 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -114.48 24.25 12.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.73 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.65 -139.07 46.77 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.688 HD11 HG22 ' A' ' 8' ' ' VAL . 48.8 mt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.906 . . . . 0.0 109.307 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.63 -53.72 59.48 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.961 -1.087 . . . . 0.0 110.829 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -73.88 -21.67 18.34 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.113 1.208 . . . . 0.0 110.456 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.25 -24.03 60.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.258 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.468 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -84.55 -31.12 24.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 109.16 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 17' ' ' ARG . 23.3 t -73.03 -35.48 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.721 0.772 . . . . 0.0 109.047 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' C ' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -77.87 -43.35 30.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.996 -0.44 . . . . 0.0 110.554 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 47' ' ' ILE . 10.7 p -61.72 -27.94 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 109.681 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -72.43 -50.35 26.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.528 -0.733 . . . . 0.0 110.025 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -61.57 -59.07 5.77 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.51 -0.743 . . . . 0.0 109.991 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -58.78 -23.51 60.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -38.98 83.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -29.06 69.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.483 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.638 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 96.5 m-85 -89.65 118.37 29.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.46 -15.68 62.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.657 -0.652 . . . . 0.0 110.243 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.35 29.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.7 86.95 6.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.391 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.712 HG12 ' CB ' ' A' ' 65' ' ' ALA . 16.7 m -89.73 119.98 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -112.12 132.82 54.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.732 . . . . 0.0 109.994 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 36' ' ' GLU . 5.0 tt -89.93 135.12 33.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.661 ' N ' HD23 ' A' ' 35' ' ' LEU . 34.2 tt0 -105.93 140.36 39.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.737 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.626 ' CE1' HG23 ' A' ' 55' ' ' ILE . 27.5 t80 -140.82 84.54 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.667 -0.646 . . . . 0.0 109.532 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.42 52.06 6.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.614 -0.679 . . . . 0.0 110.089 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.86 -12.96 64.17 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.412 -0.899 . . . . 0.0 110.874 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -89.48 86.91 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -1.175 . . . . 0.0 109.348 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 m -91.63 92.97 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.879 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.94 147.5 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.01 142.55 57.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD23 ' HB3' ' A' ' 26' ' ' ALA . 7.2 tp -64.14 -13.75 50.27 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.618 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.22 48.36 1.63 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.186 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 50' ' ' VAL . 16.8 t -150.27 84.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.818 . . . . 0.0 109.139 -179.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.667 HD11 HG11 ' A' ' 23' ' ' VAL . 33.1 mt -67.45 -46.31 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 0.0 109.255 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 ttm -64.35 -29.74 70.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.634 -0.667 . . . . 0.0 109.36 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.07 91.88 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 46' ' ' SER . 21.8 t -70.49 -39.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.972 . . . . 0.0 109.286 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 47' ' ' ILE . 33.7 t -64.11 -30.63 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -68.14 -31.6 71.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.637 -0.664 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.91 -67.58 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.79 47.8 1.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 37' ' ' TYR . 15.5 mt -63.73 157.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.953 . . . . 0.0 109.122 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -136.01 -170.49 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -84.13 150.66 25.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 109.474 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.02 46.95 14.53 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.33 178.46 6.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.481 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.78 147.75 49.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.679 . . . . 0.0 109.466 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.418 ' HB ' HD21 ' A' ' 35' ' ' LEU . 28.4 pt -142.5 157.36 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -131.37 109.63 10.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 109.639 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.563 HD12 ' CD1' ' A' ' 6' ' ' PHE . 90.0 mt -92.32 152.41 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.729 . . . . 0.0 109.145 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -150.2 109.54 3.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.78 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.712 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 126.64 35.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 103.86 5.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.475 -0.766 . . . . 0.0 109.618 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.54 -130.85 1.8 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.86 -74.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.629 -0.924 . . . . 0.0 109.59 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -90.34 53.0 2.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 16.4 pt-20 -67.8 -30.45 69.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.869 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.27 -37.81 60.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.712 . . . . 0.0 109.797 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.83 -24.88 58.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 110.19 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.784 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.9 -43.18 20.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.832 . . . . 0.0 110.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -62.51 -42.01 99.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.9 p-10 -74.13 -26.93 60.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 -60.77 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.805 . . . . 0.0 109.28 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -61.95 -28.07 69.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 109.969 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -56.61 19.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.919 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.79 -28.28 69.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -67.8 -32.59 73.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -30.78 66.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -81.17 -24.17 37.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.635 -0.666 . . . . 0.0 109.989 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -73.98 -69.33 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.61 -28.79 70.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.45 44.73 5.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 93.3 mt -81.87 -33.82 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.612 -0.934 . . . . 0.0 109.572 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.03 153.45 10.85 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.387 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -91.56 153.48 19.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 10.3 tttm -143.28 150.31 39.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.659 . . . . 0.0 109.631 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -97.16 152.42 18.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 63' ' ' ILE . 96.5 m-85 -142.08 148.2 38.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.627 -0.671 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -110.11 117.61 34.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.712 . . . . 0.0 109.145 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.727 HG22 HD11 ' A' ' 14' ' ' ILE . 15.5 t -74.15 112.97 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.736 -0.602 . . . . 0.0 109.503 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.6 17.62 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.701 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.25 38.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 109.373 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.12 91.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.552 -0.717 . . . . 0.0 109.716 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -75.17 -29.61 60.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.438 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 -166.38 24.87 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 8' ' ' VAL . 62.8 mt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.567 -0.96 . . . . 0.0 109.435 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -57.88 -60.96 8.36 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.875 -1.141 . . . . 0.0 110.575 -178.594 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.59 -13.67 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.265 1.31 . . . . 0.0 110.786 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -79.91 -26.12 40.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 108.974 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.403 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -82.09 -29.78 31.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -0.755 . . . . 0.0 109.056 179.389 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.38 -43.93 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.1 mt -69.11 -51.6 36.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.465 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.9 p -53.44 -29.54 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -70.75 -40.68 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.411 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 22.7 m -69.52 -63.95 0.97 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.926 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -54.92 -24.91 25.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.468 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 t -60.06 -44.86 94.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 109.328 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -65.45 -28.85 69.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.623 -0.673 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -89.65 129.91 36.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 109.269 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.23 -7.98 58.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.618 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.4 168.93 1.87 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.98 . . . . 0.0 109.707 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.99 87.09 4.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.429 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.926 HG12 ' HB2' ' A' ' 65' ' ' ALA . 19.0 m -95.84 98.64 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -107.11 131.89 53.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 0.0 109.761 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.821 HD11 HD12 ' A' ' 61' ' ' ILE . 8.5 tt -89.99 153.19 20.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.328 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' N ' HD23 ' A' ' 35' ' ' LEU . 9.1 tp10 -126.07 145.25 50.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.759 . . . . 0.0 109.447 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.617 ' HB3' HD23 ' A' ' 53' ' ' LEU . 29.9 t80 -160.29 108.48 1.66 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.531 -0.731 . . . . 0.0 109.835 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.82 50.52 8.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 109.93 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.49 27.98 71.71 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.41 97.92 5.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 109.133 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -91.79 102.02 14.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.557 -0.714 . . . . 0.0 110.062 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.95 147.46 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.87 135.37 52.4 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.879 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.5 tm? -53.99 -25.62 21.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.373 -0.829 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.7 mttt -90.61 54.58 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.86 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -145.64 85.22 1.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 19' ' ' ALA . 30.7 mt -67.42 -40.32 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.708 -0.62 . . . . 0.0 110.118 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.4 ttt -74.45 -27.68 60.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.48 -0.762 . . . . 0.0 109.835 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.89 59.14 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 46' ' ' SER . 37.4 t -67.39 -38.58 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -1.017 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -29.17 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.47 -0.768 . . . . 0.0 109.626 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.9 p -65.77 -29.62 70.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 37' ' ' TYR . 9.5 mp -62.49 -56.09 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.561 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.18 43.65 3.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.625 HD13 HD12 ' A' ' 14' ' ' ILE . 42.2 mt -70.88 158.0 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -1.003 . . . . 0.0 109.3 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.94 -164.47 1.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.551 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -66.94 130.14 42.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.586 -0.696 . . . . 0.0 109.568 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.65 79.7 0.94 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -147.97 167.35 25.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.611 -0.934 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.51 119.85 23.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 109.27 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 35' ' ' LEU . 26.5 pt -120.33 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.717 . . . . 0.0 109.556 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -112.25 111.84 23.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.603 -0.685 . . . . 0.0 109.738 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.548 HD12 ' CE2' ' A' ' 6' ' ' PHE . 90.1 mt -92.41 158.75 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 63' ' ' ILE . 5.5 p -150.31 103.13 3.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.926 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.96 123.66 36.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.49 105.77 4.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.56 -124.89 0.93 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.02 -65.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.962 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -97.97 53.83 1.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.18 -29.76 68.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.531 -0.73 . . . . 0.0 109.816 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.43 -36.16 58.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.769 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.84 -23.9 58.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.703 . . . . 0.0 110.111 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.85 -43.6 19.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.825 . . . . 0.0 110.722 -179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -63.87 -41.53 97.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.23 -0.919 . . . . 0.0 110.542 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.718 ' N ' HD12 ' A' ' 74' ' ' LEU . 24.5 p-10 -76.81 -22.49 53.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 -179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB1' ' CG2' ' A' ' 25' ' ' THR . . . -68.98 -53.96 17.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.258 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -73.22 -26.34 61.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.513 -0.742 . . . . 0.0 109.995 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -58.47 6.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.416 -0.802 . . . . 0.0 109.76 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -29.11 68.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.449 -0.782 . . . . 0.0 109.702 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.0 m -68.49 -34.22 75.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmm -71.49 -32.25 68.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.636 -0.665 . . . . 0.0 109.455 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -77.28 -27.38 53.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.66 -0.65 . . . . 0.0 109.951 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 p -71.46 -70.66 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.485 -0.759 . . . . 0.0 109.637 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -64.43 -28.29 69.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.691 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.57 45.35 6.49 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 86' ' ' LEU . 96.2 mt -83.33 -37.9 22.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.579 -0.953 . . . . 0.0 109.845 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.67 114.4 0.5 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.994 . . . . 0.0 109.613 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.642 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 154.34 1.66 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.361 -0.837 . . . . 0.0 110.563 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -139.66 165.78 26.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.682 -0.636 . . . . 0.0 109.48 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -118.18 126.78 52.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' A' ' 63' ' ' ILE . 73.7 m-85 -109.44 150.15 28.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.584 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.86 117.11 33.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.415 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.624 HG13 HD11 ' A' ' 14' ' ' ILE . 26.6 t -76.22 124.19 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.648 -0.657 . . . . 0.0 109.661 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 9' ' ' THR . 9.2 m -142.5 21.57 2.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.899 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 143.39 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.1 -43.56 70.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.533 -0.73 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -69.04 -35.59 76.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 0.0 109.462 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.73 -164.15 12.97 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' A' ' 55' ' ' ILE . 27.2 mm . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.978 . . . . 0.0 109.307 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.9 mmm180 -59.58 -61.27 8.2 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.958 -1.088 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.9 Cg_endo -69.49 -17.48 38.78 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.296 1.33 . . . . 0.0 110.669 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.1 -25.95 52.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.483 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.7 m -82.98 -29.92 28.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.25 -41.85 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.669 0.747 . . . . 0.0 109.162 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' A' ' 44' ' ' LEU . 97.2 mt -71.97 -47.02 55.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.978 -0.451 . . . . 0.0 110.587 -179.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.2 p -59.07 -28.92 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -44.22 70.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.648 -0.657 . . . . 0.0 110.011 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -66.67 -59.68 3.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.484 -0.76 . . . . 0.0 110.013 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -57.61 -22.14 43.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 110.499 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.2 t -59.13 -40.91 86.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.277 -0.89 . . . . 0.0 109.719 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -69.05 -26.62 65.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.73 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.684 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 94.1 m-85 -89.82 121.6 32.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.64 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.36 -18.84 63.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.691 -0.631 . . . . 0.0 110.089 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.8 148.46 25.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.212 -0.93 . . . . 0.0 109.848 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -89.78 92.05 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.728 HG12 ' CB ' ' A' ' 65' ' ' ALA . 17.0 m -91.69 120.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -117.7 134.22 55.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.972 HD11 HD12 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -89.5 145.59 25.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.05 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.38 129.11 55.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.397 -0.815 . . . . 0.0 110.084 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.443 ' CD2' HG12 ' A' ' 55' ' ' ILE . 54.1 t80 -160.33 141.42 12.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.533 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.79 33.78 17.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.722 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.76 30.16 74.19 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -125.32 175.29 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.626 -0.926 . . . . 0.0 108.989 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.5 m -148.65 101.2 3.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.11 146.49 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.644 -0.66 . . . . 0.0 109.227 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -70.22 140.82 52.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -62.85 -15.51 54.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.203 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -88.26 49.68 1.84 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 50' ' ' VAL . 7.0 t -150.07 90.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.696 HG23 ' HB3' ' A' ' 19' ' ' ALA . 32.1 mt -71.43 -45.48 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.824 -0.548 . . . . 0.0 109.773 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ttt -66.17 -27.22 67.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.771 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.91 -37.15 51.04 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 46' ' ' SER . 41.5 t -65.56 -35.8 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.516 -0.991 . . . . 0.0 109.45 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.72 -29.3 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.493 -0.754 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.0 p -62.76 -33.09 74.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.566 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mp -74.55 -55.01 6.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.489 -0.757 . . . . 0.0 109.277 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.03 64.99 2.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.628 HD12 ' HB ' ' A' ' 14' ' ' ILE . 15.2 mt -74.5 162.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.97 . . . . 0.0 109.165 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -136.33 -172.04 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.579 -0.7 . . . . 0.0 109.746 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 142.92 38.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.58 8.03 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.94 166.91 17.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.961 . . . . 0.0 109.434 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.25 123.03 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.677 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.972 HD12 HD11 ' A' ' 35' ' ' LEU . 29.9 pt -113.87 138.68 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.551 -0.718 . . . . 0.0 109.366 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.09 108.73 19.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.762 . . . . 0.0 109.692 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.716 HG12 HD12 ' A' ' 35' ' ' LEU . 86.7 mt -93.27 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -150.08 106.45 3.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.638 -0.664 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.728 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.99 124.99 35.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 108.93 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.439 -0.788 . . . . 0.0 109.831 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -142.44 6.37 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.53 -63.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.991 . . . . 0.0 109.381 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -97.63 41.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.662 -0.648 . . . . 0.0 109.334 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -49.15 78.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.659 -0.65 . . . . 0.0 110.794 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.519 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.4 m120 -60.89 -36.4 79.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.156 -0.965 . . . . 0.0 109.983 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.3 -22.88 60.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.587 -0.696 . . . . 0.0 110.651 -179.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.748 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.04 -48.04 13.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.925 . . . . 0.0 110.852 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.742 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -60.65 -45.05 95.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.304 -0.872 . . . . 0.0 110.857 -178.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.742 ' N ' HD12 ' A' ' 74' ' ' LEU . 21.1 p-10 -68.87 -27.34 65.72 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.684 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -63.75 -54.7 31.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 108.758 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.05 -28.72 70.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.643 -0.661 . . . . 0.0 109.783 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -62.31 -53.99 47.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -60.31 -27.9 67.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.813 . . . . 0.0 109.922 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -71.54 -33.79 69.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.4 mmm -71.66 -31.82 67.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -82.12 -21.37 36.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 110.155 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.0 p -59.54 -40.28 86.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.972 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -111.76 -50.74 2.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.575 -0.703 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.03 54.29 0.19 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 86' ' ' LEU . 84.6 mt -85.56 -63.6 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.595 -0.944 . . . . 0.0 109.608 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 118.82 1.14 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.478 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -178.97 153.52 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 109.21 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -151.88 139.39 19.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.615 -0.678 . . . . 0.0 109.848 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.3 m -89.92 121.15 31.77 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.72 ' CD1' HD12 ' A' ' 63' ' ' ILE . 71.6 m-85 -103.71 152.29 21.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.65 . . . . 0.0 109.694 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -100.71 131.25 46.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.559 -0.713 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 55' ' ' ILE . 17.2 t -90.04 114.49 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.516 -0.74 . . . . 0.0 109.632 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -135.42 21.18 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.595 -0.691 . . . . 0.0 109.857 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.22 32.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.545 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -69.8 -50.53 42.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -73.45 -30.31 63.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -152.62 18.86 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.764 ' HB ' HD12 ' A' ' 55' ' ' ILE . 17.7 mm -109.52 58.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.98 . . . . 0.0 109.143 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.418 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.62 76.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.873 -1.142 . . . . 0.0 112.563 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.18 -54.18 44.26 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 120.919 -1.113 . . . . 0.0 111.347 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.0 Cg_endo -72.56 -25.61 17.52 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 C-N-CA 121.36 1.373 . . . . 0.0 110.313 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -71.45 -21.39 61.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.558 -0.714 . . . . 0.0 109.332 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -85.02 -31.23 23.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 17' ' ' ARG . 17.1 t -71.29 -37.64 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.664 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.0 mt -75.01 -50.4 16.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.009 -0.432 . . . . 0.0 110.299 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.768 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.7 p -53.91 -29.12 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.241 -0.912 . . . . 0.0 109.95 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -73.6 -39.85 64.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.704 . . . . 0.0 109.472 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -68.49 -66.62 0.55 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -54.71 -23.25 16.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.52 -0.737 . . . . 0.0 110.47 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.29 -45.0 92.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.405 -0.809 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -62.7 -28.62 70.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.643 -0.661 . . . . 0.0 109.479 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.95 129.17 36.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 -16.93 59.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.703 -0.623 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 150.96 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.21 -0.931 . . . . 0.0 109.91 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.01 83.38 6.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.696 -0.628 . . . . 0.0 109.49 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.758 HG12 ' CB ' ' A' ' 65' ' ' ALA . 22.1 m -89.67 123.53 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.41 146.22 48.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.55 -0.719 . . . . 0.0 110.036 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.73 HD11 HD12 ' A' ' 61' ' ' ILE . 2.9 tt -96.31 157.09 16.06 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.519 ' N ' HD23 ' A' ' 35' ' ' LEU . 2.6 tt0 -124.09 134.21 53.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.514 -0.741 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.615 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 67.2 t80 -160.17 129.33 5.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.0 109.785 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.34 30.89 20.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.631 -0.668 . . . . 0.0 109.975 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.26 30.46 71.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.38 116.46 17.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.579 -0.954 . . . . 0.0 109.296 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -96.13 107.86 20.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.612 -0.68 . . . . 0.0 109.96 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.7 148.06 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -65.23 132.75 49.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.861 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.3 tm? -52.05 -26.78 11.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.768 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.92 53.83 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -143.47 84.78 1.82 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.686 HD11 HG11 ' A' ' 23' ' ' VAL . 26.8 mt -67.88 -40.11 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.764 -0.585 . . . . 0.0 109.776 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 tpt -76.52 -26.12 54.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.568 -0.708 . . . . 0.0 109.878 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.03 -31.98 57.12 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 46' ' ' SER . 39.4 t -73.52 -27.8 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.551 -0.97 . . . . 0.0 109.638 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 47' ' ' ILE . 25.2 t -62.01 -33.73 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.376 -0.828 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.0 p -63.26 -31.89 73.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.66 -45.51 61.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.86 62.31 5.61 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.764 HD12 ' HB ' ' A' ' 14' ' ' ILE . 54.4 mt -75.74 153.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.985 . . . . 0.0 109.34 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.43 -166.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.0 109.702 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 142.07 34.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.649 -0.657 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 43.61 6.25 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.615 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -137.5 178.98 6.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.961 . . . . 0.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -132.77 153.5 51.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 109.488 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 35' ' ' LEU . 27.1 pt -141.21 144.33 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.606 -0.684 . . . . 0.0 109.286 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.02 116.71 27.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.596 -0.69 . . . . 0.0 109.772 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD12 ' CD1' ' A' ' 6' ' ' PHE . 85.8 mt -102.84 151.03 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 p -150.4 113.34 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.529 -0.732 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.758 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.81 130.48 36.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.4 99.88 3.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.81 -138.36 3.77 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.96 -74.14 0.34 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.975 . . . . 0.0 109.388 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.78 50.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.4 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.31 -31.44 70.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 109.983 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 2' ' ' ALA . 1.0 OUTLIER -73.95 -35.93 64.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.39 -0.819 . . . . 0.0 109.835 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 -26.38 63.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.428 -0.795 . . . . 0.0 110.31 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -78.93 -45.03 21.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 111.259 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -60.62 -41.8 95.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -0.935 . . . . 0.0 110.603 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.694 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.97 -25.7 60.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 29' ' ' TYR . . . -64.0 -57.04 10.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.04 -28.44 70.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 109.842 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.24 -55.05 36.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.62 -26.64 65.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.485 -0.759 . . . . 0.0 110.089 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.4 m -72.07 -34.9 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -28.51 63.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.744 -0.597 . . . . 0.0 109.474 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -85.21 -23.32 28.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.709 . . . . 0.0 110.107 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -67.3 -50.64 59.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.396 -0.815 . . . . 0.0 109.657 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.49 -42.55 9.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.8 43.41 0.95 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 86' ' ' LEU . 92.4 mt -81.84 -31.33 31.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.981 . . . . 0.0 109.463 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.16 168.88 42.01 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.654 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.05 153.37 48.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 129.09 26.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 109.657 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.869 ' OG1' HG23 ' A' ' 62' ' ' THR . 45.9 m -99.13 136.55 38.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.611 -0.681 . . . . 0.0 109.374 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 63' ' ' ILE . 76.7 m-85 -119.54 174.49 6.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.564 -0.71 . . . . 0.0 109.718 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.6 129.72 54.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.612 -0.68 . . . . 0.0 109.217 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HD11 ' A' ' 14' ' ' ILE . 21.5 t -89.74 113.34 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.577 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 16.31 3.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.704 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.14 34.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.289 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -62.1 -49.92 73.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.502 -0.749 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -69.12 -28.81 66.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.576 -0.702 . . . . 0.0 109.554 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.35 -152.01 23.11 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 8' ' ' VAL . 61.8 mt -113.76 77.81 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.979 . . . . 0.0 109.394 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.409 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.07 80.5 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.822 -1.174 . . . . 0.0 112.256 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -54.58 -54.96 43.02 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.929 -1.107 . . . . 0.0 111.285 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.64 -22.74 23.82 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.114 1.21 . . . . 0.0 110.347 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.493 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.86 -22.63 59.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.423 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -83.13 -29.75 28.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.256 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.17 -40.16 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 109.178 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 44' ' ' LEU . 96.1 mt -73.25 -43.81 60.48 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.954 -0.467 . . . . 0.0 110.394 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.3 p -61.52 -29.83 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.873 . . . . 0.0 109.479 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -45.42 74.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.556 -0.715 . . . . 0.0 109.753 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -64.3 -60.48 3.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.465 -0.772 . . . . 0.0 109.758 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 45' ' ' LYS . . . -57.8 -20.92 39.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.608 -0.683 . . . . 0.0 110.624 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -60.45 -40.6 91.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -66.58 -32.11 73.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 109.374 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 71.9 m-85 -90.96 130.34 36.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.563 -0.71 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.2 14.13 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 177.65 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.71 78.21 2.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.772 HG12 ' HB2' ' A' ' 65' ' ' ALA . 17.5 m -89.39 85.86 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.677 -0.639 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.0 123.71 34.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.738 -0.602 . . . . 0.0 109.956 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 63' ' ' ILE . 42.0 tp -91.51 133.57 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -119.42 129.53 54.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.627 -0.671 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.755 ' HB3' HD22 ' A' ' 53' ' ' LEU . 16.2 t80 -116.4 74.16 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.65 -0.656 . . . . 0.0 109.834 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 48.3 85.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.574 -0.704 . . . . 0.0 111.409 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.95 -37.72 3.33 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB3' HD21 ' A' ' 53' ' ' LEU . 12.5 mmtt -89.64 161.56 16.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.396 -1.061 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 m -150.1 75.93 1.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.613 -0.679 . . . . 0.0 109.708 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.764 ' CG2' HD11 ' A' ' 53' ' ' LEU . 3.6 m -92.52 145.14 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -71.87 141.79 49.55 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 22' ' ' LEU . 1.6 tm? -54.9 -27.62 44.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.408 -0.808 . . . . 0.0 109.168 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.71 56.1 3.17 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -150.21 89.87 1.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 19' ' ' ALA . 21.0 mt -66.43 -37.15 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.814 -0.554 . . . . 0.0 109.796 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 ttm -75.28 -24.93 57.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.69 -0.631 . . . . 0.0 109.906 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.12 44.68 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 46' ' ' SER . 53.1 t -68.33 -43.94 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.997 . . . . 0.0 109.209 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.59 -29.33 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 p -70.96 -26.27 63.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 0.0 109.802 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.764 HD11 ' CG2' ' A' ' 42' ' ' VAL . 61.5 mt -59.67 -33.88 72.13 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.466 -0.771 . . . . 0.0 109.958 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.03 38.41 35.45 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 56' ' ' ALA . 34.6 mt -75.45 163.59 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.968 . . . . 0.0 109.123 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.478 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -148.56 -162.38 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.902 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -85.99 68.83 10.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.63 63.95 0.01 OUTLIER Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.474 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -141.88 -175.72 4.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.884 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -132.32 132.52 43.03 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.209 -0.664 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.583 ' HB ' HD11 ' A' ' 35' ' ' LEU . 22.9 pt -122.53 151.1 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.714 . . . . 0.0 109.545 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.869 HG23 ' OG1' ' A' ' 5' ' ' THR . 7.3 m -139.95 108.43 5.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.8 mp -91.43 161.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.582 -0.699 . . . . 0.0 109.85 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 63' ' ' ILE . 9.7 p -150.62 105.95 3.36 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.772 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -90.88 135.14 33.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.96 92.42 1.72 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -0.778 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.27 129.14 1.15 Allowed Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 55.88 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.677 -0.896 . . . . 0.0 111.031 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -122.81 64.13 0.97 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 110.003 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.654 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 14.5 pt-20 -57.84 -35.24 70.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.48 -0.763 . . . . 0.0 110.342 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 -32.94 73.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.514 -0.742 . . . . 0.0 110.093 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.73 -25.31 53.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.453 -0.779 . . . . 0.0 110.457 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.792 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.93 -40.8 23.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.814 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -66.35 -42.21 88.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 0.0 110.451 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.709 ' N ' HD12 ' A' ' 74' ' ' LEU . 22.2 p-10 -75.09 -22.99 57.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.385 -0.822 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -65.81 -58.68 5.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.091 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.792 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -69.74 -25.15 63.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -0.772 . . . . 0.0 110.064 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HA ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -62.81 -59.57 4.68 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.311 -0.868 . . . . 0.0 109.965 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -60.17 -28.97 68.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 109.774 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -66.46 -35.58 80.63 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.713 -0.617 . . . . 0.0 109.641 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -85.33 -21.59 28.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.495 -0.753 . . . . 0.0 110.283 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.8 p -70.66 -52.59 20.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.79 -29.07 22.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.539 -0.726 . . . . 0.0 109.549 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.18 5.56 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 86' ' ' LEU . 74.0 mt -81.58 -44.72 16.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.644 -0.915 . . . . 0.0 109.53 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.47 141.92 7.19 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.399 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.17 153.57 25.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -140.09 164.91 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.569 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -112.12 128.78 56.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.608 -0.682 . . . . 0.0 109.329 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 63' ' ' ILE . 78.0 m-85 -117.53 150.19 39.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.418 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.72 129.49 51.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 59' ' ' ALA . 21.5 t -90.78 118.46 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.731 -0.606 . . . . 0.0 109.554 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 9' ' ' THR . 19.5 m -140.24 24.81 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 109.755 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.82 149.28 34.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.457 -0.777 . . . . 0.0 109.47 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.16 -45.53 69.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.605 -0.685 . . . . 0.0 109.499 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -76.02 -31.66 59.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.618 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.25 -148.17 17.96 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.563 HD12 HG21 ' A' ' 55' ' ' ILE . 59.9 mt -113.66 79.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.989 . . . . 0.0 109.498 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.717 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.717 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -57.29 -42.58 81.99 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.161 -0.962 . . . . 0.0 112.943 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 15' ' ' HIP . 1.9 ttt85 -56.52 -57.16 25.13 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.744 -1.223 . . . . 0.0 111.082 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -70.11 -17.81 35.74 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.076 1.184 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.646 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -80.65 -21.98 40.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.539 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 2.6 m -83.41 -31.32 26.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.58 -39.23 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.799 0.809 . . . . 0.0 108.933 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.5 mt -72.95 -49.78 27.33 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.539 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.3 p -57.74 -29.44 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.87 -43.09 72.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.465 -0.772 . . . . 0.0 109.835 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -66.48 -59.84 3.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.934 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -59.62 -23.62 63.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.542 -0.724 . . . . 0.0 110.373 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.2 t -61.73 -37.53 84.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.372 -0.83 . . . . 0.0 109.425 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.34 -20.67 60.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.719 -0.613 . . . . 0.0 110.169 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.68 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 85.5 m-85 -89.54 128.02 35.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.27 -0.893 . . . . 0.0 109.597 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -70.13 -24.93 63.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.646 . . . . 0.0 109.711 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.8 39.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.803 . . . . 0.0 109.852 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.72 95.57 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.672 -0.642 . . . . 0.0 109.565 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.628 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.8 m -89.85 142.85 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -132.6 130.59 40.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.29 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 36' ' ' GLU . 2.5 tt -89.83 139.11 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.709 ' N ' HD23 ' A' ' 35' ' ' LEU . 7.0 tt0 -113.96 113.97 25.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 109.842 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.702 ' CE1' HG23 ' A' ' 55' ' ' ILE . 13.6 t80 -95.47 68.02 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.511 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m120 48.13 85.07 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.551 -0.718 . . . . 0.0 111.178 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.12 -39.82 2.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -89.53 159.01 17.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.398 -1.06 . . . . 0.0 109.37 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -150.18 91.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.585 -0.697 . . . . 0.0 109.885 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -65.48 146.08 55.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.618 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -65.54 -12.06 49.44 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.823 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -88.47 48.73 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 50' ' ' VAL . 46.7 t -150.14 95.54 2.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.828 . . . . 0.0 109.164 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 19' ' ' ALA . 28.8 mt -77.12 -40.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.716 -0.615 . . . . 0.0 109.589 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.65 -29.1 63.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.52 -29.43 67.96 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 46' ' ' SER . 43.8 t -73.65 -43.47 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -1.046 . . . . 0.0 109.452 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.42 -29.81 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.618 -0.676 . . . . 0.0 109.588 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.8 p -66.57 -30.65 71.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.8 mt -63.67 -51.32 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.635 -0.665 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.37 50.33 2.41 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.702 HG23 ' CE1' ' A' ' 37' ' ' TYR . 55.2 mt -77.0 159.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.59 -0.947 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -147.82 179.38 7.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.852 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -61.84 147.17 47.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.529 -0.732 . . . . 0.0 109.78 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 64.07 2.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -150.37 125.11 9.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.991 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.04 124.58 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.565 -0.709 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' HB ' HD21 ' A' ' 35' ' ' LEU . 32.3 pt -112.48 160.85 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.555 -0.716 . . . . 0.0 109.249 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 m -136.0 111.5 9.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.645 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 6' ' ' PHE . 90.2 mt -91.9 160.28 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 63' ' ' ILE . 9.6 p -149.91 101.21 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.104 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.628 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.97 126.87 35.9 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.88 111.4 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 -135.1 2.91 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.94 -57.08 3.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.583 -0.951 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -104.83 45.86 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.571 -0.706 . . . . 0.0 109.302 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -60.44 -37.01 79.55 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.571 -0.705 . . . . 0.0 110.191 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 74.7 m-80 -67.77 -37.77 82.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 109.985 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.66 -25.28 62.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.393 -0.817 . . . . 0.0 110.138 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -79.87 -42.1 24.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.409 -0.807 . . . . 0.0 111.21 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.0 pp -62.02 -41.59 98.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.19 -0.944 . . . . 0.0 110.271 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.68 ' N ' HD12 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -76.17 -23.58 54.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.333 -0.854 . . . . 0.0 109.788 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.68 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -63.89 -60.09 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 109.306 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.91 -28.82 69.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.007 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -59.31 -52.64 64.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 109.841 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -63.3 -27.53 69.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.596 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.0 m -68.89 -31.59 70.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.7 mmt -71.35 -30.8 66.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -86.22 -17.43 34.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 110.316 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 p -73.11 -52.95 12.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -100.9 10.71 40.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.45 99.01 0.01 OUTLIER Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 mt -140.5 -50.71 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.519 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.04 139.36 6.42 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.996 . . . . 0.0 109.522 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.72 152.34 26.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.655 -0.653 . . . . 0.0 109.589 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -142.69 142.7 32.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.566 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 m -95.14 128.58 42.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.687 -0.633 . . . . 0.0 109.373 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.546 ' CD1' HD12 ' A' ' 63' ' ' ILE . 85.4 m-85 -112.88 152.62 29.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.619 -0.676 . . . . 0.0 109.583 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -116.06 116.34 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.623 -0.673 . . . . 0.0 109.203 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.715 HG22 HD11 ' A' ' 14' ' ' ILE . 11.4 t -75.5 118.93 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.346 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -116.63 -15.26 10.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.618 -0.676 . . . . 0.0 110.333 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.18 146.3 39.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.149 -0.97 . . . . 0.0 109.887 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -49.76 71.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.657 . . . . 0.0 109.574 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -63.26 -30.96 72.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.499 -0.751 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.86 -138.39 14.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 8' ' ' VAL . 57.1 mt -122.48 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.937 . . . . 0.0 109.541 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.628 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -58.69 -35.64 72.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.153 -0.967 . . . . 0.0 112.264 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HB2' ' NE2' ' A' ' 15' ' ' HIP . 9.8 mtm180 -58.24 -60.13 11.17 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.879 -1.138 . . . . 0.0 110.527 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.669 ' HB3' HD13 ' A' ' 86' ' ' LEU . 32.4 Cg_endo -70.7 -15.94 33.59 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.318 1.345 . . . . 0.0 110.681 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.568 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.56 -25.92 50.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.212 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.417 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -83.54 -30.47 27.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.22 -36.79 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.672 0.748 . . . . 0.0 109.044 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB3' HD21 ' A' ' 44' ' ' LEU . 72.2 mt -75.26 -44.81 43.87 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.999 -0.438 . . . . 0.0 110.366 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.843 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.7 p -60.7 -29.07 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.677 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.31 -36.91 63.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.503 -0.748 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 m -67.33 -60.07 2.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.48 -0.762 . . . . 0.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -59.1 -21.79 59.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.446 -0.784 . . . . 0.0 110.107 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.8 t -57.2 -38.9 74.38 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.285 -0.884 . . . . 0.0 109.758 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.98 -30.01 66.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.585 -0.697 . . . . 0.0 109.42 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 77.4 m-85 -92.65 124.97 37.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.523 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -82.24 2.8 30.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 110.625 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.2 -179.78 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.544 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.34 80.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 0.0 109.41 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 65' ' ' ALA . 34.8 m -89.61 111.84 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.671 . . . . 0.0 109.248 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -120.64 134.12 55.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.551 -0.718 . . . . 0.0 110.028 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.3 tt -92.35 154.95 18.24 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.647 ' N ' HD23 ' A' ' 35' ' ' LEU . 23.1 tt0 -134.4 129.93 36.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.459 -0.776 . . . . 0.0 109.865 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.435 ' CD2' HG12 ' A' ' 55' ' ' ILE . 39.3 t80 -160.31 132.47 6.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 109.687 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 60.16 40.71 17.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.52 -0.737 . . . . 0.0 109.978 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.78 28.09 65.16 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.24 102.79 7.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.582 -0.952 . . . . 0.0 109.129 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 m -93.5 99.85 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.593 -0.692 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.65 146.55 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -67.79 143.02 56.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 22' ' ' LEU . 7.4 tp -62.99 -14.98 54.54 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.164 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.843 ' HA ' HG23 ' A' ' 23' ' ' VAL . 2.4 mptt -87.67 49.98 1.91 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 50' ' ' VAL . 23.3 t -150.24 99.23 2.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.0 mt -79.39 -39.94 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 109.858 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 ttt -75.75 -17.72 59.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.426 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -90.03 -44.55 4.73 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 46' ' ' SER . 45.0 t -61.32 -29.44 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.444 -1.033 . . . . 0.0 109.788 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' ILE . 40.6 t -75.93 -30.68 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.48 -0.763 . . . . 0.0 109.285 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -62.23 -26.66 68.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.443 -0.786 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 49' ' ' GLY . 1.7 mp -62.06 -52.73 62.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.87 54.74 1.48 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.525 HD12 ' HB ' ' A' ' 14' ' ' ILE . 46.7 mt -77.44 157.67 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.539 -0.977 . . . . 0.0 109.337 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.41 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.2 -171.22 3.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.567 -0.708 . . . . 0.0 109.421 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -68.19 144.75 54.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.641 -0.662 . . . . 0.0 109.625 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.79 54.76 7.0 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.14 155.89 48.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.956 . . . . 0.0 109.472 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.37 122.06 43.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.565 -0.71 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.612 HD12 HD11 ' A' ' 35' ' ' LEU . 22.6 pt -118.23 133.23 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -104.65 120.34 41.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.528 -0.732 . . . . 0.0 109.872 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.546 HD12 ' CD1' ' A' ' 6' ' ' PHE . 82.3 mt -110.5 148.77 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.46 112.55 4.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.552 -0.717 . . . . 0.0 110.194 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.877 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -91.14 130.07 37.07 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.89 105.29 5.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.854 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.92 -136.05 3.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.9 -73.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.988 . . . . 0.0 109.659 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -90.31 51.9 2.12 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.682 -0.636 . . . . 0.0 109.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.579 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 10.4 pt-20 -67.66 -28.33 67.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.5 -0.75 . . . . 0.0 109.81 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -77.57 -35.22 53.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 109.561 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 38.6 m-20 -76.8 -20.47 56.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.47 -0.769 . . . . 0.0 110.107 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.804 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.65 -43.65 18.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.49 -42.91 91.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.349 -0.845 . . . . 0.0 110.547 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.71 ' N ' HD12 ' A' ' 74' ' ' LEU . 44.7 p-10 -75.87 -22.11 56.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.25 -57.58 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -64.34 -31.18 72.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.569 -0.707 . . . . 0.0 109.648 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -58.55 -52.62 64.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.174 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -62.22 -27.58 69.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 m -69.11 -32.76 72.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -70.83 -31.5 68.24 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -77.89 -27.85 49.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.727 -0.608 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -77.41 -66.33 0.85 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.501 -0.75 . . . . 0.0 109.651 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.87 -28.71 69.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.571 -0.706 . . . . 0.0 109.713 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 34.99 15.86 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 18' ' ' PRO . 92.7 mt -81.95 -39.49 23.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.647 -0.914 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.52 30.1 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.548 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.71 152.62 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -143.99 149.33 36.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.623 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 m -99.48 119.01 37.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 109.554 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.448 ' CD1' HD12 ' A' ' 63' ' ' ILE . 68.4 m-85 -98.61 162.15 13.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.675 -0.641 . . . . 0.0 109.336 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 135.0 52.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.345 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.87 107.33 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.596 -0.69 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -122.3 -1.43 9.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.547 -0.721 . . . . 0.0 110.562 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.57 136.42 57.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.131 -0.98 . . . . 0.0 109.577 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.49 -38.97 92.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.516 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -72.48 -30.94 64.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.531 -0.731 . . . . 0.0 109.395 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -151.59 20.04 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 55' ' ' ILE . 23.8 mm -109.27 82.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.592 -0.946 . . . . 0.0 109.335 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.54 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -71.69 -32.11 67.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.91 -1.119 . . . . 0.0 112.423 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -60.51 -51.34 80.62 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.752 -1.217 . . . . 0.0 111.291 -178.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -73.08 -23.67 17.99 Favored 'Trans proline' 0 C--N 1.326 -0.637 0 C-N-CA 121.036 1.157 . . . . 0.0 110.474 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -72.25 -27.76 62.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.352 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.438 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.2 m -81.83 -29.51 32.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.522 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.696 HG12 HG21 ' A' ' 80' ' ' THR . 29.9 t -71.76 -40.05 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.829 0.823 . . . . 0.0 108.858 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' C ' HD11 ' A' ' 44' ' ' LEU . 95.7 mt -71.43 -51.4 24.09 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.941 -0.474 . . . . 0.0 110.208 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.8 p -54.79 -27.65 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.38 -0.825 . . . . 0.0 110.037 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -74.12 -37.86 63.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.709 . . . . 0.0 109.959 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -72.8 -62.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 0.0 110.147 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -57.71 -20.71 36.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.13 -40.85 91.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -71.06 -22.57 62.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.624 -0.672 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.4 130.21 35.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 0.0 109.647 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -73.61 -25.96 60.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.676 -0.64 . . . . 0.0 109.754 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 145.26 44.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.448 -0.783 . . . . 0.0 109.639 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.63 97.09 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.608 -0.683 . . . . 0.0 109.602 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CB ' ' A' ' 65' ' ' ALA . 21.4 m -92.56 138.68 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -132.48 142.16 49.11 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.456 -0.778 . . . . 0.0 110.332 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 61' ' ' ILE . 8.8 tt -102.47 122.61 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.44 150.75 21.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.474 -0.766 . . . . 0.0 110.026 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 55' ' ' ILE . 26.9 t80 -160.38 115.27 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.733 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 64.04 27.1 14.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.673 -0.642 . . . . 0.0 110.285 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.7 -18.13 51.55 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.338 -0.934 . . . . 0.0 110.892 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.85 112.28 23.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.228 -1.16 . . . . 0.0 109.169 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 m -95.84 114.19 25.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.699 -0.625 . . . . 0.0 109.842 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.95 147.68 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -70.27 136.39 49.82 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.877 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.2 tm? -55.03 -25.15 28.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.429 -0.795 . . . . 0.0 109.405 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.557 ' HA ' HG23 ' A' ' 23' ' ' VAL . 9.4 mttt -90.28 56.57 3.42 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -150.37 86.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.636 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 15.4 mt -61.28 -60.73 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.739 -0.601 . . . . 0.0 109.723 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 ttp -66.64 -27.2 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.7 74.87 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 46' ' ' SER . 45.8 t -87.93 -32.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -1.067 . . . . 0.0 109.529 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' C ' ' A' ' 15' ' ' HIP . 33.6 t -71.85 -23.8 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.471 -0.768 . . . . 0.0 109.861 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.3 p -59.24 -39.62 83.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.282 -0.886 . . . . 0.0 109.793 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 53' ' ' LEU . 4.0 mp -63.82 -34.02 76.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.211 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.07 4.74 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 14' ' ' ILE . 51.3 mt -75.41 153.73 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.963 . . . . 0.0 109.175 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.19 -179.0 6.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.701 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -62.47 136.08 57.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.756 -0.59 . . . . 0.0 109.652 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.77 56.86 1.69 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.37 -178.52 6.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.995 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -136.5 159.55 41.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.68 . . . . 0.0 109.277 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 35' ' ' LEU . 21.3 pt -150.22 138.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -115.63 105.66 13.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.695 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.448 HD12 ' CD1' ' A' ' 6' ' ' PHE . 88.8 mt -92.4 148.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 p -150.52 112.92 4.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.578 -0.701 . . . . 0.0 109.631 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.822 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -90.26 134.47 34.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.66 104.66 6.14 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.7 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.22 -145.21 8.22 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -59.55 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.637 -0.92 . . . . 0.0 109.584 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -96.28 42.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.602 -0.686 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.15 -32.81 73.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.707 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -72.04 -50.0 32.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 109.461 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -61.9 -21.81 65.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 0.0 110.339 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -79.03 -51.8 9.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.363 -0.836 . . . . 0.0 111.557 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -56.34 -42.34 77.56 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.006 . . . . 0.0 110.809 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -72.14 -27.08 62.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.0 109.106 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -60.42 -61.38 2.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.378 -0.826 . . . . 0.0 109.148 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.2 mp -60.56 -25.89 66.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.736 . . . . 0.0 109.86 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -60.55 -54.45 45.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.41 -0.806 . . . . 0.0 109.961 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -61.79 -27.37 68.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.303 -0.873 . . . . 0.0 109.714 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.696 HG21 HG12 ' A' ' 21' ' ' VAL . 54.2 m -68.66 -34.51 75.82 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.0 mmt -71.58 -31.87 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -91.52 -6.17 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.702 -0.624 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 p -78.09 -50.24 12.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -98.2 -59.52 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.553 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 139.55 69.22 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 86' ' ' LEU . 95.3 mt -109.39 -50.41 3.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.631 -0.923 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.55 154.24 25.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.445 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 65' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -178.01 151.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.671 -0.643 . . . . 0.0 109.28 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -146.41 148.76 32.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.618 -0.676 . . . . 0.0 109.58 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 m -89.59 133.12 34.77 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.824 ' CE1' HD12 ' A' ' 63' ' ' ILE . 67.5 m-85 -117.57 148.58 41.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.954 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.72 115.75 29.6 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.849 HG22 HD11 ' A' ' 14' ' ' ILE . 8.9 t -68.86 109.93 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.687 -0.633 . . . . 0.0 109.402 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -117.03 -8.81 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 110.466 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.53 142.07 57.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.096 -1.003 . . . . 0.0 109.63 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.54 -40.75 97.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.582 -0.699 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -74.83 -30.19 61.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.626 -0.671 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.71 -145.54 17.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.849 HD11 HG22 ' A' ' 8' ' ' VAL . 52.9 mt -114.69 59.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.632 -0.922 . . . . 0.0 109.292 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.424 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.25 -46.0 57.84 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.757 -1.215 . . . . 0.0 112.191 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -50.34 -53.13 48.03 Favored Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 120.965 -1.084 . . . . 0.0 111.542 -178.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -73.38 -25.2 15.68 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.389 1.392 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.68 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.83 -18.6 60.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.526 -0.734 . . . . 0.0 109.615 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.428 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -87.03 -32.99 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 108.941 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.57 -35.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HB3' HD21 ' A' ' 44' ' ' LEU . 68.4 mt -76.38 -51.24 12.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.018 0.437 . . . . 0.0 110.248 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 47' ' ' ILE . 11.4 p -54.8 -27.78 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.32 -0.862 . . . . 0.0 109.976 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -44.81 55.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.588 -0.695 . . . . 0.0 109.727 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -62.06 -62.23 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.546 -0.721 . . . . 0.0 109.845 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -55.22 -22.67 18.76 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.443 -0.786 . . . . 0.0 110.715 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -43.39 90.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.258 -0.901 . . . . 0.0 109.884 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -66.61 -29.32 69.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -90.05 126.9 35.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.487 -0.758 . . . . 0.0 109.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.84 -17.66 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.741 -0.599 . . . . 0.0 110.283 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.87 147.14 29.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.203 -0.936 . . . . 0.0 109.922 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.34 90.59 8.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG12 ' CB ' ' A' ' 65' ' ' ALA . 19.6 m -89.75 128.21 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -124.98 135.09 52.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.558 -0.714 . . . . 0.0 109.869 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.05 HD11 HD12 ' A' ' 61' ' ' ILE . 1.2 tt -89.72 155.07 19.45 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.12 142.55 51.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.867 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.542 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 59.3 t80 -160.37 128.09 4.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.68 36.66 19.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.477 -0.764 . . . . 0.0 110.012 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.62 22.9 78.05 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -116.2 169.28 9.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -1.059 . . . . 0.0 108.89 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 m -145.58 97.58 3.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.76 146.37 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -68.67 146.17 53.23 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 22' ' ' LEU . 6.8 tp -67.0 -10.71 52.59 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.311 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HA ' HG23 ' A' ' 23' ' ' VAL . 14.0 mttt -88.55 48.26 1.61 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.831 -1.168 . . . . 0.0 107.91 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.702 ' O ' HG23 ' A' ' 50' ' ' VAL . 45.2 t -149.54 85.08 1.43 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.847 . . . . 0.0 109.009 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.688 HD11 HG11 ' A' ' 23' ' ' VAL . 39.5 mt -69.06 -39.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.801 -0.562 . . . . 0.0 109.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ttt -73.53 -29.37 62.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.563 -0.71 . . . . 0.0 109.606 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.27 -38.07 81.39 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 46' ' ' SER . 44.0 t -60.67 -27.72 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.995 . . . . 0.0 109.691 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.4 t -83.91 -25.74 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.815 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -60.37 -38.92 85.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.443 -0.786 . . . . 0.0 109.799 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.42 -55.59 15.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.454 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.27 51.93 0.85 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 56' ' ' ALA . 42.9 mt -75.62 162.16 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.562 -0.964 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.9 -163.16 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -78.85 157.0 28.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.56 -0.712 . . . . 0.0 109.557 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.97 61.03 6.82 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -138.39 173.21 11.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.931 . . . . 0.0 109.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -127.98 141.45 51.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.566 -0.709 . . . . 0.0 109.208 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.05 HD12 HD11 ' A' ' 35' ' ' LEU . 20.2 pt -141.97 164.12 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.523 -0.736 . . . . 0.0 109.559 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -132.58 117.24 17.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.627 -0.67 . . . . 0.0 109.836 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.824 HD12 ' CE1' ' A' ' 6' ' ' PHE . 89.6 mt -99.2 152.07 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -150.4 110.16 4.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.508 -0.745 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.759 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -91.35 130.09 37.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.99 103.19 4.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.453 -0.779 . . . . 0.0 109.98 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.27 -132.31 2.06 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.81 -67.18 0.85 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.963 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 46.53 1.19 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.548 -0.72 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 5.8 pt-20 -63.04 -37.25 86.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.49 -0.756 . . . . 0.0 110.21 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.25 -36.74 77.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 109.867 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -76.64 -20.59 56.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.457 -0.777 . . . . 0.0 110.284 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.776 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.16 -42.8 20.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.49 -41.64 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.438 -0.789 . . . . 0.0 110.047 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.715 ' N ' HD12 ' A' ' 74' ' ' LEU . 15.9 p30 -79.27 -16.9 55.71 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.783 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -71.45 -52.37 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.776 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -65.28 -33.14 75.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.567 -0.708 . . . . 0.0 109.466 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.66 -52.81 63.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.551 -0.718 . . . . 0.0 109.987 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.12 -27.62 65.77 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.133 -0.98 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.2 m -69.86 -37.22 76.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mtt -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -76.15 -26.0 55.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 0.0 109.734 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 p -82.57 -67.03 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.729 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -66.71 -29.87 69.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.53 -0.731 . . . . 0.0 109.581 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.73 2.93 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.83 -30.37 20.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.654 -0.909 . . . . 0.0 109.743 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.7 146.94 5.91 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.479 -1.012 . . . . 0.0 109.469 -179.925 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -173.74 154.98 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.716 . . . . 0.0 109.543 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.52 139.92 19.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.561 -0.712 . . . . 0.0 109.651 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -89.96 143.15 27.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.205 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 63' ' ' ILE . 27.0 m-85 -125.92 169.76 12.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.566 -0.709 . . . . 0.0 109.7 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.76 135.82 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.582 -0.699 . . . . 0.0 109.332 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.674 HG22 HD11 ' A' ' 14' ' ' ILE . 12.1 t -81.43 112.08 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 109.319 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 m -114.12 -12.08 12.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 0.0 110.545 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 141.74 50.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -0.966 . . . . 0.0 109.985 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.71 -43.11 94.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.9 p -74.07 -32.78 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.53 -0.731 . . . . 0.0 109.366 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.54 -139.58 15.38 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.674 HD11 HG22 ' A' ' 8' ' ' VAL . 58.1 mt -122.96 82.33 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.593 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.66 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.66 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -54.18 -36.3 63.25 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.34 -0.85 . . . . 0.0 112.305 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -60.16 -61.31 8.18 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 120.943 -1.098 . . . . 0.0 110.589 -178.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HB3' HD22 ' A' ' 86' ' ' LEU . 31.9 Cg_endo -69.59 -12.36 33.07 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 121.283 1.322 . . . . 0.0 111.177 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -81.88 -28.89 32.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.867 . . . . 0.0 109.008 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -78.89 -30.02 44.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 17' ' ' ARG . 11.5 t -68.78 -49.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.809 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.833 ' HB3' HD11 ' A' ' 44' ' ' LEU . 86.8 mt -63.91 -54.69 30.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.9 p -51.6 -28.58 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.307 -0.871 . . . . 0.0 110.506 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.01 -54.59 17.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.525 -0.735 . . . . 0.0 110.245 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 m -59.94 -53.35 58.87 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.399 -0.813 . . . . 0.0 110.411 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.88 -24.33 62.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.412 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.49 -37.74 79.04 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -71.57 -28.75 64.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.775 -0.578 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 81.7 m-85 -94.58 125.45 39.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.448 -0.782 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.85 9.31 19.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.671 -0.643 . . . . 0.0 110.716 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.8 179.22 1.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.092 -1.005 . . . . 0.0 109.478 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -102.75 76.03 1.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.639 -0.663 . . . . 0.0 109.237 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.839 HG12 ' HB2' ' A' ' 65' ' ' ALA . 29.0 m -89.62 108.91 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -117.09 134.31 54.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.717 HD12 HG12 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -89.47 160.82 16.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -128.43 152.75 47.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.36 87.54 1.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.758 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 61.84 48.65 5.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.565 -0.709 . . . . 0.0 109.681 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.06 -7.47 74.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HB3' HD21 ' A' ' 53' ' ' LEU . 11.3 mmtm -91.09 101.32 14.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.153 -1.204 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.35 98.03 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.558 -0.714 . . . . 0.0 109.746 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.77 148.1 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.7 140.95 56.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.837 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.3 tm? -57.22 -28.95 63.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 0.0 109.132 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.751 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.41 60.52 4.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.823 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -147.67 83.08 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.583 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 35.6 mt -66.21 -40.55 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.728 -0.607 . . . . 0.0 109.657 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -77.6 -27.39 51.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.56 -0.713 . . . . 0.0 109.96 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.26 -29.72 63.87 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 46' ' ' SER . 42.9 t -73.52 -31.23 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -1.011 . . . . 0.0 109.579 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.28 -28.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.6 p -63.41 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.51 -0.744 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 40' ' ' LYS . 24.2 mt -64.31 -72.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.563 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.4 48.93 0.3 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 56' ' ' ALA . 16.5 mt -75.97 162.05 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.981 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -150.06 -177.42 5.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 109.36 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 148.26 52.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.588 -0.695 . . . . 0.0 109.398 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.07 70.94 1.0 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -175.49 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.494 -1.004 . . . . 0.0 109.569 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -131.39 148.49 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 pt -149.8 153.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.621 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -127.75 127.07 42.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.713 . . . . 0.0 109.664 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.717 HG12 HD12 ' A' ' 35' ' ' LEU . 78.0 mt -112.31 148.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.598 -0.689 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 p -150.77 112.11 4.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 0.0 109.955 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.839 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.93 134.41 35.13 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.83 103.3 3.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 0.0 109.661 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.73 -128.71 1.37 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.22 -59.47 2.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -104.44 52.65 0.75 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.533 -0.73 . . . . 0.0 109.637 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 10.0 pt-20 -65.5 -38.75 90.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.49 -0.756 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -69.98 -37.97 75.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 110.115 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 48.8 m-20 -76.71 -19.42 57.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.785 . . . . 0.0 110.26 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.825 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -82.0 -43.9 17.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.16 -41.94 94.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.489 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.7 ' N ' HD12 ' A' ' 74' ' ' LEU . 42.1 p-10 -78.08 -20.33 52.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 109.727 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.26 -55.91 9.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -0.903 . . . . 0.0 108.593 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.825 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -68.87 -29.13 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.498 -0.751 . . . . 0.0 109.782 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -54.58 42.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.397 -0.815 . . . . 0.0 110.192 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.59 -33.54 71.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.807 . . . . 0.0 109.774 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -65.67 -34.06 77.33 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 mmm -71.94 -28.07 63.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.736 -0.603 . . . . 0.0 109.65 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -82.47 -23.8 34.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.591 -0.693 . . . . 0.0 110.177 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -85.85 -31.56 22.19 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 109.918 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -93.78 -21.8 19.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.725 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.06 33.3 29.75 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 18' ' ' PRO . 83.5 mt -81.94 -60.45 2.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.946 . . . . 0.0 109.615 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.31 156.04 26.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.423 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -117.14 150.79 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.567 -0.708 . . . . 0.0 109.414 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.936 ' HD2' HD13 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -142.74 142.09 31.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.754 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.5 m -96.51 143.56 27.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -127.21 174.04 9.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.547 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.86 124.39 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.596 -0.69 . . . . 0.0 109.416 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' CG2' HD11 ' A' ' 14' ' ' ILE . 11.1 t -88.32 123.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.382 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.84 10.95 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 110.258 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 147.13 35.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.429 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.19 -31.21 71.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.684 . . . . 0.0 109.584 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -80.68 -30.44 36.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 109.466 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.25 37.01 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.557 HD11 ' CG2' ' A' ' 8' ' ' VAL . 65.8 mt -106.76 80.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.558 -0.966 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.521 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -62.61 -48.21 80.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.175 -0.953 . . . . 0.0 112.734 -177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.439 ' HB2' ' CE1' ' A' ' 15' ' ' HIP . 0.3 OUTLIER -51.48 -54.51 38.29 Favored Pre-proline 0 N--CA 1.508 2.462 0 O-C-N 120.801 -1.187 . . . . 0.0 111.55 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.2 Cg_endo -71.28 -23.2 24.49 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.122 1.214 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.645 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -74.94 -19.97 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.484 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.418 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -84.73 -32.66 23.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 108.815 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.58 -35.37 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.656 0.741 . . . . 0.0 109.039 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' HB3' HD21 ' A' ' 44' ' ' LEU . 97.6 mt -76.57 -43.79 37.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.0 -0.437 . . . . 0.0 110.28 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.879 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.7 p -62.63 -28.31 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 109.458 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -69.77 -48.05 60.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.529 -0.732 . . . . 0.0 109.954 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -62.1 -57.35 11.9 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -0.758 . . . . 0.0 109.903 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 44' ' ' LEU . . . -57.53 -23.18 48.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.542 -0.724 . . . . 0.0 110.372 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -59.75 -41.1 90.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.667 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -64.62 -32.04 73.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 54.4 m-85 -93.49 131.28 38.86 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.665 . . . . 0.0 109.397 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -94.29 12.56 26.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.557 -0.715 . . . . 0.0 110.345 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.12 169.43 11.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -91.03 76.99 6.13 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.929 HG12 ' HB2' ' A' ' 65' ' ' ALA . 19.4 m -89.63 89.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.596 -0.69 . . . . 0.0 109.527 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.87 123.84 42.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 109.7 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.514 ' C ' HD23 ' A' ' 35' ' ' LEU . 10.4 tt -89.51 108.3 19.58 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -89.13 123.72 33.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.739 . . . . 0.0 109.703 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.16 72.32 0.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.6 t30 48.45 85.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.513 -0.742 . . . . 0.0 111.32 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 -38.69 3.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.36 159.47 17.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -1.119 . . . . 0.0 109.621 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -147.78 85.1 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.634 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -99.71 145.44 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.24 139.87 41.34 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD23 ' CB ' ' A' ' 26' ' ' ALA . 6.6 tp -58.99 -16.2 16.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.879 ' HA ' HG23 ' A' ' 23' ' ' VAL . 1.2 mptp? -86.92 49.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.774 -1.204 . . . . 0.0 108.197 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.745 ' O ' HG23 ' A' ' 50' ' ' VAL . 41.8 t -151.0 93.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 0.0 109.074 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.645 HG23 ' HB3' ' A' ' 19' ' ' ALA . 22.3 mt -71.11 -39.07 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.624 -0.672 . . . . 0.0 109.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -72.46 -28.52 62.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.585 -0.697 . . . . 0.0 109.614 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.72 -28.62 64.8 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 46' ' ' SER . 45.4 t -74.62 -26.25 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.475 -1.015 . . . . 0.0 109.679 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -78.95 -26.98 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.434 -0.791 . . . . 0.0 109.794 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.2 p -68.42 -34.69 76.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 109.564 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 42' ' ' VAL . 16.3 mt -63.38 -45.92 88.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.461 -0.774 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.83 61.59 1.84 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.425 HD12 ' HB ' ' A' ' 14' ' ' ILE . 22.8 mt -88.96 149.17 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.562 -0.964 . . . . 0.0 109.142 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.98 -168.98 3.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.562 -0.711 . . . . 0.0 109.772 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -64.62 130.29 43.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.695 . . . . 0.0 109.682 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.16 55.66 2.06 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.36 30.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.61 -0.935 . . . . 0.0 109.577 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -95.08 145.82 24.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.266 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -136.71 152.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.493 -0.755 . . . . 0.0 109.522 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 m -127.35 152.53 47.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.409 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mt -142.37 143.58 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.449 -0.782 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -147.85 107.84 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.605 -0.684 . . . . 0.0 109.971 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.929 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -90.53 130.97 36.52 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.31 97.1 3.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.88 -131.51 1.47 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.58 -71.23 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.933 . . . . 0.0 109.73 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -99.01 61.38 1.25 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.527 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.67 -27.55 66.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.537 -0.727 . . . . 0.0 109.995 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.94 -35.07 43.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.47 -0.769 . . . . 0.0 109.975 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 36.8 m-20 -73.73 -22.26 59.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.741 . . . . 0.0 110.344 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.814 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.6 -43.67 18.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.936 HD13 ' HD2' ' A' ' 4' ' ' LYS . 4.4 pp -68.7 -39.82 80.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.479 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.0 p30 -79.13 -20.48 48.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 109.795 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -72.73 -56.05 5.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.326 -0.859 . . . . 0.0 108.838 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.1 mt -66.65 -34.19 77.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.545 -0.722 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.63 -52.73 64.25 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.94 -26.74 68.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.373 -0.83 . . . . 0.0 109.709 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.5 m -70.22 -32.94 71.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.072 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.46 -27.12 63.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.725 -0.61 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -25.6 26.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.539 -0.726 . . . . 0.0 110.148 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 p -66.63 -54.33 24.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.535 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.49 -29.8 22.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.48 -0.763 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 48.99 4.53 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 86' ' ' LEU . 76.6 mt -82.43 -42.66 18.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.979 . . . . 0.0 109.511 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.38 142.87 8.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.497 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.89 153.79 19.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.728 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HD2' HD13 ' A' ' 74' ' ' LEU . 11.2 mtpp -141.8 133.79 27.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.688 -0.633 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -89.98 130.37 36.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.287 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 63' ' ' ILE . 93.5 m-85 -116.02 154.2 30.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.0 109.604 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.37 127.82 54.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.635 -0.666 . . . . 0.0 109.235 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.73 114.13 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 m -121.12 -5.13 9.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.568 -0.707 . . . . 0.0 110.57 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.66 150.43 40.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.21 -57.46 11.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.467 -0.77 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -65.81 -33.4 75.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.625 -0.672 . . . . 0.0 109.414 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.59 -132.8 11.06 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.526 HG22 HG11 ' A' ' 50' ' ' VAL . 62.7 mt -116.24 83.58 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.954 . . . . 0.0 109.387 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.423 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.36 67.18 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.634 -1.291 . . . . 0.0 112.153 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.4 ttt85 -53.75 -53.93 52.09 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.961 -1.087 . . . . 0.0 111.377 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.7 Cg_endo -73.87 -24.66 15.14 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.192 1.262 . . . . 0.0 110.523 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -71.99 -22.42 61.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.413 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.433 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -84.5 -31.95 24.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.007 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 17' ' ' ARG . 15.1 t -69.67 -39.38 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 44' ' ' LEU . 94.5 mt -74.84 -51.84 12.93 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.553 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.793 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -52.33 -28.44 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.252 -0.905 . . . . 0.0 110.149 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -74.84 -42.65 57.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -68.55 -65.62 0.68 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.459 -0.775 . . . . 0.0 109.935 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.581 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -53.38 -24.64 12.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.473 -0.767 . . . . 0.0 110.581 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.22 -45.97 90.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 109.469 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -63.87 -25.52 68.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.645 -0.66 . . . . 0.0 109.822 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 91.2 m-85 -89.57 124.39 34.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.79 -21.24 65.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.603 -0.686 . . . . 0.0 110.072 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 147.88 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -89.88 88.96 7.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.608 -0.682 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.833 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.4 m -90.8 129.85 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -129.36 140.33 51.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.507 -0.745 . . . . 0.0 109.975 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 61' ' ' ILE . 6.4 tt -92.3 149.09 21.64 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -115.18 141.8 47.53 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.597 ' HD2' HD23 ' A' ' 53' ' ' LEU . 35.2 t80 -160.28 115.82 2.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.532 -0.73 . . . . 0.0 109.983 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 t30 63.9 23.47 13.37 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.557 -0.714 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.71 -18.21 51.25 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.788 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -88.97 118.55 28.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -1.172 . . . . 0.0 109.158 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -95.08 117.5 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.709 -0.619 . . . . 0.0 109.886 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.07 147.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.8 135.45 51.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.828 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.7 tm? -53.07 -29.12 28.37 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.369 -0.832 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.793 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -91.25 62.05 4.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -148.92 87.09 1.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 23' ' ' VAL . 39.3 mt -71.45 -38.76 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.733 -0.604 . . . . 0.0 109.873 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.1 ttp -77.7 -27.51 50.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.532 -0.73 . . . . 0.0 109.987 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.16 49.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 46' ' ' SER . 46.6 t -66.35 -33.36 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.471 -1.017 . . . . 0.0 109.759 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 t -75.59 -30.71 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 109.614 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.7 p -63.3 -28.02 69.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.692 . . . . 0.0 109.854 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HD2' ' A' ' 37' ' ' TYR . 5.7 mp -69.15 -76.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.761 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.02 51.79 0.23 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 37' ' ' TYR . 15.0 mt -78.93 158.33 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.576 -0.955 . . . . 0.0 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -153.18 -168.15 2.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -73.9 146.44 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.757 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.63 57.32 3.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.14 170.64 15.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.946 . . . . 0.0 109.538 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -126.85 129.93 49.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.594 -0.692 . . . . 0.0 109.469 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 35' ' ' LEU . 24.4 pt -119.88 146.41 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.671 -0.643 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -122.06 107.33 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.747 . . . . 0.0 109.646 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.702 HD12 ' CE1' ' A' ' 6' ' ' PHE . 75.3 mt -92.54 154.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.644 -0.66 . . . . 0.0 109.282 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -150.12 105.95 3.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.644 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.833 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.78 124.34 34.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.36 107.4 7.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.463 -0.773 . . . . 0.0 109.79 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.01 -138.84 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.25 -64.7 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.965 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.08 42.07 1.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.96 -28.6 67.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -0.75 . . . . 0.0 109.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -74.21 -35.49 63.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.26 -25.37 59.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.675 . . . . 0.0 110.03 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.789 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.6 -43.67 20.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.397 -0.814 . . . . 0.0 110.689 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.686 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -62.09 -41.62 98.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.327 -0.858 . . . . 0.0 110.69 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.686 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.8 p-10 -74.46 -27.07 60.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.246 -0.909 . . . . 0.0 109.764 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -64.24 -57.67 8.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.805 . . . . 0.0 109.266 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -63.59 -27.35 69.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.493 -0.755 . . . . 0.0 109.876 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.71 -58.01 9.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 109.682 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.85 -26.59 65.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.45 HG21 HG12 ' A' ' 21' ' ' VAL . 29.4 m -71.98 -34.02 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.468 -0.77 . . . . 0.0 109.015 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.6 -29.91 65.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -85.81 -21.19 28.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.69 . . . . 0.0 110.305 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -80.75 -55.07 5.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -73.45 -27.07 61.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.825 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.25 39.79 6.29 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 18' ' ' PRO . 80.7 mt -81.74 -52.76 6.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.687 -0.89 . . . . 0.0 109.651 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.24 145.8 12.59 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.593 -0.945 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.775 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.79 158.12 44.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.583 -0.698 . . . . 0.0 109.294 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -142.78 132.73 24.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 109.734 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 61' ' ' ILE . 32.2 m -95.07 139.05 31.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.543 -0.723 . . . . 0.0 109.297 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 63' ' ' ILE . 91.3 m-85 -122.69 162.76 21.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.524 -0.735 . . . . 0.0 109.709 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.76 125.23 50.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 14' ' ' ILE . 9.7 t -77.81 123.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.522 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 9' ' ' THR . 18.2 m -129.92 3.37 4.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.588 -0.695 . . . . 0.0 110.544 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.39 46.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.039 -1.038 . . . . 0.0 109.47 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.18 -37.71 88.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.693 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -80.01 -30.19 39.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.63 -0.669 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.81 -148.6 18.88 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.824 HD11 HG22 ' A' ' 8' ' ' VAL . 58.8 mt -114.42 86.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.945 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.451 ' O1P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' HB3' ' O1P' ' A' ' 15' ' ' HIP . . . -56.57 -37.54 70.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.181 -0.949 . . . . 0.0 112.241 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HB2' ' NE2' ' A' ' 15' ' ' HIP . 0.0 OUTLIER -57.39 -60.66 9.07 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.856 -1.153 . . . . 0.0 110.598 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.8 -15.1 36.79 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.302 1.335 . . . . 0.0 110.787 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -79.71 -24.99 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.1 m -82.99 -29.59 28.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.187 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.36 -40.49 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.669 0.747 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HB3' HD21 ' A' ' 44' ' ' LEU . 95.4 mt -72.09 -46.35 57.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.967 -0.458 . . . . 0.0 110.397 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.814 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.0 p -60.03 -29.01 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.791 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.61 -43.57 72.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.475 -0.766 . . . . 0.0 109.975 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 m -68.04 -60.83 2.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.049 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.607 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -57.2 -23.6 48.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.411 -0.806 . . . . 0.0 110.41 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -59.83 -41.3 91.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -26.39 67.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.632 -0.667 . . . . 0.0 109.743 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 90.8 m-85 -89.66 127.95 36.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.4 -0.813 . . . . 0.0 109.604 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -71.82 -21.62 61.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.806 -0.559 . . . . 0.0 110.075 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 149.1 23.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.67 92.46 9.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.63 -0.669 . . . . 0.0 109.449 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.859 HG12 ' CB ' ' A' ' 65' ' ' ALA . 35.9 m -92.8 102.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 109.195 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.72 137.68 41.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.777 . . . . 0.0 110.096 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.3 tt -90.77 150.56 21.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' N ' HD23 ' A' ' 35' ' ' LEU . 9.0 tt0 -120.72 135.43 55.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.481 -0.762 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.759 ' HB3' HD23 ' A' ' 53' ' ' LEU . 57.9 t80 -160.21 125.9 4.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 64.09 21.44 12.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.523 -0.735 . . . . 0.0 110.519 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.01 55.37 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.908 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -89.07 122.78 32.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -1.187 . . . . 0.0 109.307 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 m -105.22 103.65 13.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.768 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.7 146.97 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -67.04 143.19 56.88 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 26' ' ' ALA . 7.0 tp -63.37 -15.09 56.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.056 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.814 ' HA ' HG23 ' A' ' 23' ' ' VAL . 7.6 mttm -87.63 48.93 1.71 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.86 -1.15 . . . . 0.0 107.973 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 50' ' ' VAL . 15.0 t -150.61 84.09 1.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 108.992 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.67 HG23 ' HB3' ' A' ' 19' ' ' ALA . 27.7 mt -64.5 -37.89 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.7 ttm -74.39 -30.3 61.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.377 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.66 -35.93 92.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 46' ' ' SER . 42.4 t -68.38 -29.01 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.937 . . . . 0.0 109.386 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 t -65.47 -34.48 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.488 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.9 p -63.17 -32.0 73.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.504 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' A' ' 37' ' ' TYR . 11.1 mp -70.54 -50.58 36.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.701 . . . . 0.0 109.393 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.84 59.46 3.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.554 HD12 ' HB ' ' A' ' 14' ' ' ILE . 49.0 mt -72.58 162.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -142.6 175.56 9.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.591 -0.693 . . . . 0.0 109.572 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -61.34 152.82 28.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.588 -0.695 . . . . 0.0 109.767 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.04 64.24 3.94 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.33 172.02 13.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.545 -0.973 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -124.76 129.8 51.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 5' ' ' THR . 23.6 pt -128.12 152.16 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.582 -0.699 . . . . 0.0 109.364 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.449 HG23 ' OG1' ' A' ' 5' ' ' THR . 1.3 m -131.67 109.43 10.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.432 HD12 ' CE1' ' A' ' 6' ' ' PHE . 88.1 mt -93.69 155.97 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.701 . . . . 0.0 109.219 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 p -150.09 110.56 4.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.64 -0.662 . . . . 0.0 109.808 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.859 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.69 131.74 35.52 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.03 107.04 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.499 -0.751 . . . . 0.0 109.662 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.5 -133.41 2.4 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.15 -61.99 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.574 -0.957 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -98.39 44.44 1.03 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.686 -0.633 . . . . 0.0 109.358 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.775 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 11.9 pt-20 -61.71 -31.29 71.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.707 . . . . 0.0 109.857 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.69 -36.47 70.6 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.565 -0.709 . . . . 0.0 109.616 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.4 m-20 -78.44 -19.55 52.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.306 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.799 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.79 -44.85 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.165 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -65.79 -41.78 91.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.247 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.6 p30 -77.65 -19.89 54.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 0.0 109.501 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -69.18 -57.16 5.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.799 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.53 -30.11 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.575 -0.703 . . . . 0.0 109.432 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -54.02 51.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.999 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.29 -26.69 66.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.341 -0.849 . . . . 0.0 109.888 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.8 m -70.18 -35.82 74.22 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.8 mmm -71.45 -30.48 66.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -83.91 -18.49 37.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.676 . . . . 0.0 110.318 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.2 p -74.81 -52.84 10.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.3 -27.49 24.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.756 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.93 48.71 4.04 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.78 -64.44 1.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.676 -0.896 . . . . 0.0 109.607 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.72 11.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.982 . . . . 0.0 109.518 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.94 153.4 33.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.43 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 7.6 tttp -135.55 140.52 44.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.702 -0.624 . . . . 0.0 109.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 m -96.63 130.49 43.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.591 -0.693 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CD2' HD12 ' A' ' 63' ' ' ILE . 97.2 m-85 -118.0 149.01 41.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.593 -0.692 . . . . 0.0 109.604 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.14 125.89 52.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 14' ' ' ILE . 15.9 t -81.4 119.6 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.598 -0.689 . . . . 0.0 109.593 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -140.49 22.27 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.571 -0.706 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.68 36.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.518 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.09 -41.18 97.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.629 -0.669 . . . . 0.0 109.322 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -78.72 -30.89 46.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.613 -0.679 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.18 -143.77 16.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 8' ' ' VAL . 57.0 mt -126.18 82.16 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.703 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.703 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -57.51 -28.44 63.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.253 -0.904 . . . . 0.0 111.974 -177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 3.7 mmt180 -62.68 -61.35 7.69 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.812 -1.18 . . . . 0.0 109.782 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.07 -13.71 36.92 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.198 1.265 . . . . 0.0 110.509 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -78.0 -30.3 50.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 108.784 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.3 m -79.5 -27.97 41.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.627 -0.67 . . . . 0.0 109.572 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.79 -48.59 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.747 0.784 . . . . 0.0 109.084 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -65.77 -42.7 90.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 122.004 -0.435 . . . . 0.0 110.614 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.854 HG11 HD11 ' A' ' 47' ' ' ILE . 13.7 p -64.22 -30.46 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -70.92 -29.77 65.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.074 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.53 -58.5 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.508 -0.745 . . . . 0.0 110.434 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -61.6 -27.7 68.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.462 -0.774 . . . . 0.0 110.427 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 p -59.85 -32.77 70.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.354 -0.841 . . . . 0.0 109.708 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -73.39 -29.67 62.77 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.8 m-85 -89.87 127.57 36.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.521 -0.737 . . . . 0.0 109.448 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.34 -2.99 44.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.684 -0.635 . . . . 0.0 110.681 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.14 167.6 3.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.073 -1.017 . . . . 0.0 109.706 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.67 82.18 3.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.606 -0.684 . . . . 0.0 109.372 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.86 HG12 ' HB2' ' A' ' 65' ' ' ALA . 21.3 m -89.69 100.75 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.697 . . . . 0.0 109.353 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -104.54 128.97 52.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.708 . . . . 0.0 109.921 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 35' ' ' LEU . 9.9 tt -89.46 142.95 27.2 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -117.01 143.03 46.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -139.87 71.19 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.566 -0.709 . . . . 0.0 109.772 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.45 62.69 2.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.564 -0.71 . . . . 0.0 110.852 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 -29.8 8.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -89.54 88.14 7.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -1.078 . . . . 0.0 109.402 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.2 m -93.04 94.7 9.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.695 -0.628 . . . . 0.0 109.778 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.07 145.83 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -70.08 146.83 50.65 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.7 tp -65.87 -12.01 51.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 23' ' ' VAL . 1.1 mptt -88.28 48.56 1.66 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.775 -1.203 . . . . 0.0 108.03 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 t -149.93 99.3 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.854 HD11 HG11 ' A' ' 23' ' ' VAL . 42.3 mm -70.47 -59.41 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.731 -0.606 . . . . 0.0 109.464 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpp -60.68 -22.19 63.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.711 -0.618 . . . . 0.0 110.163 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.87 63.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.8 t -68.78 -34.42 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.95 . . . . 0.0 109.616 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.3 t -71.83 -26.5 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.622 -0.674 . . . . 0.0 109.746 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.9 p -70.31 -33.93 72.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.473 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.1 -37.4 87.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.605 -0.684 . . . . 0.0 109.281 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.05 51.6 5.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 mt -78.44 152.36 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.992 . . . . 0.0 109.097 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.97 -168.58 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.547 -0.721 . . . . 0.0 109.8 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.49 131.93 50.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.672 -0.643 . . . . 0.0 109.704 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.93 55.58 1.98 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.41 172.96 12.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.548 -0.971 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -131.99 156.16 46.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.656 . . . . 0.0 109.296 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 pt -149.61 139.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.49 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 m -117.87 109.28 16.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.534 -0.729 . . . . 0.0 109.561 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.571 HD12 ' CD2' ' A' ' 6' ' ' PHE . 81.8 mt -96.85 150.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.589 -0.694 . . . . 0.0 109.401 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -150.24 109.88 4.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.653 -0.654 . . . . 0.0 109.609 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.86 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -89.73 131.49 35.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.11 101.72 4.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.802 . . . . 0.0 109.76 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.9 -123.67 0.85 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.95 -62.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.949 . . . . 0.0 109.314 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -96.64 51.51 1.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.64 -0.662 . . . . 0.0 109.293 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.413 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -67.91 -27.39 66.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -80.69 -33.15 35.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 41.0 m-20 -77.38 -21.61 52.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.73 . . . . 0.0 110.23 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.802 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.31 -43.21 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 110.342 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.55 -42.76 91.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.318 -0.864 . . . . 0.0 110.438 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 74' ' ' LEU . 33.3 p-10 -75.9 -21.95 56.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -0.873 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.81 -56.88 7.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -65.96 -30.58 71.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.682 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -53.28 60.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.14 -29.22 69.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.7 m -66.73 -35.31 79.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.6 mmm -71.59 -28.21 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -69.99 -47.49 61.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 109.908 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.6 p -66.91 -59.12 3.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -59.28 -23.44 62.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.505 -0.747 . . . . 0.0 110.154 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.89 34.97 88.79 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.92 -44.61 16.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.97 . . . . 0.0 109.616 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -176.19 28.67 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.494 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.731 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -51.46 152.53 2.58 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.378 -0.826 . . . . 0.0 110.501 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -140.91 167.93 21.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.693 -0.629 . . . . 0.0 109.517 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -112.4 150.75 30.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.341 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.57 148.58 41.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.556 -0.715 . . . . 0.0 109.507 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 121.47 45.4 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.573 ' CG2' HD11 ' A' ' 14' ' ' ILE . 21.4 t -87.02 125.56 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.564 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -143.93 22.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.712 . . . . 0.0 109.861 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 145.29 36.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.488 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.11 -43.18 95.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 0.0 109.674 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -77.44 -29.25 52.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 109.433 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.36 -155.83 24.53 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.757 ' HB ' HD12 ' A' ' 55' ' ' ILE . 61.4 mt -109.02 66.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.537 -0.978 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.409 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.22 84.54 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.949 -1.095 . . . . 0.0 112.359 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.11 -55.59 29.65 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.853 -1.154 . . . . 0.0 111.196 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.7 Cg_endo -71.74 -23.32 22.81 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.233 1.288 . . . . 0.0 110.212 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.14 -22.33 61.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 0.0 109.309 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.415 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -84.33 -31.64 24.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.074 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.72 -40.52 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.614 0.721 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.768 ' HB3' HD11 ' A' ' 44' ' ' LEU . 92.3 mt -74.57 -51.77 13.66 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.008 -0.433 . . . . 0.0 110.357 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.824 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.4 p -51.83 -30.69 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -74.09 -39.76 63.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.605 -0.684 . . . . 0.0 109.75 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.2 m -66.53 -64.43 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.51 -0.743 . . . . 0.0 109.894 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -55.51 -24.28 30.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.369 -0.832 . . . . 0.0 110.531 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -61.37 -43.44 98.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.359 -0.838 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -62.96 -26.73 68.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 109.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CG ' ' HB2' ' A' ' 73' ' ' ALA . 93.2 m-85 -89.78 125.16 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.683 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -69.87 -22.97 63.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.4 147.81 25.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.373 -0.829 . . . . 0.0 109.858 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.06 95.83 10.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.643 -0.661 . . . . 0.0 109.759 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.765 HG12 ' CB ' ' A' ' 65' ' ' ALA . 21.6 m -97.04 120.41 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -116.88 123.92 48.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.554 -0.717 . . . . 0.0 110.326 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.116 HD11 HD12 ' A' ' 61' ' ' ILE . 7.2 tt -90.12 148.65 22.87 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -126.05 158.13 36.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.0 110.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.805 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 18.7 t80 -147.42 105.35 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -81.4 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.77 -0.581 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.87 26.56 1.46 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 114.88 19.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.468 -1.019 . . . . 0.0 109.175 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.2 m -89.79 90.07 8.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.586 -0.696 . . . . 0.0 110.025 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.83 148.04 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.43 139.75 36.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.843 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.4 tm? -53.54 -27.47 26.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.439 -0.788 . . . . 0.0 109.15 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.824 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.56 57.93 3.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.1 t -148.72 110.14 4.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 19' ' ' ALA . 24.9 mt -89.37 -42.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.251 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.445 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.2 ttt -79.15 -24.03 43.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.482 -0.761 . . . . 0.0 110.163 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.22 -29.5 53.35 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 46' ' ' SER . 39.5 t -84.3 -42.82 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -1.018 . . . . 0.0 109.742 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 48' ' ' MET . 12.1 p -61.94 -37.43 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -57.4 -29.48 64.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.699 -0.626 . . . . 0.0 110.107 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.41 -53.14 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 0.0 109.348 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.06 58.52 1.67 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.757 HD12 ' HB ' ' A' ' 14' ' ' ILE . 47.0 mt -78.12 162.91 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.647 -0.914 . . . . 0.0 109.211 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -144.95 -161.21 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 109.827 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 66.2 9.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.88 53.99 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -140.15 168.34 20.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.92 . . . . 0.0 109.554 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -126.14 133.26 51.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.116 HD12 HD11 ' A' ' 35' ' ' LEU . 26.8 pt -124.84 136.75 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.616 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -112.63 112.4 23.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.539 ' CG1' HD12 ' A' ' 35' ' ' LEU . 91.0 mt -93.71 155.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.644 -0.66 . . . . 0.0 109.343 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -149.45 104.68 3.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.717 -0.615 . . . . 0.0 109.349 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.765 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.56 135.04 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 106.94 4.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 109.519 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.44 -144.24 7.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.2 -73.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.958 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -95.32 45.47 1.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.721 . . . . 0.0 109.308 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.42 -43.22 83.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.448 -0.782 . . . . 0.0 110.28 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.575 ' HA ' HD21 ' A' ' 74' ' ' LEU . 4.8 m120 -62.35 -37.15 84.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.881 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 7.5 m-20 -67.45 -33.26 74.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.694 -0.629 . . . . 0.0 110.984 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB2' ' CG ' ' A' ' 29' ' ' TYR . . . -73.44 -53.57 10.36 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.319 -0.863 . . . . 0.0 111.615 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -54.6 -45.64 73.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.241 -0.912 . . . . 0.0 111.297 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.74 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -67.1 -27.82 67.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 109.079 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.612 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -62.64 -52.36 63.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.072 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.37 -31.07 72.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 109.84 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.82 -52.2 66.09 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.87 . . . . 0.0 109.996 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.28 -27.62 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.6 m -70.62 -33.88 71.5 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmt -71.54 -31.13 66.69 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -86.24 -17.27 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.313 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.9 p -60.52 -49.93 75.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.308 -0.87 . . . . 0.0 109.81 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.42 -54.88 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.494 -0.754 . . . . 0.0 109.518 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.78 52.45 0.08 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.0 -63.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.562 -0.963 . . . . 0.0 109.566 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.49 134.89 4.7 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.534 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -60.92 153.66 24.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.425 -0.797 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -138.22 165.01 27.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.5 m -115.83 138.21 51.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.693 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 63' ' ' ILE . 75.3 m-85 -125.02 144.85 50.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.552 -0.718 . . . . 0.0 109.369 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.52 129.99 54.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.505 HG13 HD11 ' A' ' 14' ' ' ILE . 16.8 t -90.5 112.88 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.429 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -116.69 -14.31 10.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.686 -0.634 . . . . 0.0 110.292 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.94 140.33 56.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.941 . . . . 0.0 109.877 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -68.56 -34.66 76.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.654 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -64.96 -28.72 69.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 109.763 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.15 -157.04 36.56 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.638 ' HB ' HD12 ' A' ' 55' ' ' ILE . 9.1 mm -110.81 89.66 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.974 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.713 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.713 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -59.61 -46.35 89.24 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.305 -0.872 . . . . 0.0 112.912 -177.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -52.91 -54.98 37.83 Favored Pre-proline 0 N--CA 1.507 2.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.563 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 31.1 Cg_endo -70.11 -23.0 29.68 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.052 1.168 . . . . 0.0 110.283 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.9 -24.14 60.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.746 . . . . 0.0 109.134 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.51 HG23 ' CD1' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -82.45 -28.82 31.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.772 . . . . 0.0 109.158 179.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -70.26 -37.79 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.6 mt -74.97 -50.9 15.12 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.538 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.775 HG23 ' HA ' ' A' ' 45' ' ' LYS . 10.0 p -53.49 -28.91 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.249 -0.907 . . . . 0.0 110.18 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.5 -37.98 55.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.486 -0.759 . . . . 0.0 110.019 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.1 m -71.95 -65.85 0.72 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.425 -0.797 . . . . 0.0 109.784 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.582 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -52.27 -27.33 14.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.674 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -61.71 -46.17 90.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.373 -0.83 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -63.24 -21.87 66.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.685 . . . . 0.0 110.003 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 84.9 m-85 -89.53 127.1 35.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.16 -28.19 69.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.66 -0.65 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.39 53.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -89.93 94.38 9.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 0.0 109.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.75 HG12 ' CB ' ' A' ' 65' ' ' ALA . 28.2 m -89.89 135.06 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.64 -0.663 . . . . 0.0 109.248 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -132.08 138.25 48.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 0.0 110.171 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.576 HD11 HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -89.07 156.02 19.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.51 129.52 35.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.305 -0.872 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.37 57.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 55.63 22.63 5.43 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.86 -41.16 0.61 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -89.96 87.79 7.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.523 -0.986 . . . . 0.0 109.414 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 35' ' ' LEU . 25.7 m -91.74 112.6 24.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.05 148.24 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -64.92 138.96 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.846 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.0 tm? -54.54 -29.61 51.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.775 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.2 mttt -90.76 61.75 4.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -150.19 87.71 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.79 ' O ' HG23 ' A' ' 51' ' ' VAL . 34.6 mt -70.33 -39.79 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.668 -0.645 . . . . 0.0 109.68 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.78 -28.56 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.537 -0.727 . . . . 0.0 109.586 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.22 57.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 46' ' ' SER . 40.5 t -77.45 -33.77 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.485 -1.009 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 47' ' ' ILE . 40.2 t -69.36 -34.29 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 109.194 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.5 p -63.08 -34.65 78.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.607 -0.683 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 50' ' ' VAL . 12.0 mt -72.89 -38.96 66.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.423 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.47 73.35 0.58 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.638 HD12 ' HB ' ' A' ' 14' ' ' ILE . 23.9 mt -81.78 151.06 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.968 . . . . 0.0 109.161 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.4 172.14 13.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.642 -0.662 . . . . 0.0 109.839 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 159.27 1.43 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.56 40.79 99.08 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.63 121.14 34.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.462 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -84.8 132.69 34.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.608 -0.683 . . . . 0.0 109.354 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 35' ' ' LEU . 18.4 pt -127.22 163.44 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 109.383 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 m -140.14 111.4 7.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 64' ' ' SER . 93.2 mt -92.35 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.473 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.0 p -150.18 103.03 3.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.822 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.75 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 121.7 32.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.96 109.88 10.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 109.669 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.35 -150.21 10.8 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.51 -65.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.517 -0.99 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.73 47.5 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.637 -0.664 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -58.65 -41.46 86.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.727 . . . . 0.0 110.139 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -62.26 -30.13 70.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.91 -25.26 58.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.83 -39.97 25.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.816 . . . . 0.0 110.982 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -65.2 -42.46 93.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 0.0 110.459 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.709 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.7 p-10 -72.08 -28.44 63.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.0 109.187 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.673 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -61.0 -64.08 1.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.45 -0.781 . . . . 0.0 109.555 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -60.67 -25.54 66.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -0.828 . . . . 0.0 109.872 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -54.56 44.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.437 -0.789 . . . . 0.0 110.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 -28.26 69.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -66.22 -35.78 81.33 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -28.5 64.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.783 -0.573 . . . . 0.0 109.558 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -80.52 -25.19 38.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.782 . . . . 0.0 110.042 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 p -81.53 -63.14 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -0.766 . . . . 0.0 109.786 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.15 -29.11 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 109.731 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.2 6.24 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.77 -34.69 30.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.627 -0.925 . . . . 0.0 109.563 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.16 -179.42 41.83 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.56 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.58 150.58 31.27 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.045 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -134.64 163.03 30.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.708 -0.62 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 134.75 54.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.733 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -119.91 161.58 20.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.715 . . . . 0.0 109.547 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -120.2 123.68 43.85 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 14' ' ' ILE . 4.1 t -83.66 120.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 0.0 109.465 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -131.95 16.19 4.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.519 -0.738 . . . . 0.0 110.183 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 144.86 36.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.52 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.46 -29.2 70.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.491 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -90.0 -30.87 17.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.745 . . . . 0.0 109.496 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.56 -150.03 19.7 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 55' ' ' ILE . 59.8 mt -112.29 91.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.987 . . . . 0.0 109.424 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.707 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.707 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -58.94 -45.12 91.21 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.214 -0.929 . . . . 0.0 112.972 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 9.2 ttp180 -54.17 -55.45 36.58 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.575 ' O ' HD12 ' A' ' 22' ' ' LEU . 31.0 Cg_endo -69.72 -22.17 32.64 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 120.922 1.081 . . . . 0.0 110.443 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -75.46 -21.66 57.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.259 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.3 m -82.12 -30.69 31.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.46 -0.775 . . . . 0.0 109.071 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 80' ' ' THR . 15.8 t -70.08 -34.49 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.783 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.2 mt -76.85 -49.1 16.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.02 -0.425 . . . . 0.0 110.5 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' A' ' 45' ' ' LYS . 7.5 p -56.54 -27.26 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -54.13 8.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.441 -0.787 . . . . 0.0 110.328 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -61.16 -60.55 3.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.524 -0.735 . . . . 0.0 110.419 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -55.49 -26.52 43.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.466 -0.771 . . . . 0.0 110.745 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -62.48 -42.12 99.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.408 -0.807 . . . . 0.0 109.474 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -64.25 -21.03 66.44 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 110.239 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.522 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 69.9 m-85 -89.4 133.88 34.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 0.0 109.696 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -77.32 -22.97 51.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.615 -0.678 . . . . 0.0 110.081 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.54 150.97 17.79 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 109.842 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.61 87.79 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.651 -0.656 . . . . 0.0 109.571 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' A' ' 65' ' ' ALA . 34.5 m -90.02 118.16 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -120.25 124.9 46.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.378 -0.826 . . . . 0.0 110.198 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.75 142.55 27.64 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -129.98 155.76 45.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -145.8 105.27 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 -81.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.35 26.58 1.85 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -124.26 99.92 6.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.511 -0.994 . . . . 0.0 108.928 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -89.85 87.27 6.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.578 -0.702 . . . . 0.0 109.957 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -89.53 146.48 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -69.89 142.85 52.93 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.845 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.6 tm? -53.95 -28.88 40.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.403 -0.811 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.774 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -90.92 59.45 4.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.858 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.6 t -150.1 89.53 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 23' ' ' VAL . 34.2 mt -71.9 -51.8 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 109.519 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.0 tpt -61.49 -28.59 69.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.748 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.699 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -72.62 -40.53 53.38 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 46' ' ' SER . 41.0 t -64.56 -28.11 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.55 -0.97 . . . . 0.0 109.601 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 47' ' ' ILE . 42.4 t -74.03 -31.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.8 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.6 p -64.3 -27.29 68.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.805 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 49' ' ' GLY . 3.3 mp -75.0 -46.76 32.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.798 . . . . 0.0 109.542 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.32 63.04 2.74 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.59 HD13 HD12 ' A' ' 14' ' ' ILE . 14.3 mt -74.21 162.58 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.922 . . . . 0.0 109.29 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -144.84 -164.61 1.96 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.517 -0.739 . . . . 0.0 109.759 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -72.98 135.23 44.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.778 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 45.16 7.43 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.03 161.72 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.598 -0.942 . . . . 0.0 109.408 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -124.5 118.59 26.96 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 151.99 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.744 . . . . 0.0 109.491 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.8 m -136.16 107.87 7.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.58 -0.7 . . . . 0.0 109.483 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 64' ' ' SER . 89.6 mt -92.25 159.28 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.614 -0.679 . . . . 0.0 109.275 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 63' ' ' ILE . 4.9 p -144.98 102.47 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.715 -0.616 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.72 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.88 121.48 32.04 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.75 105.33 6.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.354 -0.841 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.45 -140.68 4.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.67 -53.27 5.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.582 -0.952 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.3 45.59 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.622 -0.674 . . . . 0.0 109.418 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.56 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 7.6 pt-20 -66.16 -33.62 76.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.548 -0.72 . . . . 0.0 109.94 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.28 -35.29 61.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.448 -0.782 . . . . 0.0 109.839 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -75.75 -20.75 58.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.464 -0.773 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.821 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.41 -43.14 19.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.267 -0.895 . . . . 0.0 110.477 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.96 -41.7 95.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.324 -0.86 . . . . 0.0 110.694 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.726 ' N ' HD12 ' A' ' 74' ' ' LEU . 26.3 p-10 -74.84 -25.92 59.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -65.59 -60.47 2.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.35 -28.41 69.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 109.771 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.15 -54.95 39.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.12 -29.14 68.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.372 -0.83 . . . . 0.0 109.978 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 21' ' ' VAL . 39.8 m -69.03 -34.2 74.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.566 ' HE3' HD21 ' A' ' 22' ' ' LEU . 26.2 mmt -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.794 -0.567 . . . . 0.0 109.607 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -75.53 -28.6 59.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.783 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.3 p -66.23 -49.76 66.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.696 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -10.83 54.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.585 -0.697 . . . . 0.0 110.46 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.77 94.24 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.85 -62.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.583 -0.951 . . . . 0.0 109.648 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.67 120.76 1.38 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -49.94 155.2 0.94 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 110.771 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.37 162.64 38.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 109.318 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 6' ' ' PHE . 5.7 m -101.34 165.98 10.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.637 -0.664 . . . . 0.0 109.466 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' CD1' HD12 ' A' ' 63' ' ' ILE . 55.2 m-85 -149.52 145.55 26.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.594 -0.691 . . . . 0.0 109.288 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -107.78 127.27 53.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.556 -0.715 . . . . 0.0 109.073 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 14' ' ' ILE . 19.5 t -90.72 120.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.753 -0.592 . . . . 0.0 109.634 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -134.12 23.5 3.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.702 -0.624 . . . . 0.0 109.929 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 144.12 37.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.366 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -56.6 -49.47 74.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.388 -0.82 . . . . 0.0 109.882 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -80.44 -29.5 37.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.371 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.63 -161.39 19.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 8' ' ' VAL . 74.4 mt -99.46 63.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.613 -0.934 . . . . 0.0 109.187 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.421 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.71 -47.8 84.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.052 -1.03 . . . . 0.0 112.608 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HB2' ' NE2' ' A' ' 15' ' ' HIP . 0.0 OUTLIER -50.68 -57.44 13.36 Favored Pre-proline 0 N--CA 1.507 2.405 0 O-C-N 120.829 -1.169 . . . . 0.0 111.184 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.5 Cg_endo -71.94 -18.31 27.97 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.333 1.355 . . . . 0.0 110.532 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -76.78 -21.69 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.787 . . . . 0.0 109.385 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -85.33 -33.87 21.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -72.5 -35.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.699 0.762 . . . . 0.0 109.068 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 44' ' ' LEU . 98.8 mt -77.17 -45.36 26.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.998 -0.439 . . . . 0.0 110.431 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 9.4 p -60.1 -27.47 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.384 -0.822 . . . . 0.0 109.845 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -73.44 -52.56 13.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.5 -0.75 . . . . 0.0 110.468 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.27 -54.39 46.33 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.422 -0.799 . . . . 0.0 110.344 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.68 -25.16 62.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.3 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.6 t -62.55 -38.6 90.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.348 -0.845 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -25.56 68.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.624 . . . . 0.0 109.931 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' CG ' ' HB2' ' A' ' 73' ' ' ALA . 88.3 m-85 -89.56 125.32 35.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 109.676 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -68.58 -24.73 64.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.775 -0.578 . . . . 0.0 109.874 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.62 144.63 42.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 109.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.67 96.14 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.773 HG12 ' CB ' ' A' ' 65' ' ' ALA . 19.8 m -89.96 131.39 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -122.08 130.61 53.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 110.379 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.718 HD11 ' HB ' ' A' ' 61' ' ' ILE . 19.1 tp -89.91 146.71 24.21 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.48 126.95 46.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.391 -0.818 . . . . 0.0 109.903 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.842 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 42.0 t80 -160.33 137.65 9.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.514 -0.741 . . . . 0.0 109.501 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.61 37.35 19.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.037 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.85 29.5 67.71 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -129.33 113.36 14.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.595 -0.944 . . . . 0.0 109.158 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.6 m -93.39 91.52 7.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.538 -0.726 . . . . 0.0 109.794 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.7 146.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.514 -0.741 . . . . 0.0 109.065 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -69.4 145.03 53.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 22' ' ' LEU . 7.0 tp -63.38 -13.25 37.49 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 5.3 mttt -87.17 50.51 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.77 -1.206 . . . . 0.0 108.113 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 50' ' ' VAL . 31.0 t -150.24 86.2 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 19' ' ' ALA . 27.7 mt -64.83 -41.36 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.768 -0.582 . . . . 0.0 109.658 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.6 tpt -72.74 -27.23 61.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.526 -0.734 . . . . 0.0 109.762 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -24.13 72.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 46' ' ' SER . 41.2 t -80.67 -31.36 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -1.058 . . . . 0.0 109.574 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 t -75.43 -28.54 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.839 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.2 p -62.08 -27.97 69.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.77 . . . . 0.0 109.776 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.53 -76.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.564 -0.71 . . . . 0.0 109.475 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.89 55.42 0.27 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 59' ' ' ALA . 17.9 mt -73.85 150.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.607 -0.937 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.03 -158.68 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.671 -0.643 . . . . 0.0 109.722 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -86.55 63.57 8.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.039 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.6 56.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.842 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -132.52 129.72 39.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.619 -0.93 . . . . 0.0 109.488 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -84.65 129.45 34.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.526 -0.734 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.718 ' HB ' HD11 ' A' ' 35' ' ' LEU . 23.7 pt -123.21 134.56 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.639 -0.663 . . . . 0.0 109.347 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -105.16 117.07 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 6' ' ' PHE . 86.8 mt -102.14 153.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -149.94 103.35 3.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.658 -0.651 . . . . 0.0 109.597 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.773 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.31 127.97 35.83 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.84 106.6 7.82 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.88 -145.67 7.17 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.09 -71.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.896 . . . . 0.0 109.594 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -98.91 52.73 0.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.535 -0.728 . . . . 0.0 109.416 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.92 -42.81 90.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.435 -0.79 . . . . 0.0 110.114 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.496 ' HA ' HD21 ' A' ' 74' ' ' LEU . 15.8 m-80 -62.0 -28.58 69.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 0.0 109.85 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.38 -23.53 50.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.433 -0.792 . . . . 0.0 110.454 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.85 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.06 -47.11 14.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.8 pp -62.26 -45.61 92.53 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.35 -0.844 . . . . 0.0 110.66 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.739 ' N ' HD12 ' A' ' 74' ' ' LEU . 36.4 p-10 -70.81 -25.26 62.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -62.1 -62.72 1.58 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.2 mp -62.76 -22.95 66.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.593 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -60.93 -52.39 65.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -64.49 -29.45 70.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -66.24 -33.85 76.68 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.3 mmt -71.75 -28.24 63.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.749 -0.595 . . . . 0.0 109.665 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -86.89 -18.96 29.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 110.47 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -74.22 -67.59 0.6 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.34 -28.56 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.604 -0.685 . . . . 0.0 109.68 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.5 35.46 5.68 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 86' ' ' LEU . 95.6 mt -81.7 -49.7 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.748 -0.854 . . . . 0.0 109.696 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.1 -179.51 36.79 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.49 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -172.95 153.57 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.628 -0.67 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -144.58 148.16 34.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.679 -0.638 . . . . 0.0 109.632 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 6' ' ' PHE . 32.5 m -92.61 159.08 15.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.712 -0.617 . . . . 0.0 109.438 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.425 ' N ' HG22 ' A' ' 5' ' ' THR . 72.6 m-85 -143.08 172.68 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 0.0 109.171 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -136.68 122.74 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.745 HG22 HD11 ' A' ' 14' ' ' ILE . 19.6 t -75.11 111.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.638 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -111.84 -16.67 13.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.728 -0.608 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.05 139.88 56.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.24 -0.912 . . . . 0.0 109.841 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.73 -42.71 90.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.1 p -63.09 -29.82 71.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.61 -0.681 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.46 -157.07 24.46 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.745 HD11 HG22 ' A' ' 8' ' ' VAL . 62.7 mt -107.44 78.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.601 -0.941 . . . . 0.0 109.599 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.619 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -54.24 -41.66 69.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.269 -0.894 . . . . 0.0 112.336 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.42 -60.7 7.67 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 120.852 -1.155 . . . . 0.0 111.001 -178.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.3 Cg_endo -69.7 -14.97 37.06 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.378 1.386 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -80.85 -23.96 38.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.371 -0.831 . . . . 0.0 109.199 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -83.91 -30.04 26.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.192 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.1 t -74.31 -36.46 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.625 0.726 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.859 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.0 mt -78.13 -43.86 27.69 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.92 -0.488 . . . . 0.0 110.367 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.6 p -59.8 -29.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 0.0 109.804 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -74.27 -42.49 59.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -65.42 -61.39 2.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.499 -0.751 . . . . 0.0 110.158 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -58.94 -25.38 63.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 0.0 110.303 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.0 t -60.92 -39.02 87.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.279 -0.888 . . . . 0.0 109.155 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -66.95 -27.72 67.7 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.581 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 98.7 m-85 -89.72 119.53 30.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.723 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -65.61 -15.74 63.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.774 -0.579 . . . . 0.0 110.278 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.51 172.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.16 -0.962 . . . . 0.0 110.013 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.82 88.67 2.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.638 . . . . 0.0 109.441 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.922 HG12 ' HB2' ' A' ' 65' ' ' ALA . 28.8 m -89.72 111.19 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.392 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -110.43 133.43 53.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.458 -0.777 . . . . 0.0 109.876 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 61' ' ' ILE . 5.4 tt -90.22 148.63 22.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.611 -0.68 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.39 107.55 12.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.51 -0.744 . . . . 0.0 109.445 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD1' HG12 ' A' ' 55' ' ' ILE . 15.2 t80 -92.88 71.69 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.441 -0.787 . . . . 0.0 110.003 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.66 85.57 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.656 -0.652 . . . . 0.0 111.592 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 -42.65 2.83 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -89.33 160.39 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.456 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.0 m -150.14 105.84 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.775 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.23 148.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 109.165 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.13 132.45 49.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.859 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.0 tm? -50.24 -28.22 7.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.324 -0.86 . . . . 0.0 109.773 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.783 ' HA ' HG23 ' A' ' 23' ' ' VAL . 18.7 mttt -90.76 61.18 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.861 ' O ' HG23 ' A' ' 50' ' ' VAL . 2.0 t -150.44 86.79 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.593 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 22.5 mt -63.93 -61.81 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.701 -0.624 . . . . 0.0 109.982 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 ttm -64.35 -21.66 66.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.465 -0.772 . . . . 0.0 110.167 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.57 60.29 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 46' ' ' SER . 46.7 t -82.18 -32.21 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.411 -1.053 . . . . 0.0 109.718 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 47' ' ' ILE . 27.3 t -64.33 -28.4 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.781 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.7 p -69.48 -25.65 64.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 0.0 110.022 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 53' ' ' LEU . 4.2 mm? -64.71 -37.12 86.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.486 -0.759 . . . . 0.0 109.592 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.88 38.02 28.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG12 ' CD1' ' A' ' 37' ' ' TYR . 28.3 mt -69.59 144.24 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.54 -0.976 . . . . 0.0 109.264 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.59 -165.76 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.49 42.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.61 72.93 0.58 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.82 170.1 16.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.54 -0.977 . . . . 0.0 109.602 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.77 143.41 48.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.591 -0.693 . . . . 0.0 109.236 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 35' ' ' LEU . 14.3 pt -145.79 126.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.539 -0.726 . . . . 0.0 109.524 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -101.64 118.39 36.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.406 HD12 ' CD1' ' A' ' 6' ' ' PHE . 91.0 mt -102.13 151.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -150.25 109.91 4.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.515 -0.74 . . . . 0.0 110.131 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.922 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -89.85 134.98 33.9 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.71 107.67 4.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.77 -127.32 1.36 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.2 -70.07 0.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.973 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -93.14 49.54 1.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.632 -0.668 . . . . 0.0 109.326 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -64.2 -40.9 97.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 0.0 110.039 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -68.48 -43.09 77.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.0 -23.9 65.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 0.0 110.314 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.22 -46.65 15.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.285 -0.885 . . . . 0.0 111.391 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -59.21 -41.74 89.31 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.697 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -73.88 -26.36 60.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.903 . . . . 0.0 109.221 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -60.27 -61.57 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.78 . . . . 0.0 109.24 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -60.64 -29.25 69.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.404 -0.81 . . . . 0.0 109.793 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.23 -37.73 86.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.487 -0.758 . . . . 0.0 109.919 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 80' ' ' THR . 1.3 pt-20 -72.75 -28.56 62.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.402 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 54.4 m -68.2 -37.6 81.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -71.24 -27.89 63.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.777 -0.577 . . . . 0.0 109.567 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -86.87 -17.64 32.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 110.453 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -75.04 -52.12 11.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.282 -0.886 . . . . 0.0 109.806 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.48 -35.1 14.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.653 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.42 44.81 1.52 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 86' ' ' LEU . 81.6 mt -81.71 -29.33 33.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -1.006 . . . . 0.0 109.635 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.15 169.09 41.9 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.569 -179.859 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.87 153.96 36.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.457 -0.777 . . . . 0.0 109.558 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -142.9 144.64 32.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.678 -0.639 . . . . 0.0 109.524 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -90.15 146.3 24.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.675 -0.641 . . . . 0.0 109.402 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.585 ' CE1' HD12 ' A' ' 63' ' ' ILE . 36.0 m-85 -126.86 161.32 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.576 -0.703 . . . . 0.0 109.561 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.02 133.77 55.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 14' ' ' ILE . 21.1 t -87.25 106.5 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.499 -0.751 . . . . 0.0 109.371 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 9' ' ' THR . 8.2 m -124.48 14.78 8.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.592 -0.693 . . . . 0.0 110.177 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 148.67 34.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -54.49 17.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.354 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -66.09 -29.3 69.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.565 -0.709 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.77 -159.31 20.27 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.667 HD11 HG22 ' A' ' 8' ' ' VAL . 62.6 mt -106.74 78.23 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.995 . . . . 0.0 109.362 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.476 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -54.86 -40.53 69.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.279 -0.888 . . . . 0.0 112.603 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HB2' ' NE2' ' A' ' 15' ' ' HIP . 0.0 OUTLIER -57.77 -60.34 10.24 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.952 -1.093 . . . . 0.0 110.845 -178.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -70.39 -13.54 33.18 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.341 1.36 . . . . 0.0 110.983 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -80.19 -28.65 38.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 108.914 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.604 HG23 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -80.84 -27.25 36.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 17' ' ' ARG . 37.4 t -71.57 -40.84 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 44' ' ' LEU . 55.8 mt -69.25 -53.98 17.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.161 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.2 p -53.14 -28.17 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -71.41 -43.12 67.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.935 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -69.18 -59.64 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.389 -0.819 . . . . 0.0 109.947 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 77' ' ' LEU . . . -57.0 -21.59 31.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.465 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.7 t -58.9 -41.84 88.15 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.262 -0.899 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -65.94 -29.51 69.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.438 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 68.9 m-85 -93.67 128.52 39.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.513 -0.742 . . . . 0.0 109.468 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.26 8.94 21.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.87 -178.44 1.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.96 75.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.834 HG12 ' HB2' ' A' ' 65' ' ' ALA . 29.2 m -89.71 124.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 109.395 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -135.03 142.8 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.612 -0.68 . . . . 0.0 109.728 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.6 tt -89.62 159.16 17.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.725 ' N ' HD23 ' A' ' 35' ' ' LEU . 7.6 tt0 -127.12 125.67 41.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 73.8 t80 -160.39 145.5 14.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.504 -0.748 . . . . 0.0 109.784 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 61.3 34.82 18.37 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.631 -0.668 . . . . 0.0 110.018 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 29.5 70.21 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -135.33 178.92 6.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.59 -0.947 . . . . 0.0 109.083 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 m -143.74 114.12 7.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.23 147.71 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -68.11 134.74 51.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.846 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.3 tm? -53.39 -26.95 21.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.456 -0.778 . . . . 0.0 109.293 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.679 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -90.63 57.07 3.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -146.38 88.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.768 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.6 mt -69.21 -39.23 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 0.0 109.993 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.5 ttm -82.59 -29.5 30.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.491 -0.755 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.03 -43.15 96.22 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 46' ' ' SER . 40.8 t -67.76 -34.01 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.49 -1.006 . . . . 0.0 109.385 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -66.4 -28.65 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.568 -0.707 . . . . 0.0 109.561 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -62.03 -34.14 75.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.505 -0.747 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mp -70.83 -46.84 62.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.583 -0.698 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.68 65.57 2.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.604 HD13 HD12 ' A' ' 14' ' ' ILE . 14.5 mt -77.09 162.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.603 -0.939 . . . . 0.0 109.269 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -134.5 -175.06 3.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.655 -0.653 . . . . 0.0 109.618 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 153.23 42.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.598 -0.689 . . . . 0.0 109.496 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.3 55.45 10.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.535 ' HB1' ' HE1' ' A' ' 37' ' ' TYR . . . -132.68 179.49 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.557 -0.967 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -132.82 140.86 48.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.611 -0.68 . . . . 0.0 109.398 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.538 HD12 HD11 ' A' ' 35' ' ' LEU . 26.9 pt -138.78 161.3 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.459 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.37 121.58 21.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.599 -0.688 . . . . 0.0 109.644 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.585 HD12 ' CE1' ' A' ' 6' ' ' PHE . 90.8 mt -105.01 149.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 p -150.3 112.83 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.834 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.79 134.59 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.01 102.87 3.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.394 -0.816 . . . . 0.0 109.821 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.88 -125.23 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.06 -72.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.956 . . . . 0.0 109.666 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.26 55.84 1.55 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.72 . . . . 0.0 109.385 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -63.18 -28.26 69.93 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.033 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -74.78 -44.4 49.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.44 -0.788 . . . . 0.0 109.946 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.8 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.5 -46.27 14.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.01 -1.056 . . . . 0.0 110.49 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.12 -42.42 96.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.348 -0.845 . . . . 0.0 110.669 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.713 ' N ' HD12 ' A' ' 74' ' ' LEU . 45.7 p-10 -75.77 -22.41 56.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 109.391 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -66.86 -59.13 3.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.339 -0.851 . . . . 0.0 108.707 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -61.69 -28.39 69.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.527 -0.733 . . . . 0.0 109.848 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' OE2' ' CE2' ' A' ' 6' ' ' PHE . 4.8 tt0 -61.18 -56.28 22.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.477 -0.764 . . . . 0.0 110.001 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.68 -30.67 70.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.384 -0.823 . . . . 0.0 110.07 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -68.56 -32.48 72.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -0.822 . . . . 0.0 108.915 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 30.6 mmm -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -76.0 -22.59 55.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.731 -0.605 . . . . 0.0 110.03 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 p -66.1 -50.04 65.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.399 -0.813 . . . . 0.0 109.675 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -97.84 10.1 41.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.565 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.5 89.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 86' ' ' LEU . 35.3 mt -132.46 -60.84 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.628 -0.924 . . . . 0.0 109.401 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.22 150.4 22.06 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -64.6 152.71 41.39 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -150.44 137.73 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.652 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.4 m -89.85 139.71 30.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.632 -0.667 . . . . 0.0 109.357 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -123.02 169.5 11.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 109.868 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 137.88 52.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.592 -0.693 . . . . 0.0 109.342 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.634 ' CG2' HG23 ' A' ' 61' ' ' ILE . 21.3 t -90.51 108.09 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.59 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -129.1 22.25 5.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.59 -0.694 . . . . 0.0 109.884 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.68 159.06 29.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.07 -61.75 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.562 -0.711 . . . . 0.0 109.167 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -71.04 -29.36 65.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.718 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.18 -139.55 14.98 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.745 ' HB ' HD12 ' A' ' 55' ' ' ILE . 55.4 mt -122.15 73.15 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.597 -0.943 . . . . 0.0 109.391 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.432 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.7 69.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.712 -1.243 . . . . 0.0 112.247 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -53.99 -54.07 51.15 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.906 -1.121 . . . . 0.0 111.092 -178.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.4 Cg_endo -73.13 -21.44 20.44 Favored 'Trans proline' 0 C--N 1.322 -0.828 0 C-N-CA 121.115 1.21 . . . . 0.0 110.293 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -75.43 -21.43 58.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.33 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.52 -31.89 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.129 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.2 -45.21 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 44' ' ' LEU . 97.3 mt -68.7 -49.57 57.88 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.8 p -55.93 -29.64 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.83 -36.16 70.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.913 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -72.43 -59.25 2.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.473 -0.767 . . . . 0.0 110.148 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.14 31.64 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.478 -0.764 . . . . 0.0 110.738 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.1 p -59.94 -42.61 94.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.289 -0.882 . . . . 0.0 109.645 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -28.02 69.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.609 -0.682 . . . . 0.0 109.622 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.447 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 78.5 m-85 -94.8 131.48 40.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.429 -0.794 . . . . 0.0 109.633 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.23 -11.46 57.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.668 -0.645 . . . . 0.0 110.422 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.3 155.73 8.55 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.039 -1.038 . . . . 0.0 109.82 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.62 82.0 6.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.581 -0.699 . . . . 0.0 109.528 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.755 HG12 ' CB ' ' A' ' 65' ' ' ALA . 33.9 m -89.68 121.97 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -124.5 126.24 45.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 110.105 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 36' ' ' GLU . 7.4 tt -89.97 155.45 19.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' N ' HD23 ' A' ' 35' ' ' LEU . 31.0 tt0 -122.16 158.53 29.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.469 -0.769 . . . . 0.0 110.053 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.808 ' CE1' HG23 ' A' ' 55' ' ' ILE . 34.3 t80 -145.48 98.46 3.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.04 -81.2 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.24 26.85 1.56 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -125.24 121.07 33.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.569 -0.96 . . . . 0.0 109.116 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.1 m -94.31 100.85 12.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.539 -0.726 . . . . 0.0 110.057 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.06 147.65 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -71.67 142.21 49.87 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 22' ' ' LEU . 1.6 tm? -58.02 -30.43 66.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.803 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.74 60.8 4.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -149.79 81.23 1.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.76 ' O ' HG23 ' A' ' 51' ' ' VAL . 37.6 mt -64.81 -38.66 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.697 -0.627 . . . . 0.0 109.662 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.81 -24.34 59.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.546 -0.721 . . . . 0.0 110.04 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 -31.24 46.08 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 46' ' ' SER . 45.7 t -79.92 -38.44 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -1.047 . . . . 0.0 109.485 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -62.9 -30.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.541 -0.724 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.7 p -67.52 -32.64 73.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 50' ' ' VAL . 15.4 mt -74.0 -55.78 5.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.544 -0.722 . . . . 0.0 109.533 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.43 63.77 1.69 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.808 HG23 ' CE1' ' A' ' 37' ' ' TYR . 61.8 mt -76.2 159.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.974 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.445 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -142.13 -175.04 4.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.707 -0.621 . . . . 0.0 109.558 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -70.46 146.96 49.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.628 -0.67 . . . . 0.0 109.603 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.42 61.88 2.39 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.33 -178.58 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.582 -0.952 . . . . 0.0 109.489 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -128.49 148.48 50.74 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.634 HG23 ' CG2' ' A' ' 8' ' ' VAL . 19.3 pt -139.81 154.63 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 109.504 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 m -134.76 113.11 11.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.6 -0.688 . . . . 0.0 109.867 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.12 155.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.25 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 p -150.22 101.04 2.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 0.0 109.841 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.755 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.76 122.38 32.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.4 104.78 4.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 109.707 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.4 -125.2 0.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.58 -69.74 0.71 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.642 -0.917 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.67 49.17 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.78 -32.41 70.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.475 -0.766 . . . . 0.0 110.023 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.35 -33.18 72.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -77.47 -23.25 50.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.732 . . . . 0.0 110.051 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.401 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.1 pp -68.16 -42.12 80.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.171 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.698 ' N ' HD12 ' A' ' 74' ' ' LEU . 39.5 p30 -78.39 -18.86 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 29' ' ' TYR . . . -69.31 -58.8 3.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.195 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -71.08 -24.96 62.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.82 -59.11 4.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -59.91 -28.55 67.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.355 -0.84 . . . . 0.0 109.771 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 40.6 m -67.25 -35.89 80.48 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.33 -28.4 64.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.699 -0.626 . . . . 0.0 109.422 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -83.0 -21.55 33.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.113 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 p -75.08 -53.61 8.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -80.17 -29.1 38.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 109.562 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.57 37.32 7.02 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.02 -37.38 26.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.691 -0.887 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.39 163.06 34.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.415 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.651 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.7 155.74 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.423 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.8 tttt -140.1 141.19 36.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.685 . . . . 0.0 109.645 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 m -99.13 158.99 15.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.59 -0.694 . . . . 0.0 109.378 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE1' HD12 ' A' ' 63' ' ' ILE . 89.2 m-85 -143.87 161.79 37.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -121.6 118.72 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.58 -0.7 . . . . 0.0 109.134 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.59 116.42 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.652 -0.655 . . . . 0.0 109.588 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -117.44 -16.03 10.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.726 -0.608 . . . . 0.0 110.357 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.55 151.97 36.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.68 -43.53 72.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.636 -0.665 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -64.3 -32.5 74.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.589 -0.694 . . . . 0.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.66 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.822 ' HB ' HD12 ' A' ' 55' ' ' ILE . 46.9 mt -132.04 87.72 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.594 -0.944 . . . . 0.0 109.428 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.421 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.65 60.54 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.743 -1.223 . . . . 0.0 111.968 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.4 ttt180 -53.77 -52.98 62.66 Favored Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 121.046 -1.034 . . . . 0.0 111.109 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -74.27 -24.6 14.3 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.137 1.225 . . . . 0.0 110.332 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -72.36 -20.88 61.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.55 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.515 HG23 ' CD1' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -85.77 -34.16 21.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 108.979 179.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG12 HG21 ' A' ' 80' ' ' THR . 19.0 t -69.95 -34.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.9 mt -76.38 -51.5 11.77 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.397 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.8 p -54.17 -27.38 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.292 -0.88 . . . . 0.0 109.918 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.76 -45.63 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.676 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.401 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 21.4 m -61.05 -59.37 5.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 109.822 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.496 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -61.52 -26.43 67.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 110.041 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.1 t -59.86 -33.3 71.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.503 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -77.09 -26.32 53.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.619 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.528 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 96.3 m-85 -89.81 123.8 34.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -62.57 -24.21 67.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.692 -0.63 . . . . 0.0 109.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.25 141.76 53.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.401 -0.812 . . . . 0.0 109.789 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -89.51 98.56 11.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.587 -0.696 . . . . 0.0 109.235 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.777 HG12 ' CB ' ' A' ' 65' ' ' ALA . 32.1 m -89.96 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.575 -0.703 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -131.96 132.84 43.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.85 147.98 23.45 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -121.27 128.73 52.65 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.477 -0.764 . . . . 0.0 109.903 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.693 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 51.9 t80 -160.49 138.49 9.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.718 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.87 37.08 15.58 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.536 -0.727 . . . . 0.0 109.754 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.76 27.98 64.93 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -123.35 168.98 11.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.597 -0.943 . . . . 0.0 109.026 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.8 m -142.22 103.52 4.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 109.95 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.83 146.2 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -69.19 142.79 54.2 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -64.05 -13.45 47.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.33 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.764 ' HA ' HG23 ' A' ' 23' ' ' VAL . 27.4 mttt -88.1 48.72 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.85 -1.157 . . . . 0.0 107.984 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 50' ' ' VAL . 21.9 t -150.54 82.36 1.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.434 -0.791 . . . . 0.0 109.049 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 51' ' ' VAL . 30.1 mt -63.63 -41.31 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.725 -0.61 . . . . 0.0 109.543 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.44 -29.98 66.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.29 -30.06 69.71 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 46' ' ' SER . 40.6 t -81.56 -31.13 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.551 -0.97 . . . . 0.0 109.343 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 47' ' ' ILE . 43.1 t -70.21 -31.68 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.616 -0.677 . . . . 0.0 109.397 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 p -63.89 -37.2 86.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.8 mt -62.38 -46.62 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.605 -0.684 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.55 71.54 1.09 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.822 HD12 ' HB ' ' A' ' 14' ' ' ILE . 59.5 mt -84.36 162.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.624 -0.927 . . . . 0.0 109.389 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.486 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -149.11 -174.14 4.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.602 -0.686 . . . . 0.0 109.617 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.9 150.31 42.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.712 -0.617 . . . . 0.0 109.686 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 62.7 3.14 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB1' ' CE1' ' A' ' 37' ' ' TYR . . . -143.63 164.88 29.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.942 . . . . 0.0 109.62 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -126.2 123.04 37.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.601 HD13 HD11 ' A' ' 14' ' ' ILE . 21.9 pt -117.56 130.52 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.601 -0.687 . . . . 0.0 109.293 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.07 115.27 29.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.52 -0.738 . . . . 0.0 109.804 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 ' CE1' ' A' ' 6' ' ' PHE . 81.6 mt -101.93 149.85 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.581 -0.699 . . . . 0.0 109.183 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 p -147.22 108.89 4.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.637 -0.664 . . . . 0.0 109.675 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.777 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.75 131.16 35.85 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.61 107.18 7.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.45 -0.781 . . . . 0.0 109.703 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -145.72 8.16 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -64.4 1.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.943 . . . . 0.0 109.65 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.14 44.34 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 14.3 pt-20 -62.03 -32.21 72.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -71.35 -33.29 69.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 109.578 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.19 -24.13 54.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.483 -0.761 . . . . 0.0 110.07 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.795 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.78 -41.51 23.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 110.457 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -64.22 -41.84 96.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.294 -0.878 . . . . 0.0 110.4 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.713 ' N ' HD12 ' A' ' 74' ' ' LEU . 40.8 p30 -76.54 -21.04 56.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.25 -0.907 . . . . 0.0 109.763 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.444 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -67.78 -56.49 9.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.747 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.795 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -64.41 -28.24 69.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.557 -0.715 . . . . 0.0 109.511 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -54.31 47.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.462 -0.774 . . . . 0.0 109.66 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.68 -27.48 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.643 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.462 HG21 HG12 ' A' ' 21' ' ' VAL . 1.6 m -67.9 -33.89 75.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -28.74 64.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.68 -0.638 . . . . 0.0 109.293 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -81.51 -25.29 36.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.602 -0.686 . . . . 0.0 110.116 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 p -72.32 -58.89 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.454 -0.779 . . . . 0.0 109.69 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -75.17 -41.23 58.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.492 -0.755 . . . . 0.0 109.451 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.6 44.33 1.98 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.77 -38.57 25.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.578 -0.954 . . . . 0.0 109.463 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.57 150.38 14.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.454 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -160.24 155.57 25.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.69 -0.631 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.697 ' HG3' HD13 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -140.06 147.61 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.631 -0.668 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -99.38 146.53 26.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 4' ' ' LYS . 80.4 m-85 -138.53 162.58 34.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -123.15 138.2 54.71 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.902 HG13 HD11 ' A' ' 14' ' ' ILE . 15.5 t -87.68 118.89 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.679 . . . . 0.0 109.729 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -128.36 9.61 6.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.77 144.13 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.996 . . . . 0.0 109.525 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.52 -34.41 74.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.9 p -71.14 -29.83 65.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.485 -0.759 . . . . 0.0 109.582 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.32 -150.62 19.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.902 HD11 HG13 ' A' ' 8' ' ' VAL . 15.6 mm -114.15 56.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.54 -0.977 . . . . 0.0 109.215 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.42 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.38 65.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.73 -1.231 . . . . 0.0 112.404 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -56.02 -52.59 71.39 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.954 -1.091 . . . . 0.0 111.112 -178.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' HB3' HD22 ' A' ' 86' ' ' LEU . 31.3 Cg_endo -71.84 -25.15 20.4 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.189 1.26 . . . . 0.0 110.497 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -71.09 -26.08 62.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 108.96 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 m -79.21 -30.2 43.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.477 -0.764 . . . . 0.0 109.27 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.67 -48.99 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.107 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB3' HD11 ' A' ' 44' ' ' LEU . 94.7 mt -65.8 -54.38 27.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.843 HG11 HD11 ' A' ' 47' ' ' ILE . 14.4 p -50.85 -30.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.388 -0.82 . . . . 0.0 110.739 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.33 -47.63 63.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.74 . . . . 0.0 110.339 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.525 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 2.8 m -65.96 -56.53 11.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -62.27 -17.78 59.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.442 -0.787 . . . . 0.0 110.437 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.0 t -64.66 -29.48 70.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -92.71 23.72 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.734 . . . . 0.0 110.399 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.485 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 65.9 m-85 -131.79 120.14 22.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -22.19 66.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.655 -0.653 . . . . 0.0 109.958 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 147.52 34.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.0 109.818 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.75 89.74 7.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.616 -0.678 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.799 HG12 ' CB ' ' A' ' 65' ' ' ALA . 27.6 m -89.89 138.65 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -133.77 135.47 43.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.786 HD12 HG12 ' A' ' 63' ' ' ILE . 4.8 tp -95.78 131.29 42.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -108.73 119.4 39.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.409 -0.807 . . . . 0.0 110.449 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.615 ' CE1' HG23 ' A' ' 55' ' ' ILE . 28.7 t80 -103.82 97.52 7.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 72.37 -81.27 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.828 -0.545 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.04 26.76 2.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -124.52 116.06 21.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -1.014 . . . . 0.0 109.012 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -91.5 104.15 16.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.428 -0.795 . . . . 0.0 110.321 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.25 147.86 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -68.2 140.37 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.853 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.1 tm? -57.96 -27.32 63.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.429 -0.795 . . . . 0.0 109.035 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.649 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.8 mttm -90.02 51.5 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.805 . . . . 0.0 109.118 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.679 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.3 t -137.87 91.96 2.63 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.843 HD11 HG11 ' A' ' 23' ' ' VAL . 40.3 mm -68.11 -62.54 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.682 -0.636 . . . . 0.0 109.641 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.8 ttm -66.5 -25.76 66.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 109.91 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.6 -30.13 75.89 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 46' ' ' SER . 41.3 t -88.69 -30.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.513 -0.992 . . . . 0.0 109.442 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' ILE . 41.4 t -69.05 -29.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.484 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 p -66.52 -30.41 70.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.717 . . . . 0.0 109.589 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 50' ' ' VAL . 27.1 mt -62.93 -66.43 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.723 . . . . 0.0 109.39 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.71 52.33 0.86 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.615 HG23 ' CE1' ' A' ' 37' ' ' TYR . 38.7 mt -78.5 150.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.548 -0.972 . . . . 0.0 109.041 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.96 -164.28 1.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.573 -0.705 . . . . 0.0 109.804 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -66.64 153.89 41.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.625 -0.672 . . . . 0.0 109.703 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.15 57.85 13.96 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -126.1 173.97 8.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.667 -0.902 . . . . 0.0 109.515 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -128.37 141.13 51.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.653 ' HB ' HD11 ' A' ' 35' ' ' LEU . 13.1 pt -142.76 126.02 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.54 -0.725 . . . . 0.0 109.373 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 m -106.89 110.07 22.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.532 -0.73 . . . . 0.0 109.828 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.786 HG12 HD12 ' A' ' 35' ' ' LEU . 79.2 mt -94.19 150.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -150.1 109.75 4.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.67 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.799 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.82 132.52 35.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.38 102.67 4.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.362 -0.836 . . . . 0.0 109.748 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.45 -134.38 2.57 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.49 -58.82 2.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.95 . . . . 0.0 109.476 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.13 47.96 1.04 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 109.327 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 16.8 pt-20 -66.9 -40.35 87.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.607 -0.683 . . . . 0.0 110.114 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -70.31 -35.64 73.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.727 . . . . 0.0 109.897 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.88 -24.18 59.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 110.105 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.815 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.65 -44.07 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.265 -0.897 . . . . 0.0 110.823 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -61.79 -42.8 99.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.293 -0.88 . . . . 0.0 110.635 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.715 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.0 p-10 -72.48 -27.51 62.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 0.0 109.151 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 25' ' ' THR . . . -61.19 -58.36 8.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 109.254 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -65.72 -22.66 66.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -62.71 1.46 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.34 -34.51 73.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.313 -0.867 . . . . 0.0 109.906 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.8 m -63.15 -32.87 74.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.408 -0.807 . . . . 0.0 108.971 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -71.33 -30.95 66.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -82.02 -19.18 40.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.651 -0.655 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.7 p -80.66 -45.51 17.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 109.739 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -81.06 -28.74 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.729 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 32.26 8.02 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 18' ' ' PRO . 91.4 mt -81.72 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.665 -0.903 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -142.19 -173.08 13.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.665 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -107.32 150.12 27.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -142.18 150.78 41.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.7 -0.625 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 m -105.3 151.09 24.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.684 . . . . 0.0 109.291 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.64 166.03 24.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.545 -0.722 . . . . 0.0 109.493 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -113.1 134.57 54.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.618 -0.676 . . . . 0.0 109.301 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.728 ' CG2' HG23 ' A' ' 61' ' ' ILE . 26.9 t -89.27 99.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.657 . . . . 0.0 109.564 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -123.37 27.15 7.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.65 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.73 155.2 31.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 109.582 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -65.46 -43.71 89.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 109.265 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.4 p -101.15 21.77 13.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 109.851 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.34 -136.79 47.64 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.464 HG22 HG11 ' A' ' 50' ' ' VAL . 61.3 mt -119.44 88.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.573 -0.957 . . . . 0.0 109.426 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.416 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.65 63.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.75 -1.219 . . . . 0.0 112.044 -178.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.1 -52.46 68.28 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 111.521 -178.398 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.9 Cg_endo -72.89 -23.89 18.29 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 121.19 1.26 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -75.36 -22.26 57.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 109.526 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.41 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -83.72 -31.19 26.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.225 179.787 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG12 HG21 ' A' ' 80' ' ' THR . 17.6 t -71.53 -42.95 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.722 0.772 . . . . 0.0 108.998 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.78 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.2 mt -70.47 -50.31 39.4 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.463 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.6 p -55.3 -28.88 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -73.01 -36.83 67.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.485 -0.759 . . . . 0.0 109.861 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -73.94 -63.78 1.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.456 -0.777 . . . . 0.0 110.202 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -56.54 -25.08 50.93 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.362 -0.836 . . . . 0.0 110.647 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.6 t -61.3 -40.9 95.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -68.36 -26.47 65.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.442 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 96.1 m-85 -89.85 128.32 36.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.342 -0.849 . . . . 0.0 109.725 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.29 -23.44 62.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.666 -0.646 . . . . 0.0 110.291 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 146.06 26.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.305 -0.872 . . . . 0.0 109.896 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 91.05 8.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.538 -0.726 . . . . 0.0 109.263 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.847 HG12 ' CB ' ' A' ' 65' ' ' ALA . 28.9 m -89.91 113.93 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.673 -0.642 . . . . 0.0 109.335 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -105.93 137.25 44.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 tt -100.72 116.27 32.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -89.61 143.21 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.843 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.561 ' CD2' HD23 ' A' ' 53' ' ' LEU . 15.1 t80 -132.38 68.9 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.7 . . . . 0.0 109.547 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.56 62.26 2.8 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.3 -38.85 2.95 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -89.15 90.88 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -1.031 . . . . 0.0 109.195 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.4 m -95.91 112.55 24.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 110.11 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.1 147.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -65.59 141.81 58.29 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.833 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.5 tm? -56.87 -29.58 63.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 109.139 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.764 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -90.97 61.02 4.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -148.78 88.74 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.597 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 34.1 mt -71.72 -40.54 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.618 -0.676 . . . . 0.0 109.937 -179.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -30.2 45.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 109.691 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.17 -40.4 92.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 46' ' ' SER . 47.4 t -63.06 -28.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.54 -0.976 . . . . 0.0 109.52 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 47' ' ' ILE . 23.5 t -70.18 -31.3 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 109.401 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -62.89 -41.02 99.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.768 . . . . 0.0 109.619 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.561 HD23 ' CD2' ' A' ' 37' ' ' TYR . 11.0 mp -63.11 -33.51 75.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 109.431 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.84 23.65 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 37' ' ' TYR . 54.6 mt -75.92 147.46 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.615 -0.933 . . . . 0.0 109.327 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.68 -167.52 1.84 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.639 -0.663 . . . . 0.0 109.658 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.52 150.34 32.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.577 -0.702 . . . . 0.0 109.538 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.84 3.7 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 179.97 6.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.601 -0.941 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.16 136.19 46.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.728 HG23 ' CG2' ' A' ' 8' ' ' VAL . 31.6 pt -124.38 162.77 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.668 . . . . 0.0 109.677 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 63' ' ' ILE . 21.0 m -136.34 161.26 36.3 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.402 ' N ' HG22 ' A' ' 62' ' ' THR . 30.2 mt -146.26 150.95 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.409 -0.807 . . . . 0.0 109.768 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -150.52 108.13 3.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.67 -0.643 . . . . 0.0 109.578 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.847 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.63 130.43 35.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 109.08 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 102.22 5.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.2 -142.24 5.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.16 -57.96 2.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.588 -0.948 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -96.72 48.3 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.688 . . . . 0.0 109.359 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.665 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 6.4 pt-20 -66.89 -29.08 68.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 109.744 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -77.74 -36.23 51.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.497 -0.752 . . . . 0.0 109.663 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 29.9 m-20 -76.16 -20.72 57.29 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.117 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.769 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.36 -44.26 17.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.906 . . . . 0.0 110.296 -179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -64.83 -42.45 94.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.466 -0.771 . . . . 0.0 110.285 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.704 ' N ' HD12 ' A' ' 74' ' ' LEU . 23.8 p30 -78.55 -19.8 52.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.462 -0.774 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -67.76 -54.32 20.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -66.56 -30.9 71.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.665 -0.647 . . . . 0.0 109.6 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.18 -52.19 66.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.43 -0.794 . . . . 0.0 110.122 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.83 -29.44 70.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.58 HG21 HG12 ' A' ' 21' ' ' VAL . 88.2 m -67.67 -33.26 74.58 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.8 mtt -67.87 -29.29 68.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -84.64 -23.49 29.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.569 -0.707 . . . . 0.0 110.184 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -73.54 -55.33 6.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -85.06 -27.92 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.524 -0.735 . . . . 0.0 109.679 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.3 67.18 1.48 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 86' ' ' LEU . 98.0 mt -106.78 -37.8 6.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.957 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.84 158.34 30.83 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.245 0.545 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -99.91 157.06 16.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.782 . . . . 0.0 109.234 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -146.32 137.78 24.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 m -89.69 159.48 17.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.674 . . . . 0.0 109.244 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CD2' HD12 ' A' ' 63' ' ' ILE . 85.6 m-85 -145.4 143.31 30.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.6 -0.687 . . . . 0.0 109.69 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.57 127.92 46.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.592 -0.693 . . . . 0.0 109.214 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 59' ' ' ALA . 20.5 t -85.96 134.21 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.586 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 9' ' ' THR . 6.2 m -149.6 27.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.583 -0.698 . . . . 0.0 109.587 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.58 146.7 36.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -58.87 5.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.721 . . . . 0.0 109.363 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.1 p -69.67 -31.31 69.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.687 . . . . 0.0 109.408 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.06 -154.22 16.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.434 ' CB ' HD12 ' A' ' 55' ' ' ILE . 38.7 mm -104.7 85.3 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.973 . . . . 0.0 109.364 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.606 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.606 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -60.77 -40.04 91.03 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.18 -0.95 . . . . 0.0 112.978 -177.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' CE1' ' A' ' 15' ' ' HIP . 1.8 ttp85 -59.06 -55.17 49.1 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 120.77 -1.206 . . . . 0.0 111.094 -178.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 31.0 Cg_endo -69.93 -21.51 32.59 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.04 1.16 . . . . 0.0 110.417 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.69 -22.53 50.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 109.272 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.461 ' HA ' HG12 ' A' ' 23' ' ' VAL . 6.5 m -81.13 -29.38 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.81 . . . . 0.0 109.152 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.24 -41.1 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB3' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -69.52 -51.78 32.53 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.297 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.4 p -57.55 -28.26 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.389 -0.819 . . . . 0.0 109.816 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -69.96 -36.64 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -60.22 2.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.627 -0.67 . . . . 0.0 110.13 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -58.83 -24.83 62.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.473 -0.767 . . . . 0.0 110.359 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 t -60.84 -39.23 88.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.414 -0.804 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -23.21 61.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.671 -0.643 . . . . 0.0 109.885 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.658 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 86.3 m-85 -89.46 127.72 35.88 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -0.865 . . . . 0.0 109.632 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.87 -22.8 62.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.72 -0.612 . . . . 0.0 109.905 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.69 145.17 45.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 109.715 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.67 93.9 9.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.56 -0.713 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.733 HG12 ' CB ' ' A' ' 65' ' ' ALA . 18.2 m -89.84 127.72 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -118.91 126.68 52.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 110.486 -178.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.562 HD21 ' HB ' ' A' ' 61' ' ' ILE . 2.3 tt -89.79 133.73 34.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -113.35 130.16 56.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.448 -0.782 . . . . 0.0 110.167 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE2' HG12 ' A' ' 55' ' ' ILE . 35.7 t80 -160.46 136.95 8.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.651 -0.656 . . . . 0.0 109.55 179.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.28 37.44 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.581 -0.7 . . . . 0.0 109.748 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.96 28.76 66.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -127.17 111.37 13.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.599 -0.942 . . . . 0.0 109.158 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -89.79 87.78 7.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.573 -0.704 . . . . 0.0 109.866 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -97.33 146.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.147 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -73.64 152.44 40.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.5 tp -69.61 -9.04 52.49 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.288 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.799 ' HA ' HG23 ' A' ' 23' ' ' VAL . 11.1 mttt -88.7 48.79 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.764 -1.21 . . . . 0.0 107.991 178.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.665 ' O ' HG23 ' A' ' 50' ' ' VAL . 13.8 t -150.41 95.43 2.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.381 -0.825 . . . . 0.0 109.298 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.665 HG23 ' HB3' ' A' ' 19' ' ' ALA . 29.7 mt -76.97 -38.81 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.677 -0.639 . . . . 0.0 109.557 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 tpt -74.65 -34.03 62.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.59 99.24 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 46' ' ' SER . 42.7 t -62.11 -28.31 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.534 -0.98 . . . . 0.0 109.424 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 t -63.2 -35.06 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 109.342 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 p -63.5 -34.58 78.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.643 -0.66 . . . . 0.0 109.365 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 42' ' ' VAL . 32.9 mt -66.01 -59.02 4.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 109.333 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.2 67.32 1.54 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 56' ' ' ALA . 50.2 mt -81.22 162.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.557 -0.967 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.98 178.57 9.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.572 -0.705 . . . . 0.0 109.463 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -62.02 137.97 58.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.48 39.96 9.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -120.47 179.59 4.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.604 -0.939 . . . . 0.0 109.468 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -137.95 153.2 49.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.678 -0.639 . . . . 0.0 109.365 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.562 ' HB ' HD21 ' A' ' 35' ' ' LEU . 20.7 pt -150.19 132.47 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.88 107.51 18.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.558 -0.714 . . . . 0.0 109.576 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.499 HD12 ' CD2' ' A' ' 6' ' ' PHE . 82.0 mt -94.11 153.81 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -148.04 107.96 4.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.633 -0.667 . . . . 0.0 109.67 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.733 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 125.92 35.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.526 -0.734 . . . . 0.0 109.06 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.85 107.12 8.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.32 8.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.61 -58.02 3.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.942 . . . . 0.0 109.536 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.63 42.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.671 . . . . 0.0 109.361 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.01 -29.24 70.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.588 -0.695 . . . . 0.0 109.798 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -78.15 -33.46 50.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 109.547 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -76.42 -22.15 55.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.721 . . . . 0.0 110.125 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.804 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -81.54 -42.52 20.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.696 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -65.08 -42.35 94.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.359 -0.838 . . . . 0.0 110.693 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.696 ' N ' HD12 ' A' ' 74' ' ' LEU . 19.6 p30 -75.06 -22.53 58.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 109.622 -179.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.658 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -67.33 -59.5 3.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 108.745 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -62.83 -28.88 70.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.52 -0.737 . . . . 0.0 109.781 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.33 -55.9 26.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.459 -0.776 . . . . 0.0 109.938 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -58.73 -27.24 64.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.417 -0.802 . . . . 0.0 110.038 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.2 m -70.91 -36.86 72.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 mmt -71.0 -29.85 65.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.754 -0.591 . . . . 0.0 109.459 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -83.5 -21.75 32.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.575 -0.703 . . . . 0.0 110.229 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -75.2 -70.22 0.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 0.0 109.781 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -62.2 -28.22 69.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.559 -0.713 . . . . 0.0 109.753 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.79 39.91 5.41 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 86' ' ' LEU . 93.7 mt -81.81 -56.12 4.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.552 -0.97 . . . . 0.0 109.373 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.78 176.54 27.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.57 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.29 153.15 20.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.599 -0.688 . . . . 0.0 109.441 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 7.3 tttp -141.71 149.47 40.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.682 -0.636 . . . . 0.0 109.374 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -89.92 153.02 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.534 -0.729 . . . . 0.0 109.476 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.563 ' CD1' HD12 ' A' ' 63' ' ' ILE . 76.7 m-85 -142.27 145.49 34.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.624 -0.672 . . . . 0.0 109.398 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.97 126.93 52.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.08 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.688 HG22 HD11 ' A' ' 14' ' ' ILE . 31.2 t -81.61 116.1 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.589 -0.694 . . . . 0.0 109.552 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -134.34 26.37 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.628 -0.67 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 86' ' ' LEU . . . -77.46 164.55 25.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 109.466 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.55 -34.22 73.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.572 -0.705 . . . . 0.0 109.316 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -114.48 24.25 12.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.73 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.65 -139.07 46.77 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.688 HD11 HG22 ' A' ' 8' ' ' VAL . 48.8 mt -121.69 87.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.906 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.426 ' NE2' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.83 65.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.758 -1.214 . . . . 0.0 112.021 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.63 -53.72 59.48 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.961 -1.087 . . . . 0.0 110.829 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -73.88 -21.67 18.34 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.113 1.208 . . . . 0.0 110.456 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -73.25 -24.03 60.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.408 -0.808 . . . . 0.0 109.258 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.468 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -84.55 -31.12 24.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 109.16 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 17' ' ' ARG . 23.3 t -73.03 -35.48 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.721 0.772 . . . . 0.0 109.047 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' C ' HD21 ' A' ' 44' ' ' LEU . 96.0 mt -77.87 -43.35 30.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.996 -0.44 . . . . 0.0 110.554 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 47' ' ' ILE . 10.7 p -61.72 -27.94 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 109.681 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -72.43 -50.35 26.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.528 -0.733 . . . . 0.0 110.025 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -61.57 -59.07 5.77 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.51 -0.743 . . . . 0.0 109.991 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -58.78 -23.51 60.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.586 -0.696 . . . . 0.0 110.398 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -38.98 83.65 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -29.06 69.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.483 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.638 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 96.5 m-85 -89.65 118.37 29.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.46 -15.68 62.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.657 -0.652 . . . . 0.0 110.243 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.35 29.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.16 -0.962 . . . . 0.0 109.901 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -89.7 86.95 6.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.391 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.712 HG12 ' CB ' ' A' ' 65' ' ' ALA . 16.7 m -89.73 119.98 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.658 -0.651 . . . . 0.0 109.37 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -112.12 132.82 54.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.732 . . . . 0.0 109.994 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 36' ' ' GLU . 5.0 tt -89.93 135.12 33.83 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.661 ' N ' HD23 ' A' ' 35' ' ' LEU . 34.2 tt0 -105.93 140.36 39.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.737 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.626 ' CE1' HG23 ' A' ' 55' ' ' ILE . 27.5 t80 -140.82 84.54 1.94 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.667 -0.646 . . . . 0.0 109.532 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.42 52.06 6.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.614 -0.679 . . . . 0.0 110.089 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.86 -12.96 64.17 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.412 -0.899 . . . . 0.0 110.874 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -89.48 86.91 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -1.175 . . . . 0.0 109.348 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 m -91.63 92.97 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.879 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.94 147.5 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -66.01 142.55 57.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD23 ' HB3' ' A' ' 26' ' ' ALA . 7.2 tp -64.14 -13.75 50.27 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.42 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.618 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.22 48.36 1.63 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.186 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 50' ' ' VAL . 16.8 t -150.27 84.64 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.818 . . . . 0.0 109.139 -179.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.667 HD11 HG11 ' A' ' 23' ' ' VAL . 33.1 mt -67.45 -46.31 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 0.0 109.255 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 ttm -64.35 -29.74 70.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.634 -0.667 . . . . 0.0 109.36 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.07 91.88 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 46' ' ' SER . 21.8 t -70.49 -39.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.972 . . . . 0.0 109.286 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 47' ' ' ILE . 33.7 t -64.11 -30.63 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.2 p -68.14 -31.6 71.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.637 -0.664 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.91 -67.58 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.63 -0.669 . . . . 0.0 109.343 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.79 47.8 1.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 37' ' ' TYR . 15.5 mt -63.73 157.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.953 . . . . 0.0 109.122 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -136.01 -170.49 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -84.13 150.66 25.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.688 -0.633 . . . . 0.0 109.474 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.02 46.95 14.53 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.33 178.46 6.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.588 -0.948 . . . . 0.0 109.481 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.78 147.75 49.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.614 -0.679 . . . . 0.0 109.466 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.418 ' HB ' HD21 ' A' ' 35' ' ' LEU . 28.4 pt -142.5 157.36 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -131.37 109.63 10.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 109.639 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.563 HD12 ' CD1' ' A' ' 6' ' ' PHE . 90.0 mt -92.32 152.41 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.533 -0.729 . . . . 0.0 109.145 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -150.2 109.54 3.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.78 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.712 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.84 126.64 35.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 103.86 5.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.475 -0.766 . . . . 0.0 109.618 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.54 -130.85 1.8 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.86 -74.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.629 -0.924 . . . . 0.0 109.59 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -90.34 53.0 2.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 2' ' ' ALA . 16.4 pt-20 -67.8 -30.45 69.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.869 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -75.27 -37.81 60.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.561 -0.712 . . . . 0.0 109.797 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.83 -24.88 58.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.587 -0.696 . . . . 0.0 110.19 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.784 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.9 -43.18 20.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.832 . . . . 0.0 110.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.2 pp -62.51 -42.01 99.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.712 ' N ' HD12 ' A' ' 74' ' ' LEU . 17.9 p-10 -74.13 -26.93 60.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 -60.77 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.413 -0.805 . . . . 0.0 109.28 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -61.95 -28.07 69.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 109.969 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -56.61 19.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.919 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.79 -28.28 69.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 m -67.8 -32.59 73.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -30.78 66.76 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -81.17 -24.17 37.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.635 -0.666 . . . . 0.0 109.989 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.3 p -73.98 -69.33 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.751 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.61 -28.79 70.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.45 44.73 5.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 93.3 mt -81.87 -33.82 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.612 -0.934 . . . . 0.0 109.572 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.03 153.45 10.85 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.387 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB1' HD23 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -91.56 153.48 19.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 10.3 tttm -143.28 150.31 39.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.659 . . . . 0.0 109.631 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -97.16 152.42 18.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.58 -0.7 . . . . 0.0 109.566 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 63' ' ' ILE . 96.5 m-85 -142.08 148.2 38.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.627 -0.671 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -110.11 117.61 34.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.712 . . . . 0.0 109.145 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.727 HG22 HD11 ' A' ' 14' ' ' ILE . 15.5 t -74.15 112.97 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.736 -0.602 . . . . 0.0 109.503 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.6 17.62 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.701 . . . . 0.0 110.091 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.25 38.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 0.0 109.373 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -44.12 91.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.552 -0.717 . . . . 0.0 109.716 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -75.17 -29.61 60.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.438 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 -166.38 24.87 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.727 HD11 HG22 ' A' ' 8' ' ' VAL . 62.8 mt -100.59 82.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.567 -0.96 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.656 ' O3P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.656 ' HB3' ' O3P' ' A' ' 15' ' ' HIP . . . -55.04 -37.74 67.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.235 -0.916 . . . . 0.0 112.285 -177.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -57.88 -60.96 8.36 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.875 -1.141 . . . . 0.0 110.575 -178.594 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.5 Cg_endo -69.59 -13.67 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.265 1.31 . . . . 0.0 110.786 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -79.91 -26.12 40.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 108.974 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.403 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -82.09 -29.78 31.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -0.755 . . . . 0.0 109.056 179.389 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.38 -43.93 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 44' ' ' LEU . 98.1 mt -69.11 -51.6 36.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.465 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 45' ' ' LYS . 11.9 p -53.44 -29.54 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -70.75 -40.68 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.697 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.411 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 22.7 m -69.52 -63.95 0.97 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.599 -0.688 . . . . 0.0 109.926 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -54.92 -24.91 25.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.468 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 t -60.06 -44.86 94.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 109.328 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -65.45 -28.85 69.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.623 -0.673 . . . . 0.0 109.23 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -89.65 129.91 36.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 109.269 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.23 -7.98 58.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.553 -0.717 . . . . 0.0 110.618 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.4 168.93 1.87 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.98 . . . . 0.0 109.707 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.99 87.09 4.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.429 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.926 HG12 ' HB2' ' A' ' 65' ' ' ALA . 19.0 m -95.84 98.64 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -107.11 131.89 53.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 0.0 109.761 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.821 HD11 HD12 ' A' ' 61' ' ' ILE . 8.5 tt -89.99 153.19 20.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.553 -0.717 . . . . 0.0 109.328 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' N ' HD23 ' A' ' 35' ' ' LEU . 9.1 tp10 -126.07 145.25 50.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.759 . . . . 0.0 109.447 -179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.617 ' HB3' HD23 ' A' ' 53' ' ' LEU . 29.9 t80 -160.29 108.48 1.66 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.531 -0.731 . . . . 0.0 109.835 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.82 50.52 8.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 109.93 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.49 27.98 71.71 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.41 97.92 5.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -1.036 . . . . 0.0 109.133 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -91.79 102.02 14.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.557 -0.714 . . . . 0.0 110.062 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.95 147.46 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.87 135.37 52.4 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.879 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.5 tm? -53.99 -25.62 21.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.373 -0.829 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HA ' HG23 ' A' ' 23' ' ' VAL . 8.7 mttt -90.61 54.58 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.86 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.1 t -145.64 85.22 1.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 19' ' ' ALA . 30.7 mt -67.42 -40.32 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.708 -0.62 . . . . 0.0 110.118 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.4 ttt -74.45 -27.68 60.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.48 -0.762 . . . . 0.0 109.835 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.89 59.14 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 46' ' ' SER . 37.4 t -67.39 -38.58 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -1.017 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -29.17 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.47 -0.768 . . . . 0.0 109.626 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.9 p -65.77 -29.62 70.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 37' ' ' TYR . 9.5 mp -62.49 -56.09 21.33 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.561 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.18 43.65 3.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.625 HD13 HD12 ' A' ' 14' ' ' ILE . 42.2 mt -70.88 158.0 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -1.003 . . . . 0.0 109.3 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -152.94 -164.47 1.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.529 -0.732 . . . . 0.0 109.551 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -66.94 130.14 42.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.586 -0.696 . . . . 0.0 109.568 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.65 79.7 0.94 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -147.97 167.35 25.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.611 -0.934 . . . . 0.0 109.437 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.51 119.85 23.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 109.27 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 35' ' ' LEU . 26.5 pt -120.33 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.717 . . . . 0.0 109.556 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -112.25 111.84 23.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.603 -0.685 . . . . 0.0 109.738 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.548 HD12 ' CE2' ' A' ' 6' ' ' PHE . 90.1 mt -92.41 158.75 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 63' ' ' ILE . 5.5 p -150.31 103.13 3.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.926 ' HB2' HG12 ' A' ' 33' ' ' VAL . . . -92.96 123.66 36.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.49 105.77 4.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.56 -124.89 0.93 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.02 -65.28 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.962 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -97.97 53.83 1.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.568 -0.707 . . . . 0.0 109.441 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.18 -29.76 68.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.531 -0.73 . . . . 0.0 109.816 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.43 -36.16 58.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.769 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.84 -23.9 58.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.576 -0.703 . . . . 0.0 110.111 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.85 -43.6 19.72 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.825 . . . . 0.0 110.722 -179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 75' ' ' ASN . 4.3 pp -63.87 -41.53 97.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.23 -0.919 . . . . 0.0 110.542 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.718 ' N ' HD12 ' A' ' 74' ' ' LEU . 24.5 p-10 -76.81 -22.49 53.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 -179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB1' ' CG2' ' A' ' 25' ' ' THR . . . -68.98 -53.96 17.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.258 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -73.22 -26.34 61.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.513 -0.742 . . . . 0.0 109.995 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -58.47 6.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.416 -0.802 . . . . 0.0 109.76 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -29.11 68.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.449 -0.782 . . . . 0.0 109.702 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.0 m -68.49 -34.22 75.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmm -71.49 -32.25 68.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.636 -0.665 . . . . 0.0 109.455 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -77.28 -27.38 53.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.66 -0.65 . . . . 0.0 109.951 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 p -71.46 -70.66 0.31 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.485 -0.759 . . . . 0.0 109.637 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -64.43 -28.29 69.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.691 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.57 45.35 6.49 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 86' ' ' LEU . 96.2 mt -83.33 -37.9 22.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.579 -0.953 . . . . 0.0 109.845 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.67 114.4 0.5 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.994 . . . . 0.0 109.613 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.642 ' O ' HD22 ' A' ' 74' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 154.34 1.66 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.361 -0.837 . . . . 0.0 110.563 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -139.66 165.78 26.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.682 -0.636 . . . . 0.0 109.48 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -118.18 126.78 52.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' A' ' 63' ' ' ILE . 73.7 m-85 -109.44 150.15 28.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.584 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -103.86 117.11 33.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.415 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.624 HG13 HD11 ' A' ' 14' ' ' ILE . 26.6 t -76.22 124.19 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.648 -0.657 . . . . 0.0 109.661 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 9' ' ' THR . 9.2 m -142.5 21.57 2.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.899 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.88 143.39 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.1 -43.56 70.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.533 -0.73 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -69.04 -35.59 76.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.582 -0.699 . . . . 0.0 109.462 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.73 -164.15 12.97 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' A' ' 55' ' ' ILE . 27.2 mm -106.94 78.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.978 . . . . 0.0 109.307 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.687 ' O2P' ' HB3' ' A' ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.687 ' HB3' ' O2P' ' A' ' 15' ' ' HIP . . . -58.95 -30.85 68.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.169 -0.957 . . . . 0.0 111.864 -177.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 4.9 mmm180 -59.58 -61.27 8.2 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.958 -1.088 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 31.9 Cg_endo -69.49 -17.48 38.78 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.296 1.33 . . . . 0.0 110.669 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 47' ' ' ILE . . . -77.1 -25.95 52.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.483 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.412 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.7 m -82.98 -29.92 28.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 t -73.25 -41.85 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.669 0.747 . . . . 0.0 109.162 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' A' ' 44' ' ' LEU . 97.2 mt -71.97 -47.02 55.14 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.978 -0.451 . . . . 0.0 110.587 -179.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' ' 45' ' ' LYS . 12.2 p -59.07 -28.92 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -44.22 70.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.648 -0.657 . . . . 0.0 110.011 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -66.67 -59.68 3.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.484 -0.76 . . . . 0.0 110.013 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -57.61 -22.14 43.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 110.499 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.2 t -59.13 -40.91 86.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.277 -0.89 . . . . 0.0 109.719 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -69.05 -26.62 65.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.73 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.684 ' OH ' ' HB2' ' A' ' 76' ' ' ALA . 94.1 m-85 -89.82 121.6 32.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.64 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.36 -18.84 63.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.691 -0.631 . . . . 0.0 110.089 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.8 148.46 25.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.212 -0.93 . . . . 0.0 109.848 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -89.78 92.05 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.728 HG12 ' CB ' ' A' ' 65' ' ' ALA . 17.0 m -91.69 120.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -117.7 134.22 55.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.972 HD11 HD12 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -89.5 145.59 25.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.05 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -118.38 129.11 55.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.397 -0.815 . . . . 0.0 110.084 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.443 ' CD2' HG12 ' A' ' 55' ' ' ILE . 54.1 t80 -160.33 141.42 12.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.533 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.79 33.78 17.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.545 -0.722 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.76 30.16 74.19 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -125.32 175.29 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.626 -0.926 . . . . 0.0 108.989 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.5 m -148.65 101.2 3.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.11 146.49 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.644 -0.66 . . . . 0.0 109.227 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -70.22 140.82 52.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 26' ' ' ALA . 6.8 tp -62.85 -15.51 54.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.203 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HA ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -88.26 49.68 1.84 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 50' ' ' VAL . 7.0 t -150.07 90.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.696 HG23 ' HB3' ' A' ' 19' ' ' ALA . 32.1 mt -71.43 -45.48 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.824 -0.548 . . . . 0.0 109.773 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ttt -66.17 -27.22 67.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.771 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.91 -37.15 51.04 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 46' ' ' SER . 41.5 t -65.56 -35.8 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.516 -0.991 . . . . 0.0 109.45 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.72 -29.3 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.493 -0.754 . . . . 0.0 109.655 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.0 p -62.76 -33.09 74.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.566 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mp -74.55 -55.01 6.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.489 -0.757 . . . . 0.0 109.277 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.03 64.99 2.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.628 HD12 ' HB ' ' A' ' 14' ' ' ILE . 15.2 mt -74.5 162.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.97 . . . . 0.0 109.165 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -136.33 -172.04 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.579 -0.7 . . . . 0.0 109.746 -179.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 142.92 38.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.58 8.03 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.94 166.91 17.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.567 -0.961 . . . . 0.0 109.434 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.25 123.03 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.618 -0.677 . . . . 0.0 109.462 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.972 HD12 HD11 ' A' ' 35' ' ' LEU . 29.9 pt -113.87 138.68 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.551 -0.718 . . . . 0.0 109.366 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.09 108.73 19.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.762 . . . . 0.0 109.692 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.716 HG12 HD12 ' A' ' 35' ' ' LEU . 86.7 mt -93.27 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -150.08 106.45 3.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.638 -0.664 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.728 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -89.99 124.99 35.23 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 108.93 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.439 -0.788 . . . . 0.0 109.831 -179.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.55 -142.44 6.37 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.53 -63.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.991 . . . . 0.0 109.381 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -97.63 41.21 1.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.662 -0.648 . . . . 0.0 109.334 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -49.15 78.12 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.659 -0.65 . . . . 0.0 110.794 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.519 ' HA ' HD21 ' A' ' 74' ' ' LEU . 3.4 m120 -60.89 -36.4 79.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.156 -0.965 . . . . 0.0 109.983 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.3 -22.88 60.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.587 -0.696 . . . . 0.0 110.651 -179.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.748 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -80.04 -48.04 13.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.925 . . . . 0.0 110.852 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.742 HD12 ' N ' ' A' ' 75' ' ' ASN . 3.4 pp -60.65 -45.05 95.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.304 -0.872 . . . . 0.0 110.857 -178.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.742 ' N ' HD12 ' A' ' 74' ' ' LEU . 21.1 p-10 -68.87 -27.34 65.72 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.251 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.684 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . . . -63.75 -54.7 31.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 108.758 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -63.05 -28.72 70.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.643 -0.661 . . . . 0.0 109.783 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -62.31 -53.99 47.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -60.31 -27.9 67.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.813 . . . . 0.0 109.922 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.0 m -71.54 -33.79 69.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.4 mmm -71.66 -31.82 67.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -82.12 -21.37 36.71 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.615 -0.678 . . . . 0.0 110.155 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.0 p -59.54 -40.28 86.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.335 -0.853 . . . . 0.0 109.972 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -111.76 -50.74 2.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.575 -0.703 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.03 54.29 0.19 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 86' ' ' LEU . 84.6 mt -85.56 -63.6 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.595 -0.944 . . . . 0.0 109.608 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 118.82 1.14 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.463 179.91 . . . . . . . . 1 1 . 1 stop_ save_